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Food processing at low temperatures has many advantages as it minimises 
undesirable chemical reactions as well as lowers the risk of microbial contamination, which 
is higher when processes are carried out at higher temperatures. Cold adapted enzymes have 
higher catalytic efficiencies than their analogous mesophilic enzymes, allowing the use of 
lower concentrations, which subsequently can be inactivated by relatively low heat 
processing and therefore reduce heat consumption. Consequently, cold adapted enzymes are 
becoming increasingly important and can help considerably in developing clean label foods 
and sustainable processes.  
Whey protein is incorporated in a variety of foods and beverages due to its proven 
beneficial effects on bone health, improved cognitive performance and even prevention of 
cancer. These whey protein hydrolysates (WPH) are produced by enzymatic digestion 
followed by heat inactivation of active enzymes. There is high market demand for cold-
adapted and thermolabile exopeptidases that could be inactivated at <50°C, following WPH 
production. Low temperature inactivation of active peptidases is essential to overcome the 
high-temperature-induced gelling of the resulting WPH peptides and successive loss of 
commercial product. Additionally, exopeptidases shape the resultant flavour profile of the 
WPH product, by eliminating terminal hydrophobic amino acids responsible for bitterness 
effect.   
The aim of this work was to understand the fundamental structure-function 
relationships underpinning the thermal properties of a protease enzyme. The main focus was 
toward engineering the thermolability of leucine aminopeptidase A (LapA), a glycoprotein 
originating from Aspergillus oryzae. To this end, a recombinant expression platform, 
utilizing P. pastoris X33 yeast strain for secretory expression of LapA into culture 
supernatant, was created. The thermolability engineering strategy, developed in the course 
of this work, was successfully tested using LapA. By reducing the number of rigidifying 
residues and/or intramolecular interactions, site-directed mutants were found that showed a 
50% decrease in half-life at 60 °C, compared to wild-type protein. These thermolabile 
mutants displayed comparable specific activity and kinetic parameters to the wild-type 
enzyme and maintained their structural and functional integrity.  
In addition, three dimensional structures of the wild-type LapA precursor and mature 
protein were solved during this work, which are the first of their kind. These structures have 
provided a detailed understanding of the potential role for the LapA pro-domain in pre-
mature inactivation and its role as an intra-molecular chaperone in LapA proteogenesis. 
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Furthermore, high resolution structures for six LapA thermolability mutants were 
determined, which helps provide a deeper structural understanding of highly compromised 
thermostability for these mutants.  
This work embodies a novel structure-to-function approach to unconventional 
engineering of thermal lability of industrially relevant peptidases and lays essential 









Environmental conditions on earth’s biosphere present different challenges to 
microorganisms. The temperatures encountered, over a variety of biotopes, spans from -80 
°C in Antarctic regions up to >100 °C in volcanic hot springs. A certain genus of bacteria 
and archaea have evolved to thrive in such harsh conditions. These are referred to as 
extremophiles. As such, extreme temperature, salinity, pressure, and pH are absolutely 
tolerated by respective extremophilic microorganisms. Very specific adaptations, at the 
molecular level, ensures the survival of such microorganisms under various environmental 
stress conditions (Demirjian et al., 2001).  
Adaptations of enzymes play a crucial role in withstanding thermal extremes. Optimization 
of protein activity and stability is the key element in maintaining appropriate cellular 
functions at very low or high temperatures (Cavicchioli et al., 2002). With regard to 
temperature, some enzymes have been isolated from organisms viable between 80-100 °C. 
Thermus aquaticus –a famous source organism of the first thermostable DNA polymerase - 
was first found in several of the Yellowstone National Park hot springs (Brock and Edwards, 
1970). Thermo- and hyperthermophiles are adapted to thrive in the range of 60-80 °C and 
>80 °C, respectively (Vieille et al., 1996). In response to the high thermal motion, 
thermophilic enzymes have evolved exceptional stability and intrinsic structural rigidity, 
leading to inherent low activity at low-to-moderate temperatures (Merz et al., 2000).  
At the other extremity of the biological temperature scale, there are organisms living at 
temperatures ranging from -20 °C to 20 °C, with optimal growth temperatures ≤15 °C  
(Deming, 2002, Morita, 1975). These are collectively called psychrophiles. There is also a 
sub-group referred to as psychrotolerant organisms, able to grow at low temperatures, but 
with optimal growth in the range of 20-35 °C (Bowman and McCuaig, 2003).  
The bulk of the earth’s biosphere is cold (<5 °C) and inhabited by psychrophiles (Siddiqui 
et al., 2013). Such mean temperatures are linked to the fact that 70% of the surface of our 
planet is covered by oceans where, due to its physical properties, the bulk of water maintains 
a temperature of 4 °C. In addition, permafrost soils occupy another 20% of earth’s terrestrial 
surface (Feller, 2010). A variety of microorganism species have been discovered, at 
seemingly inhabitable biotopes, such as porous rocks in Artic dry valleys (-60°C), brine 
veins between polar sea ice crystals (-20 °C) and super-coiled cloud droplets (Vaitilingom 
et al., 2010, Feller, 2010). If one takes into account eukaryotic species that find niches in 
cold environments, then psychrophiles can be concluded to be the most abundant 
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extremophiles on earth. Interestingly, psychrophilic bacteria exhibit the ability to maintain 
reaction rates, comparable to their mesophilic counterparts at higher temperatures, and it is 
worth noting that doubling times at 4 °C for certain cold-adapted strains have been 
demonstrated to compare with those of E. coli at 37 °C (Pomeroy and Wiebe, 2001, Feller 
and Gerday, 2003).     
Despite the significant variety of cold-adapted microorganisms in the biosphere, their 
survival strategies, their functioning at the cellular and even molecular level, as yet, remains 
poorly understood, compared to their mesophilic and thermophilic counterparts. In recent 
decades, it has been discovered that, primarily, cold adaptation is associated with enzymes 
that function effectively at low temperatures (Smalas et al., 2000, Georlette et al., 2004). 
However, other adaptive traits have also been identified, such as increased membrane 
fluidity (Russell, 1997) and expression of cold-shock and antifreeze proteins (Michel et al., 
1997, Muryoi et al., 2004).  
 
1.2 Protein synthesis and folding in psychrophiles 
For a long time, protein synthesis and folding at low temperatures were considered as 
requiring specific adaptations and possessing constrains in these temperature-sensitive 
processes (Araki, 1991, Hebraud and Potier, 1999). Only recently have these challenges been 
projected to the level of proteomics and transcriptomics (Casanueva et al., 2010, Piette et al., 
2011), which have yielded contrasting patterns in cold adaptation (Watanabe et al., 2012, 
Rodrigues et al., 2008). However, some general trends have emerged: 
Translation. It appears that protein synthesis may be a rate-limiting step in cold-adapted 
bacteria e.g. the Antarctic bacterium P. haloplanktis was shown to devote 30% of its 
upregulated proteins at 4 °C to protein synthesis (Piette et al., 2010).  
Protein folding. The over-expression and trigger of chaperonins (e.g. TF – ribosome bound 
trigger factor) was observed in cold-adapted microorganisms (Qiu et al., 2006, Kawamoto 
et al., 2007). 
Proline isomerization. This is an important aspect of polypeptide folding in psychrophilic 
proteins. Since proline isomerization is a rate-limiting step for folding of most proteins 
(Baldwin, 2008), at low temperatures this process should become even slower. Thus, cold-
adapted polypeptides exhibit reduced proline content (Feller and Gerday, 2003). The 
observed over-expression of prolyl isomerases in psychrophilic bacteria further supports the 
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evidence for the requirement to accelerate protein folding in psychrophiles (Zheng et al., 
2007, Goodchild et al., 2004).          
 
1.3 Biocatalysis at low temperatures 
Extreme temperatures present different challenges to proteins: a low-temperature 
environment increases viscosity and, due to insufficient kinetic energy, enzymatic activation 
barriers are difficult to overcome, which remarkably reduces reaction rates (Siddiqui et al., 
2013). The latter can be decreased 30- to 80-fold when the reaction temperature is lowered 
from 37 °C to 0 °C (Ermak and McCammon, 1978).  
The catalytic constant kcat defines the turnover rate at which the maximum number of 
substrate molecules are converted to product, per active site per unit of time. The temperature 
dependence of chemical reactions is commonly described by the Arrhenius equation: 
kcat = Ae -Ea/RT 
where kcat is the catalytic rate constant, A is the pre-exponential factor; Ea is the activation 
energy (which is also written as ∆G#), R is the gas constant (8.314 kJ mol-1 K-1) and T is the 
absolute temperature. Consequently, even a small reduction in temperature will cause an 
exponential decrease in the reaction rate. 
One of the main characteristic features of psychrophilic enzymes is the shift of the apparent 
optimal T with a concomitant decrease in stability. Cold-adapted enzymes compensate for a 
shortage of kinetic reaction energy by increasing the catalytic rate, which can be up to 10-
fold higher compared to heat-stable orthologs (Siddiqui and Cavicchioli, 2006). An increase 
in catalytic rates arises from the decrease in the activation energy barrier, in catalysed 
reactions (Figure 1.1). 
The following calculation for activation energy (∆G#) stems from the well-known Gibbs free 
energy equation: 
∆G# = ∆H# - T∆S#,  
where ∆G# is the change in activation energy, ∆H# is the change in activation enthalpy, ∆S# 
is the change in activation entropy, and T is absolute temperature. This equation suggests 
that in order to decrease the activation energy one needs either to make the activation 
enthalpy more negative or the activation entropy more positive. Cold-adapted enzymes 
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proceed with low enthalpy change (this is, in fact, primary kinetic adaptation in 
psychrophilic enzymes), which is structurally achieved by a requirement to disrupt less 
enthalpy-driven interactions within the active site during the activation process (Low et al., 
1973, Feller and Gerday, 2003). These interactions are required to be broken during the 
formation of the transition state from the ground state substrate.    
Psychrophilic enzymes achieve higher kcat rates by decreasing the activation free energy 
(∆G#) barrier between the ground state (substrate) and the transition state (TS#) - enzyme-
substrate complex (ES*) (Figure 1.1). Also, the figure represents the evolutionary adaptive 
drift of psychrophilic enzymes towards lowering affinity for the substrate (higher Km), which 
contributes to the increase in reaction rates. Transition state theory implies that when the 
enzyme meets the substrate, the enzyme-substrate complex (ES) falls into the energy pit. 
The ES* activated transition state has to be achieved before the reaction can complete 
yielding enzyme and product. As can be seen in Figure 1.1, cold-active enzymes encounter 
a less deep energy pit due to their lower affinity for the substrate. Thus the magnitude of the 
energy barrier is reduced, yielding higher catalytic activity.  
Figure 1.1 Optimisation of activity by decreasing substrate affinity in cold-adapted 
enzymes.  The energy pit is indicated by a red arrow. Weak substrate binding (dashed line) 
decreases the activation energy barrier for cold-adapted enzymes (∆G#psychro) compared to 
mesophilic counterparts (∆G#meso). Adapted from (Feller, 2013). 
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Indeed, cold-adapted enzymes are often characterised by increased Km values i.e. reduced 
affinity for the substrate. This phenomenon is associated with increased disorder of the 
enzyme-substrate ground state complex, which is a consequence of overall flexibility of the 
active site and the whole molecular edifice (Fields, 2001). Similarly, there is a trend toward 
decreased affinity for various ions, cofactors, inhibitors and reduced substrate specificity in 
cold-adapted enzymes (Davail et al., 1994, D'Amico et al., 2006, Okubo et al., 1999, Alvarez 
et al., 1998, Smalas et al., 2000). The evolutionary pressure of decreasing substrate affinity 
(Km) in order to maximise the reaction rates (kcat) has been well illustrated by the examples 
of lactate dehydrogenase from Antarctic fish (Fields and Somero, 1998) and cold-adapted α-
amylase (D'Amico et al., 2001). The decrease in the magnitude of ∆G# is also related to the 
decrease in ∆H# (contribution from intra-molecular interactions) leading to the increased 
flexibility of the structural elements forming the active site. This adaptation permits cold-
active proteins to outperform warm-adapted homologues at low temperatures.   
Figure 1.2 Temperature dependence on the activity of psychrophilic (blue) and mesophilic 
(black) protein homologues. Adapted from (Feller, 2013).
7 
 
Figure 1.2 illustrates how different functional enzyme classes adopt the same strategy in 
compensating for slow reaction rates at low temperatures by i) a significant increase in 
specific activity and ii) shift of Topt to lower temperature range and resulting heat lability. 
Although the catalytic rate of psychrophilic α-amylase is lower than its mesophilic 
homologue, thus cold adaptation for this enzyme can be considered as incomplete, 
suggesting potential to further increase the activity at low temperatures.   
 
1.4 Stability of extremophilic proteins 
Protein stability determinants reside within the folded conformation and network of 
molecular forces and interactions. The driving force for protein folding and the main 
determinant of protein stability is the hydrophobic effect. Once other residues are brought 
into contact, weaker molecular interactions (H-bonds, van der Waals) further modulate 
stability. Salt bridges, disulfide bonds, and aromatic interactions also contribute to increased 
rigidity. Structural factors such as the occurrence of glycine and proline residues are also 
involved, whereby the former allows large dihedral rotations along the alpha carbon, and the 
latter restricts dihedral angles of its own and preceding residues (Piette et al., 2011).  
To understand the origin of temperature adaptation and find ways to alter the thermal 
properties of enzymes, it is useful to compare the thermodynamic behaviour and temperature 
responses of protein orthologs along the temperature scale.  
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Figure 1.3 Thermal unfolding of 
extremophilic proteins. Thermograms of 
α-amylases and DNA ligases as recorded 
by DSC. Psychrophilic (blue), mesophilic 
(black), and hyperthermophilic (red) 
protein homologues. The stability 
domains are indicated by thin black lines 
under the curves of meso- and 
thermophilic proteins. Adapted from 
(Georlette et al., 2003, D'Amico et al., 
2001) 
 
Microcalorimetric studies indicate the effects of thermally induced unfolding of proteins 
adapted to distinct temperatures.  In Figure 1.3, the area under the curve reflects the amount 
of heat absorbed during unfolding. It is evaluated by calorimetric enthalpy - ∆Hcal, which 
tends to decrease going from thermophilic-to-psychrophilic proteins. The transition for 
psychrophilic proteins is sharp and symmetric as opposed to its meso- and thermophilic 
counterparts. This relates to the low stability of the psychrophilic protein fold and indicates 
the cooperative mode of unfolding, whereby fewer intermolecular interactions results in 
lower stability and causes pronounced unfolding. Whereas, thermophilic proteins undergo 
stepwise denaturation and resist unfolding with various intermediate unfolded states arising 
(Georlette et al., 2003, D'Amico et al., 2001).  
The flexibility of protein in solution is best described as fluctuations of larger populations 
of conformers. These conformational transitions are very complex, involving backbone and 
side chain motions, including but not limited to bond rotations, stretching and torsional 
motions (Feller, 2010). Thus, determination of these vast parameters (comprising flexibility) 
can be further complicated. However, the permeability of protein structure can serve as a 
great flexibility indicator as was shown by fluorescence quenching experiments with 
extremophilic proteins (D'Amico et al., 2003, Collins et al., 2003). The reported permeability 
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study (Figure 1.4) investigated three structurally homologous α-amylases (α-amylase from 
Pseudoalteromonas haloplanktis (AHA) is the best characterized psychrophilic enzyme 
isolated from an Antarctic bacterium). The quencher – acrylamide – was used to measure 
the accessibility of tryptophan across the protein molecule and, more specifically, its ability 
to penetrate the structure is a good indication of protein permeability. The nature of the 
flexible protein backbone of the psychrophilic homologue allows the quencher molecule to 
penetrate with a higher propensity, while the more compact meso- and thermophilic α-
amylases both display a lower extent of permeability and thus flexibility.  
 
Figure 1.4 Permeability of homologues of α-amylases at room temperature, as estimated by 
fluorescence quenching. Psychrophilic protein (blue), mesophilic (black), thermophilic 
(red). The larger intrinsic fluorescence attenuation (F0/F) and the steep slope for the 
psychrophilic protein indicate that the acrylamide can easily permeate the structure. Adapted 
from (Feller, 2013).    
The apparent differences in structural flexibility across thermally adapted proteins are further 
supported by neutron scattering experiments (Tehei et al., 2004). Since neutron wavelengths 
and energies match protein motion amplitudes and frequencies, neutron spectroscopy allows 
quantification of macromolecular dynamics, including thermal motion. Using this technique, 
the decrease in intramolecular rigidity and enhanced dynamics were again confirmed in 
psychrophilic proteins (Tehei et al., 2004).  
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1.5 Structural characteristics of psychrophilic enzymes    
In the course of evolution, psychrophilic enzymes developed a spectrum of adaptive 
properties in order to maintain their intramolecular flexibility. Individual studies and 
exhaustive comparisons with mesophilic and thermophilic homologues revealed a number 
of structural adaptations of psychrophilic proteins. For example, local mobility is provided 
by clustering glycine residues (Kulakova et al., 2004, Mavromatis et al., 2002); the flexibility 
within the secondary structure elements is achieved by reducing the number of proline 
residues in the loops joining these elements (Sakaguchi et al., 2007). Prolines are 
highlighted, particularly as an increased number of proline residues decreases the 
conformational entropy of the unfolded state (more than the folded state) and thus reduces 
the force of entropy-driven unfolding. Proline residues restrict their own dihedral angles and 
that of the preceding residue and, therefore, reduce the conformational freedom at this 
location of the polypeptide chain (Arnorsdottir et al., 2007). There are several factors that 
influence thermolability of psychrophilic enzymes. For example, psychrophilic enzymes 
exhibit a reduced number of aromatic interactions, H-bonds and salt bridges (seen in a lower 
content of arginine residues, which can form multiple electrostatic interactions) compared 
to mesophilic proteins (Smalas et al., 1994, Xie et al., 2009, Siddiqui et al., 2006). 
Furthermore, since the hydrophobic effect is mainly responsible for compactness of structure 
within the protein core, psychrophilic proteins soften this effect by reducing the size and 
relative hydrophobicity of nonpolar residue clusters (Saelensminde et al., 2009). Cold-
adapted proteins incorporate larger cavities in their interior with more water molecules 
embedded. There are several other factors such as; stabilising metal cofactors, such as 
calcium, are bound by affinity several orders of magnitude lower compared to mesophilic 
enzymes (Davail et al., 1994, Feller et al., 1994); disulphide bridges, stabilising tertiary 
structure, are sometimes dismissed in psychrophilic proteins (Siddiqui et al., 2005b, 
D'Amico et al., 2002b); in certain cold-adapted proteins an increase in the number of surface 
exposed nonpolar residues is observed, which is entropy-driven destabilising factor 
(Aghajari et al., 1998, Russell et al., 1998, Georlette et al., 2003); more acidic pI values are 
observed for cold-adapted proteins, which is apparently linked to their more extensive 
network of surface exposed negatively charged residues providing improved interactions 
with solvent and resulting in essential flexibility at close-to-zero temperatures (Feller et al., 
1999); and finally, improved dynamics of the external shell of psychrophilic proteins appears 
linked to their lower content of arginine-mediated surface ion pairs, where the number of 
electrostatic interactions clearly rises going from psychrophilic to hyperthermophilic 
proteins (Vetriani et al., 1998, Yip et al., 1995). The thermostabilizing effect of arginine 
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guanidinium groups was demonstrated with psychrophilic AHA protein, whereby lower 
lysine-to-arginine ratio was attributed to cold-adaptation of this enzyme (Siddiqui et al., 
2006).  
All of these structural attributes are not found in every psychrophilic enzyme but, rather it 
appears that individual enzymes adopt their own combination of structural adaptations to 
function at low temperatures and there is no universal solution to achieve the localized or 
overall flexibility within a molecular scaffold. Importantly, this also implies that there are 
multiple routes for any protein system to achieve cold adaptation.  
Figure 1.5 illustrates the weakened intramolecular interaction network within a 
psychrophilic homologue of α-amylase, which contributes to flexibility and dynamics of the 
protein backbone that is required for cold adaptivity.  
 
Figure 1.5 Structural superimposition of psychrophilic (blue) and mesophilic (red) 
homologous α-amylases. Left: overlay of the active site residues; substrate analog, chloride 
and calcium ions are indicated in yellow, green and blue, respectively; the 24 residues 
forming direct or water-mediated interactions superimpose almost identically, suggesting 
that determinants of cold adaptation are lying outside the active site center. Right: the 
mutation N150D disrupts a salt bridge with the corresponding Lys side chain in the cold-
adapted protein. The mutation V196F disrupts a triple face-to-edge aromatic interaction. 
Mutant K300R results in a monodentate coordination of the chloride ion, instead of a 
bidentate coordination by Arg in the mesophilic protein, as demonstrated by the crystal 
structure of the single mutant (Aghajari et al., 2002). Mutations T232V and Q164I decrease 
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the apolarity of the hydrophobic core clusters in the psychrophilic enzyme and the double 
mutation Q58C/A99C eliminates a disulfide bond. Adapted from (Cipolla et al., 2011).  
 
Also, thermolability and low temperature activity can be achieved via very subtle 
cooperative action of long loop insertion and stabilization of an ordered water molecule 
chain in the vicinity of the active, as demonstrated for the psychrophilic β – glucosidase 
(BglU) enzyme (Miao et al., 2016). A single H299 residue (stabilizing ordered waters) was 
attributed to active site heat lability of this protein. Also, in the following mutational study 
of BglU, lower contents of Pro, Arg and Glu were shown to contribute to the determined 
psychrophilic properties of this enzyme (Miao et al., 2017).       
Some very unique cold adaptation determinants also have been found in eukaryotic proteins. 
A seven amino acid stretch was shown to confer cold adaptivity and required flexibility of 
the cytosolic C-terminal region of the transport protein in Antarctic icefish (Chionodraco 
hamatus). Moreover, upon translocation of this region (VDMSRKS) to a mesophilic 
ortholog protein, the recipient gained cold adaptation (Rizzello et al., 2013). 
 
1.5.1 Activity-flexibility-thermolability relationships    
The catalytic activity of enzymes generally involves ‘breathing’ movements, upon 
accommodation of the substrate associated with conformational changes in the protein 
structure. The catalytic efficiency, at a given temperature, is governed by the ease of these 
movements. In fact, the enzyme needs to establish a proper balance between rigidity, which 
allows the enzyme to maintain the required conformation to keep the substrate in place and 
flexibility, which enables the enzyme to carry out its function (Jaenicke, 1991a, Jaenicke, 
1991b). A low-temperature environment presents higher viscosity and low kinetic energy of 
the molecules. Thus psychrophilic proteins tend to increase plasticity and reduce the number 
of interactions within their molecular edifice. The acquired flexibility along with lowered 
affinity for the substrate determine the increased catalytic rates of cold-adapted proteins 
(D'Amico et al., 2001). The concomitant heat lability of psychrophilic proteins is a result of 
attained local and global flexibility within the molecular scaffold. In principle, this would 
imply that destabilisation of a heat stable protein molecule, via disruption/weakening of the 
intramolecular interactions, would allow one to engineer a thermolabile enzyme.
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Numerous directed evolution experiments have revealed that when mutant libraries are 
created, to screen for improved activity at low temperatures (no other evolutionary 
constraints applied), the best mutant candidates display the canonical properties of 
psychrophilic enzymes (D'Amico et al., 2002a). Random mutations improving both stability 
and activity are rare as shown by examining hundreds of mutants (Cherry et al., 1999, Giver 
et al., 1998). Consequently, it seems that from an evolutionary point of view the most 
frequent and accessible event to improved catalytic activity at low temperatures would be 
the loss of thermal stability.    
The positive correlation between cold-activity and heat-lability was also challenged by 
concluding that there was a lack of selective pressure for stable proteins such that instability 
of these proteins is a result of genetic drift in natural evolution (Wintrode and Arnold, 2000). 
However, this situation most likely is more complicated, as nature created multi-domain 
cold-adapted enzymes that contain a heat-labile catalytic domain and a mesophilic-like 
(more stable) non-catalytic domain (Claverie et al., 2003, Lonhienne et al., 2001). Thus, it 
is unlikely that genetic drift is the dominant factor for different domains in the same protein. 
In contrast, heat-stable enzymes from thermophilic organisms are known to be less active at 
low temperatures and acquire larger values of activation entropy and enthalpy (D'Amico et 
al., 2003). Therefore, an inverse correlation between substrate turnover at low temperatures 
and molecular rigidity of thermophilic proteins is apparent. This signifies the stability – 
activity trade – off evolved in hot-adapted enzymes.     
1.5.2 Activity-stability trade-off and active site flexibility in psychrophilic 
enzymes  
Previous observations can be summarised in a single activity-stability trade-off model. 
Psychrophilic proteins show high intrinsic activity at low temperatures at the expense of 
reduced stability (hence thermolability). While the increased stability and structural rigidity 
in thermophilic proteins results in diminished catalytic rates at similar temperatures. 
Thermolabile and cold-active α – amylase (AHA) was demonstrated to display localised 
active site flexibility, which is attained via unfavourable active site geometry that also 
promotes higher activity (Siddiqui, 2017). A flexible active site bearing unfavourable 
interactions permits more effective binding of the transition state (TS#). Competitive 
inhibitors mimicking the transition state were shown to significantly improve the 
thermostability (Tm: from 44 to 61 °C) of highly active AHA, thereby binding to residues 
via favourable interactions. The thermophilic homologue from B.amyloliquefaciens showed 
14 
 
no improvement in Tm upon inhibitor binding, because the active site pocket is already 
optimized for higher stability at the expense of activity (Siddiqui et al., 2005a). Therefore, 
the thermal lability the active sites of cold-adapted enzymes stems from highly flexible 
geometry as a result of fewer enthalpic interactions. The pronounced active site heat lability 
can be exploited in engineering mesophilic enzymes towards inactivation at lower 
temperatures.             
1.5.3 The folding funnel model 
Integrated kinetic, structural and biophysical data from enzymes adapted to extreme 
temperatures has been summarized by a model based on folding funnels (D'Amico et al., 
2003). Activity-stability relationships and energy landscapes of psychrophilic and 
thermophilic enzymes can be described using these models (Figure 1.6). In general, the 
model represents folding-unfolding events in psychrophilic and mesophilic proteins. The 
height of each funnel (free energy of folding) corresponds to the conformational stability 
(which is lower in psychrophilic enzymes). The upper edge of the funnel is occupied by the 
unfolded state (random coil) conformations. This edge in psychrophilic proteins is slightly 
longer due to the larger distribution of unfolded states. Upon the folding event of protein, 
the level of free energy decreases along with the size of the conformational ensemble 
(represented as the funnel narrowing). The bumpiness of the funnel edges for thermophilic 
proteins corresponds to intermediate folding-unfolding states, resembling local energy 
minima. In contrast, the conformational states of psychrophilic protein appear to unfold in a 
cooperative fashion, representing no unfolding intermediates (also see Figure 1.3). This is 
linked to a lower number of stabilizing interactions and the absence of stable domains. As a 
result, the edges of the funnel are smooth for psychrophilic proteins. The bottom of the 
funnel corresponds to the stability of the native state ensemble, and it also displays the 
significant difference between the two extremophilic enzymes. The bottom of the rigid 
thermophilic enzyme can be characterized as a single global minimum or as having only a 
few minima with relatively high energy barriers between them (Kumar et al., 2000, Tsai et 
al., 1999). The rugged bottom observed for unstable psychrophilic enzymes represents a 
large population of interconverting conformers with low energy barriers. Thus, the rigidity 
of the native state is directly correlated to the energy barrier height. This is in agreement 
with the results of the fluorescence quenching (Figure 1.4) and neutron scattering 
experiments discussed earlier (Tehei et al., 2004). In this context, the activity-stability 
relationship in these extremozymes depends on the properties of the base of the folding 
funnel. Indeed, it has been argued that upon substrate binding to the association-competent 
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sub-population, the equilibrium between all conformers is shifted towards this sub-
population, leading to the active conformational ensemble (Kumar et al., 2000, Tsai et al., 
1999). In the case of the rugged bottom of the folding funnel of psychrophilic enzymes, this 
equilibrium shift only requires a modest free energy change and a low enthalpy change for 
inter-conversion of the different conformations of the numerous conformational isomers 
existing in the wide conformer ensemble. The low energy barriers across a spectrum of 
micro-states would result in an overall decreased activation energy and a high kcat. Moreover, 
the increased flexibility would cause the cold-adapted enzyme to spend more time in 
conformations that are not optimal for substrate binding and result in a high Km (Somero, 
2004).  
 
Figure 1.6 Folding funnel model of extremophilic proteins. These schematic energy 
landscapes represent the plot of the free energy of folding (E) versus conformational 
diversity. The height of the funnels relates to conformational stabilities, the top of the funnels 
– unfolded states in random coil conformations, bottom – native and catalytically active 
conformations. The ruggedness of the bottom corresponds to energy barriers for 
interconversion indicative of the structural fluctuations of the native state. Adapted from 
(D'Amico et al., 2003).      
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1.6 Cold-adapted thermolabile proteases 
There are only a few cold-adapted proteases that have been structurally and functionally 
characterised. With respect to known exopeptidases, the well-described aminopeptidase 
from Colwellia psychrerythraea (ColAP) displays common features of psychrophilic and 
thermolabile enzymes (Bauvois et al., 2008, Huston et al., 2008). The comparison with its 
mesophilic homologue, human leukotriene A4 hydrolase, revealed that Tm values were at 
least 15 °C lower and kcat were 8-fold higher for ColAP, yielding lower thermal stability and 
higher specific activity of the psychrophilic enzyme. Structural permeability studies by 
fluorescence quenching also identified ColAP as exhibiting more permeable compared to its 
mesophilic homologue. A lower number of proline residues, ions pairs, and buried 
hydrophobic residues were identified as the main structural determinants of weak 
conformational stability and thermolability for ColAP (Huston et al., 2008).  
By contrast, known cold-adapted endoproteases are extremely well represented in the 
literature. One of the first insights into the determinants of cold adaptation came from studies 
of subtilisins S39 and S41 secreted by psychrophilic Bacillus (Narinx et al., 1997, Davail et 
al., 1994). Mutagenesis of subtilisin S39 and, in comparison to Subtilisin Carlsberg, showed 
three orders of magnitude lower affinity for calcium and a higher number of Asp residues in 
loops for the psychrophilic homologue (Narinx et al., 1997). Importantly, a single mutation 
T85D significantly increased the affinity for calcium and dramatically improved 
thermostability for S39, which was comparable to that of Subtilisin Carlsberg. This study 
highlights the importance of bound calcium ions for the thermal stability of subtilases. 
Similarly, subtilisin S41 was shown to be able to induce a more flexible and heat labile 
conformation due to four extended surface loops, which create a very hydrophilic surface 
(11 extra Asp residues) and a lower affinity for calcium, compared to the mesophilic 
Subtilisin Carlsberg (Davail et al., 1994). Another psychrophilic subtilase, termed P6, was 
isolated from Antartic bacteria in which Ala284 was identified as an important hot spot in 
the cold adaptation of mesophilic subtilases during laboratory evolution (Acevedo et al., 
2013).  
Some of the psychrophilic subtilases have evolved very diverse structural composition, 
particularly, eukaryotic homologous family members. The MCP-01 protease secreted by the 
deep-sea cold-adapted bacterium Pseudoalteromonas sp. SM9913 was reported to have a 
multi-domain architecture in contrast to the homologous S8 family members that are 
comprised of a single domain polypeptide. This protease, termed deseasin, displayed a 
catalytic region, a linker, a P-proprotein domain and a PKD domain, with only the catalytic 
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domain bearing a moderate degree of homology to the S8 family subtilases (Chen et al., 
2007).  
1.6.1 Engineering low-temperature activity and thermolability in hydrolases 
Highly flexible residues have a low number of contacts with other amino acids and produce 
a local perturbation inside the complex network of non-covalent interactions. They can 
trigger protein unfolding due to their large thermal fluctuations (Yu and Huang, 2014). 
Therefore, most of the below described cases of protein engineering aim to introduce a 
certain degree of local flexibility and counteract on rigid ‘hot spots’.  
In a recent study, Subtilisin Carlsberg (sC) was engineered to have increased thermolability 
(12-fold) and specific activity (1.5-fold) via a single P210G substitution in the β8-β9 turn 
region (Figure 1.7) (Fuchita et al., 2012). This region has been shown to display a higher 
abundance of proline residues in mesophilic and thermophilic subtilases. Interestingly, a 148 
amino acid insertion in the β8-β9 region is found in the subtilisin-like serine endoprotease 
from Shewanella sp. AS-11, which may introduce the required flexibility between the 
secondary structure elements in the cold-adapted enzyme (Dong et al., 2005). 
Figure 1.7 Structure of Subtilisin Carlsberg 
(pdb:3UNX). Active site residues are shown as 
sticks (grey), Pro210 in β8-β9 turn is shown in 
magenta, and calcium coordination sites are 
depicted as yellow spheres.   
 
Mesophilic subtilisin Savinase was engineered towards low-temperature activity and 
thermolability by inserting a highly flexible eight amino acid fragment from psychrophilic 
subtilisin TA39 (Tindbaek et al., 2004). This H5 hybrid displayed an increase in low-
temperature activity, a decrease in thermostability and, improved flexibility in both the 
substrate binding region and globally, as shown by molecular dynamics and DSC (Tindbaek 
et al., 2004).  
Subtilisin BPN` was engineered extensively to confer cold adaptation by in vitro random 
mutagenesis. The single V84I mutation was shown to slightly increase the activity of mutant 
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subtilisin BPN` in the 5-10 °C temperature range, but had no effect on the thermolability 
compared to the wild - typeenzyme (Kano et al., 1997). In a similar study, taking advantage 
of a directed evolution approach, cold adaptation of subtilisin BPN` was achieved through 
V72I, A92T, and G131D mutations, and the catalytic efficiency of the resultant mutant was 
found to be 100% higher at 10 °C (Taguchi et al., 1998b). Interestingly, the V72I mutation 
on its own had a significant effect on thermolability of subtilisin BPN`. However, the triple 
mutant (V72I+A92T+G131D) recovered the thermal stability. In addition, randomisation 
and saturation mutagenesis at position G131 identified a series of subtilisin BPN` mutants 
with improved proteolytic activities at 10 °C and conferred thermolability to varying 
degrees, revealing potential hot spots for cold adaptation in subtilisins (Taguchi et al., 2000). 
A saturation mutagenesis approach on identified rigid ‘hot spots’ in protein structure was 
also implemented for engineering proteins with increased thermolability. The lowest B-
factor residues (indicative of high rigidity) are selected for iterative saturation mutagenesis 
strategy, whereby the randomisation at every identified ‘hot spot’ produces large libraries of 
mutants requiring extensive screening. This approach has lead to destabilisation and 
significantly increased thermolability of lipase from Pseudomonas aeruginosa (Reetz et al., 
2009). The best mutant displayed a 20 °C decrease in inactivation temperature without 
affecting its catalytic performance.    
One of the other factors that have an impact on enzyme low-temperature activity is 
uncompetitive substrate inhibition. The industrial protease Savinase (Bacillus lentus) was 
used as a model to show that by chemically modifying the enzyme it was possible to increase 
its low-temperature productivity by sterically blocking the allosteric site, thereby reducing 
uncompetitive substrate inhibition (Siddiqui et al., 2009). 
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1.6.2 Identified strategies to achieve thermolability and cold-adaptivity  
Based on the literature review in previous sections, a number of strategies were identified in 
order to address the problem in this project. The desired thermolability with potentially 
added enhanced cold-activity properties in target enzymes can be mainly achieved in the 
following ways.   
Increasing overall conformational flexibility 
This can be achieved by reducing the number of intra-molecular interactions (electrostatic, 
covalent and hydrophobic), improving interactions with solvent (introducing more 
negatively charged surface residues, solvent-exposed apolar groups), reducing the number 
of surface salt bridges.   
Surface loop engineering – entropic approach 
Multiple studies indicate the importance of surface residues (particularly in loops) in 
defining the thermal properties of an enzyme. Restricted rotation around Cα – N bond in 
pyrrolidine ring of proline renders this residue to have the lowest conformational entropy 
(especially in unfolded state). In contrast, due to the missing β – carbon glycine shows the 
highest conformational entropy. To further destabilise the temperature – denatured state we 
can exploit these entropic residue effects.  
Proline residues were shown both to enhance the thermostability (when introduced in surface 
loops of psychrophilic proteins) and improve the thermolability (when eliminated from 
surface loops in mesophilic proteins). Therefore, a special emphasis will be given to proline 
residues in our mutagenesis strategy to confer local disorder. Several reports indicated that 
the unfolding process might be initiated from the disordered surface loop (Deng et al., 2014, 
Anbar et al., 2012).     
Enhancing thermal lability of the active site  
Since the main aim of this study is to inactivate the enzyme at low temperatures, mutations 
may be targeted to introduce local flexibility in the active site pocket, thereby distorting the 




Rigid cluster (‘hot spot’) engineering 
Intrinsic overall structural rigidity is a defining property of protein thermostabilisation. 
Therefore, identifying the rigid residues (‘hot spots’) defined by low B-factors in a crystal 
structure of the target protein may help to direct rational substitutions at these sites which in 
turn would confer localised or overall flexibility to protein structure.   
 
1.7 Industrial applications of cold-adapted enzymes 
Despite the enormous potential to reveal the diversity of biomolecules and bioprocesses 
occurring in psychrophilic organisms, which could have a significant impact in industrial 
applications, our understanding of the ecology, physiology, and enzymology of cold-adapted 
organisms still remains limited (Huston, 2008). The discovered and characterised 
psychrophilic microorganisms constitute only <1% of the total successful attempts (to isolate 
these) since the traditional isolation and cultivation laboratory methods are usually 
detrimental to these extremophiles (Giovannoni et al., 1990). Consequently, the existing 
diversity of biocatalysts from psychrophiles is under-represented. However, recent advances 
in metagenomics and high throughput sequencing allows researchers to bypass the 
cultivation step in order to isolate novel genes encoding unique biocatalysts (Huston, 2008).  
The biotechnological potential of these cold-adapted biocatalysts originates from their 
structural and thermodynamic properties: the inherent flexibility and low substrate affinity 
allow them to display higher kcat values in low-to-moderate temperatures, high 
thermolability at elevated temperatures and functionality in organic solvents (Cavicchioli et 
al., 2002, Margesin and Feller, 2010). Current industrial processes, utilising high-
temperature adapted enzymes, can benefit from substantial energy savings if more 
productive (at low temperatures) cold-adapted biocatalysts are employed. Thus, it was not 
too long before they found application in a variety of industries from household detergents, 
to molecular biology and baking (Cavicchioli et al., 2011). Industrial processes, sensitive to 
the occurrence of secondary reactions, heat-sensitive substrates or increased risk of 
microbial contamination, all benefit from reduced temperature biocatalysis (Jeon et al., 
2009). In food and feed industries, it is imperative to avoid harming or changing the 
nutritional value and flavour of the heat-sensitive substrates and products. Furthermore, 
selective inactivation at moderate temperatures by heat-labile enzymes permits controllable 
inhibition of sequential reactions at intermediate steps in the food industry (Cavicchioli et 
al., 2011).  
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1.7.1 Industrial application of cold-adapted proteases 
The market value of global enzyme sales was estimated to reach $6 billion by 2011, 
increasing by 7% annually (McCoy, 2001).  Proteases represent one of three largest groups 
of industrial enzymes and account for about 60-65% of global sales of enzymes, where 
alkaline proteases constitute 25% (Rao et al., 1998). The vast majority of commercial 
proteases (two-thirds) come from microbial sources, although the enzymes from plants and 
animals also are produced (Kumar and Takagi, 1999). Most of the neutral and alkaline 
commercial proteases originate from Bacillus sp. These proteases typically are active in the 
pH range 5-8, display broad substrate specificity, and are not very thermo-tolerant (Rao et 
al., 1998). 
Only in the last decade, the full potential of cold-adapted proteases (regarding catalytic 
capabilities at low temperatures and thermolability) has been recognised by a number of 
industries (Kuddus and Ramteke, 2012). Some industrial uses of proteases in the industry 
are discussed briefly below. 
Detergents 
Enzymes have been added to laundry detergents for over 50 years to remove proteinaceous 
stains. The very first protease incorporated in washing formulations was Alcalase (Subtilisin 
Carlsberg) back in 1960. 
The apparent benefits of cold washing are decreased energy consumption, protected colours 
and prolonged life of the fabric. Due to higher or equivalent efficiency of cold-adapted 
proteases (as opposed to warm-adapted analogues), the processing times become shorter 
which contributes to extra energy savings. The lack of stability within other detergents and 
chemicals in washing formulations limited the utilisation of cold-adapted enzymes in the 
final product (Kuddus and Ramteke, 2012). However, several suitable proteases were 
recently identified: cold active serine protease –CP70 (Flavobacterium balustinum) – has a 
temperature optimum 20 °C lower compared to the typical detergent protease – Savinase. It 
is also tolerant to a range of pH 6.5 – 10 and is resistant to surface-active/bleaching agents. 
The psychrophilic alkaline protease from Stenotrophomonas maltophilia also appeared as a 
potential candidate for improving future washing formulations due to its excellent stability 
and proteinaceous stain removal capabilities (Kuddus and Ramteke, 2009, Kuddus and 





Food companies are required to maintain low food processing temperatures to minimise 
undesirable chemical reactions and to reduce the chances of microbial contamination, both 
of which are more pronounced at elevated temperatures. In this regard, cold-adapted 
proteases find important use in a variety of food processing applications; accelerated 
maturation of cheese, treatment of beer (Margesin and Schinner, 1994), tenderization of meat 
and taste improvement of refrigerated meat (He et al., 2004). 
Molecular biology 
Heat-labile proteases could be used as inactivation agents to other catalytic enzymes once 
the desired reaction is complete, as demonstrated with hydrolysis of Taq polymerase 
mediated by thermolabile A9 protease (Moran et al., 2001). This permits to avoid PCR 
product purification step, which is time-efficient and cost-effective in recombinant cloning 
protocols.   
Textiles  
Cold-active enzymes have found numerous niches in the textile industry. These are used for 
fabric finishing, degumming threads of raw silk to remove sericin (a proteinaceous agent 
covering silk fibers) and modifying the surface of wool (Najafi et al., 2005, Kuddus and 
Ramteke, 2012).  
Bioremediation 
The advantages of high catalytic efficiency at low temperatures of psychrophilic proteases 
can serve a purpose in wastewater treatment, bioremediation of polluted soils and protein 
contaminate cold environments (Kuddus and Ramteke, 2012). 
Therapeutics 
ColdZyme® (Enzymatica AB, Lund, Sweden), a mouth spray, uses a cold-adapted protease 
from cod. It was shown to reduce the incidence of common cold and to suppress the 




1.8 Production of protein hydrolysates 
1.8.1 Protein enzymatic hydrolysis in functional food development  
Enzymatic hydrolysis of a vast array of protein isolates are known to be beneficial and 
significantly increase their functional properties and nutritional value. For instance, 
enzymatic hydrolysis forms a basis in the production of fermented soy products, which in 
turn display improved flavor and absorptivity properties (Sun, 2011). Due to reduced 
antigenicity of the resultant protein hydrolysates, they find use in peptide-based 
hypoallergenic infant formulas, hospital weight control, enteric and other therapeutic diets 
(Cordle, 1994, Adlernissen, 1977). Food-derived bioactive peptides (BAPs) have a potential 
to exert many beneficial, health-enhancing effects in vivo (Rutherfurd-Markwick, 2012). 
These naturally inaccessible oligomeric amino acid combinations are released by the 
hydrolytic action of proteases both in vivo and in vitro. Many biological functions have been 
ascribed to these food-derived peptides, such as antioxidant, antihypertensive (ACE 
inhibition), immunoregulatory properties (Najafian and Babji, 2014, Power et al., 2013).   
Controlling degree of hydrolysis (DH) becomes the key in an effort to reduce the bitterness 
in the resulting hydrolysates, which directly affects customer acceptance. Enzymatic 
debittering protocols utilizing exo- and endopeptidases can both improve the DH and bitter 
taste (FitzGerald and O'Cuinn, 2006). Therefore there is an ever increasing demand in the 
functional food industry for effective peptidase blends to produce bioactive, hypoallergenic, 
non-bitter tasting functional small molecular peptides.      
1.8.2 Enzymatic hydrolysis of whey protein 
Whey protein hydrolysates (WPH) due to their nutritional value have been incorporated into 
functional foods for several years. The WPH are used in infant formulae, sports nutrition 
products, clinical foods, instant beverages, weight management products and much more.  
Whey proteins have a high protein quality score and contain a relatively high proportion of 
branched-chain amino acids – Val, Leu, Ile (BCAA, 26%) (Bos et al., 2000). In this respect, 
the significant amount of leucine present in whey protein can be extremely beneficial, as 
leucine plays a key role in protein metabolism and the translation initiation pathway of 
muscle protein synthesis (Anthony et al., 2001).  
Enzymatic hydrolysis is usually the method of choice to produce WPH, as it is conducted 
under mild conditions thus retaining the nutritional quality. The resultant WPH display a 
high degree of hydrolysis and a variety of short peptides, which are less allergenic due to the 
destruction of allergenic epitopes (Siemensma et al., 1993). In the process of WPH 
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hydrolysis, a low content of free amino acids is preferred due to the absorbance differences 
in the intestine; a product with more di- and tripeptides will be absorbed more efficiently 
(Boza et al., 2000). To achieve such a digestion profile, endoprotease (e.g. Alcalase) is 
usually employed for prolonged hydrolysis of whey protein, ensuring the absence of free 
amino acids in the final product. One of the cornerstones in commercial production of 
hydrolysates is developing an enzyme mixture that produces the desired ratio of amino acids, 
di-, tri- and oligopeptides (Lahl and Braun, 1994). Production of hydrolysates, by the action 
of endopeptidases and exopeptidases, is considered the most effective way to obtain protein 
hydrolysates with defined characteristics (Clemente, 2000) (Figure 1.8).  
Figure 1.8 Hydrolysis of whey protein by the simultaneous action of endoprotease and 
exopeptidase enzymes. The bitter peptides containing C- or N-terminal hydrophobic amino 
acids are degraded by the specific action of exopeptidases. A hydrophobic amino acid is 
represented by blue hexagon. 
Bitterness of WPH 
In their natural state, proteins do not contribute chemically to the formation of flavour in 
foods. However, protein hydrolysates have an array of flavours. The industry faces a real 
challenge to try and reduce the bitterness of whey protein hydrolysates, which reduces 
customer acceptance. Bitterness is caused by peptides (>10 kDa) containing terminal 
hydrophobic amino acids such as Pro, Leu, Phe, etc. (Saha and Hayashi, 2001). The 
bitterness of protein hydrolysates is particularly undesirable in beverages.  
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Enzymatic de-bittering serves as the main tool to further process the WPH for flavour 
development. For example, soybean protein is incubated with Alcalase (Subtilisin Carlsberg) 
and the resultant bitter product is further hydrolyzed by Flavourzyme, yielding an improved 
taste profile with the reduced bitterness of the soybean polypeptide mixture (Ma et al., 2013). 
Flavourzyme is a fungal extract from Aspergillus oryzae containing two exopeptidases, 
namely LapA and Lap2, either of which can remove the N-terminal hydrophobic amino acids 
contributing to the pronounced bitter flavor of protein hydrolysates. On the other hand, the 
essiantial and bioactive amino acids are usually those containing hydrophobic and/or 
aromatic side chains. Therefore the segregation of these amino acids from small functional 
peptides may compromise their bioactive properties (Carreira et al., 2003).    
Inactivation of proteases 
From a practical point of view, when the desired characteristics of the hydrolysate have been 
achieved, the active endoprotease or/and exopeptidase need to be deactivated, preventing 
further hydrolysis (Conesa and FitzGerald, 2013). This is usually achieved by heat treatment 
causing thermal denaturation of previously active peptidases. Yet, upon heating various 
undesirable chemical (Maillard reaction products) and physical (peptide denaturation) 
effects have been observed. Hence, the biological, functional and nutritional properties of 
hydrolysates are affected by heat processing, and energy input must be minimised (Nicoli et 
al., 1997, Lijun et al., 2012). Therefore, this phase of the enzymatic WPH production is of 
significant importance to the food industry (Xue et al., 2012).  
Mesophilic proteins utilised in current formulations of commercial peptidase enzyme blends 
(e.g. Alcalase, Flavourzyme) require high temperature (>85 – 90 °C) treatment to achieve 
complete inactivation. To date, there are no reported alternative industrial formulations 
containing either cold – adapted or thermolabile peptidases for whey protein hydrolysis 
market.  
Gelation of WPH 
Upon heating (>70 °C) the mixture of WPI/WPC and proteolytic peptidases, the forming 
bioactive oligopeptides (WPH) along with partly hydrolysed globular proteins are 
susceptible to gelation. The mechanistic principle of the high temperature induced complex 
gelation process is not fully understood. Nonetheless, several models have been proposed, 
whereby formation of reactive -SH groups upon denaturation and aggregation were deemed 
to promote non-specific disulphide covalent linkages. Concomitantly, the aggregation, is 
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supported by hydrophobically interacting interpeptide networks (Oldfield et al., 1998). 
During the heating process, an unfolded form of β – Lactoglobulin 2 (β – Lg 2), abundant in 
whey protein, aggregates with α – Lactalbumin and κ – casein on the surface of the casein 
micelle (via the -SH group). The latter gelation effects were observed following WPI 
treatment with Alcalase and were attributed to hydrophobic interactions of β – Lg derived 2 
– 6 kDa peptides (Otte et al., 1997). These insoluble aggregates can also clog and damage 
heat exchangers, pasteurisation equipment vessels and form sediments in heated WPH 
mixture, spoiling the end product.             
 
In conclusion, there is a high demand in Industry for thermolabile endo- and exopeptidases 
that can be inactivated by mild heat treatment such that the beneficial properties and quality 
of the vegetable and whey protein hydrolysates are preserved. 
 
1.9 Importance of this project 
The industrial partner – Biocatalysts Ltd – is offering novel enzyme solutions for food and 
healthcare industries. Biocatalysts identified a commercial need to engineer proteases that 
can be inactivated <50 °C. Development of cold-active and thermolabile proteases, through 
protein engineering existing mesophilic variants (of, for example, Subtilisin Carlsberg, and 
Leucine aminopeptidase A), would allow the industry to benefit from improved properties 
of these enzymes. Advantages would include: increased catalytic rates at low and moderate 
temperatures (detergent industry, energy savings), thermolability (complete inactivation of 
the functional enzyme at moderate temperatures) and elimination of gelation of WPH at 
elevated temperatures.  
The need for combined endo- and exopeptidase activities for efficient hydrolysis of whey 
protein and flavour development influenced the selection of target enzymes in this project. 
Additionally, the knowledge gained in this project will contribute to fundamental 
understanding of protein engineering to affect the thermodynamic behaviour of protein in an 
unconventional way, specifically, increasing the thermolability and flexibility of the 




1.10 Target enzymes in this project 
Combining the interests from an industrial partner and our academic interest in fundamental 
structure-function approaches, it was agreed that one endoprotease and one aminopeptidase 
used in industry, will be selected for mutagenesis experiments in an effort to engineer more 
thermolabile enzymes.  
1.10.1 Subtilisin Carlsberg (sC) 
Subtilisin Carlsberg, a serine endoprotease with 274aa, is an extracellular enzyme produced 
by Bacillus licheniformis and belonging to the superfamily of S8_S53 proteases (BLAST). 
It is classified as a member of the superfamily of Subtilases: subtilisin-like serine proteases 
(Barrett and Rawlings, 1995, Rawlings and Barrett, 1994). Subtilisin Carlsberg is a single 
polypeptide protein displaying a characteristic alpha/beta subtilisin-like fold with a 7-
stranded parallel beta sheet (SCOP). The active site is composed of the classic 
D32/H64/S221 catalytic triad, where serine acts as a nucleophile, aspartate as an electrophile 
and histidine as a base. Two Ca2+ coordination sites are present in the active form, exhibiting 
different affinities for Ca2+ ions. Subtilisin Carlsberg is non-specific alkaline endoprotease, 
containing a binding surface channel that can accommodate at least six amino acid residues 
(Siezen, 1996). The temperature optimum for activity of wild-type sC is 60 °C in alkaline 
pH 7-10. Thermal deactivation is achieved at 80-85 °C in 5 to 10 minutes (data provided by 
Biocatalysts Ltd).   
1.10.2 Leucine Aminopeptidase (LapA) 
The other commercial enzyme that has been selected is LapA, which is an exopeptidase that 
catalyses the removal of an N-terminal amino acid from a polypeptide chain and, as the name 
implies, displays a preference for leucine. LapA originates from a eukaryotic fungus 
Aspergillus oryzae, and is present in the commercial A.oryzae peptidase extract – 
Flavourzyme. LapA was reported to display an optimal temperature at 60 °C and optimal 
pH of 8.5, while the enzyme was inactivated at temperatures >70 °C (Matsushita-Morita et 
al., 2011). LapA was predicted to have two glycosylation sites with the N-linked attachment 
of sugars. As extracellular LapA originates from a eukaryotic fungus, N-linked glycosylation 
probably plays an important role in the structure and/or function of this enzyme (Imperiali 
and O'Connor, 1999). The presence of disulphide bonds in LapA was also implicated to be 
important for the activity (Matsushita-Morita et al., 2011).  
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There is no crystal structure currently available for LapA. However, the closest structural 
homologue – leucine aminopeptidase from Vibrio proteolytica (AAP) shares 34% sequence 
identity with LapA (BLAST) (Figure 1.9).  
 
Figure 1.9 Crystal structure of leucine aminopeptidase from Vibrio proteolytica (AAP) 
(pdb: 1AMP). AAP is represented as a homodimer. The essential cofactors –Zn ions- are 
shown as grey spheres.  
The recombinant expression of this natively extracellular exopeptidase might result in the 
formation of inclusion bodies, as described in the protocols established for AAP (Hartley et 
al., 2009). Also, the N-terminal propeptide was shown to be a prerequisite for appropriately 
folded and functional AAP (Bzymek et al., 2004). Therefore, it is very likely that these same 
principals would apply to LapA such that the propeptide sequence should precede the mature 
sequence in any recombinant expression constructs of LapA.  
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1.11 Aims and objectives 
The aim of the present study is to engineer industrially relevant proteases to obtain 
thermolability and cold adaptivity. The two proteins of interest (to Biocatalysts) are LapA a 
leucine aminopeptidase from Aspergillus oryzae and Subtilisin Carlsberg sC from Bacillus 
licheniformis. Improved catalytic activities of these cold-adapted proteases at low and 
moderate temperatures would allow their replacement of thermostable equivalents in 
industrial whey protein digestion and would allow the company to use less active enzymes. 
Such cold-adapted proteases could offer a substantial energy savings during the production 
process. The added thermolabile character of these proteases would facilitate rapid and 
effective inactivation of proteolysis (at intermediate steps) and would prevent heat-sensitive 
protein hydrolysates from gelation.  
Specific objectives are to: 
• Identify structurally viable mutations, using the known crystal structure of 
Subtilisin Carlsberg, which may lead to improved thermolability.  
• Clone and express potential thermolabile mutants of Subtilisin Carlsberg and 
test for activity at low temperature.  
• Determine the three-dimensional structure of LapA using X-ray 
crystallography. 
• Identify structurally viable mutations, using the new crystal structure of 
LapA, which may lead to improved thermolability.  
• Implement the production of the best thermolabile mutants on a pilot scale at 













2.1 Sequence and structure bioinformatics  
2.1.1 Subtilisin Carlsberg (sC) from Bacillus licheniformis 
The sequences of pre-pro and mature sC were obtained from UNIPROT and Protein Data 
Bank (PDB), respectively. The accession codes were P00780 for the former and 1R0R for 
the latter.  
Pairwise and multiple sequence alignments were performed using the TCOFFEE 
(Notredame et al., 2000) sequence alignment package, making use of the MUSCLE 
algorithm (Edgar, 2004). The BLAST server from the National Centre of Biotechnology 
Information (NCBI) (Altschul et al., 1997) was employed in order to determine homologous 
proteins.  
The lowest B-factor values, as determined in the X-ray crystal structure, for the selected 
model (PDBid 3UNX) were analysed using B-FITTER (Reetz and Carballeira, 2007).  
For visualizing and rendering multiple sequence alignments ESPript and ENDscript 
interfaces were used (Robert and Gouet, 2014).  
For mutational analysis and annotating three-dimensional models, Accelrys Studio 
Visualiser (Accelrys Software Inc., San Diego, CA, 2009) and PyMOL (The PyMOL 
Molecular Graphics System, Version 1.7.4 Schrödinger, LLC) were used.  
2.1.2 Leucine aminopeptidases from Aspergillus oryzae 
LapA was modeled using the online Integrated Protein Structure and Function Prediction 
Server (IntFOLD) server (Roche et al., 2011). Alternative models were also produced using 
PHYRE2 (Kelley and Sternberg, 2009) and RaptorX (Kallberg et al., 2012) servers. Tertiary 
structures of the predicted LapA thermolability mutants were modelled using SWISS-
MODEL server (Biasini et al., 2014).  
LapA and GAP pocket and cavity analysis was performed on CASTp server (Liang et al., 
1998). Rigidity analysis was conducted on KINARI-Web server (Fox et al., 2011).  
Pairwise structural alignment was conducted using the Dali Lite pairwise comparison server 
(Holm and Rosenstrom, 2010). Structural comparisons and superimpositions were also 
generated using the TM-align server (Zhang and Skolnick, 2005) 
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For the prediction of LapA melting temperature (Tm) the Predictor server (by P.C. Lyu Lab., 
Institute of Bioinformatics and Structural Biology, National Tsing-Hua University, Hsin-
Chu, Taiwan, http://tm.life.nthu.edu.tw) was used. 
 
2.2 DNA manipulation 
2.2.1 Polymerase chain reaction 
PCR was performed in accordance with standard protocols used with Premixed 2X solution 
of Taq DNA Polymerase (Promega, UK) and CloneID™ 1X Colony PCR Master Mix 
(Lucigen, US). The PCR steps used the following conditions: 
Denaturation – initial denaturation step included heating the sample to 98ºC for 30s; 
Denaturation for another 5s at 98ºC, Primer annealing – 60-65 ºC for 30 sec., Elongation – 
at 72 ºC for 1 min/kb. A final elongation step, for 3 minutes at 72 ºC, was allowed to ensure 
that all ssDNA was extended. Finally, all samples were incubated at 4 ºC. 
2.2.2 Plasmid DNA purification 
Plasmid DNA purifications from bacterial biomass were performed using the QIAprep Spin 
Miniprep Kit (QIAGEN), PureYield™ Plasmid Miniprep System (Promega, UK) and 
PureYield™ Plasmid Midiprep System (Promega, UK) according to the manufacturer`s 
instructions. The cells were harvested from a 3 - 5 ml overnight culture for purification using 
Miniprep system, and from a 100 mL culture for purification using Midiprep system.  
2.2.3 DNA extraction from agarose gel 
QIAquick Gel Extraction Kit from QIAGEN was used according to the manufacturer`s 
instructions to purify DNA samples from 1% agarose gels, as follows:   
1.5 mL Eppendorf tube containing a slice of agarose gel and 3 volumes of buffer QG (0.5M 
ammonium acetate, 10 mM magnesium acetate, 1 mM EDTA, 0.1% SDS, pH 8.0) were 
added followed by incubation at 50 ºC water bath for 10 min. The dissolved sample was 
transferred to QIAquick spin column and centrifuged at 12.000 x g for 1 min to allow the 
DNA to bind to the silica matrix. A wash step (0.75 mL of buffer containing ethanol was 
added to the spin column followed by incubation of 5 min.) was performed. DNA was eluted 
into a 1.5 mL Eppendorf tube, using 50 µL of 50 ºC ddH2O following the pre-incubation for 
4 min for increased DNA yield. 
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2.2.4 DNA restriction digest 
Other DNA endonucleases used in this project (SacI-HF, HinfI) were obtained from NEB 
(UK) and digestion protocols were performed according to manufacturer’s instructions.  
2.2.5 In-Fusion molecular cloning 
Recombinant LapA and sC expression constructs were obtained utilising InFusion cloning 
kit. The In-FusionTM HD Cloning Kit (Clontech, USA) was composed of CloneAmp HiFi 
PCR Premix, 5X In-Fusion HD Enzyme Premix, pUC19 Control Vector, linearized (50 
ng/µl), 2kb Control Insert (40ng//µl), PCR Clean-up kit, Stellar® competent cells. 
Gel-purified PCR products (genes to be cloned) and gel-purified digested vectors were 
combined with In-FusionTM enzyme, followed by incubation for 15 min. at 50 ºC. 2.5 µL 
of the reaction mixture was transformed into Stellar® competent cells.  
2.2.5.1 pOPINE/pOPINP vector restriction digest and clean-up  
pOPINE and pOPINP vector DNA were digested with NcoI-PmeI and KpnI-PmeI 
endonuclease pairs, respectively. In a 200 µL PCR tube, 50 µL total reaction mix was 
assembled. 1 unit of enzyme was used to digest 1000 ng of DNA using optimal buffering 
conditions with CutSmartTM buffer 1X (50 mM Potassium Acetate, 20 mM Tris-acetate, 10 
mM Magnesium Acetate, 100 µg/ml BSA, pH 7.9). The reaction mixture was incubated for 
1h at 37 ºC and the reaction products were analysed on an agarose gel. 
The PCR generated amplicons of appropriate gene insert, and linearised pOPINE/P vectors 
were purified using NucleoSpin Gel and PCR Clean-up Kit (Clontech, UK) according to 
manufacturer`s instructions. 
2.2.5.2 InFusion reaction 
Gene inserts with PCR-generated 15bp homologous overlaps were combined with linearized 





















2 µL 2 µL 2 µL 2 µL 
ddH20 3 µL 2.2 µL 4 µL 5 µL 
Table 2.1 InFusion cloning assembly in 10 µL reaction.   
The assembled reactions were allowed to proceed for 15 min. at 50 .  
1 µL of completed reaction mixture was transformed to 50 µL of chemically competent 
StellarTM (Clontech, UK) cells. 
100 µL of regenerated cells were plated on agar supplemented with ampicillin (100mg/mL).  
2.2.6 Quickchange site-directed mutagenesis protocol 
LapA thermolability mutants were generated using Quickchange II Lightning (Agilent) site-
directed mutagenesis kit according to manufacturer’s instructions. In brief, mutagenenic 
primers were designed using an online tool: 
http://www.genomics.agilent.com/primerDesignProgram.jsp). Site-directed mutations were 
introduced by performing mutagenic PCR as a first step, utilising wild-type LapA expression 
cassette as a template. Amplification products were treated with a DpnI enzyme to digest the 
parent DNA, followed by transformation to XL1-Blue Supercompetent cells. Several E.coli 
transformants from each mutant were propagated. The extracted plasmid DNA was verified 
to contain the desired mutation by Sanger sequencing. 100 mL of E.coli cultures were 
cultivated to obtain the required biomass for medium scale plasmid DNA preparation and 
subsequent linearisation with SacI endonuclease before transforming into competent 
P.pastoris X33 strain.    
 
2.3 Electrophoresis 
2.3.1 Agarose gel electrophoresis 
1% w/v agarose gels were prepared by dissolving the respective amount of agarose in 1X 
TAE buffer (40mM Tris, 20mM acetic acid, 1mM EDTA) buffer, supplemented with 
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SYBR® Safe DNA gel stain (Life Technologies, UK). Samples were prepared using 1X 
Purple Dye (NEB, UK) (2.5% Ficoll®-400, 10mM EDTA, 3.3mM Tris-HCl, 0.08% SDS, 
0.02% Dye 1, 0.001% Dye 2, pH 8.0). DNA bands were separated using horizontal gel tank 
Sub-gel midi Submarine (Fisher, UK) by running the gel for 40 min under 120V. Bands were 
visualised under UV light using a benchtop UV gel doc system (UVP, Cambridge, UK).   
2.3.2 SDS – PAGE gel electrophoresis  
Two gel running systems have been employed in this work; either precast gels (NuPAGE® 
Novex® 4-12% Bis-Tris Gels, 1.0 mm, 15 well) together with the Invitrogen NuPage® 
Novex® Gel System or Tricine-glycine custom-poured gels together with Bio-Rad Mini-
PROTEAN® Tetra cell system. 
All protein samples were prepared by taking 15 µL of protein sample and mixing with 5 µL 
of NuPAGE® SDS Sample Loading Buffer (Life Technologies, UK). Before loading, the 
mixture was incubated in a TechneDri-block DB-2A at 95°C for 3 minutes. The 
electrophoresis was allowed to proceed for 50 min. under 200V. Staining of the gels was 
performed using InstantBlue® (Generon, UK) quick stain, incubating for 15 min.  
2.3.3 Western Blot Analysis 
Western blotting was used to investigate the expression of recombinant Subtilisin Carlsberg 
and LapA proteases, as each construct tested possessed a hexahistidine tag at the N or C-
terminus, which was used for cross-reactivity with 6xHis specific antibody. Proteins 
separated by SDS-PAGE were blotted onto a nitrocellulose membrane using a semi-dry 
method, as follows: thin filter papers were immersed in Transfer buffer (25 mM Tris, 192 
mM glycine, 10% methanol) for 2 min. The filters were placed on the Blotter. The membrane 
was also kept in Transfer buffer (TB) for 5 min and placed on the top of filter papers. 
Analysed SDS-gel was kept in TB for 5 min and placed on the top of the membrane. Another 
three TB pre-soaked filter papers were placed on the top. Some TB was pipetted on the top 
to keep the system wet; the sandwich was rolled over with the pen to remove trapped air 
bubbles. The Blotter was left to run for 1h and 30 min at 15V (120mA). Blocking solution 
(TBST (Tris Buffered Saline with Tween® 20: 20 mM Tris pH 7.5, 150 mM NaCl, 0.1% 
Tween 20) + 5% skimmed milk) was prepared. The membrane was inspected for sufficient 
transfer of proteins from the SDS-gel. The membrane was incubated in Blocking solution 
with gentle rocking for 1h at ambient temperatures or overnight at 4 ºC. 5-10 mL of Blocking 
solution was saved, and Histidine-specific antibody was added according to the ratio 1:500, 
or 10 µL in 5 mL. The membrane was washed 3 times with TBST, changing to fresh buffer 
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each time. The solution from step 11 was poured over the TBST-washed membrane and left 
gently rocking for 1h at RT. The membrane was then washed 3 times with TBST in the same 
way as in step 12 and repetitively placed on cling film to get rid of any residual buffer. 
Chemiluminescent Clarity™ Western ECL Substrate (Bio-Rad) was applied with a pipette, 
followed by 5 min incubation time at RT and another layer of cling film was placed over the 
membrane for longer term storage. The resulting bands were visualized using an ImageQuant 
LAS 4000 (GE Healthcare).  
 
2.4 Quantification methods 
2.4.1 Quantification of recombinant DNA 
A NanoDrop® 1000 (Thermo Scientific) spectrophotometer was used to measure the 
concentration of linear and plasmid DNA fragments at 260 nm. Purity was estimated by the 
ratio 260/280 nm.  
2.4.2 Quantification of recombinant LapA  
LapA proteins were quantified either by Bradford assay (Bio-Rad, USA), using BSA as a 
standard or spectrophotometrically, employing a NanoDrop® ND-1000 (Thermo Scientific) 
using the LapA absorbance extinction coefficient (23,505 M-1cm-1). The concentration of 
recombinant LapA in crude P.pastoris supernatant could only be determined by Bradford 
assay due to impurities interfering with spectrophotometric measurements.     
 
2.5 Microbiology methods 
2.5.1 Bacterial transformation 
Unless otherwise stated, the transformation protocol was performed as follows: Competent 
cells were taken out of the -80 ºC freezer, briefly centrifuged and kept on ice for 5 min to 
thaw. 5-10 ng of plasmid DNA was mixed with 50-100 µL of competent cells. The mixture 
was kept on ice for 30 min.  Heat shock was carried out for 30 s at 42 ºC, and then the mixture 
was placed back on the ice for 2 min. SOC outgrowth medium (1X SOC Outgrowth Medium: 
2% Vegetable Peptone, 0.5% Yeast Extract, 10 mM NaCl, 2.5 mM KCl, 10 mM MgCl2, 10 
mM MgSO4, 20 mM Glucose) was added to the mixture and then placed in a 37 ºC shaker 
incubator for 1 h at 220 rpm. The bacterial solution was transferred onto an agar plate 
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containing selection marker and spread evenly across the plate and incubated at 37 ºC 
overnight. 
2.5.2 Glycerol stocks 
500 µL glycerol stocks were prepared by mixing 375 µL cell culture (OD600 = 0.4-0.6) and 
125 µL of sterilized 32% glycerol, combined in a sterile cryogenic or 1.5 mL Eppendorf 
tube, followed by freezing at -80 ºC. 
2.5.3 Preparation of competent cells 
LB was inoculated with a single colony of bacteria and cultured overnight at 37 ºC. The 
culture was further grown the next day until OD600 = 0.4, following inoculation using the 
overnight culture diluted 100-fold. Cell culture was placed on ice for 20 min, followed by 
centrifugation at 3,000 x g for 10 min. at 4 ºC. Cells were resuspended in ice-cold 0.1M 
CaCl2 followed by incubation for 30 min. and subsequent centrifugation at 3,000 x g for 10 
min. at 4 ºC. The supernatant was discarded and the pellet resuspended in ice-cold 0.1M 
CaCl2 supplemented with 15% v/v glycerol. 50 µL aliquots have been made and frozen in 
liquid nitrogen for storage at -80 ºC. 
 
2.6 Recombinant Protein Expression in E.coli 
2.6.1 pOPIN expression vectors 
Recombinant protein expression was conducted, taking advantage of the T7 expression 
system utilized in the pOPIN family of vectors (OPPF, UK) and pET-21a vector (Novagen). 
These vectors provide a 6X His-tag either at the N-terminus (pET-21a and pOPINF vectors) 
or the C-terminus (pOPINE vector), as well as providing a pelB signal peptide (pOPINP 
vector). The recombinant tag can be removed by enterokinase or Rhinovirus 3C protease. 
The antibiotic resistance marker in these vectors is ampicillin. 
2.6.2 Bacterial expression 
BL21 (DE3) E. coli expression strain and its derivatives, Lemo21 (NEB), B834 (NEB), 
Rosetta (NEB), SoluBl21 (AMSBio) were used. Both Luria-Bertani (LB) Broth and M9 





Components (LB)  Components (M9) in 1L 
 1.0% Tryptone 
Na2HPO4 (anhydrous) 6g, KH2PO4 
3g, NaCl 0.5 g, NH4Cl 1g 
0.5% Yeast Extract 100mM CaCl2 1mL 
1.0% Sodium Chloride (NaCl) 1M MgSO4 1mL 
pH 7.0 Glycerol 0.3%  
Table 2.2 Components of LB broth (left) and M9 minimal media (right) used for bacterial 
growth 
 
2.6.3 Small-scale expression 
All preliminary recombinant LapA over-expression trials were carried out using 10 mL 
cultures. A single BL21 (DE3) colony harbouring recombinant LapA expression construct 
was transferred to 2 mL LB broth and incubated at 37 ºC shaker (220 rpm) overnight. 200 
µL of the overnight inoculum was transferred to 10 mL of fresh LB media. The optical 
density (OD) at 600 nm was regularly monitored to attain a value between 0.5 and 1.0 
absorbance units, after which IPTG (1 mM final) was added to induce protein expression. 
The pre-induction sample was taken for further analysis on SDS – PAGE. The induced 
cultures were then incubated for 16-20h at either 37 ºC or 20 ºC. Following the harvest at 
16,000 x g, cells were lysed with the BugBuster® Master Mix (Novagen) and soluble versus 
insoluble protein fractions were analysed on SDS-PAGE.  
Minimal media expression trials were performed as follows: A colony of the SoluBL21 was 
inoculated into 1-2 ml of M9 minimal media with ampicillin (100 µg/mL final). The 
inoculum was left to grow overnight at room temperature in a shaker/ incubator at 200 rpm. 
300 µL of the overnight culture was inoculated into 5mL of fresh M9. Cells were left to grow 
at room temperature until an OD600 of at least 0.4, followed by addition of IPTG to a final 
concentration of 1 mM. Cells were incubated overnight at room temperature, in a 
shaker/incubator at 200 rpm. Post-induction sample was taken, and the cells were pelleted 




2.6.4 Disruption of bacterial cells 
Mechanical (ultrasonication) and chemical cell disruption were used to disrupt the cells. A 
Sonifier® and an S-450D digital ultrasonic processor (Branson) equipped with a double step 
1/8" (3.2mm) ultrasonic probe immersed into the cell solution, were used for all experiments. 
For chemical cell disruption, BugBuster® Master Mix (Novagen) was chosen.  
Ultrasonication: 
The instrument was set to 40% amplitude, 5-second pulse, for 2 minutes only once. For small 
scale preparations (<1 mL) a 3.2 mm diameter probe or 40% amplitude, 5-second pulse, for 
5 minutes, 3 times was used. For large scale preparations (> 30 mL), a 6 mm diameter, 
tapered 1/4" (6.4mm) probe was used. 
BugBuster® treatment: 
5 mL of BugBuster® was used for approximately 1g of wet cell paste, followed by 10-20 
min incubation on a rotating mixer at RT.  
Once the crude cell lysate was obtained, 50 µL sample was taken. The cell lysate was 
centrifuged for 10 min. at 16.000 x g and the clear supernatant was sampled. The two samples 
were retained for analysis on SDS-PAGE. 
2.6.5 Periplasmic extraction 
The recombinant expression of Subtilisin Carlsberg (sC) carried the pelB signal peptide, 
which directed the protein to the periplasm where it was subsequently extracted using 
osmotic shock treatment.  
In this method, the E. coli cells carrying the sC protein were treated with an ice-cold osmotic 
shock solution (20-25% w/v sucrose, 5 mM EDTA, 20 mM Tris, pH 8.0). The resulting 
suspension, the 'sucrose` fraction, was centrifuged at 8,000 x g. The pellet was re-suspended 
in 5-10 mM MgCl2 to complete the osmotic shock. The suspension was centrifuged at 8,000 
x g. The resulting supernatant was the `periplasmic` fraction.  
 
2.7 Protein purification 
2.7.1 Immobilised metal affinity chromatography (IMAC)  
All recombinant proteins (sC, LapA) were tagged with a 6x-Histidine tag to facilitate 
purification using a HiTrapTm affinity column. 
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HiTrapTm 5mL pre-packed affinity columns (GE Healthcare) were used in conjunction with 
a ÄKTA FPLC system to isolate the desired proteins. The buffers used are provided in Table 
2.3. 
Binding buffer (A) Elution buffer (B) 
50mM Tris pH=8.0 50mM Tris pH=8.0 
500mM NaCl 500mM NaCl 
30mM imidazole 500mM Imidazole 
Table 2.3 Buffers used in IMAC for HiTrapTM 5mL columns. 
 
Purification followed the following steps unless otherwise stated. The NiNTA column was 
charged using 0.1 NiSO4 and washed with 10 column volumes (CV) of Milli-Q water to 
remove residual Ni2+ ions. The column was then pre-equilibration with 5-10 CV of Buffer 
A. Cell lysate was loaded, following filtration through a Millipore 0.2 µm sterile filter. The 
unbound and non-specifically bound proteins were washed with 3-5 CV Buffer A. The 
bound recombinant protein was eluted with 5 CV of 100% Buffer B, or a 10 CV linear 
gradient was applied. Aliquots representing whole cell lysate, column flow-though (unbound 
protein), wash stages and final elution were taken, and the contents were visualised using 
SDS-PAGE. 
2.7.2 Purification and refolding of refLapA protein from E.coli inclusion bodies 
Pellet with inclusion bodies were re-solubilised in 8M Urea buffer (50mM Tricine pH = 8.0, 
500 mM NaCl, 8M Urea) gently agitating for 1 hour. The non-dissolved debris was separated 
by centrifugation for 20 min at 16,000 x g. IMAC: the supernatant was loaded on HisTrapTM 
FF 5 ml (GE Healthcare, UK) nickel affinity column pre-equilibrated with wash buffer (50 
mM Tricine pH = 8.0, 500 mM NaCl, 8M Urea) and re-solubilised refLapA eluted in 50 mM 
Tricine pH = 8.0, 500 mM NaCl, 8M Urea and 200 mM Imidazole. refLapA was allowed to 
slowly refold by reducing the concentration of Urea in the buffer: IMAC-eluted fraction was 
dialysed against refolding buffer (10 mM Tricine pH = 8.0, 1 mM ZnCl2) for 20h at 4 ºC. 
The refLapA was further purified on HiLoad SuperdexTM 16/60 200pg (GE Healthcare, UK) 
gel filtration column pre-equilibrated with 20 mM Tricine pH = 8.0, 1 mM ZnCl2. Collected 
2 ml fractions with most specific activity were pooled and concentrated on Vivaspin 15R – 
10,000 Dalton Centrifugal Filter Units (Sartorius, UK) containing HydroSart® membrane.  
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2.7.3 Native LapA (flavLapA) purification from Flavourzyme 
Flavourzyme 500MG commercial Aspergillus oryzae peptidase preparation was a gift from 
Biocatalysts Ltd. (UK). 2 ml of 2 g/L (total protein content) Flavourzyme solution was 0.22 
µM filtered and loaded on HiLoad SuperdexTM 16/60 200pg (GE Healthcare, UK) gel 
filtration column equilibrated in 20 mM Tris pH = 8.0, 500 mM NaCl. This way a mixture 
of 8 peptidases present in Flavourzyme (Merz et al., 2015) could be crudely separated based 
on their molecular weight. Fraction containing most of the native LapA (flavLapA) from the 
latter step was loaded on HiPrep™ 26/10 53mL Desalting column and buffer exchanged into 
20 mM Tris pH = 8.0 prior to loading on HiTrapTM Q HP anion exchange column pre-
equilibrated with 20 mM Tris pH = 8.0. Column was washed with 10 CV of equilibration 
buffer or until no trace of protein appeared in the eluate. flavLapA was eluted with increasing 
gradient (0-1M) of NaCl (20 mM Tris pH = 8.0, 1M NaCl). To remove residual brown 
pigment associated with the protein, flavLapA from previous anion exchange step was 
loaded on HiTrapTM Phenyl HP 5ml (GE Healthcare, UK) hydrophobic interaction (HIC) 
column pre-equilibrated with high salt buffer (20mM Tris pH = 8.0, 1.5M Ammonium 
sulphate) and eluted with low salt buffer (20mM Tris pH = 8.0). This step was required 
repeating several times to remove traces of pigment prior to crystallisation. Final two 
purification steps of native LapA involved: 1) HIC-purified fraction was heat-treated to 67 
°C for 20 min in the presence of 500mM NaCl to remove any residual contaminating 
A.oryzae proteins (α-amylase and neutral protease I). Protein precipitate (contaminants) was 
separated from supernatant (flavLapA) by centrifugation at 16,000 x g for 10 min, 2) the 
successive supernatant was loaded on HiLoad SuperdexTM 16/60 200pg (GE Healthcare, 
UK) gel filtration column equilibrated in 20mM HEPES pH = 8.0. Eluted homogenous 
flavLapA from Flavourzyme was concentrated and stored at -20 °C for further analysis.     
2.7.4 Protein concentration 
All proteins were concentrated using Amicon Ultra -15 Centrifugal Filter Units – 10,000 
NMWL (Merck Millipore), Amicon Ultra-0.5 mL Centrifugal Filter Units – 10,000 NMWL 
(Merck Millipore) or Vivaspin 15R – 10,000 Dalton Centrifugal Filter Units (Sartorius).           
2.8 Protein crystallisation 
2.8.1 High throughput crystallisation screening 
The OPPF has commercial blocks of crystallisation screens available (containing 96 
different conditions for each 96-well plate used). Crystallisation was achieved by the vapour 
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diffusion sitting drop method (Chayen, 1998a) in 96-well plates. Native and wild-type LapA 
crystallisation screens were performed using: 
PACT premier HT-96 (Molecular dimensions)  
JCSG-plusTM Screen (Molecular dimensions) 
INDEX HT (Hampton Research) 
Morpheus® HT-96 (Molecular dimensions) 
PEG/Ion HT (Hampton Research) 
WIZARD (Molecular dimensions) 
The resultant protein crystals were mounted in microscopic loops and cryo-protected with 
mother liquor supplemented with 20-25% glycerol (v/v) or ethylene glycol. 
2.8.2 24-well plate crystallisation screening 
Several 24-well crystallization plates were set up in order to optimize conditions identified 
in the 96-well plate screen to obtain diffraction quality crystals. Crystallization was achieved 
by vapour diffusion hanging drop method (Chayen, 1998b). In brief, 1 µl of purified protein 
solution and 1 µl of crystallisation solution were combined on a clean 22mm square 
coverslip. The cover slip was placed over top of the reservoir chamber containing the 
screening reagents, with the crystallisation drop facing the reservoir solution. Vacuum grease 
was applied around the perimeter of the edge of each reservoir chamber providing a sealant 
for the coverslip over the well. The crystallisation trays were incubated at RT and monitored 
under a light microscope at regular intervals (typically, after 1 day, then 3 days, 1 week, 
weekly then monthly)  for the appearance of crystals. The stock solutions used were 4M 
Ammonium Phosphate, 1M Sodium Acetate, 1M Citrate, 2M ZnCl2, 2M KSCN, 5M NaCl, 
2M HEPES. All reagents were purchased either from Molecular Dimensions or Sigma-
Aldrich, and the solutions were made using Milli-Q pure water. 
2.8.2.1 Crystallisation of native flavLapA 
flavLapA from Flavourzyme was crystallised at 6 mg/ml in 20mM HEPES, pH = 8.0. Using 
robotics at OPPF, flavLapA crystallization trials were set up in 200 nl (100 nl protein plus 
100 nl reservoir solution) drops using JCSG-plusTM HT-96 screen (Molecular dimensions, 
UK). Crystals of flavLapA appeared in 3-4 days under F2 condition (0.1M Citrate, pH = 5.0, 
3.2 M Ammonium sulphate) at 21 °C. 
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2.8.2.2 Crystallisation of recombinant LapA wild-type proteins 
Crystallisation screening was carried out using HTP robotics at Oxford Protein Production 
facility (OPPF, UK) (96 well commercial sparse matrix screens, sitting-drop vapour 
diffusion method) and crystallisation optimisation was carried out in the home laboratory 
using 24 well, hanging-drop vapour diffusion.  
A pre-crystallisation test (PCT) for each purified protein was performed prior to 
crystallisation screening. The PCT Testing Kit (Hampton Research Ltd) was used according 
to the following protocol: 4 reservoirs are used in the Greiner crystallization plate to pipette 
approximately 100 µL of screening solutions A1, A2, B1 and B2. Half of the microliter of 
reservoir solution and protein solution are combined in one drop. Wells used are sealed with 
clear sealing foil. Drops were monitored under the microscope after 15 min. If A1 and/or A2 
wells contained a light granular precipitate, then protein was deemed close to the right 
concentration. If A1 and/or A2 wells contained heavy precipitate, then most likely the 
protein was too concentrated and should be diluted to 50-70% of existing concentration. If 
the drops remained clear, then the protein concentration is too dilute and further 
concentration is needed to increase the concentration at least two-fold.  
wtproLapA, wtLapA recombinant proteins were crystallised at 13 mg/ml and 11 mg/ml 
concentrations, respectively. Both proteins were buffer exchanged into 20mM Tricine pH = 
8.0, 1mM ZnCl2 prior to crystallisation. wtproLapA crystals with dimensions 0.5 × 0.04 × 
0.005 mm formed under F10 condition (0.1 M Bis-Tris, pH = 5.5, 0.2 M NaCl, 25% PEG 
3,350) in the Index HT™ screen (Hampton Research, USA) in 3 days at 21 °C. wtLapA 
crystals were produced in 24-well plate format at room temperature under previously 
identified crystallisation conditions for flavLapA from Flavourzyme (0.1M Citrate, pH = 
5.0, 3.2 M Ammonium sulphate).  
2.8.2.3 Crystallisation of LapA thermolability mutant proteins 
Crystallisation of LapA mutants were conducted under previously determined Index HT™ 
F10 (0.1 M Bis-Tris, pH = 5.5, 0.2 M NaCl, 25% PEG 3,350) condition. Crystallisation 
drops were set-up in 24-well Grainer plate by hanging-drop vapour diffusion method. LapA 
mutant protein solutions were prepared at very high 30 – 50 mg/ml concentration. Crystals 
were visible after 24 h incubation at 21 °C.    
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2.8.1 Data Collection, Structure Determination & Refinement 
Prior to data collection, crystals were cryo-protected by quick transfer through a mixture of 
mother liquor and 20% ethylene glycol (with the exception of wtproLapA, which had 25% 
PEG in the mother liquor) and flash cooled to 100K in liquid nitrogen.  
Diffraction data were collected at Diamond Light Source (UK), on beamlines I02 and I03. 
The diffraction data were recorded, by fine slicing (0.1° degree oscillation), on a Pilatus 6M 
detector. Indexing and integration were completed automatically by XDS (Kabsch, 2010) 
and xia2 (Winter et al., 2013).   
All the LapA structures were solved by maximum likelihood molecular replacement with 
PHASER (McCoy et al., 2005), using the coordinates of an established LapA homology 
model; LapA homology model was generated using the IntFold2 server (Roche et al., 2011), 
which identified aminopeptidase from Vibrio sp. (34% sequence identity) as a closely related 
structural homologue (PDBid: 1RTQ), as the template. Resulting LapA models were 
manually built, fitting to the resulting electron density maps, using COOT (Emsley and 
Cowtan, 2004). All structures were refined using PHENIX (Adams et al., 2010). 
MolProbity4 was used for structure validation. Structural images were prepared using 
PyMOL. 
 
2.9 Protein thermal and spectroscopic analysis 
2.9.1 Differential Scanning Fluorimetry (DSF) measurements 
In brief, this assay measures increase in fluoresce signal of Sypro-Orange dye, which binds 
to increasingly exposed hydrophobic patches of unfolded protein populations arising from 
increased temperature of the system. The obtained fluoresce curve midpoint value Tm 
corresponds to the temperature of half-unfolded protein population. 50 µL samples for DSF 
measurements were prepared in the following order: 2 µL of concentrated 5,000X Sypro-
Orange (Invitrogen, Carlsbad, US) dye was diluted with 38 µL of sample buffer (20 mM 
Tricine, pH=8.0, 1 mM ZnCl2). 1 µL of at least 5 – 10 mg/ml LapA protein was mixed with 
42 µL of sample buffer and 7 µL of previously diluted dye, avoiding the formation of 
bubbles. The prepared samples were transferred to 96 – well plate and measurements were 
recorded on Mx3000P qPCR System (Agilent Technologies, CA, US) within 25 – 90 °C 
interval at a scanning rate of 1 °C/min.  Melting temperature (Tm) was transition midpoint 
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value between the start point and the maximum point which was calculated using the 
manufacturer’s software.  
2.9.2 Differential Scanning Calorimetry (DSC) measurements 
LapA protein samples were analysed using NanoDSC 6300 instrument (TA instruments, 
New Castle, DE) equipped with 300 µL platinum cell. Protein concentrations were in the 
range of 0.5 – 1.5 mg/ml. Heat flow and endothermic peaks were monitored at a scanning 
rate of 1 °C/min. Protein endotherm peaks were adjusted to their respective concentration 
and molecular weight and converted to molar heat capacity. Analysis with NanoAnalyze 
v3.7 software package yielded protein melting point (Tm) and thermodynamic parameters 
(∆H, ∆S).  
2.9.3 Circular Dichroism (CD) spectroscopy of LapA proteins 
The circular dichroism spectra for all resultant proteins were recorded in the range of 360 to 
190 nm at 20 ºC using a Chirascan series 800 spectrophotometer. Measurements were taken 
using a 1 nm step size in a 0.1 mm path length quartz cell. CD data was averaged from 
independent 5 scans for each sample. Samples of refLapA, flavLapA, wtLapA, wtproLapA 
and wt∆proLapA proteins were analysed at 36 µM, 30 µM, 21 µM, 25 µM and 40 µM 
concentrations, respectively, buffered in 20 mM HEPES, pH = 8.0.  
 
2.10 LapA enzymatic assays 
2.10.1 Lap enzymatic assay – 3 mL format 
LapA specific activity was determined spectrophotometrically using a synthetic substrate 
(Leu-pNA) and monitoring the formation of the p-nitroanilide moiety (pNA) as absorbance 
at 405nm (ε = 9.9 mmol-1cm-1) in a cuvette with 1 cm path length. Peptidase assays were 
performed on CE1020 1000 Series spectrophotometer (Cecil Instruments). 
The reagents used for the assay were as follows: 
 1. 0.05 M Phosphate Buffer, pH 7.2 (at 37ºC) – stable for 3 months at room 
temperature. 
 2. 0.024M L-Leucine-p-nitroanilide -stable for 3 months when frozen 
120.6 mg of L-Leucine-p-nitroanilide (Sigma, UK) was dissolved in approximately 15 mL 
of methanol and made up to a final volume of 20 mL with phosphate buffer. 
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Calculation of specific activity: 
Ug-1 = 

 , where 
Vt = 1ml 
Vs = 0. 333 ml 
1000 = convert from mg to g in enzyme concentration 
[E] = enzyme concentration in mg/ml 
E = extinction coefficient of L-leucine and p- nitroaniline (9.9 mmol/cm) 
Unit definition: 
One unit will hydrolyze 1.0 µmole of Leu-pNA to L-leucine and p-nitroaniline per minute 
at 
pH 7.2, at 37 °C, and 24 mM substrate concentration. 
2.10.2 Lap enzymatic assay – 300µL microplate assay 
All the reaction conditions and specific activity calculations were equivalent to 3 mL assay 
format, except the reaction volume was reduced to 300µL. This was necessary to adopt LapA 
assay to measurements in a plate format. Greiner CELLSTAR® 96 well plates were used 
along with SpectraMax Plus 384 Microplate Reader (Molecular Devices, CA, USA) to 
measure the increase in absorbance at 405 nm. Rainin electronic multichannel pipettes were 
utilized to dispense 10 µL of enzyme followed by programmed 3 mixing cycles to ensure 
even distribution of reactants. Absorbance values were recorded for 60 seconds on SoftMax 
Pro Software (Molecular Devices, CA, USA).  
2.10.3 LapA thermolability assay 
LapA enzymes were diluted to a concentration, which would give a change in absorption 
between 0.1 and 1.0 for the most accurate measurement. These diluted aliquots were 
incubated at 5 different temperatures: 37, 50, 60, 70 and 80 °C. The samples were withdrawn 
every 15 minutes and cooled either on ice for 3 minutes (3 mL cuvette assay) or 4 °C PCR 
thermo-block for 5 minutes (300 µL microplate assay) prior to measuring residual specific 
activity. The cooling step was required to normalize reaction kinetics of the sampled 
enzymes from different temperatures.  
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2.10.4 LapA enzyme kinetic assay 
Enzyme reaction kinetic data was obtained by measuring LapA reaction velocity at 
increasing concentrations (0.008 – 0.8 mM) of LPNA at 37 °C. The protocol was 
analogous to LapA activity plate assay, except the LPNA substrate varied and was not in 
excess. Formation of the liberated p-nitroanilide product was monitored for 60 seconds 
from initiation. The increase in absorbance was recorded every 5 seconds. Reaction rates 
were calculated from slopes within first 40 seconds, where the reaction response was 
linear. Reaction velocity (mM/sec) versus initial concentration of LPNA in the reaction 
was analysed by non-linear regression using Graph-Prism software, and best-fit values for 
Vmax and Km were obtained. The concentration of LapA active sites (Ea) was equivalent to 
a molar concentration of LapA added to the reaction (mM). Catalytic constant - kcat (s-1) – 
was defined as Vmax/Ea ratio. Catalytic efficiency was calculated as kcat/Km ratio. 
 
2.11 Industrial pasteurisation for LapA protein inactivation 
Industrial small-scale pasteuriser Armfield FT74XTS (HTST/UHT) was utilised to perform 
industrial pasteurisation trials with Flavourzyme and recombinantly expressed LapA 
proteins. The instrument was capable of 10L/h sample feeding rate. LapA protein samples 
were diluted to the concentration required to give a change of absorbance between 0.1 – 0.5 
in standard 3 mL LapA cuvette assay. The instrument was set to either 15 or 30 second 
holding time for a range (65 – 80°C) of different temperatures. Samples were collected 
following 15 – 30 second pasteurisation at the predetermined temperatures. Residual specific 
activity was measured by a standard LapA assay following cooling the enzyme sample to 
the room temperature.       
2.12 Other analyses  
2.12.1 Deglycosylation with PNGase F 
The glycoproteins were processed using peptide -N-Glycosidase F, also known as PNGase 
F, an amidase that cleaves between the innermost GlcNAc and asparagine residues of high 
mannose, hybrid, and complex oligosaccharides from N-linked glycoproteins.  
Denaturing Reaction Conditions: 
20 µg of glycoprotein, 1 µl of 1X Glycoprotein Denaturing Buffer (0.5% SDS, 40 mM DTT) 
and H2O were combined to make a 10 µl total reaction volume. Glycoprotein was denatured 
by heating reaction at 95°C for 5 minutes. Reaction chilled on ice and centrifuged for 10 
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seconds. Total reaction volume made to 20 µl by adding 2 µl 1X GlycoBuffer 2 (50 mM 
Sodium Phosphate, pH 7.5), 2 µl 10% NP40 and 6 µl H2O. 1 µl of PNGase F added followed 
by gentle mixing. Reaction incubated at 37°C for 1 hour. Reaction analysed by SDS-PAGE.  
 
Non-Denaturing Reaction Conditions: 
20 µg of glycoprotein, 2 µl of 10X GlycoBuffer 2 (50 mM Sodium Phosphate, pH 7.5) and 
H2O were combined to make a 20 µl total reaction volume. 2 µl of PNGase F added followed 
by gentle mixing. Reaction incubated at 37°C for 24 hours. Reaction analysed by SDS-
PAGE.  
2.12.2 DNA sequencing 
All constructs were verified by Sanger sequencing before expression trials at the Source 
Bioscience Facility, Oxford.  
2.12.3 Mass Spectrometry  
All MS analyses were carried out at the University of St. Andrews BBSRC Mass 
Spectrometry and Proteomics Facility. Protein identification was performed by conventional 
tryptic digest of the shipped SDS gel band, followed by MALDI MS-MS analysis of the 
resulting peptides.  
2.13 Recombinant cloning and expression of LapA in eukaryotic 
host – Pichia pastoris 
2.13.1 Strains, plasmids and culture conditions 
P.pastoris X33 strain was obtained from Biogrammatics, Inc (Carlsbad, CA, USA). 
Secretory expression vector - pJexpress 912 – was provided by DNA 2.0 (USA).    
E.coli BL21 (DE3) (fhuA2 [lon] ompT gal (λ DE3) [dcm] ∆hsdS λ DE3 = λ sBamHIo 
∆EcoRI-B int::(lacI::PlacUV5::T7 gene1) i21 ∆nin5) expression strain and DH5α (fhuA2 
∆(argF-lacZ)U169 phoA glnV44 Φ80 ∆(lacZ)M15 gyrA96 recA1 relA1 endA1 thi-1 hsdR17) 
cloning strain were purchased from New England Biolabs (NEB,UK). 
Primers used in this study were obtained from Sigma (UK). ZeocinTM was purchased from 
Invitrogen (USA). All other reagents were purchased from Sigma (UK) and were of 
analytical grade.  
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2.13.2 Construction of recombinant expression vectors and 
transformations  
Recombinant LapA open reading frames (Genebank accession: XP_001825745.1) were 
codon-optimised and cloned into the pJ902 vector, by DNA 2.0, using the EcoRI and NotI 
restriction sites. In this way, an expression construct, harbouring the LapA native signal 
peptide and propeptide sequences (pJ-npro-LapA), was obtained. A second expression 
construct, containing a deletion of the LapA propeptide (pJ-∆pro-LapA) was produced, 
utilising the QuickChangeTM II site-directed mutagenesis kit from Stratagene (USA). 
Deletion of the propeptide sequence was achieved by performing PCR with designed primers 
1; 5'-GGACGCTATCTGGATAAGCTAATGCGCTTGCC-3' and 2; 5'-
GGCAAGCGCATTAGCTTATCCAGATAGCGTCC-3', using the pJ-npro-LapA construct 
as a template.  
Following SacI linearization and clean-up, recombinant plasmids were transformed into an 
X33 expression strain by electroporation (1500 V single pulse in a 2 mm electroporation 
cuvette). Immediately following electroporation, the cells were resuspended in 0.5ml 1M 
sorbitol and 0.5ml YPD (1% yeast extract Y, 2% soy peptone P, 2% dextrose D) and 
incubated for 2h at 30ºC under gentle agitation. The revived cells were then plated onto YPD 
agar (1% yeast extract, 2% soy peptone, 2% dextrose, 2% agar), containing either 100 µg/ml 
or 2000 µg/ml ZeocinTM and incubated at 30 ºC 2-4 days. The resulting P.pastoris colonies 
were verified, by PCR, for appropriate genomic integration using the method previously 
described (Looke et al., 2011). In each case, 10 transformants were screened, picking the 
largest, single colonies. Each single colony was patch-plated onto a separate YPD agar plate 
and residual cells were re-suspended in 100µL lysis solution (200 mM lithium acetate, 1% 
SDS), followed by incubation at 70 ºC for 15 min. Following 96% ethanol precipitation, the 
DNA pellet was re-suspended in 100 µL sterile water and 1µL (in each case) was used in 
each subsequent genomic PCR. Clone ID (Lucigen, USA), PCR pre-mix and a pair of AOX 
primers (AOX1-F; 5’-GACTGGTTCCAATTGACAAGC-3’ and AOX1-R; 5’-
GCAAATGGCATTCTGACATCC-3’) were used, under the following conditions: 1 cycle 
of 98 ºC for 2 min, 30 cycles at 98 ºC for 30 s, 56 ºC for 30 s, 72 ºC for 1 min, finishing with 
72 ºC for 5 min. The PCR products of predicted size were visualised on a 1% agarose gel.    
2.13.3 Over-expression of recombinant LapA in P.pastoris 
Recombinant proteins were over-expressed in a P. pastoris X-33 strain (Mut+), under control 
of the PAOX1 methanol inducible promoter. Shake flask expression trials were conducted in 
BMGY (1% yeast extract, 2% soy peptone, 1% glycerol, 1.34% YNB*, 4E-5% biotin, 
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100mM potassium phosphate, pH 6.0) and BMMY (1% glycerol replaced by 0.5% 
methanol). Genomic PCR-verified P.pastoris clones were inoculated into 50 ml BMGY 
medium in 250 ml baffled conical flasks and incubated in a shaker (250 rpm) for 16h at 28 
ºC. Once the OD600 reached 2-8, an equivalent amount of cells (corresponding to OD600 of 
1) were harvested and re-suspended in 100 ml of BMMY and shaken (250 rpm) in 500 ml 
conical baffled flasks at 28 ºC for 4-5 days. Every 24h, the cultures were supplemented with 
0.5% final concentration of methanol to maintain induction and OD600 cell densities were 
recorded. After 120h of maintaining recombinant protein expression, the cell cultures were 
harvested by centrifugation at 6000 x g for 15 min. The supernatant was sampled and 
recombinant LapA protein detected on SDS-PAGE (NuPAGE® Novex® 4-12% Bis-Tris 
gels).    
*YNB – yeast nitrogen base, with no amino acids. Rich growth medium containing nitrogen 
sources, vitamins, trace elements, salts.   
P.pastoris micro-fermentation trials were conducted using Biolector (M2P Labs, UK) micro-
fermenter with controlled levels of humidity, oxygen and agitation. A 48 well Biolector 
FlowerPlate (M2P Labs, UK)  plate was inoculated with a selection of recombinant colonies 
from agar plates into 1ml of BMGY medium and incubated at 30°C, 85% relative humidity 
with 1100 rpm agitation on a 2 mm orbital axis for 16 h (overnight). A 1:100 dilution in 
BMGY of 20 µl of biomass from several wells was measured for OD600 to assist in 
converting Biolector AU readings for biomass into OD600 values. Typically, growth was 
between 25 to 35 OD600. 1 ml cultures were recovered in sterile Eppendorf tubes, centrifuged 
for 1 min at 13,000 rpm and resuspended in 500 µl of BMMY. A new Flowerplate was 
inoculated with 1ml BMMY and a volume of each culture resuspension providing a final 
OD600 of approximately 1.0. Cultures were then grown as for the BMGY inocula with 
additions of 50% Methanol to a final concentration of 0.5% (10 µl per 1 ml of culture) every 
24 h. P.pastoris supernatants were harvested after 120 h and analysed on SDS-PAGE.   
2.13.4 Purification of recombinant LapA from P.pastoris supernatant     
Over-expressed wtproLapA, wtLapA, wt∆proLapA and thermolability mutant proteins were 
purified from P.pastoris supernatant employing 2 different protocols: 1) crude P.pastoris 
supernatant, containing recombinant LapA, was dialysed against 20 mM Tricine pH = 8.0, 
1 mM ZnCl2 for 16h at 4 ºC, then filtered through a 0.22 µm steri-filter prior to loading onto 
a 5 mL HiTrapTM Q HP anion exchange column, pre-equilibrated with 20 mM Tricine pH = 
8.0, 1 mM ZnCl2. The column was washed (10 column volumes) with equilibration buffer 
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until no trace of protein appeared in the eluate. Recombinant LapA was eluted using an 
increasing gradient (0 - 1M) of NaCl (20 mM Tricine pH = 8.0, 1 mM ZnCl2, 1M NaCl). 
Active fractions were pooled and concentrated, using 10 kDa MW cut-off ultrafiltration 
membranes. In each case, the respective protein concentrate was loaded onto a HiLoad 
SuperdexTM 16/60 200pg (GE Healthcare, UK) gel filtration column, pre-equilibrated with 
20 mM Tricine pH = 8.0, 1 mM ZnCl2. Homogeneous, recombinant LapA fractions were 
concentrated and stored at -20 ºC for further analysis; or 2) Alternatively, crude P.pastoris 
supernatant, containing the respective recombinant LapA constructs, was saturated to 90% 
ammonium sulphate by adding hard salt, followed by stirring for 1h at ambient temperature. 
LapA precipitant was pelleted by centrifugation at 16,000 g for 20 minutes. The collected 
pellet was re-suspended in 20mM Tricine pH = 8.0, 1 mM ZnCl2, followed by dialysis 
against the same buffer overnight at 4 ºC. At this point the purification procedure was 
equivalent to 1), starting at the anion exchange chromatography step. Recombinant protein 
purified, using protocols 1) and 2), was analysed on SDS-PAGE. 
The purification protocol depicted in Figure 2.1 was found to be most optimal to obtain 






Figure 2.1 Schematic of recombinant LapA purification workflow. From crude P.pastoris 
supernatant to homogenous activated recombinant LapA protein: time required – 3 days.   
 
Day  2 
Day  3 
Day  1 
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2.13.4.1 Activation of purified LapA proenzymes 
Activation of purified LapA proenzymes was achieved by incubating the target protein with 
AP1 protease fractions purified from Flavourzyme. The hydrolysis of propeptide domain 
was allowed to proceed for 1 – 2 hours at 37 ºC. The resultant mixture was subsequently 
loaded on MonoQ AEX column to isolate active mature LapA domain for downstream 
analysis and thermolability assays.  
2.13.5 Heterologous protein expression in Pichia pastoris - experimental 
workflow 
Experimental workflow of generating wild-type and mutant recombinant LapA P.pastoris 
strains is represented in Table 2.4 and Table 2.5, respectively.  
Table 2.4 Experimental pipeline for development of P.pastoris wild-type LapA strains and 
initial expression trial.  
 
Step order Step description Duration 
1 Quickchange PCR and E.coli transformation 1 day 
2 Colony PCR transformant verification  1 day 
3 Plasmid DNA purification and sequencing   1 day 
4 Large scale plasmid DNA preparation and 
linearization 
1 day 
Step order Step description Duration 
1 Gene synthesis and codon optimisation  14 days 
2 Linearized DNA transformation to P.pastoris 
X33 strain 
1 day 
3 Growth of transformants 3 days 
4 Colony PCR clone verification 1 day 
5 250 - 500mL shake-flask expression trial  6 days 
6 Glycerol stock preparation for positive 
P.pastoris mutant strains 
1 day 
 Total 26 days 
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5 Mutant DNA transformation to P.pastoris X33 1 day 
6 Mutant colony growth 3 days 
7 Colony PCR clone verification 1 day 
8 Small scale Biolector expression trial  5 days 
9 Glycerol stock preparation for positive 
P.pastoris mutant strains 
1 day 
10 Large scale shake flask trial 7 days 
11 Chromatography purification steps 4 days 
12 Enzymatic activation of LapA mutant 
precursors 
1 day 
13 Final purification step to isolate active mature 
LapA variants 
3 days 
 Total 30 days 
Table 2.5 Experimental pipeline for development of P.pastoris mutant strains, LapA protein 
expression and purification. Duration column represents number of days equivalent to 
preparing 5 different LapA mutant proteins.  
 
Table 2.5 describes sequential experimental workflow of cloning, expression and 
purification of LapA thermolability mutants. Recombinant expression of LapA proteins in 
eukaryotic host – Pichia pastoris – presented considerable challenges regarding the number 
of experimental steps, duration and complexity, which in turn increases probability of 
failure. To obtain 5 homogenous pure LapA mutant proteins for preliminary analysis at least 
30 days was required, provided every experiment in this sequence was successful. In fact, 
most of the times number of days would increase to at least 50 if travelling times to 
Biocatalysts and weekends were taken into account. Every experimental step was carried out 
in Reading, except steps 5 – 8 were implemented at Biocatalysts due to requirement of 
specialist equipment: electroporator for transformation of P.pastoris cells and Biolector for 




Chapter 3 FLAVOURZYME – ISOLATION OF NATIVE 




3.1 Introduction  
Flavourzyme is a commercial fungal extract obtained from Aspergillus oryzae fermentation 
broth. The commercial preparation is known to display endoprotease and exopeptidase 
activities and contains at least five known proteases (Blinkovsky et al., 2000). Flavourzyme 
is utilised across a number of food hydrolysis applications, mainly for flavour development 
of resultant bitter whey protein hydrolysates (WPH). Enzymatic de-bittering serves as the 
main tool to further process WPH for flavour development. For example, soybean protein is 
incubated with Alcalase (Subtilisin Carlsberg) and the resultant bitter product is further 
hydrolysed by Flavourzyme, yielding an improved taste profile with reduced bitterness of 
the soybean polypeptide mixture (Ma et al., 2013). Flavourzyme fungal extract contains two 
exopeptidases, namely, leucine aminopeptidase A (LapA) and leucine aminopeptidase 2 
(Lap2), either of which can remove the N-terminal hydrophobic amino acid residues that 
contribute to the pronounced bitter flavour of protein hydrolysates. Comprehensive 
structural and functional characterization of Flavourzyme proteases would be of benefit to 
determine the contribution of each protein to the process of enzymatic whey hydrolysis. 
At the start of the project, attempts were made to purify aminopeptidases directly from 
Flavourzyme, as this is a readily available, abundant commercial protein mixture (provided 
by Biocatalysts Ltd, UK). Thus, Flavourzyme provides a potential source of the enzymes of 
interest, from which, upon successful purification, could provide native LapA and Lap2 
proteins for structure determination and functional characterisation. In order to rationally 
design potential point mutations, which could render LapA thermolabile, it is desirable to 
obtain a three-dimensional structure. This would then allow direct incorporation of 
mutations that could result in altered thermal properties of this commercial aminopeptidase. 
Moreover, this structure-based mutagenesis approach would circumvent any inaccuracies 
arising, as a result of utilising an homology model, and would reduce speculative mutations 
that could lead to misfolded versions of the recombinant protein. In other words, having a 
three-dimensional structure of the target protein, obtained by X-ray crystallography, reduces 
the extent of mutant screening effort and allows a more accurate prediction of the 
implications of the rationally selected mutations. This has been a priority objective from the 
beginning of the project. Lap2, a non-specific aminopeptidase, is also produced by 
Aspergillus and, therefore, already is present in the commercially available Flavourzyme. It 
was decided to purify this aminopeptidase, along with LapA, for crystallisation studies and 
structural determination, which would provide insight into its mode of action and provide a 




3.2 Isolation of native Aspergillus aminopeptidases from 
Flavourzyme 
Partial separation of Flavourzyme proteases was achieved using size exclusion 
chromatography (SEC), even after a single purification step, as indicated in Figure 3.1. As 
none of the proteases isolated from the commercial preparation are recombinantly produced, 
any subsequent purification relies solely on the native properties of the given enzymes, such 










Figure 3.1 Separation of Flavourzyme proteins by size using a gel filtration column (HiLoad 
16/60 200pg, GE Healthcare). Fractions 1-5 contained protein (see Figure 3.2), and fraction 
6 contained unidentified small molecular weight compounds. 
 
Figure 3.1 shows the chromatogram obtained from an initial separation of Flavourzyme, 
following a single run on a size exclusion column (SEC), loading 3 mg of crude Flavourzyme 
extract and elution of 2 mL fractions from the SEC column. This purification step permitted 
a partial separation of an otherwise complex mixture of varying molecular weight 
Flavourzyme proteins. The identified Flavourzyme peaks were analysed for protein content, 










Figure 3.2 Analysis of Flavourzyme purification and 3-step isolation of flavLapA. 
Purification protocol for flavLapA (indicated by single arrow): i) separation Flavourzyme 
fractions on gel filtration column, Flav – Flavourzyme proteins prior to separation, I-IV- 
protein elution in four distinct peaks based on molecular weight, Fraction II contains Lap2 
(smeary band) protein, Fraction III (rectangle) – further purified using anion exchange 
(AEX) chromatography; ii) and further separation of Fraction III proteins (amylase – dashed 
double arrow; neutral protease I – solid double arrow) by AEX chromatography, using a 
linear gradient elution with increasing concentration of NaCl; iii) completion of flavLapA 
purification by adjusting 140 mM fraction (rectangle) to 500 mM NaCl and heating to 67 °C 
for 20 min., followed by final purification using SEC. 
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Following a successful initial separation of Flavourzyme proteins, it was not clear which 
fraction contain the target aminopeptidases (flavLapA and Lap2). The desired LapA and 
Lap2 enzymes were identified in the complicated mixture of proteins, using the LAP specific 
activity assay (see section 2.10.1) and mass spectrometry (section 2.12.3). MS analysis of 3 
gel bands, clearly revealed the identity of LapA, Lap2 and TAKA alpha-amylase (Figures 
10.1 - 10.3; Appendix I). LAP activity assay (Table 3.1), of each of the SEC fractions, 
showed Fraction II and Fraction III possessed the highest activity, and coincidently these 
were expected to contain Lap2 and LapA, respectively. Fraction IV showed moderate 
activity, and Fraction V showed negligible activity (not shown on the gel).  
Purified Flavourzyme fraction Specific activity (U/mg) 
Fraction II 8.0 ± 0.5 
Fraction III 20.0 ± 0.2 
Fraction IV 5.0 ± 0.3 
Fraction V 0.7 ± 0.1 
Table 3.1 LAP specific activities measured in SEC-isolated Flavourzyme fractions.   
 
3.2.1 Isolation of flavLapA 
Recently, an automated protocol, involving 9 steps, for purification of all Flavourzyme 
proteins (including flavLapA) was reported (Merz et al., 2015). In this study, we took a quite 
distinct approach to purification of native Aspergillus oryzae leucine aminopeptidase A, 
involving only 3 steps to isolate flavLapA from Flavourzyme commercial enzyme blend 
(Figure 3.2, i-ii-iii). A comprehensive description of flavLapA purification protocol is 
provided in section 2.7.3. In brief, the successive Fraction III from the initial SEC separation 
step was firstly loaded on AEX column. A subsequent AEX step was required to separate 
flavLapA from α-amylase and an unidentified brown pigment that is known to associate with 
the protein (Schalk et al., 1992). The latter we found very challenging and repetitive cycles 
using AEX chromatography were necessary to eliminate traces of this amber pigment, which 
was mandatory for crystallisation trials. Following repetitive AEX cycles, the eluent 
obtained was pigment-free (at 140 mM NaCl) and almost amylase-free, whilst at 1M NaCl 
the fraction contained most of the amylase and pigment (appeared dark brown) (Figure 3.2, 
ii). This mysterious brown pigment (Mr < 2kDa) was previously reported to associate with 
other Lap peptidases, and was briefly characterised by EPR to be spectroscopically active 
and contain Fe(III) ligand (Schalk et al., 1992, Hartley et al., 2009, Aphale and Strohl, 1993, 
Bennett and Holz, 1997). 
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Heat treatment was required as a penultimate step in the purification of flavLapA to 
efficiently separate it from contaminating neutral protease I and other lower MW proteins 
present in Flavourzyme (Figure 3.2, iii). Characteristic high thermal stability of native LapA 
allowed incubation at 67-70 °C for prolonged times, without precipitating the enzyme and/or 
losing activity. However, it is worth noting, that precipitation of other contaminating proteins 
in 20 minutes could only be achieved in the presence of 500mM NaCl or equivalent ionic 
strength of ammonium sulphate (results not shown). Similarly, intrinsic thermostability was 
utilised in the purification of an homologous aminopeptidase from Aeromonas proteolytica 
(AAP) (Prescott and Wilkes, 1976). As a result, homogenous, pigment-free flavLapA was 
obtained, following heat treatment at 67 °C for 20 minutes in the presence of 500 mM NaCl 
(Figure 3.2, iii). Purification of flavLapA by temperature denaturation proved particularly 
useful in the successful isolation of flavLapA. The discovery of this simple LapA 
purification method facilitated the ability to obtain higher yields of pure enzyme. 
 
3.2.2 Isolation of Lap2 
Figure 3.2 shows that Lap2 is the predominant enzyme in Fraction II and it appears to be 
homogenous. Thus, only one further purification step was attempted in an effort to obtain 
pure Lap2. In this instance, standard AEX chromatography protocol was applied for the 




Figure 3.3 UV trace (left) and SDS-PAGE gel (right) of AEX fractions from Fraction II 
purification. Gel analysis: 1 – Fraction II from SEC; 2 – 80 mM NaCl AEX peak; 3, 4 – 200 
- 250 mM NaCl AEX elution range; Lap2 is indicated by red arrows. The smearing of Lap2 
protein band indicates hyperglycosylation. Major contaminant protein is indicated by the 
dark blue arrow. 
 
It is easy to observe that the Lap2 protein 'smears' on the SDS gel (Figure 3.3). This is 
characteristic of the N-linked glycosylation of this eukaryotic protein (Blinkovsky et al., 
2000). These added sugars significantly contribute to the total MW of Lap2, and as a result, 
the migration of Lap2 on SDS-PAGE is observed at around 70 kDa. The predicted MW of 
Lap2, using ProtParam, is 52 kDa whereby the protein was reported to migrate around 56 
kDa following deglycosylation of the N-linked sugars (Blinkovsky et al., 2000). The 
smearing on the gel is a result of the heterogeneity of the glycosylated protein in the solution 
i.e. different degrees of glycosylation results in a variety of similar molecular weights for 
the same protein.  
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3.2.3 Initial challenges in flavLapA and Lap2 crystallisation trials  
3.2.3.1 Crystals of TAKA alpha-amylase 
Before the purification protocol for flavLapA was optimised, Fraction III was used to 
perform initial crystallisation screens in 96 – well plates, using high throughput robotics at 
Oxford Protein Purification Facility (OPPF-UK). It was anticipated that flavLapA crystals 
could still form, following the identification of a favourable condition using multiple 
commercial random screening matrices. On the other hand, Taka alpha-amylase was a rather 
abundant protein in Fraction III, therefore, not surprisingly, crystals of this protein 
preferentially formed overnight under JCSG F5 condition (Figure 3.4). Unfortunately, no 
crystals were obtained for flavLapA, even after two months, suggesting a more homogenous 
flavLapA preparation was required. 
 
Figure 3.4 Crystals of the TAKA alpha-amylase from Aspergillus oryzae (Flavourzyme). 
These crystals appeared in 24h under JCSG F5 condition (0.2 M Magnesium chloride 
hexahydrate, 0.1 M Tris pH = 8.5, 50 % v/v Ethylene glycol).  
 
The identity of TAKA alpha-amylase crystals were verified by X-ray crystallography and 
molecular replacement structure determination. We obtained a model at 1.69 Å resolution, 
which is a minor improvement to the highest resolution model (2.1 Å) available in PDB 
database at the time.  
Twenty crystallisation screens were set up in order to obtain diffraction quality crystals of 
LapA and Lap2, as isolated from Flavourzyme. In all trials, either Taka alpha-amylase or 
salt crystals were observed. It may be that the inhibition of crystal formation of the desired 
proteins is a result of the multiple N-glycosylation sites for these particular proteases 
(Matsushita-Morita et al., 2011, Blinkovsky et al., 2000). Based on the SDS-PAGE and MS 
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analysis of LapA and Lap2, the contribution to the molecular weight by these sugars is quite 
significant, i.e. an additional 7 kDa for the former and an additional 18 kDa for the latter. 
Thus, the effect of such heavy chains of sugars on crystal packing is unpredictable. By 
contrast, Taka alpha-amylase crystallises easily overnight from the first preparation of 
enzyme sample (Figure 3.4). This raises the question of the actual contribution of the 
glycosylation sites to the crystallisation process, as a single linked GlcNAc site for this 
amylase has been reported previously (Vujicic-Zagar and Dijkstra, 2006). However, this 
Taka alpha-amylase has only one glycosylation site as opposed to multiple sites in LapA (2 
sites) and Lap2 (6 sites), which would have a more pronounced effect on crystallisation, due 
to the inherent increased heterogeneity. Enzymatic deglycosylation can be used to overcome 
these problems (see the following section 3.2.3.2).  
3.2.3.2 Deglycosylation of Flavourzyme-isolated native Lap enzymes 
The glycoproteins flavLapA (further LapA) and Lap2 were subjected to PNGase F treatment 
in order to investigate the extent of glycosylation. LapA and Lap2 can potentially possess 2 
and 6 glycosylation sites, respectively. The removal of flexible N-linked sugars could 
facilitate the crystallisation of these proteins, since uncontrolled glycosylation can introduce 
heterogeneity into the sample preparation, which will interfere with crystallisation.  
20 µg of LapA and Lap2 were treated with PNGase and half of the reaction mixture was 
analysed on SDS-PAGE (Figure 3.5). The effect of PNGase was investigated under 














Figure 3.5 Analysis of LapA and Lap2 deglycosylation. Left to right: 1 – Flavourzyme-
purified LapA untreated, 2 – denatured LapA treated with PNGase, 3 – native LapA treated 
with PNGase after 4h, 4 - native LapA treated with PNGase after 24h, 5 - Flavourzyme-
purified Lap2 untreated, 6 - denatured Lap2 treated with PNGase, 7 -  native Lap2 treated 
with PNGase after 4h, 8 - native Lap2 treated with PNGase after 24h.   
 
As demonstrated in Figure 3.5, the treatment with PNGase was 100% effective on denatured 
and native LapA (after 24h). However, the equivalent degree of deglycosylation for Lap2 
could be achieved for the denatured protein only. The inaccessibility of some glycosylation 
sites (for PNGase enzyme) could explain why deglycosylation was incomplete in the case 
of native Lap2. This can be further verified, as smearing of both the 4 h and 24 h samples 
for Lap2 was still present, as observed by SDS-PAGE. However, some deglycosylation has 
occurred, as seen by the downshift in the molecular weight compared to untreated Lap2. This 
experiment verified the presence of fewer glycosylation sites on the LapA enzyme. 
Therefore, these sugars can potentially be removed prior crystallisation of flavLapA.    
To study the effect of deglycosylation on function, Lap activity assays were performed with 
fully deglycosylated LapA and partially deglycosylated Lap2. The activity of LapA was 
almost completely abolished – with only 1.5% activity recovered compared to the native 
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glycosylated LapA. Lap2 showed a 2-fold reduction in activity compared to the native 
enzyme (Table 3.2). Coincidentally, the findings from this experiment are in agreement with 
elimination of the N-glycosylation site in recombinant LapA (M5 mutant) by site-directed 
mutagenesis (sections 6.1.3 and 6.5.1.1), whereby the removal of N-linked sugar was 
detrimental to enzyme activity.  




flavLapA 94.6 ± 2.2 1.42 ± 0.5 
Lap2 21 ± 2.0 10.40 ± 0.4 
Table 3.2 Effect of glycosylation on the specific activity (U/mg) of LAP enzymes.    
 
3.2.4 Crystallisation of flavLapA   
Once the purification of flavLapA from Fraction III was optimised, by introduction of a 
heating step, the resulting homogenous LapA population readily crystallised in 3 – 4 days ( 
Figure 3.6).  flavLapA from Flavourzyme crystallised at 6 mg/ml in 20mM HEPES, pH = 
8.0 under JCSG F2 condition (0.1M Citrate, pH = 5.0, 3.2 M Ammonium sulphate) at 21 °C. 
 
 




3.2.5 Data collection and refinement of flavLapA crystal structure  
The crystal structure of flavLapA was determined to 2.71 Å resolution (see Table 10.1, 
Appendix III). The crystal packing showed spacegroup C2 with four LapA monomers in the 
asymmetric unit (Figure 3.7). At this resolution, a single N-acetylglucosamine (NAG) 
moiety was found covalently linked to the ND nitrogen of asparagine 87 (N87), showing N-
linked glycosylation. Further evidence of N-glycans were not definitive.  
Figure 3.7 Crystal structure of flavLapA at 2.71 Å resolution. Four protein monomers (A – 
D) were found in the asymmetric unit. Catalytic ZN ions are depicted as red spheres. 
 
By contrast, the observed crystal packing for the mature recombinant LapA (wtLapA) 
structure was quite distinct (see section 5.1). The wtLapA structure showed P6322 
spacegroup and only 1 molecule in the asymmetric unit. The observed differences in the 
crystal packing can be attributed to the different N-linked carbohydrate structures present in 
Aspergillus versus Pichia, which appears to affect the spatial packing and crystal contacts. 
The additional heat-induced purification step could result in structural alterations in 
flavLapA and thus play a role in the deglycosylation process. Therefore, it was concluded 
that the observed four molecules in the asymmetric unit of flavLapA is likely a 
crystallographic artefact and does not represent the biologically active molecule.         
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3.2.6 Evidence of primary thermal unfolding states in flavLapA  
The implemented heating step (67 °C, 20 minutes) in the purification protocol of flavLapA 
had a noticeable effect on protein fold integrity.  
Quite remarkably, each of the monomers in the asymmetric unit exhibit unique structural 
differences. Analysis and superimposition of Cα traces of each monomer (compared to each 
other) indicates significant surface loop movements (Figure 3.8). The most affected regions 
can be found in residues 140 - 144, 180 – 190, 215 – 220 and 265 – 275. Monomer B shows 
the most secondary structure content with two ZN ions coordinated at the active site pocket, 
as expected. A helix at 233 – 235 appears only in Monomer B. This structural element holds 
a catalytically conserved glutamate E233 motif in place at the active site. Thus, the observed 
movement of the E234 sidechain was the most significant in Monomers A, C and D with 1.5 
– 1.7 Å shift with respect to each other (Figure 3.8C). Altered positions of the sidechains of 
other active site residues were also apparent.  
Interestingly, only a single ZN ion was found in the active sites of Monomers A, C and D. 
Also, the corresponding ZN atom in each monomer was not directly superimposable. Taken 
together, these observations seem to suggest that we have trapped different states of thermal 




Figure 3.8 Superimposition of different asymmetric unit monomers of flavLapA. Monomer 
A – cyan, Monomer B – violet, Monomer C – orange, Monomer D – wheat; A Active site 
view: ZN ions are indicated as spheres; B 180° rotation view along y-axis; C 
Superimposition of active site residue sidechains and catalytic ZN atoms. 
69 
 
Figure 3.9 Superimposition of Monomer B (flavLapA) and wtLapA structures. Monomer B 
of flavLapA – violet, wtLapA – yellow. A Active site view: ZN ions are indicated as spheres, 
catalytic residues are shown as sticks; B 180° rotation view along y-axis. 
 
Figure 3.9 illustrates the major structural changes that occur in flavLapA protein compared 
to the crystal structure of recombinant LapA (wtLapA) (reported in section 5.1). The latter 
corresponds to appropriately folded, fully active LapA protein. As a result of thermal 
unfolding, two surface helices appear to be unravelled in flavLapA. The 215 – 220 region 
appears to have become so mobile that the K215-A218 residue stretch could not be traced in 
the electron density map and therefore could not be modeled (Figure 3.8, B; Figure 3.9, B). 
Additionally, the position of the active site residues and catalytic ZN atoms (I and II) are 
significantly altered. In particular, in flavLapA, ZN(I) atom appears to be completely 
expelled from the tetrahedral coordination geometry, resulting in a 4.2 Å movement. At the 
same time, the position of ZN(II) atom is shifted by 2.6 Å with respect to the same atoms in 
wtLapA protein (Figure 3.9, A).  
The observed distorted active site geometry, in the flavLapA structure, was also reflected in 
the reduced specific activity towards Leu-p-nitroanilide substrate. Surprisingly, it still 
retained a substantial level of activity and showed 94.6 ± 2.2 U/mg, which is approximately 
67% of that observed for the wtLapA (140.15 ± 4.8 U/mg). Overall structural comparison, 
using the TM-Align server, showed an RMS difference of 0.59 over 291 residues, between 
flavLapA Monomer B and wtLapA coordinates, confirming significant structural differences 
between the two crystal structures.    
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The flavLapA crystal structure has offered a deeper understanding of the thermal unfolding 
process of LapA. It seems apparent that unfolding has initiated at the surface loop regions 
and then propagated to the secondary structure elements (unravelling of 265 – 275 and 215 
– 220 helical elements). Coincidentally, in our thermolability mutagenesis strategy, we have 
also targeted the 267 – 272 helix, specifically with D271T (M8) mutation. It is likely that 
the success of this destabilising mutation could be attributed to the fortuitous selection of 
this region. Consequently, we have managed to mirror the thermal unfolding process 
required to inactivate the LapA protein.  
Analysis of flavLapA structure permits a more intuitive design of future mutagenesis 
libraries. Following the same rationale, future efforts toward LapA thermolability 
engineering could involve selecting mutations across a number of surface loops, including 




3.3 Isolation of NP1 and AP1 proteases from Flavourzyme 
Since LapA aminopeptidase is natively expressed in the form of precursor protein and is not 
a self-activating enzyme, it was speculated that LapA zymogen could be processed by one 
of the non-specific proteases present in Flavourzyme: neutral protease I (NPI) and/or 
alkaline protease I (API). These proteases in the Flavourzyme commercial enzyme mixture 
have been isolated previously by Merz at al. (Merz et al., 2015).  
Isolated Fraction IV from Flavourzyme contains at least two non-specific proteases (AP1 
and NP2) (Figure 3.2, i) that potentially are capable of effectively cleaving LapA 
propeptide, as shown previously (4.3.7.1). Thus, a 20% w/v Flavourzyme solution was 
separated into individual fractions by SEC (as described previously, section 3.2). Next, 
Fraction IV was loaded onto a 5ml Q HP AEX column, pre-equilibrated with 20mM Tricine 
pH 8.0, 1mM ZnCl2 and 1mM CaCl2. After 100mL wash, to remove unbound proteins, 
elution using a 1% stepwise gradient was initiated, using an equivalent buffer containing 1M 
NaCl. The main fractions eluted at 50, 170, 190 and 650 mM NaCl concentration increments 
in the elution buffer (Figure 3.10).  
  
Figure 3.10 SDS-PAGE of AEX purification of proteins in Flavourzyme fraction IV. Eluted 
fractions of increasing NaCl concentration are indicated. NP2 – neutral protease 2; AP1 – 




In this AEX purification experiment, AP1 protease did not strongly bind to the positively 
charged resin and continuously eluted in the flow-through and in the 50 mM NaCl fraction. 
Also, some NP2 protease and protein degradation products co-eluted in these fractions 
(Figure 3.10). Taka α-amylase and flavLapA eluted at 170 mM NaCl. NP2 separated at 190 
mM NaCl and was the most homogenous protein fraction obtained.  
It was not possible to separate AP1 and NP2 at 50 mM NaCl. However, there was no AP1 
present at 190 mM NaCl, which purely consisted of NP2, suggesting it has a considerably 
higher net negative charge and therefore bound to the AEX resin with increased affinity. 
This distinct separation of AP1 and NP2 proteins into discrete AEX fractions allowed 
investigation into which of the two non-specific proteases naturally activates LapA 
precursor.  
3.3.1 Improved isolation protocol of AP1 and NP1 proteases 
The current AP1 purification protocol consists of two purification steps: SEC separation of 
Flavourzyme proteins into 5 distinct pools (fractions 1 – 5), followed by separation of 
proteins in Fraction IV using AEX resin. In the protocol suggested by Merz et al. (Merz et 
al., 2015), it was possible to isolate another neutral protease (NP1) from Flavourzyme, along 
with AP1, in a single cation exchange chromatography (CAX) run. NP1 is another potential 
activator of LapA zymogen in Flavourzyme. Therefore, it was important to test whether NP1 
and AP1 are both equally important in LapA processing or whether they work synergistically 
to produce the appropriate N-terminal processing of LapA.  
A 20% w/v Flavourzyme solution (corresponding to approximately 12 mg of total protein) 
was prepared in cation exchange chromatography binding buffer (10mM Sodium acetate pH 
4.85, 0.1 ZnCl2, 0.1mM CaCl2) and loaded onto a 5mL SP HP CAX column. Fractions were 
eluted with equivalent buffer containing 1M NaCl.  
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Figure 3.11 Purification of Flavourzyme neutral proteases by CAX.  
 
Based on SDS-PAGE of the eluted CAX fractions, binding to the purification resin was not 
very efficient as there were still a large proportion of NP1, AP1 and NP2 proteins visible in 
the flow through (Figure 3.11). However, all the non-specific proteases present in 
Flavourzyme eluted in the 50 mM NaCl fraction. Also, AP1 protease showed a marginally 
increased affinity to the negatively charged CAX resin and eluted in the 80 mM NaCl 
fraction. Thus, it became possible to isolate AP1 in a single purification step, as opposed to 
the alternative lengthy protocol described above. Obtaining the NP1 protease in the same 
pool of enzymes (50 mM NaCl fraction) provided an opportunity to further separate it from 
AP1 protease and subsequently characterise it in the processing of the LapA zymogen. 
Furthermore, the 50mM NaCl CAX peak was applied to a MonoQ AEX column (Figure 




Figure 3.12 AEX purification analysis of 50mM NaCl CAX Flavourzyme fraction. NaCl 
elution peaks are shown as UV absorption chromatogram (left). SDS-page analysis of 
identified peaks (right): 1 – CAX flow through; 2 – 50mM NaCl CAX peak applied to AEX 
MonoQ column; 3, 4 – 50mM NaCl AEX peak; 5 – 100mM NaCl AEX peak; 6 – 120mM 
NaCl AEX peak; 7 – 140mM NaCl AEX peak; 8 – 160mM NaCl AEX peak; 9 – 180mM 
NaCl AEX peak. 
 
AP1 and NP1 Flavourzyme proteases were successfully separated using a MonoQ column, 
due to their slightly distinct binding affinity to the positively charged AEX resin. AP1 eluted 
at 50 – 120 mM NaCl, along with some NP2 protein, whereas the more strongly bound NP1 
eluted at 140 – 180mM NaCl. This rapid, two – step purification protocol enabled efficient 
isolation of the AP1 and NP1 non-specific proteases from Flavourzyme by combining 
complementary CAX – AEX purification techniques. Isolation of both NP1 and AP1 
proteases from Flavourzyme enabled the trials of LapA propeptide cleavage described in 
sections 4.3.7.1 and 4.3.7.2.  
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Chapter 4 OPTIMISATION OF HETEROLOGOUS 
EXPRESSION OF TARGET PROTEINS IN PROKARYOTIC 




4.1 Escherichia coli as host for recombinant protein expression 
At the onset of this thesis work, our industrial partner (Biocatalysts Ltd) had identified a 
number of commercially utilised exo- and endopeptidase enzymes that could be subjected 
to protein engineering in an effort to manipulate and exploit thermal properties, particularly 
thermolability. The selected peptidases (Subtilisin Carlsberg – sC and leucine 
aminopeptidase – LapA) originated from prokaryotic (sC) and eukaryotic (LapA) hosts. Due 
to the reduced complexity of an E.coli expression system and available expertise in our 
laboratory, this prokaryotic host was selected to conduct initial cloning and over-expression 
trials for the selected target proteins. A high-throughput cloning and expression platform 
also was available at the OPPF-UK research complex at Harwell, which could be used to 
screen for multiple expression constructs in E.coli, if deemed necessary. 
4.1.1 Selected endoprotease – Subtilisin Carlsberg (sC) 
Typically, subtilisin-like serine proteases are secreted into the extracellular environment 
upon expression in its natural host. And, in fact, Bacillus–derived sC endopeptidase is an 
extracellularly secrete enzyme. Therefore, a suitable E.coli expression strategy was first 
established to increase the success of obtaining soluble recombinant protein, since 
recombinant expression of such excreted proteins in the E. coli cytoplasm often results in 
the formation of insoluble protein aggregates or cell toxicity. As a result, laborious protein 
refolding techniques often need to be employed to recover the protein of interest from 
inclusion bodies (Parry, 2002). Despite these efforts, several successful cases of cytosolic 
expression of subtilisin-like serine proteases have been reported (Ghasemi et al., 2012, 
Taguchi et al., 1998a).   
To overcome any potential solubility problems, directing expression of sC in E.coli to the 
periplasm must be attempted, which could provide a less reducing environment with a lower 
abundance of naturally produced host proteins. The well-established and effortless sucrose 
extraction of periplasmic proteins was another added benefit of such a recombinant protein 
expression strategy (Neu and Heppel, 1965) and anticipated to provide a ready source of 
protein. It was expected that periplasmic expression in E.coli, of recombinant sC, would 
likely result in expression of the different forms of sC (mature and immature sC) as 
previously described (Sroga and Dordick, 2002). E.coli signal peptidases should effectively 
remove the signal sequence from the polypeptide chain, however, it is known that the 
propeptide induced automaturation of sC is a complex and slow process yielding a mixture 
of mature and pro-subtilisins (Shinde and Inouye, 1996, Yabuta et al., 2001). Nevertheless, 
directing expression of the recombinant protein to the periplasmic space in E. coli appears 
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to be a viable and robust method of obtaining soluble serine proteases (Koma et al., 2007, 
Wu et al., 2004). Furthermore, it is known that the mature part of the sC gene requires co-
expression with a propeptide, which acts as an intramolecular chaperone (Shinde and Inouye, 
1996, Ikemura et al., 1987). This propeptide has been shown to be obligatory for appropriate 
folding of subtilisin. Thus, the propeptide should precede the mature sequence in 
recombinant constructs of Subtilisin Carlsberg. Therefore, it was decided to over-express sC 
as zymogen both intracellularly and directed to the periplasmic space in E.coli.  
4.1.1.1 Bioinformatic analysis of Subtilisin Carlsberg (sC) 
An extensive literature survey was conducted in order to identify determinants of cold-
adaptation and heat lability in the superfamily of subtilisin-like serine proteases (see Table 
4.1). Such a comprehensive search enabled a list of potential site-directed mutations to be 
compiled, together with a rationalisation for each mutation. Taken together with a multiple 
sequence alignment (MSA) (section 2.1.1) of psychrophilic and thermophilic homologues 
of sC, numerous potential mutagenesis targets have been summarised in Table 4.1. 
The approach outlined herein utilises rationally designed mutations, based on accumulated 
knowledge from the literature that has been shown to destabilise the structure of mesophilic 
enzymes and to confer more flexibility to loops, break existing salt bridges, disrupt 
hydrophobic packing within the core of the protein, reduce the content of secondary structure 
(extend loop regions) and change the coordination pattern of any bound ions, in this case 
Ca2+. In addition, for the known structures (namely sC), crystallographic B-factor values  
also can be utilised as a guide for each of the target residues to be mutated, since a 
crystallographic B factor provides additional information regarding the mobility/flexibility 
of any given atom and/or residue (Reetz et al., 2009). In this case, the individual B-factors 
were assessed, using the on-line programme B-FITTER (Reetz and Carballeira, 2007), in the 










Pro 210 8.58 
Could be mutated to Gly or Ala. Reported in the literature to increase thermolability of sC (Fuchita et al., 
2012) 
Pro 5 8.09 
Located at the N-terminus, rigid (according to B factor). Increasing flexibility in C and/or N termini has been 
shown to have a destabilising effect on a protein (Riise et al., 2007) 
Pro 9 11.17 
Located further along the N-terminus, moderately rigid according to B factor, contained within a helical 
motif. Mutating Pro9 could help unravel the helix, which is predicted to increase flexibility (in general, 
reduction of secondary structures is desirable). This Pro is not conserved, Lys is found in homologous 
psychrophilic proteases. 
Pro 40 11.52 
His9 (B factor 7.38), Pro40 (B factor 11.52), Asp41 (B factor 7.43)  known as 'HPD' region. It may be that 
Pro40 is restricting the conformational flexibility of nearby residues (low B-factor values are observed in 
this region). Asp41 is coordinating a Ca2+ ion. These 3 residues are a potential site for randomisation 
(saturation mutagenesis).  
Pro 85 8.99 
Pro85 is well conserved within the superfamily. However, it is found in a loop, which could alter the 
conformation of the loop and subsequent Ca2+ coordination. 
Pro 167 9.14  Located in a loop. Strictly conserved. 
Pro 200 7.75  Part of a very conserved stretch of residues. 
Pro 225 5.26 
The most rigid residue in the structure. Close to Ser221 – active site residue. Potential to introduce a bulky 
residue that would not disrupt the helix completely but would introduce some conformational flexibility. 
Likely not relevant in the first round of mutations but could become important for later consideration, when 
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a shift of lower optimal temperature is desired. It also could introduce flexibility in the region of the active 
site, which could make the active site more readily accessible. 
Arg 
Arg 247 12.01 Disrupt E197-R247 salt bridge to weaken thermostability. 




Met 124 8.74 
M124T mutation would change the hydrophobicity pattern and present a more solvent exposed pocket, as 
Thr does not form favourable hydrophobic contacts, by comparison, and has a smaller side chain. Strictly 
conserved, away from the active site with respect to sequence, but close in proximity with respect to 
structure. Could be considered later, if there is a need to increase flexibility in the vicinity of the active site 
to increase accessibility. 
Met 222 9.87 
Strictly conserved, pointing towards the active site, preceding active site residue Ser221. Both M222 and 
M124 could be mutated to Thr, as it has been reported to be favourable in psychrophilic proteins. 
Val 84 7.01 
V84I. This mutation was shown to increase low-temperature activity in subtilisin BPN' compared to wild - 
typeenzyme (Kano et al., 1997). 
Val 72 6.99 V72I mutation was shown to have a large effect on thermolability of subtilisin BPN' (Taguchi et al., 1998b).  
Leucines  
Substitution of Leu to Ala/Val was reported to be favourable in psychrophilic enzymes. There are a relatively 




Table 4.1 The selected site-directed mutations for sC based on an extensive literature survey and multiple sequence alignment, as described in 
the text.  
Residues 




G131M/G131W substitutions were shown to confer increased low-temperature activity and thermolability 
for subtilisin BPN'; sC Carlsberg & BPN' share 70% identity (Taguchi et al., 2000). Also, G131D and D197N 
were reported to cold adapt subtilisin BPN (Tange et al., 1994).  
Ser 98  
Ser 99 
12.56 
15.27 S98D, S99D/ S105D, G106D. An increased number of negatively charged amino acids were observed in 
homologous cold-adapted proteases of sC, particularly, a high percentage of these were exposed on the 
surface of loops (Kulakova et al., 1999).  A negative surface potential is a common feature of cold-adapted 
enzymes, as many of these are characterized as acidic proteins. 








Y262 motif  
Destabilisation of the N and/or C termini. The C-terminus could be unravelled to make it more flexible. 
Flexible C and N termini were reported to lead to thermolability (Riise et al., 2007). Unravelling of the S260-
F261-Y262 helical motif could infer thermolability. 
Glu-Asp 
mutation  
Asp has a less favourable conformational entropy for stability than Glu and, Glu to Asp substitutions were 




4.1.1.2 Optimisation of recombinant cloning and expression of Subtilisin 
Carlsberg  
In order to direct the recombinantly expressed sC protein to either the E.coli cytoplasm or 
periplasm, specifically tailored pOPIN vectors (kindly donated by OPPF-UK) were utilised. 
The recombinant sC gene was designed to be inserted into both pOPINP and pOPINE 
expression vectors. These vectors present similar features, except the pOPINP (periplasmic 
expression) vector, also contains the pelB leader sequence, which is absent in the pOPINE 
vector (cytoplasmic expression). Also, pOPINF was later tried to test the effect of an 
additional N-terminal 6xHis-tag.  
The full open reading frame, containing the sC gene in the pOPINP vector, is shown in 
Figure 4.1. Cleavage of the pelB leader sequence was predicted, using the SignalP 4.1 










Figure 4.1 The amino acid sequence for sC in the pOPINP vector. Colour coding 
corresponds to pelB + propeptide + mature polypeptide + L + 6xHis. PelB is the signal 
peptide sequence that directs the expressed recombinant protein from the cytosol to the 
periplasm in E. coli, which in turn increases the chance of obtaining more soluble protein 
due to a less reducing environment and isolation from the vast majority of other E.coli 
proteins. 
 
A more visual representation of the components of the expression system used is provided 
in Figure 4.2.  
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Figure 4.2 Subtilisin Carlsberg expression vector constructed, employing InFusion cloning 
as described in section 2.2.5. The expression is driven by the T7 promoter; the pelB signal 
peptide directs recombinant protein expression to the periplasm and the propeptide sequence 
is required for correct folding and activation of Subtilisin Carlsberg. Lys – lysine is 
recognised by enterokinase for the effective hexahistidine tag cleavage.  
*there is no pelB signal peptide present in the pOPINE vector. 
 
The expression strains selected were the conventionally used BL21 (DE3) and Lemo21 (a 
derivative of the latter). Lemo21 allows titration of the expression levels by addition of L-
Rhamnose. This was important due to potential inclusion body formation, as the strong T7 
promoter-induced high rate of expression could interfere with the required maturation and 
correct folding of Subtilisin Carlsberg. The additional capabilities of the Lemo21 expression 
strain eliminate the need to design further constructs with a more tunable promoter (such as 
pBAD) in order to control the expression levels of recombinant protein (Guzman et al., 
1995). 
4.1.1.3 Challenging over-expression of sC in E.coli 
Following the successful cloning into target expression vectors, no recombinant sC was 
detected by SDS-PAGE and Western Blot in the first three expression trials (data not shown). 
To help resolve the lack of sC recombinant protein expression, a time course expression 
experiment, i.e. sample the expression at several continuous time points as the expression 
proceeds, was carried out. Samples at 2h, 4h, and 16h growth were taken. This was necessary 
in order to capture the expression of sC at an early stage, in the event that the protein was 
toxic to the E.coli cells and/or autolysis of sC had occurred. Upon ultrasonication processing, 
the cell resuspension buffer was supplemented with 1mM PMSF, to prevent autolytic 
degradation of sC. However, the outcome was similar – still, no recombinant sC was 
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detected. As the initial expression attempts did not yield any recombinant protein, it was 
decided to re-clone the sC constructs into pOPINP, pOPINE and pOPINF expression vectors 
utilising In-Fusion cloning as described in section 2.2.5 and re-evaluate expression in E.coli.  
Following construct verification by Sanger sequencing, sC-pOPINP, sC-pOPINE and sC-
pOPINF constructs were obtained, and a small scale expression trial was carried out in both 
B834 (DE3) and Lemo21 (DE3) expression strains. The cultures were incubated at 37 °C 
post-induction with IPTG, as described in section 2.6.3.   












Figure 4.3 Recombinant sC small scale expression analysis by SDS-PAGE. sC-pOPINP 
construct: 1,2,3,4 – pre-induction, culture supernatant, lysate, soluble fractions, respectively, 
in B834 cells; 5,6 – positive control of empty pOPINP; 7,8,9,10 - pre-induction, culture 
supernatant, lysate, soluble fractions, respectively, in Lemo21 cells; sC-pOPINF construct: 
11,12,13,14 - pre-induction, culture supernatant, lysate, soluble fractions, respectively, in 
B834 cells; 15,16,17 - pre-induction, lysate, soluble fractions, respectively, in Lemo21 cells; 
sC-pOPINE construct: 18,19 – lysate, soluble fractions, respectively, in B834 cells; Red 
















Figure 4.4 Recombinant sC small scale expression analysis by Western Blot. sC-pOPINP 
construct: 1,2 - lysate, soluble fractions, respectively, in B834 cells; 3,4 - lysate, soluble 
fractions, respectively, in Lemo21 cells; sC-pOPINF construct: 5,6 - lysate, soluble 
fractions, respectively, in B834 cells; 7,8 - lysate, soluble fractions, respectively, in Lemo21 
cells; Red arrows indicate the location of recombinant sC proenzyme (expected molecular 
weight 38 kDa). 
 
SDS-PAGE and Western Blot analysis indicated successful over-expression of sC-pOPINP, 
E,F constructs as inclusion bodies in the insoluble fractions (Figure 4.3 and Figure 4.4), 
possibly due to the high post-induction temperature and inappropriate time allowed for 
polypeptide folding. The predicted migration pattern of these protein constructs was near 38 
kDa, which was confirmed by the SDS-PAGE gels. The recombinant sC over-expression 
levels were quite low for all the constructs tested. This may be linked to the E.coli toxicity 
caused by recombinant Subtilisin Carlsberg and its subsequent degradation during the 
expression process. In particular, the periplasm-extracted sC (Figure 4.4 lanes 1 and 3) 
appeared to be in extremely low quantity.  
The next obvious experimental step was to reduce the post-induction temperature in an effort 
to slow down protein expression and provide a longer time for the folding process. Also, the 
cells were only allowed to produce sC for 5 hours, in an effort to reduce the extent of 
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autocatalytic degradation and improve the yield. sC-pOPINE construct was selected as the 
best expressor, as identified in the previous round (Figure 4.3, lane 18). In this next round 
of sC expression, the temperature was dropped to 28 °C, post-induction.   
 
Figure 4.5 Western Blot analysis of recombinant expression and purification of the sC-
pOPINE construct. A. insoluble and soluble fractions are indicated by red and green stars, 
respectively; 1,2 – sC expressed in Lemo21 cells; 3,4 - sC expressed in B834 cells, harvested 
after 5 h; 5,6 - sC expressed in B834 cells, harvested after 16 h; B. IMAC His-Trap 
purification: E – imidazole elution (100% buffer B). Soluble sC population is indicated by 
arrows.   
 
 
Figure 4.5 demonstrates that reduction of post-induction temperature had a substantial effect 
on soluble expression of sC. Although a small fraction of recombinant sC appeared as a 
soluble protein in B834 cells (Fig. 4.5 lane 4), the vast majority stayed in inclusion bodies. 
Also, the prolonged expression time resulted in sC degradation (Fig. 4.5 lane 6).  
A small quantity (only traceable on Western Blot) of active sC could be recovered, following 
an IMAC His-Trap purification (lane E) via the engineered C-terminal hexahistidine tag, 
suggesting a high rate  of autocatalytic degradation. As a result, only a trace amount of pure 




4.1.2 Selected exoprotease – leucine aminopeptidase A (LapA) 
Aspergillus – derived LapA exopeptidase is an extracellularly secreted enzyme. LapA 
originates from a eukaryotic organism and is known to contain N-linked glycosylation and 
intrinsic disulphide linkage, which is predicted to be essential for activity (Matsushita-
Morita et al., 2011). In addition, as the N-terminal propeptide must precede the mature 
sequence in all successive expression constructs, suggests a requirement of enzymatic 
activation to obtain a functional LapA protein. Therefore, the recombinant E.coli cloning 
and expression strategy for LapA included directing the protein to the periplasmic space to 
eliminate the disulphide-unfavourable reducing environment of the E.coli cytoplasm. LapA 
was produced, as a precursor, both intracellularly and in the periplasmic space (section 
4.1.2.1). At this stage, post-translational N-glycosylation was considered non-essential for 
the activity of LapA.  
4.1.2.1 Expression of recombinant Lap thermolability mutants 
At the onset of this work, a number of LapA and Lap2 expression constructs were obtained 
from Biocatalysts Ltd (the project industrial partner). The constructs obtained were designed 
in silico by Dr. Jonathan Mullins (Cardiff University), as part of a separate project with 
Biocatalysts Ltd, prior to our involvement in the project. However, none of these constructs 
had been tested for over-expression (Table 4.2). At the same time, the superiority of the 
SoluBL21 expression strain, to improve the recombinant protein solubility, was planned to 
be evaluated. Previous attempts (by Biocatalysts Ltd) showed that, for the constructs tested, 
the Lap mutants expressed as inclusion bodies (see section 3.6). Therefore, new attempts 
focused on the use of the SoluBL21 expression strain, in an effort to obtain soluble 




Table 4.2 The list of LapA (sequence denoted 20.3) and Lap2 (sequence denoted 20.1) 
mutants predicted to show thermolability, according to predictive work of J. Mullins 
(Cardiff). Adapted from a Biocatalysts Ltd internal report. 
 
All LapA and Lap2 mutants (Table 4.2) were engineered (in silico) towards achieving 
thermolability, using a novel thermodynamic approach developed by Dr J. Mullins. The 
sequence alterations mainly included deletions, insertions and truncations of N- and C-
terminal parts of Lap proteins. Only the mutant numbered 10_20.3 (LapA) was the 
unmodified mature version of the wild - type(WT) enzyme.  
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An initial expression trial was conducted with 10_20.3, 14_20.3, 1_20.1, 6_20.1 constructs. 
The SoluBL21 E.coli cell line and M9 minimal media were utilised, and the protein over-
expression was carried out, according to sections 2.6.2 – 2.6.4. Induced cells were grown at 
RT for 16 h. Also, construct 10_20.3 (LapA WT) was expressed in SoluBl21 combined with 
LB Broth. Induced cells were grown at 18  for 16 h.  
Figure 4.6 shows that recombinant expression was successfully obtained for 10_20.3 (LapA 
WT), 1_20.1 (Lap2), 6_20.1 (Lap2). A fraction of 10_20.3 protein was expressed as soluble 
protein, whereas both 20.1 mutants were expressed as inclusion bodies (observed in the cell 
lysate but not in the soluble supernatant). Constructs 1_20.1 and 6_20.1 match the expected 
molecular weights of 25.5 kDa and 29 kDa, respectively (Table 4.2). No obvious 












Figure 4.6 SDS-PAGE gel of LapA and Lap2 mutant expression trial. Left to right: M – 
protein ladder, Fraction III from SEC of Flavourzyme, Lap2 – purified from Flavourzyme, 
LapA – purified from Flavourzyme, 10_20.3 M9 – pre-induction+lysate+soluble supernatant 
samples (expressed in M9 minimal media), 10_20.3 LB - pre-induction+lysate+soluble 
supernatant samples (expressed in LB Broth), 14_20.3 M9 - pre-induction+lysate+soluble 
supernatant samples (expressed in M9 minimal media), 10_20.3 LB 4h – sample after 4h of 
induction, 1_20.1 M9 - pre-induction+lysate+soluble supernatant samples (expressed in M9 
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minimal media), 6_20.1 M9 - pre-induction+lysate+soluble supernatant samples (expressed 
in M9 minimal media). Recombinant proteins are indicated by red arrows. 
Additional Lap proteins from the mutant library (Table 4.2) were tested for expression in 
the SoluBL21 strain. However, none of the constructs tested (as illustrated in Figure 4.6) 
produced soluble protein in the intracellular E.coli expression trials (results not shown). This 
was verified by both SDS-PAGE and Western Blot analysis. Only wild - typeLapA 
(10_20.3) appeared in the soluble fraction using the SoluBL21 strain (confirmed by Western 
Blot).  
The insolubility of LapA and Lap2 thermal mutants was most likely due to misfolding. Upon 
receipt of the actual engineered sequences, a thorough investigation of the effects of these 
mutations on an homology model of Lap (Figure 10.7, Appendix II) used prior to our 
subsequent structure determination, suggested that the engineered alterations for the 
majority of these mutants were extensive, often involving complete removal of essential, 
core regions of secondary structure that would very likely affect proper folding of the 
polypeptide. Thus, it was difficult to establish whether SoluBL21 strain was advantageous 
to the general solubility of the recombinant protein. However, the fact that only the wild - 
typesequence showed soluble expression, further suggests the detrimental effect of the 
mutations on the protein integrity. 
SoluBL21 cell lysate of 20.3_10 (LapA WT) was tested for activity. Only about 10% activity 
(9.1 ± 0.2 U/mg) was observed compared to the activity of native Flavourzyme-purified 
LapA (94.6 ± 2.2 U/mg). As this was crude cell lysate, some non-specific processing of 
Leucine-p-nitroanilide (substrate) might have occurred. Although 20.3_10 recombinant 
protein was active, it may have suffered from the lack of available Zn2+ ions required for 
enhanced activity. And, eventhough 20.3_10 (LapA WT) was present in the soluble 
supernatant of the SoluBL21 cell lysate, the weak activity might stem from the protein being 




4.1.2.2 Characterisation of recombinant mature LapA (20.3_10) 
Since 20.3_10 LapA construct provided access to soluble mature protein in E.coli lysate, it 
was decided to explore its properties further.   
4.1.2.2.1 Expression levels of recombinant mature LapA (20.3_10) 
In order to estimate the expression levels of soluble recombinant LapA in different E.coli 
expression strains, 10_20.3 plasmid DNA was transformed into BL21 (DE3), Lemo21 (DE3) 
and SoluBL21 expression strains. Additionally, the effect of culturing BL21 cells in M9 
minimal media versus LB media was investigated. The expression levels were verified by 
SDS-PAGE and Western Blot analysis (Figure 4.7). 
 
Figure 4.7 Assessing expression of soluble recombinant LapA (20.3_10). A. SDS-PAGE 1, 
2 – insoluble and soluble fractions, respectively, BL21 (DE3); 3, 4 - insoluble and soluble 
fractions, respectively, Lemo21 (DE3); 5,6 - insoluble and soluble fractions, respectively, 
SoluBL21; 7,8 - insoluble and soluble fractions, respectively, BL21 (DE3) in M9 media; 
9,10 - insoluble and soluble fractions, respectively, BL21 (DE3) in LB media; B. WB 11, 12 
– insoluble and soluble fractions, respectively, in WB of SoluBL21; 13,14 - insoluble and 
soluble fractions, respectively, in WB of BL21 (DE3); 15,16 - insoluble and soluble 
fractions, respectively, in WB of Lemo21; red arrow indicates the location of recombinant 




BL21 (DE3) produced the most soluble LapA enzyme (Figure 4.7 A, lane 2). The levels of 
expression from Lemo21 (DE3) and SoluBL21 appear comparable (Figure 4.7 A, lanes 4 
and 6). This was further verified by Western Blot, where most of the soluble LapA was 
obtained in BL21 (DE3) cells (Figure 4.7 B, lane 14). No increase in the expression of 
soluble LapA protein was observed in BL21 (DE3) cells when M9 versus LB expression 
was compared (Figure 4.7 A, lanes 8 and 9). Therefore, BL21 (DE3) expression strain, 
combined with growth in LB medium, was selected for further over-expression of 
recombinant LapA. 
It is important to note that 20.3_10 protein was prone to formation of higher oligomeric 
states (~70 kDa band, Figure 4.7 B, lanes 11 - 15) in both insoluble and soluble (lower 
extent) fractions, as indicated by Western-Blot analysis.   
4.1.2.2.2 Purification and characterisation of soluble LapA (20.3_10) 
Soluble recombinant LapA, obtained from E.coli BL21 (DE3) lysate, was further purified 
and analysed. 20.3_10 LapA was purified using a 2-step protocol, whereby IMAC 
purification was followed by anion exchange chromatography, as described in section 2.7.1.  
 
Figure 4.8 Purification of recombinant 20.3_10 LapA by IMAC (A) and IEX (B). 1 – soluble 
supernatant of BL21 (DE3) containing LapA (red arrow), 2 – flow through from IMAC, 3 – 
unbound protein wash from IMAC, 4 – eluted fraction containing LapA from IMAC, 5- 
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dialysed LapA fraction following IMAC, 6 – IMAC-eluted LapA fraction loaded on IEX 
column, 7 – IEX flow through, 8, 9, 10 – peaks collected from IEX. The red arrow indicates 
the location of recombinant mature LapA enzyme (expected molecular weight 33.3 kDa).  
 
The IMAC-eluted fraction, containing recombinant LapA (Figure 4.8A, lane 4) had several 
contaminant proteins present. Thus, IEX chromatography was performed to further purify 
recombinant LapA, following overnight dialysis in 50 mM Bis-Tris Propane pH 8.0, 1mM 
ZnCl2. Dialysis was carried out to remove 0.5 M sodium chloride and 0.2 M imidazole, 
resulting from IMAC elution. The peaks in the IEX purification step were eluted at 110 mM, 
400-800 mM, 850-1000 mM of NaCl for lane 8, 9 and 10, respectively (Figure 4.8). Most 
of the recombinant LapA is contained within the fraction corresponding to lane 9. Elution of 
the LapA fraction at a high NaCl concentration implies a very tight interaction with the anion 
exchange resin. Thus, although IMAC purification provided separation of LapA from crude 
cell lysate, not much further separation was achieved in the subsequent IEX step, likely due 
to the very highly charged nature of LapA or possibly due to misfolding (which potentially 
exposes more hydrophobic and/or charged residues for enhanced interaction with other 
proteins).    
Lap activity assay was performed on the IMAC- and IEX-purified LapA fractions (see 
section 2.10.1), which exhibited only about 10% (9.1 ± 0.2 U/mg) of the activity obtained in 
the Flavourzyme-purified native LapA fraction (94.6 ± 2.2 U/mg). Since the 20.3_10 
construct possesses a hexahistidine tag anchored to its N-terminus, followed by the mature 
domain of Lap, it is likely that the inability to acquire a full catalytically competent enzyme 
stems from the lack of the ‘chaperone-like’ propeptide domain.  
4.1.2.3 Refolding studies of recombinant mature LapA (20.3_10) 
Since the observed activity of the recombinant LapA, obtained from soluble BL21 (DE3) 
over-expression, was particularly low, it was decided to re-solubilise the inclusion bodies 
using 8 M urea. Inclusion bodies, containing insoluble recombinant LapA, were re-
solubilised in 200 mL buffer containing 50 mM Tricine pH 8.0, 500 mM NaCl and 8 M 
Urea, followed by stirring for 24 h at 4 ºC. The solubilised supernatant was loaded onto an 
IMAC column and the purification proceeded according to section 2.7.1, except 8 M urea 
was included in the purification buffers. The IMAC-eluted fraction, containing LapA in 8 M 
urea (Figure 4.9, lane 6), was dialysed against 10 mM Tricine pH 8.0, 1 mM ZnCl2. 
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Subsequently, 8 mg of dialysed and re-folded LapA preparation was subjected to SEC 
purification, and the active fractions were pooled together (Figure 4.9 B, lanes 13 and 14).  










Figure 4.9 Purification of recombinant LapA from inclusion bodies by IMAC (A) and SEC 
(B). 1 – sample of re-solubilised pellet, 2,3,4 – flow through steps, 5 – unbound wash, 6 – 
eluted fraction; 7,8,9,10-12 – inactive SEC fractions, 13, 14 – active SEC fractions. Red 
arrows indicate the location of recombinant LapA enzyme. Black rectangle indicates pooled 
active LapA fractions. 
 
Binding of recombinant LapA to the IMAC column was not particularly efficient, as seen 
by substantial protein in the flow-through from the column (Figure 4.9 A, lanes 2 - 4). The 
imidazole-eluted fraction still contained several contaminant proteins. The bulk of the 
protein eluted from the size exclusion column was inactive, possibly due to mis-folding 
and/or non-specific aggregation. However, a correctly folded subset of the recombinant 
LapA eluted in separate fractions (Figure 4.9 B, lanes 13-14) and was combined for 
subsequent crystallisation trials, which were not successful (data not presented).   
The final pool of the refolded recombinant LapA (refLapA) showed a specific activity of 




4.1.2.4    Cloning and expression of recombinant LapA proenzyme (pro-
LapA) 
The previous work indicated potential problems with the folding of mature LapA 
polypeptide in E.coli (sections 4.1.2.2.2 and 4.1.2.3). Recombinant mature sequence of 
LapA was cloned, along with its native propeptide sequence, as it had been reported 
previously that the propeptide sequence was necessary for proper folding in the case of Lap 
from Vibrio sp. (Bzymek et al., 2004) - the closest structural homologue to LapA. Thus, pro-
LapA was cloned into the pOPINP expression vector, utilising In-Fusion cloning, as 
described in section 2.2.5. Following construct verification by Sanger sequencing (section 
2.12.2), a pro-LapA-pOPINP construct was obtained. A small scale expression trial for this 
new construct was carried out in B834 (DE3), Lemo21 (DE3) and Rosetta (DE3) expression 
strains. The cultures were incubated at 37 °C, post-induction with IPTG, as described in 
section 2.6.3. After 16 h, expression was analysed by SDS-PAGE and Western Blot (Figure 
4.10). 
 
Figure 4.10 Recombinant pro-LapA expression analysis. A (SDS-PAGE): 1,2 – negative control of 
empty pOPINP vector: lysate (1), soluble (2); 3,4,5,6 – pre-induction, culture supernatant, lysate, 
soluble fractions, respectively, in B834 cells; 7,8,9,10 - pre-induction, culture supernatant, lysate, 
soluble fractions, respectively, in Lemo21 cells; 11,12,13 - culture supernatant, lysate, soluble 
fractions, respectively, in Rosetta cells; B (Western Blot): 1, 2 - lysate, soluble fractions, respectively, 
in B834 cells; 3,4 - lysate, soluble fractions, respectively, in Lemo21 cells; Red arrows indicate the 
location of recombinant pro-LapA enzyme. 
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SDS-PAGE and Western Blot analysis indicated expression of the pro-LapA-pOPINP 
construct in inclusion bodies only, which could be due to the high post-induction temperature 
and insufficient time allowed for proper/complete polypeptide folding. The predicted 
migration pattern of this protein construct was at 40 kDa, which was observed. Western Blot 
analysis also revealed that recombinant LapA might form a dimer (high MW band above 50 
kDa), which could not be separated under reducing and denaturing SDS-PAGE conditions. 
Recombinant LapA production in the periplasm was not advantageous, with regard to its 
solubility. Therefore, it was decided to attempt cytoplasmic over-expression and improve 
protein solubility by controlling the rate of folding at lower temperatures. For this purpose, 
a pro-LapA-pOPINE construct was made, harbouring a C-terminal hexahistidine tag for 
downstream purification, with both 28 and 15 °C post-induction temperatures tried. The 
decreased post-induction temperature had a positive effect on pro-LapA solubility. Figure 
4.11 A shows that more LapA proenzyme was produced at 28 °C. However, no further gain 
in soluble pro-LapA population was noticeable when the temperature was reduced to 15 °C.  
LapA proenzyme bound the IMAC affinity resin, however, the elution profile indicated 
either the presence of co-eluting contaminant proteins or other oligomeric states of pro-LapA 
recombinant protein (Figure 4.11). The latter is more apparent from the SDS-PAGE analysis 
of IMAC-eluted fraction, where additional bands are present above and below pro-LapA 
(Figure 4.11 B).  
Figure 4.11 Western Blot analysis of recombinant expression and purification of the pro-LapA-
pOPINE construct. A insoluble and soluble fractions are indicated by red and green stars, 
respectively; 1,2 – expression in B834 cells at 28 °C; 3,4 - expression in B834 cells at 15 °C; B 
IMAC purification: E – imidazole elution (100% buffer B); an equivalent E loaded on SDS-PAGE 
is shown on the far right; Soluble pro-LapA population is indicated by arrows. 
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From the initial expression trials in E.coli, it was clear that pro-LapA was prone to forming 
non-specific aggregates and formation of inclusion bodies could be slightly alleviated by 
reducing the post-induction temperature. However, only a trace amount of inactive LapA 
precursor could be recovered, following purification, and the contaminants constituted a 
higher proportion in the eluate. 
 
4.2 Concluding remarks from target protein expression in E.coli  
Recombinant expression of Subtilisin Carlsberg in E.coli proved to be very challenging, 
mainly due to insolubility and autocatalytic degradation of the target protein sequence tried. 
Directing protein transport to the periplasmic space did not circumvent these challenges. 
Only traces of purified sC could be detected on Western Blot, obtained from a relatively 
large amount of biomass (1.6 L). This would hinder subsequent in vitro studies, including 
thermolability mutant expression and crystallisation, of Subtilisin Carlsberg.  
Similar challenges were experienced with recombinant over-expression of leucine 
aminopeptidase A in E.coli. Although the refolded population of mature LapA (refLapA) 
from E.coli inclusion bodies was moderately active, it was highly likely that propeptide 
sequence was required to obtain a fully functional enzyme. However, the bulk of 
recombinant LapA, produced with its propeptide domain, appeared in inclusion bodies, even 
following optimisation of the expression conditions. Additionally, the intracellularly 
obtained soluble fraction of pro-LapA could not be readily isolated from other E.coli lysate 
proteins, was susceptible to aggregation, and was shown to be inactive. 
Coincident with this work, preliminary recombinant LapA expression trials in Pichia 
pastoris were showing promise (worked conducted by research scientists at Biocatalysts 
Ltd). Therefore, in conclusion to these two pieces of work, it was agreed that food grade 
recombinant expression host Pichia pastoris could provide a more viable route for over-




4.3 Pichia pastoris as host for recombinant protein expression 
LapA enzymes originate from the eukaryotic fungus Aspergillus oryzae. Post-translational 
modifications, such as N-linked glycosylation, were predicted to be present in native LapA 
produced by A. oryzae and subsequently could be important either for folding and/or 
function of the enzyme, providing a further driver for the choice of Pichia pastoris as a 
suitable expression host.  
4.3.1 Initial attempts of wild-type LapA over-expression  
For this work, two expression constructs were produced; one harbouring a native signal 
secretion sequence plus the propeptide sequence preceding the LapA N-terminal mature 
domain, the other harbouring a MATα S. cerevisiae secretion sequence plus the propeptide 
sequence preceding the LapA N-terminal mature domain. The preliminary work (by 
Biocatalysts Ltd) showed that both of these constructs yielded comparable levels of 
extracellular secreted recombinant LapA precursor. However, due to the presence of 
propeptide, the expressed protein required subsequent enzymatic activation, which was not 
a cost-effective process for Biocatalyst Ltd. Nevertheless, this work provided the rationale 
to continue recombinant LapA expression in P. pastoris and to explore a variety of other 
expression constructs, in an effort to obtain soluble, functional mature protein.  
LapA (codon optimised and synthetised gene by DNA 2.0, California, USA) containing its 
N-terminal native signal sequence and propeptide was placed under the control of a PAOX 
methanol-inducible promotor in a pD912 expression vector. In this way, an expression 
construct harbouring the LapA native signal peptide and propeptide sequences (pD-npro-
LapA) was obtained. Other variants of LapA also were produced (pD-∆pro-LapA and pD-
npro-LapA-His6, Table 4.3), as detailed in the following sections. The rationale behind 
making the last two constructs was to determine whether LapA could be expressed and 
properly folded in the absence of propeptide in P.pastoris (∆pro construct) and whether 
subsequent expression could be facilitated by co-linking a hexahistidine tag to the C-












































Table 4.3 Open reading frame amino acid sequences of LapA expression constructs 
synthesised in pD912 P. pastoris expression vector. Native LapA secretion signal, 
propeptide, mature sequence and His6 tag are depicted in red, blue, black and purple, 
respectively. 
 
4.3.1.1 Generating a P. pastoris expression strain for wtproLapA  
20 µg of pD-npro-LapA plasmid DNA was linearized using SacI-HF endonuclease, as 
described in section 2.13.1. Approximately 7 µg of linearized DNA was recovered for 
transformation. The quality of linearized DNA was evaluated on 1% agarose gel (Figure 
4.12).    
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Figure 4.12 1% DNA agarose gel of SacI-HF linearized pD-npro-LapA plasmid DNA. 
Ladder - 1 kb DNA Ladder (NEB, UK), Lane 1 - Linear empty pD912 vector, Lane 2 – linear 
pD-npro-LapA.  
 
Figure 4.12 shows a single, narrow DNA band for the linearized pD-npro-LapA plasmid. If 
SacI-HF digestion was inefficient, typically, the resulting DNA bands would become 
smeared, indicating supercoiled plasmid DNA. The pD-npro-LapA transformation protocol 
did not include screening for ‘Bonus’ transformants. Electroshocked X33 cells were 
dispersed on agar plates containing 100 µg/mL Zeocin. Approximately 70 colonies were 
observed, following a 3-day incubation at 28ºC. Five large and five small colonies were 
picked for colony PCR to account for any phenotypic difference among P.pastoris 
transformants. PCR reactions were performed, according to section 2.13.1, using AOX1 
primers: 5’ – GACTGGTTCCAATTGACAAGC – 3’ and 5’ – 
GCAAATGGCATTCTGACATCC – 3’.   
 
 
Figure 4.13 1% DNA agarose gel analysis of PCR amplicons of pD-npro-LapA 
transformants. Ladder - 1 kb DNA Ladder (NEB, UK), Lanes 1 – 10 represent different 
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transformants. Positive (+, PCR using pD-npro-LapA as a template) and negative (-, PCR 
using empty X33 strain) controls are indicated. AOX1 (2.2 kb) and wtproLapA (1.2 kb) 
amplified loci are indicated by arrows.    
 
It is clear that colony PCR produced many non-specific bands (below that indicated for 
wtproLapA; Fig 4.13). Transformants 6 and 7 gave single profiles of only a weak signal for 
the putative amplicon of wtproLapA (expected size 1267 bp). The negative control also has 
a band of equivalent size to the wtproLapA amplicon. Therefore, a false positive signal with 
other transformants clearly was possible. Nevertheless, clones 6, 7 and 9 were selected for 
further expression trials. Clones 6 and 7 exibited the most clean amplification profiles. Clone 
9 was randomly selected.  
4.3.1.2 Shake flask expression trial of wtproLapA 
Positive transformants were subjected to a shake flask expression trial, according to section 
2.13.3.  In brief, 250 mL secondary cultures were initiated in 2L baffled flasks to ensure 
appropriate aeration. Table 4.4 shows the cell density measured in cultures after 23h 
incubation and the volume of primary culture that was centrifuged to inoculate a secondary 
culture, equivalent to OD600 = 1. Importantly, the following morning primary cultures were 
found shaking at a temperature just under 36 ºC, due to a fault with the incubator. 
Temperatures above 30 ºC may induce cell death of P. pastoris. However, the experiment 
was continued, since it was not clear how the incubator failure to maintain the correct 
temperature (during the course of the experiment) could affect protein expression.  
Flask OD600 23h 
Volume (mL) of culture added to BMMY 
(250mL) 
Clone 6 20 12.5 
Clone 7 27 9.26 
Clone 9 29 8.62 
Table 4.4 Cell density measured in the primary culture of different wtproLapA clones.  
  
Table 4.5 shows the cell densities observed in the secondary cultures of different wtproLapA 
clones within a 5-day continuous MeOH induction. Likely, due to previous overheating of 
the primary cultures, it was observed that growth in the secondary cultures was not steadily 
increasing (Clone 9) or the OD’s were fluctuating (Clone 7).   
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Flask OD600 24h OD600 48h OD600 72h OD600 96h OD600 120h 
Clone 6 22 24 19 26 33 
Clone 7 25 25 23 23 32 
Clone 9 17 17 17 22 26 
Table 4.5 Cell density measured in the secondary culture of different wtproLapA clones.  
 
After 120h, wtproLapA supernatants were sampled and analysed by SDS-PAGE (Figure 
4.14). However, no firm conclusions could be drawn regarding the expression of 
recombinant wtproLapA. Multiple protein bands of varying molecular weights were 
observed for clones 6, 7 and 9 (Figure 4.14). The predicted molecular weight of wtproLapA 
is 39.3 kDa, excluding glycosylation. Therefore, the observed band for each of clone 6 and 
9, close to the 29 kDa molecular weight marker, was unlikely to represent a wtproLapA 
protein. No LapA specific activity was detected from clone 6, 7 or 9 supernatants, suggesting 
absence of the expressed target protein. Additionally, the presence of other lower and higher 
molecular weight bands could be an indication of ER-associated degradation (ERAD) or 
initiation of the unfolded protein response (UPR) in P. pastoris (Vanz et al., 2014). This 
could be a consequence of the over-heating in the primary culture step.   
 
Figure 4.14 SDS-page analysis of wtproLapA supernatants, following 120h induction. Lane 
1 – Clone 6; Lane 2 – Clone 7; Lane 3 – Clone 9; red arrows indicate the lower and higher 





4.3.1.3 Purification of wtproLapA Clone 7  
Despite the problems experienced, AEX purification was attempted, using clone 7 
supernatant, in order to ensure no inactive LapA precursor or mature protein was expressed 
in this trial. Eluted fractions were subjected to LapA assay, but none of these displayed 
activity. Only accumulation of low molecular weight polypeptides was noticeable (at the 
bottom of the gel, Figure 4.15) suggesting severe protein degradation products. This 
provided further evidence to suggest that the ERAD response in P. pastoris had been 
triggered during cultivation of the primary culture.      
 
Figure 4.15 SDS-PAGE analysis of wtproLapA 
supernatants and subsequent AEX purification. Lanes 
1, 2, and 3 correspond to sampled supernatants of 
clones 6, 7 and 9, respectively. Lanes 4, 5 and 6 
correspond to eluted 0.1, 0.2 and 1M NaCl AEX 




4.3.1.4 Generating a P. pastoris expression strain of wtΔproLapA  
A second expression construct, containing a deletion of the LapA propeptide (pD-∆pro-
LapA) was produced, utilising the QuickChangeTM II site-directed mutagenesis kit (see 
section 2.13.1 for details). Deletion of the propeptide sequence was achieved by performing 
PCR with the following designed primers: 5'-
GGACGCTATCTGGATAAGCTAATGCGCTTGCC-3' and 5'-
GGCAAGCGCATTAGCTTATCCAGATAGCGTCC-3', using the pD-npro-LapA 
construct as a template. Following the QuickchangeTM PCR reaction and subsequent 
transformation into E.coli, successive clones were screened by colony PCR, using the AOX1 
primer set. Twenty single colonies (numbered 1-20) were randomly picked and patch plated 
on LB agar, containing 100 µg/mL Zeocin. With the exception of number 4, all of the pD-





Figure 4.16 1% DNA agarose gel of PCR amplicons of pD-∆pro-LapA E.coli clones. 
Positive (+), PCR using pD-∆pro-LapA as a template, control is indicated. The expected size 
of ∆pro-LapA amplicon is 1084 bp. 
 
Transformant number 12 was randomly selected for large scale plasmid DNA preparation 
(see section 2.2.2 for details). Following MidiPrep plasmid DNA purification, 354 µg of pD-
∆pro-LapA vector was obtained and 20 µg was subsequently linearized with SacI-HF. As 
demonstrated in Figure 4.18, a successful DNA linearization quality check was required 
before transformation. Around 5 µg of linearized DNA was transformed into a P. pastoris 
X33 strain, screening for multiple genome recombination events (‘Bonus’ transformants) on 
agar supplemented with 2 mg/mL Zeocin.           
4.3.1.5 Generating a P. pastoris expression strain of wtproLapAhis  
A third expression construct, harbouring a C-terminal hexahistidine (His6) tag also was 
cloned using a QuickChangeTM II site-directed mutagenesis kit and pD-npro-LapA plasmid 
as a template. The addition of a His6-tag in the pD-npro-LapA-His6 expression construct 
was implemented by performing PCR with the following designed primers: 5'-
TTGCTGACTCTCTGAAACATCACCATCACCATCACTAAGGGGCGGCCGC-3' and 
5'-GCGGCCGCCCCTTAGTGATGGTGATGGTGATGTTTCAGAGAGTCAGCAA-3'. 
A carboxypeptidase A recombinant His-tag cleavage site (Lys) also was engineered 
upstream of the histidine repeats.  
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Following a QuickchangeTM PCR reaction and subsequent transformation into E.coli, 
plasmid DNA of successive clones was extracted and screening was performed using HinfI 
digestion (see section 2.2.4 for details). PCR-based colony screening was not feasible, due 
to a modest difference between pD-npro-LapA and pD-npro-LapA-His6 amplicons. HinfI 
digestion of plasmid DNA should have revealed a small band difference of 628 bp and 604 
bp between the template above and the mutant DNA, respectively. 300 ng each of control 
and 5 mutant clone plasmid DNA were treated with HinfI and loaded on a 1.5% agarose gel 
for analysis (Figure 4.17).    
Figure 4.17 shows that all five mutant clones displayed a smaller (604 bp) DNA band and, 
therefore, had the His6-tag successfully cloned. Clone number 1 was selected for large-scale 
plasmid DNA preparation, as described in section 2.2.2.  
 
 
Figure 4.17 1.5% DNA agarose gel analysis of HinfI-digested pD-npro-LapA-His6 plasmid 
DNA clones. A. Simulation of the expected digestion pattern: lane 1 – band pattern in 
original vector, positive control (pD-npro-LapA), lane 2 – band pattern in the mutated pD-
npro-LapA-His6 vector; B. Actual HinfI digestion patterns observed for positive (+) control 




Following MidiPrep plasmid DNA purification, 168.2 µg of the pD-npro-LapA-His6 vector 
was obtained and 20 µg was subsequently linearized with SacI-HF. Following verification 
of linearisation (Figure 4.18), around 6 µg of linearized DNA was transformed into a P. 
pastoris X33 strain, screening for multiple genome recombination events (‘Bonus’ 
transformants) on agar supplemented with 2 mg/mL Zeocin.           
 
Figure 4.18 1% DNA agarose gel of SacI-HF linearized pD-∆pro-LapA and pD-npro-LapA-
His6 plasmid DNA. Lanes 1 and 3 correspond to undigested and digested pD-∆pro-LapA, 
respectively; lanes 2 and 4 correspond to undigested and digested pD-npro-LapA-His6, 
respectively. 1.5 µg of DNA was loaded in each sample lane.   
 
Figure 4.18 shows single, narrow DNA bands for pD-∆pro-LapA and pD-npro-LapA-His6 
linearized expression plasmid (lanes 3 and 4). As stated previously, if the SacI-HF digestion 
was inefficient, the DNA bands would be smeared, indicating super-coiled plasmid DNA. 
In this case, smearing of untreated plasmid DNA is clearly seen in lanes 1 and 2.  
 
4.3.1.6 Optimising P. pastoris colony PCR  
Previous colony PCR for wtproLapA transformants was conducted in the laboratory at 
Biocatalysts Ltd. Following formation of P. pastoris colonies, strains pD-∆pro-LapA and 
pD-npro-LapA-His6 were brought back to Reading to resume with colony PCR clone 
identification, which appeared to be difficult to replicate. Due to unidentified reasons, colony 
PCR was not producing any visible DNA bands on the agarose gel, even when using the 
previously established protocol (section 2.13.1). It was assumed that the failure of the PCR 
reaction could arise from problems in either the DNA extraction step or differences in 
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heating block temperatures of different PCR machines. Therefore, for the purposes of these 
and further experiments, requiring colony PCR for wtproLapA transformants, these were 
carried out on site at Biocatalysts Ltd (as described below), then transferred to Reading. 
4.3.2 Ab initio development of wtproLapA and wtΔproLapA P. pastoris 
expression strains 
Due to complications in the previous rounds of expressing recombinant LapA precursor and 
the challenges with colony PCR clone identification at Reading, it was decided to re-generate 
the P. pastoris expression strains for wtproLapA and wt∆proLapA proteins.   
However, this time all the protocol steps outlined in Table 2.4 were carried out at 
Biocatalysts Ltd. Screening for multiple genome recombination events (‘Bonus’ 
transformants), on agar supplemented with 2 mg/mL Zeocin, yielded around 30 single 
colonies for both wtproLapA and wt∆proLapA transformants. Ten large and ten small 
colonies were picked for colony PCR, from both strains, in the event that there was a 
phenotypic difference among P. pastoris transformants. PCR reactions were set up, 
according to section 2.13.1, using the following AOX1 primers: 5’ – 
GACTGGTTCCAATTGACAAGC – 3’ and 5’ – GCAAATGGCATTCTGACATCC – 3’.  
Figure 4.19 shows that the colony PCR of pD-npro-LapA clones produced clean 
amplification signals just above the 1 kb reference mark (expected amplicon size 1267 bp). 
Clones 2, 3, 5, 6, 12, 15 and 16 were selected for shake flask expression trials. Since all 
randomly selected colonies were growing on extremely high concentration Zeocin plates, 
clones that produced no amplification product were likely to contain the recombinant LapA 




Figure 4.19 1% DNA agarose gel of PCR amplicons of pD-npro-LapA P.pastoris 
transformants. Positive (+, PCR using pD-npro-LapA as a template) and negative (-, PCR 
using empty X33 strain) controls are indicated.    
 
Similarly, the colony PCR of pD-∆pro-LapA clones produced clean amplification signals 
just above 1 kb reference mark (expected amplicon size 1084 bp) (Figure 4.20). Clones 5, 
6, 7, 8, 9, 12 and 13 were selected for shake flask expression trial.  
 
Figure 4.20 1% DNA agarose gel of PCR amplicons of pD-∆pro-LapA P. pastoris 
transformants. Positive (+) control PCR using pD-∆pro-LapA as a template is indicated.    
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4.3.2.1 Shake flask expression trial of wtproLapA and wtΔproLapA 
Selected transformants were subjected to shake flask expression trials, according to section 
2.13.3.  250 mL secondary cultures were initiated in 2L baffled flasks to ensure appropriate 
aeration. Table 4.6 and Table 4.7 show the cell density measured in cultures after 23h 
incubation and the volume of primary cultures that were centrifuged to inoculate the  
secondary cultures, equivalent to OD600=1.  
Table 4.6 Cell density measured in the primary culture of different wtproLapA clones.   






wtproLapA OD600 23h 
Volume (mL) of culture added to BMMY 
(100mL) 
Clone 2 47 2.13 
Clone 3 45 2.2 
Clone 5 46 2.2 
Clone 6 52 1.9 
Clone 12 47 2.13 
Clone 15 43 2.33 
Clone 16 46 2.2 
wt∆proLapA OD600 23h 
Volume (mL) of culture to BMMY 
(100mL) 
Clone 5 47 2.2 
Clone 6 43 2.2 
Clone 7 40 2.5 
Clone 8 32 3.2 
Clone 9 48 2.1 
Clone 12 41 2.5 
Clone 13 45 2.2 
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Table 4.8 shows the cell densities observed in the secondary cultures of different wtproLapA 
clones within a 5-day continuous MeOH induction. After each addition of MeOH, a steady 
increase in cell density was noticeable across all wtproLapA clones tested. Before harvesting 
supernatants at 120h, OD600 reached an expected range between 35 – 50, indicating healthy 










Table 4.8 Cell density measured in the secondary culture of different wtproLapA clones. 
 
Table 4.9 shows cell densities observed in secondary cultures of different wt∆proLapA 
clones within a 5-day continuous MeOH induction. Similar healthy P. pastoris cell growth 



















Clone 2 12 15 21 33 39 
Clone 3 14 21 25 35 46 
Clone 5 11 17 20 34 37 
Clone 6 12 15 22 30 35 
Clone 12 15 20 22 36 46 
Clone 15 13 18 23 41 49 












Clone 5 13 16 21 31 35 
Clone 6 15 19 27 37 40 
Clone 7 16 19 25 31 36 
Clone 8 16 18 25 32 37 
Clone 9 15 18 26 32 37 
Clone 12 17 21 34 40 42 
Clone 13 12 19 25 38 45 
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After 120h, wtproLapA and wt∆proLapA supernatants were sampled and analysed on SDS-
PAGE (Figure 4.21).  
 
Figure 4.21 SDS-PAGE of wtproLapA and wt∆proLapA supernatants, following 120h 
MeOH induction. Lanes corresponding to different clone numbers are labelled. Expression 
control – P. pastoris X33 empty strain is also shown. Red and orange arrows indicate mature 
(~37 kDa) and precursor (~44 kDa) forms of LapA protein, respectively. 10 µL of each 
supernatant was loaded onto the gel.  
 
In general, the recombinant protein secreted by P. pastoris in the supernatant was very pure, 
with almost no contaminant proteins. The clonal variation was apparent in the supernatant 
profiles of the wtproLapA strain (Figure 4.21, Clones 3, 12). Most of the wtproLapA 
proteins were expressed as precursors, except Clone 12, where the bulk of recombinant 
protein appeared in the active form. Some pre-processed protein also was noticeable in other 
wtproLapA supernatants ( 
Figure 4.21, Clones 15 and 16). Conversely, no obvious clonal variation was present in the 
expression profiles of the wt∆proLapA strain. Since the wt∆proLapA expression construct 
contained a deletion of the propeptide domain, the recombinant protein was secreted in the 
mature form, across all clones. Based on the SDS-PAGE analysis, it was evident that the 
wt∆proLapA strain exhibited significantly lower secretion levels in P. pastoris supernatant 
(Figure 4.21). The secretion levels of the recombinant protein were also estimated by 
Bradford assay in each supernatant: clones of the wtproLapA strain showed protein content 
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in the range of 0.2 – 0.4 mg/ml, whereby equivalent values for wt∆proLapA clones varied 
between 0.05 - 0.07 mg/ml. The 4-fold reduction in secretion levels of wt∆proLapA highlight 
the likely requirement of the prodomain in LapA expression.  
Specific activity levels in each crude supernatant were measured using a standard LapA 









Table 4.9 LapA specific activities measured in the crude P. pastoris supernatants. NA – no 
activity. Mostly active clones are highlighted in grey.  
 
Since most of the wtproLapA clones were secreted as precursors, none or very low levels of 
activity were detected in the respective supernatants, suggesting that the LapA propeptide 
acted as an intra-molecular inhibitor. Only Clone 12 of wtproLapA showed significant levels 
of specific activity, owing to the activated form of the enzyme present in this supernatant. 
Interestingly, only Clone 7 of wt∆proLapA showed a substantial increase in activity. 
However, the resultant mature wt∆proLapA recombinant proteins were very sensitive to 
changes in temperature. Several repetitive cycles of incubation on ice lead to complete 
enzyme inactivation. A single freeze-thaw cycle with Clone 7 showed the same effect. No 
significant change in activity was observed for wtproLapA Clone 12 when the equivalent 
stability tests were performed. These observations might suggest a lack of stable protein fold 








Clone 2 NA Clone 5 NA 
Clone 3 0.03 Clone 6 NA 
Clone 5 NA Clone 7 15.2 
Clone 6 0.05 Clone 8 NA 
Clone 12 2.1 Clone 9 0.42 
Clone 15 0.03 Clone 12 0.3 
Clone 16 0.8 Clone 13 NA 
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4.3.2.2 Replicating expression trial for wtLapA Clone 12 deviant   
To further investigate the observed completely mature secretion of wtLapA (an apparent 
outlier), it was decided to replicate the expression trial in P. pastoris from prepared glycerol 
stocks. Some wtLapA glycerol stock was streaked on YPD agar supplemented with 2000 µg 
to ensure the growth of ‘Bonus’ transformants with multiple recombinant gene insertions. 
10 individual clones were picked to inoculate primary cultures to account for potential clonal 
variation. Standard shake flask expression protocol was implemented (section 2.13.3). 
Following 120h, supernatants were sampled and analysed on SDS-PAGE (Figure 4.22).  
 
Figure 4.22 SDS-PAGE analysis of wtLapA Clones 1 – 10 supernatant, following 120h 
MeOH induction. Lanes correspond to clone numbers from 1 to 10.  
 
In this expression trial, of 10 individual wtLapA clones, the completely mature population 
could not be found in any of the supernatants analysed (Figure 4.22). Obvious clonal 
variation was present, where Clone 1 secreted additional high molecular weight proteins, 
while Clone 10 failed to secrete any significant amount of recombinant enzyme. Clone 2 
displayed the highest proportion of mature LapA enzyme after 120h. It was concluded, that 
due to explicit clonal variation in recombinant LapA expression, formerly observed mature 
secretion wtLapA cannot be reliably replicated and, therefore, was accidental. Consequently, 
any successive recombinantly expressed LapA precursors would require enzymatic 




4.3.3 Downstream processing and analysis of expressed LapA proteins  
4.3.3.1 Enzymatic activation of wtproLapA precursor protein  
To enable verification of secreted LapA specific activity, the LapA precursor required 
activation by enzymatic treatment with either commercially available non-specific proteases 
or one of the native LapA activators present in Flavourzyme. Previously isolated 
Flavourzyme fractions (section 3.2) were used to treat recombinant LapA precursor, in the 
crude supernatant. An underlying aim was to identify a protease in the commercial enzyme 
blend, which would naturally activate LapA precursor protein.  
To activate the enzyme, 10 µg of Proteinase K and isolated Flavourzyme fractions were 
combined with 100 µg of target wtproLapA precursor (Clone2). The increase in LapA 
specific activity was monitored over the course of 90 minutes at 37 ºC, also withdrawing 
samples, for subsequent SDS-PAGE analysis, every 30 minutes (Figure 4.23).          
 
Figure 4.23 Enzymatic activation of wtproLapA protein. A – addition of Flavourzyme; B – 
addition of Proteinase K; C – addition of Flavourzyme fraction I; D - addition of 
Flavourzyme fraction II; E – addition of Flavourzyme fraction III; F - addition of 
Flavourzyme fraction IV; G - addition of Flavourzyme fraction IV; proLapA – untreated 
LapA precursor in crude supernatant.      
Enzymatic cleavage of LapA propeptide was most evident in samples A, B, and F (Figure 
4.23). A band shift of around 7 kDa (predicted by ProtParam tool, Expasy) is clearly 
observed. This experiment established that LapA activator most likely was found in isolated 
fraction IV, which contains AP1 and NP2 proteases, also as described previously (Merz et 
al., 2015). The action of Proteinase K caused severe proteolysis of recombinant LapA 
enzyme (sample B), whereby propeptide cleavage by non-specific AP1 and NP2 proteases 
left mature protein intact (sample F).         
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Apart from sample F, no significant increase in specific activity was noticeable following 
90-minute treatment of LapA precursor (data not shown). Also, it was noticed that baseline 
LapA activity arising from native LapA proteases (Lap2 present in fraction II, flavLapA 
present in fraction III) was dramatically reduced, when Flavourzyme fractions were 
combined with P. pastoris crude supernatant (NOTE: as these were crude supernatants, 
activity data are not presented herein, see Table 4.10 for specific activity from corresponding 
purified proteins). This suggested that purification of LapA precursor was necessary to re-
evaluate enzymatic activation, since impurities in P. pastoris compromised the activity of 
both recombinant activated LapA and native Lap enzymes in Flavourzyme.     
4.3.3.2 Purification and further activation of wtproLapA precursor protein 
LapA precursor was purified by AEX chromatography (see section 2.13.4 for details) from 
Clone 2 wtproLapA crude supernatant. Enzymatic activation was replicated using crude 
Flavourzyme solution, Proteinase K, and purified Flavourzyme fractions (III, IV, and V), as 
before. This time removal of LapA propeptide was immediately visible even after 30 minutes 
incubation at 37 ºC (Figure 4.24). Proteinase K still degraded most of the recombinant LapA 
precursor (Fig. 4.24, sample B). Efficient propeptide cleavage with crude Flavourzyme and 
fraction III suggest only trace amounts of AP1 or NP2 were required for activation. Isolated 
fraction III contains 100-fold less proteases.  
 
Figure 4.24 Enzymatic activation of wtproLapA protein. A – addition of Flavourzyme; B – 
addition of Proteinase K; C – addition of Flavourzyme fraction III; D - addition of 
Flavourzyme fraction IV; E – addition of Flavourzyme fraction V. 
Table 4.10 illustrates that purified LapA precursor possessed low activity of 1.5 U/mg 
compared to Clone 2 crude supernatant with no activity, suggesting the presence of a small 
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activated protein population in the non-treated sample, which exhibits activity upon removal 
of bulk contaminants. In fact, this can be seen in  
Figure 4.23 as a very weak band below inactive LapA precursor. The final observed 
activities following enzymatic treatment corresponded to 6, 7-fold activation of treated LapA 
enzyme in relation to inactive precursor (Table 4.10, last column).    









absorbance rate  






 Untreated LapA 
precursor 
 0.135 0.167 0.149 0.149 1.5 ± 0.1 U/mg - 
A Flavourzyme  0.72 0.87 0.95 0.05 9.1 ± 0.2  U/mg 6.4 
B Proteinase K 0.78 0.85 0.95 No activity 9.6 ± 0.5 U/mg 6.4 
C Fraction III 1.28 1.14 1.32 0.22 11.1 ± 0.3 U/mg 7.4 
D Fraction IV 0.95 0.91 0.85 0.07 7.9 ± 0.4  U/mg 5.3 
E Fraction V 0.208 0.22 0.305 No activity 3.1 ± 0.2 U/mg 1.58 
                                                                                                             *Background - adjusted 
 
Table 4.10 LapA precursor activation data. Background absorbance signal from each 
fraction was subtracted from the final measured rate after 90 minutes and specific activity 
was calculated from the residual absorbance rate.  
 
4.3.3.3 Purification and deglycosylation of activated LapA proteins   
Chromatographic AEX purification on 5 mL Q HP column was performed using the 
endogenously activated Clone 12 deviant (wtLapA) protein and maturely expressed Clone 7 
wt∆proLapA protein (Figure 4.21). Mostly active protein eluted in the range of 140 - 200 
mM NaCl for both proteins, thus, higher salt elution fractions were discarded.  
Following AEX purification, wtLapA protein was treated with PNGase to test if recombinant 
LapA enzyme expressed in P. pastoris was glycosylated and to estimate the effect of N-




Figure 4.25 AEX purification and deglycosylation of activated wt∆proLapA and wtLapA 
proteins. SDS-PAGE analysis (left); Corresponding lanes with the respective measured 
specific activities (right); NA – no activity.    
 
In general, the observed specific activities for recombinant purified wt∆proLapA and 
wtLapA proteins were quite low (0 - 20.9 ± 0.5 U/mg) compared to the previously reported 
specific activity for native LapA of 142.0 ± 0.2 U/mg (Matsushita-Morita et al., 2011). Also, 
purified native flavLapA (from Flavourzyme) and refolded (refLapA), expressed in E.coli, 
displayed activities of 94.6 ± 2.2 and 59.5 ± 1.1 U/mg, respectively. A negligible amount of 
activity from wt∆proLapA enzyme was likely due to misfolded and/or partially folded 
enzyme. Furthermore, purified wtLapA still had a considerable amount of brown pigment 
bound. Therefore, it was speculated that this could cause partial enzyme inhibition. Similar 
pigment – induced inhibition of activity was already observed in the purification process of 
flavLapA (section 3.2). Additional AEX purification did not eliminate all of the associated 
pigment from wtLapA. It was decided to explore alternative ways of purifying activated 
wtLapA from P. pastoris supernatant (section 4.3.4).  
Recombinant wtLapA protein appeared to be N-glycosylated. The estimated size of N-
glycan could be in the range of 3 – 5 kDa, based on the band shift observed on SDS-PAGE. 
This is potentially distributed across two predicted asparagine glycosites (N87 and N288). 
The effect of N-linked glycan removal on wtLapA specific activity was quite detrimental; 
50% loss in activity was observed following 24h incubation with PNGase. It is important to 
note that deglycosylation effect was only partial, under non-denaturing conditions, likely 
due to limited glycosite accessibility in fully folded wtLapA protein (Figure 4.25, lane 4). 
Further investigation was required to understand the importance of N-linked glycosylation 
for specific activity and for potential thermostability of recombinant LapA.  
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4.3.3.4 N – terminal sequencing of activated LapA proteins           
To gain a better mechanistic understanding of LapA precursor processing in P. pastoris, N 
– terminal sequencing was performed on different enzymatically processed LapA variants. 
Purified activated wtLapA Clone 12 seemed to possess a fully processed N – terminus. 
Additionally, purified wtproLapA Clone 2 was subjected to treatment with a small amount 
of Flavourzyme. The anticipated N-terminus, resulting from the action of AP1 and NP2 
proteases, should have been equivalent to mature native LapA from Flavourzyme 
(flavLapA).  
Unexpectedly, the processed N – terminus of wtLapA Clone 12 protein displayed an 'AVT' 
extension (Figure 4.26) compared to the original extremity reported by Morita et. al 
(Matsushita-Morita et al., 2011). This was later confirmed by the structural solution of 
wtLapA Clone 12 enzyme. Even more interesting, the N – terminus presented by wtproLapA 
Clone 2 protein, following enzymatic processing by Flavourzyme, showed two distinct 
populations of protein were present in a single sequenced protein band. The actual N-
terminus could only be resolved by having prior knowledge of the exact protein sequence 
(Figure 4.26, B(right)). It is possible that two different enzymes, with diverse specificity, 
are responsible for the appropriate processing of LapA propeptide in Aspergillus oryzae. 
Alternatively, insufficient incubation time with Flavourzyme yielded not fully processed 














Figure 4.26 N – terminal sequencing results for the different activated forms of wtproLapA 
protein. A. First five residues at the N – terminus of wtLapA Clone 12; B. SDS – PAGE of 
Flavourzyme - activated wtproLapA Clone 2 protein (left). Original N – terminal amino acid 
sequence (middle). Reordered amino acids using knowledge of actual polypeptide sequence 
(right). The sequencing was performed by Alta Biosciences, UK.   
 
Clone 12 was an outlier in the expression trial of LapA precursor protein (Figure 4.21), as 
it was present as mature enzyme. This suggests that it was most likely processed by a co-
secreted exogenous proteolytic enzyme from P. pastoris. Interestingly, the specificity of this 
unidentified enzyme could be similar to the one present in Flavourzyme, since the N-
terminus of Flavourzyme – activated Clone 2 was identical to that of the Clone 12 outlier, 
possessing an additional 3 – residue 'AVT' extension to the original LapA N – terminus 
(Figure 4.26, B). The observed N – terminus, in a fully refined structural solution of 




4.3.3.5 Genomic sequencing of wtLapA Clone 12 deviant  
It was important to verify that the explicitly different secretion profile of Clone 12 was not 
a result of genetic mutation within the AOX locus, in which the wtLapA expression cassette 
was integrated. For that purpose P. pastoris colony PCR was performed to amplify the target 
integrated wtLapA portion of the expression cassette, followed by sequencing of the resultant 
amplicon and matching against the expected sequence (Figure 4.27). The primers used in 
the amplification: 5’ – GAGGCAGAGAAATGGGCACT – 3’ and 5’ – 
TCATCTGCTGCGAGATAGGC – 3’. See section 2.2.1 for further details of the method. 
 
Figure 4.27 Pairwise sequence alignment of expected (top) and observed wtLapA (bottom) 
sequences. Translated propeptide sequence is overlaid with the DNA sequence: LapA 
propeptide and mature domain boundary is highlighted in purple and indicated by outward 
facing arrows.    
 
The Sanger-sequenced wtLapA amplicon (section 2.12.2) was found to match the expected 
sequence, containing LapA propeptide. Hence, no deletion was seen in the propeptide region 
of integrated pD-npro-LapA expression cassette in P. pastoris AOX locus. Therefore, as 
speculated, maturation of wtLapA Clone 12 must be a post-translational event, most likely 





4.3.4 Optimization of purification protocol of activated wtLapA from P. pastoris 
supernatant 
Since previous attempts of AEX chromatography alone did not fully separate activated LapA 
from tightly bound brown pigment (section 4.3.3.3), alternative methods for isolation of 
purified protein were required. Two mysterious brown pigments (Mr < 2kDa) were 
previously reported to associate with other Lap peptidases and were briefly characterized by 
EPR to be spectroscopically active and contain Fe(III) ligand (Schalk et al., 1992, Hartley et 
al., 2009, Aphale and Strohl, 1993, Bennett and Holz, 1997).  
Ammonium sulfate precipitation seemed an attractive way of cleaning up recombinant 
protein from the bulk of P. pastoris supernatant. Also, it served as a quick concentration 
method of the target protein from a large volume of supernatant. Based on previous 
knowledge regarding the properties of P. pastoris growth media and partial characterization 
of brown pigment, selective gel filtration seemed appropriate to separate the target protein 
from low molecular weight peptides and pigments present in the growth media.  
Clone 12 wtLapA supernatant was saturated to 90% with AmSO4 and left to equilibrate at 4 
ºC for 24h. The resultant protein pellet was harvested by high speed (30,000 x g) 
centrifugation and subsequently re-suspended in gel filtration buffer. 0.2 µm filtered protein 
suspension was loaded onto a SEC column (as described in section 2.13.4).  
 
Figure 4.28 shows three distinct peaks. The nature of the first peak could not be established, 
since it exhibited no LapA activity and no observable band on SDS-PAGE (not shown). A 
broad peak from 90 mL to 110 mL showed extremely high UV absorption, however, it too 
showed no particular band on the SDS-PAGE (not shown). Once eluted, this fraction 
appeared intense brown in color and, therefore, possibly contained most of the pigments 
present in the P. pastoris supernatant. It showed a tiny amount of specific activity (2.3 ± 0.5 
U/mg). However, this was possibly due to residual carry over from an overlapping active 
wtLapA peak at 80 mL. The characteristic high absorption of these associating ‘brown 
pigments’ at 280 nm hindered LapA protein quantification using purification chromatogram 
and spectrophotometric instruments, superseding the absorption arising from aromatic 
amino acids in the protein chain.    
The eluted wtLapA peak at around 80 mL was 4.3-fold more active than AEX-alone formerly 
purified batch, with 90.5 ± 0.3 U/mg specific activity after SEC, compared to 20.9 ± 0.5 
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U/mg after AEX-alone.  This was a significant improvement in specific activity. However, 
the activity level still was comparable to purified flavLapA (94.6 ± 2.2 U/mg). By 
concentrating the 80 mL wtLapA fraction, using an ultracentrifugation device, a light brown 
protein layer was visible on the membrane, suggesting some fraction of pigment was still 
bound to wtLapA, thus likely preventing the release of full activity potential.  
The most highly active wtLapA peak from SEC could be conveniently loaded directly onto 
an AEX Q HP column, without the need of an intermediate buffer exchange step. The peak 
eluted at 140 mM NaCl, during this purification step, contained no traces of brown pigment, 
which appeared to remain strongly bound to the AEX resin and could only be removed 
completely by performing a 2 M NaCl wash. This final pigment-free wtLapA fraction 
displayed maximal specific activity of 140.15 ± 4.8 U/mg, which was higher to that observed 
for flavLapA. Also, complete elimination of brown pigments, in the final AEX purification 
step, ensured an homogeneous wtLapA protein population for subsequent crystallization 
trials (Figure 4.28, B). Interestingly, a higher molecular weight association was noticeable 
in the absence of reducing agent in protein sample buffer, probably mediated by covalent 
disulphide bonds between SDS-unfolded wtLapA proteins (non-reducing lane, Figure 4.28, 
B). Also, the absence of possible wtLapA higher oligomeric states was confirmed by Native-
PAGE analysis (Figure 4.28, C), which further verified wtLapA sample homogeneity, a 





Figure 4.28 wtLapA Clone 12 purification and analysis. A. Elution profile from Superdex 
75 SEC matrix. Peaks and their corresponding specific activities are indicated; B. SDS-
PAGE analysis of AEX purified, pigment-free wtLapA protein. The star indicates a fraction 
used in crystallization trial; C. Native-PAGE analysis of AEX purified, pigment-free 
wtLapA protein.   
  
4.3.5 Purification of wtproLapA precursor from P. pastoris supernatant for 
crystallization 
Similar to the anticipated crystal structure of activated mature wtLapA, it was decided to 
attempt the structural solution of the LapA precursor enzyme, which would help elucidate 
the structural and possibly functional role of the propeptide domain. Since recombinant 
LapA was secreted in the form of proenzyme (wtproLapA), unprocessed enzyme population 
was readily available for purification. An equivalent purification procedure to that of the 
mature wtLapA protein was assumed and followed (section 4.3.4).  
4.3.5.1 Purification of wtproLapA Clone 16 
Clone 16 wtproLapA supernatant was saturated to 90% with AmSO4 and left to equilibrate 
at 4 ºC for 24h. The resultant protein pellet was harvested by high speed (30,000 x g) 
centrifugation and subsequently re-suspended in gel filtration buffer, as previously described 
(see section 2.13.4). 0.2 µm filtered protein suspension was loaded on SEC column. Figure 
4.29 shows three distinct peaks eluted from the SEC column. The last two broad peaks 
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showed no LapA activity and eluted as very pigmented fractions. Interestingly, the observed 
dynamics of the conductivity curve followed the pattern of the last UV absorption peak. This 
might be a result of eluting AmSO4 from the LapA sample loaded or, more likely, to the 
brown pigment Fe(III) moieties giving rise to a striking increase in conductivity.       
 
Figure 4.29 wtproLapA Clone 16 SEC purification and SDS-PAGE. A. Elution profile from 
Superdex 75 SEC matrix; trace in brown corresponds to changes in conductivity; B. SDS-
PAGE analysis of SEC purification. Lane 2 – crude supernatant of Clone 16 LapA precursor 
after 120 h harvesting. Lane 3 (starred) – the same supernatant, following a single freeze-
thaw cycle. Lanes 4 and 5 - eluted active 80 mL peak.    
 
The most active peak eluted at around 80 mL, similarly to the elution pattern of mature 
wtLapA (see Figure 4.28). Therefore, the additional 7 kDa propeptide domain did not 
significantly affect the hydrodynamic volume of the wtproLapA protein and, consequently, 
its retention time on the gel filtration matrix. The specific activity of the 80 mL peak was 
surprisingly high  (75 ± 0.3 U/mg), since this should have been an inactive precursor. 
Subsequent analysis on SDS-PAGE revealed induced maturation of wtproLapA Clone 16, 
which can be noticed from a clear molecular weight band shift (Figure 4.29, last three 
fractions). While the observed high specific activity in the previous SEC fraction 
(corresponding to mature protein) could easily be explained, the phenomenon of this 
wtproLapA autoprocessing on the gel filtration column could not be explained. It appears 
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that this batch of LapA precursor was progressively processed to mature protein by either an 
autocatalytic mechanism or another co-purified protease in the P. pastoris supernatant. 
However, Clone 16 LapA precursor was not fully processed in either the SEC-eluted fraction 
or the following AEX purification step. A small portion of this enzyme still contained 
covalently linked propeptide domain (Figure 4.29, lane 5).    
Since this purified LapA batch was of heterogeneous composition, with the bulk of the 
population consisting of mature processed protein, it was unlikely to yield crystals of LapA 
precursor. Therefore, it was decided to replicate the same purification protocol with a 
different wtproLapA batch (Clone 5).   
4.3.5.2 Purification of wtproLapA Clone 5 
Since the previous purification strategy gave rise to the unexplained maturation of LapA 
precursor, it was decided to alter the purification protocol yet again. Instead of the 
concentration of protein by AmSO4 precipitation, followed by gel filtration, it was decided 
to purify wtproLapA Clone 5 solely by anion exchange chromatography. Also, this clone 
was selected due to the presence of a negligible amount of matured enzyme compared to 
other wtproLapA supernatants (Figure 4.21).  
This time, wtproLapA Clone 5 supernatant was 4-fold concentrated by ultracentrifugation 
and subsequently dialyzed into AEX binding buffer overnight. Purification on a 5 mL Q HP 
column yielded 80 mM, 140 mM, 200 mM, 300 mM and 1 M NaCl peaks (Figure 4.30, A). 
Interestingly, the bulk of LapA precursor still eluted in the 140 mM peak, again suggesting 
the presence of prodomain did not affect binding on the positively charged AEX resin. Only 
the 140 mM peak was collected and repetitively applied onto an AEX column to remove 
traces of bound brown pigments. Following 3 rounds of elution at 140 mM NaCl from the 
AEX column, all of the associating pigments were completely eliminated and the resultant 
protein pool was SEC purified for final polishing and salt removal. The latter purification 
step yielded a single, symmetrical sharp wtproLapA peak at around 76 mL (Figure 4.30, C). 




      
Figure 4.30 wtproLapA Clone 5 purification and SDS-PAGE analysis. A. Eluted fractions 
from 5 mL Q HP column and SDS-PAGE analysis: 1 – defrosted supernatant, 2 – supernatant 
after storing at RT overnight, 3 – supernatant after dialysis, 4 – 140mM NaCl peak, 5 – 
200mM NaCl peak, 6 – 300mM NaCl peak, 7 – 1M NaCl peak;  B 2nd AEX run: eluted 
fractions from 5 mL Q HP column and SDS-PAGE analysis: gel lanes agree with peaks 
eluted; C Final LapA precursor pool eluted at 76 mL from SEC.   
 
Figure 4.30 A demonstrates that this time the majority of the recombinant LapA protein was 
in the form of the precursor in the defrosted supernatant. The zymogen/mature protein 
population ratio stayed the same throughout the purification process of wtproLapA Clone 5, 
and no signs of progressive propeptide cleavage were noticeable. In the 2nd round of AEX 
purification, an attempt to separate LapA zymogen from mature protein population was 
made. The NaCl concentration in the elution buffer was steadily increased in 1% increments. 
A triple peak at 80 mM NaCl was eluted, which exhibited no protein band on the SDS-PAGE 
(Figure 4.30, B: lanes 1, 2, 3). A mixture of two LapA populations still eluted at 140 mM 
NaCl concentration. The final SEC-eluted wtproLapA Clone 5 fraction (Figure 4.30, C) was 
concentrated to 9.4 mg/ml and subjected to subsequent crystallization trials (see section 
2.8.2.2).   
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4.3.6 Considerations of LapA protein purification from P. pastoris supernatant 
LapA recombinant wild-type proteins were purified using the protocol described in section 
2.13.4. However, later in the project, the standard low-resolution 5 mL Q HP AEX column 
was replaced with a MonoQ 4.6/100 PE high-resolution column. The latter allowed running 
the purification under high pressure (3.0 – 4.0 bar) due to the smaller particle beads, hence 
improving peak sharpness and separation. A separation of LapA precursor, from the majority 
of mature LapA population, was enabled on the MonoQ column, which aided the subsequent 
crystallisation process due to improved sample homogeneity. LapA precursor was 
successfully isolated from partially matured protein by elution at 80 mM NaCl concentration 
on MonoQ, whereas, typically, a mixture of mature and proenzyme LapA populations would 
only elute at 140 mM NaCl concentration on Q HP (Figure 4.35).  
Consequently, a two-step purification protocol was almost sufficient to eliminate the 
majority of brown pigment from LapA sample. Firstly, recombinant LapA pellet from the 
AmSO4 precipitation step was resupended and loaded onto the SEC column in order to 
separate the protein of interest from the bulk of low molecular weight contaminants and 
brown pigment arising from the supernatant media (Figure 4.31). The second step involved 
loading the pooled active LapA fractions from the previous SEC onto an AEX column (Q 
HP/MonoQ). The eluted LapA precursor peak (140 mM NaCl) from this step would be 
almost pigment-free (Figure 4.32 and Figure 4.33). LapA precursor was then treated with 
AP1 protease and the resultant protein mixture was loaded onto the MonoQ column again, 
to separate an active mature LapA protein population. Any residual pigment was completely 
eliminated in this final purification step. Residual brown pigment was found to have an 
adverse effect on LapA activity and interfere with spectrophotometric protein quantification. 
Therefore, removal of any remaining pigment was critical, to prevent experimental bias 
across LapA mutant samples. In this respect, the MonoQ column was superior to Q HP, as 
it was more discriminating and permitted improved separation of protein from pigment.  
Extracellular secretion of recombinant protein in P.pastoris already acts as primary 
purification step. To further shorten the process, other purification routes were tested, in 
addition to the one described above. Since the recombinant LapA constructs harboured no 
affinity tags, the proteins could only be purified using their intrinsic physicochemical 
properties such as size, charge and hydrophobicity. It was not possible to load the harvested 
supernatant directly onto the AEX resin, due to the acidic pH of the P.pastoris expression 
culture (pH 5.0-6.0). For the protein to efficiently bind the anion exchange resin, the pH 
maintained in the binding buffer must be at least 1 unit above the theoretical pI of the target 
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protein (LapA precursor, pI ~4.9). LapA supernatant was concentrated and buffer-exchanged 
using ultrafiltration and the resultant protein solution was applied on the AEX resin using 5 
mL Q HP columns. However, the 140 mM NaCl eluted fraction still contained a substantial 
amount of associating brown pigment. Even subsequent (twice repeated) re-applications on 
the AEX column did not separate all pigment from LapA precursor.  
 
Figure 4.31 Wild-type LapA purification on SEC column, following AmSO4 precipitation. 
LapA protein – main activity peak containing LapA precursor; Brown pigment peak – 





Figure 4.32 Typical peak elution pattern for LapA protein on a 5 mL Q HP AEX column. 
Higher concentration NaCl peaks contain increasing amounts of brown pigment, with 1 M 
NaCl fraction being the most pigmented (on-column appearance is also shown).   
 
Figure 4.32 summarizes a typical LapA elution pattern, observed on a 5 mL Q HP AEX 
column. The majority of LapA precursor elutes in the 140 mM NaCl fraction, which is the 
least pigmented. The LapA-bound pigment in this fraction can only be revealed by 
performing ultrafiltration (appearance of a concentrated brown layer towards the bottom of 
the membrane). The 200 mM and 400 mM eluted NaCl fractions were usually very 
pigmented and, therefore, discarded. The bulk of the pigment elutes in the 1 M NaCl wash, 
suggesting it contains highly negatively charged species binding to the resin with high 
affinity. This fraction usually contains small MW peptides from the media and LapA 





Figure 4.33 Typical elution pattern of LapA protein from MonoQ AEX column. UV 
absorption trace is depicted by blue line, conductivity is depicted by brown line. SDS-PAGE 
of eluted fractions is given on the right. Approximately 50 µg of total protein was loaded 
into each of the first two lanes of the gel. 
 
In Figure 4.33, the SDS-PAGE (on the right) shows a typical distribution of LapA precursor 
and mature populations across the MonoQ-eluted fractions. The MonoQ AEX resin also 
enabled separation of an 80 mM NaCl peak, which mainly was comprised of LapA 
precursor. This fraction could then be concentrated and subjected to crystallisation 
screening. An equivalent 80 mM NaCl fraction could not be eluted from the Q HP column 
(Figure 4.32). The 140 mM NaCl fraction from the Mono Q column typically contained a 
1:1 ratio of pro- and mature LapA populations. Interestingly, the majority of recombinant 
LapA, in the harvested supernatant, exists in a form of precursor (not shown). From a number 
of purifications performed on LapA precursor protein, it was evident that some form of 
precursor activation occurred during the purification process. However, the basis of this 
process could not be established. When partially purified solution, containing LapA 
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precursor, was left at room temperature for 24 h and SDS-PAGE analysis was performed the 
following day, no evidence of an autocatalytic process could be observed. Hence, the 
progressive cleavage of LapA propeptide, during the course of the purification process, must 
be due to the hydrolytic action of small amounts of co-purified exogenous protease in the 
P.pastoris supernatant.         
4.3.7 Exploring the cleavage of propeptide in wtproLapA proenzyme  
The unexplained phenomenon of self-maturation of LapA precursor in the purification 
process of wtproLapA Clone 16 was also noted in the Clone 2 batch (results not shown). To 
investigate whether this was an autocatalytic process, supernatants of wtproLapA Clones 2, 
5 and 16 were kept at RT and on ice (control) for 24h and changes in the distribution of 
protein populations were observed on SDS-PAGE (Figure 4.34). The maturation process 
observed could be a consequence of co-secreted, non-specific proteolytic activity in P. 
pastoris supernatant, which should become evident from prolonged incubation at room 
temperature.    
   
Figure 4.34 SDS-PAGE analysis of putative LapA autocatalytic maturation. t0 – defrosted 
supernatant sample, ice – control sample following 24h incubation on ice, RT – sample 
following 24h incubation at room temperature.   
 
However, no significant differences in LapA proenzyme processing were observed 
following incubation of selected supernatants on ice or at room temperature for 24h. 
Previously observed increases in the proportion of self-matured protein, in defrosted 
supernatants of Clone 2 and Clone 16, were not apparent in this experiment. Therefore, the 
recognized LapA self-maturation phenomenon in this context remained unclear. It was 
concluded, that LapA precursor requires treatment with exogenous protease for activation 
and this process is not autocatalytic. Also, there are no reported M28 family di-metallic 
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aminopeptidases with automaturation ability. The pro-form of the closest structural 
homologue known to date, Lap from Vibrio proteolyticus, required activation with 
Proteinase K (Bzymek et al., 2004).    
4.3.7.1 Enzymatic processing of wtproLapA proenzyme with AP1 and NP2 
Previous attempts to use fraction IV from Flavourzyme to activate recombinant LapA 
precursor expressed in P. pastoris yielded promising results (sections 4.3.3 and 4.3.3.2). 
Therefore, the next rational step was to test individually isolated enzymes (AP1 and NP2) 
from fraction IV for their ability to process LapA pro-protein. The isolation protocol of AP1 
and NP2 is described in section 3.3.     
Purification of Clone 16 LapA precursor was attempted in section 4.3.5.1. This batch of 
LapA zymogen displayed a phenomenon of propeptide degradation in the purification 
process. However, a small fraction of this protein remained immature following the final 
AEX purification step. Thus, enzymatic activation of this remaining wtproLapA population 
was attempted, using isolated AP1 and NP2 pools from Flavourzyme to determine which 
enzyme is responsible for activation of native LapA pro-protein in Aspergillus oryzae. Also, 
Clone 16 was treated with commercially available Subtilisin Carlsberg and Proteinase K 
non-specific proteases.  
15 µg of purified Clone 16 enzyme was combined with approximately 1 µg of each effector 
proteins and, while continuously incubating at 37 ºC, samples were withdrawn at set time 
points to monitor the progress of LapA precursor processing.    
AP1, Subtilisin Carlsberg, and Proteinase K immediately processed the Clone 16 zymogen 
population. No pro-protein was visible, even following 5 minute incubation (Figure 4.35). 
Subtilisin Carlsberg appears to have processed more than half of the initial content of Clone 
16, whereas Proteinase K almost completely degraded the recombinant LapA pro-enzyme. 
Hence, the commercial non-specific proteases were not considered as potential candidate 





Figure 4.35 SDS-PAGE analysis of wtproLapA Clone 16 enzymatic treatment with 
proteases. NP2 – added neutral protease 1 (190 mM NaCl peak); AP1 – added alkaline 
protease 1 (50mM NaCl peak); sC – added Subtilisin Carlsberg; ProtK – added Proteinase 
K; + Control – Clone 16 purified protein kept at 37 ºC for 4h. Red and blue arrows indicate 
processed and unprocessed enzyme populations, respectively.  
 
NP2 did not seem to have a significant propeptide cleavage ability. Therefore, it was 
concluded that AP1 protease is the most likely enzyme for future processing of recombinant 
LapA zymogens. At the same time, AP1 did not cause severe degradation of the Clone 16 
enzyme and was proposed to primarily activate native LapA upon secretion into the 
extracellular environment of Aspergillus oryzae.      
4.3.7.2 Comparison of recombinant LapA precursor activation by NP1 and 
AP1 proteases  
In the improved isolation protocol of Flavourzyme proteases, neutral protease 1 (NP1) was 
also purified from Flavourzyme (section 3.3.1). It was important to confirm whether NP1 
protein could also be involved in LapA activation. For further elucidation of the mechanism 
of LapA N-terminal processing, it was deemed necessary to use both Flavourzyme-isolated 
NP1 and AP1 proteases in the same LapA zymogen activation trial and confirm any tentative 
differences in N-terminal processing.   
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Three different wtproLapA batches were utilized in this experiment: Clone 12, Clone 5 and 
Clone 16, which were formerly purified using the standard protocol (section 2.13.4). These 
LapA zymogens were combined with isolated AP1 and NP1 fractions from CAX – AEX 
purification protocol (see section 3.3.1). Following 60 minute incubation at 37 ºC, samples 
were analyzed by SDS – PAGE (Figure 4.36).  
Figure 4.36 Analysis of enzymatic processing of different LapA zymogen proteins. Added 
fractions, which were eluted from a MonoQ column, in the ultimate AEX purification step, 
are indicated at the bottom of the gel. Activating proteases contained in these fractions are 
shown at the top. Red and blue arrows indicate processed and unprocessed enzyme 
populations, respectively. Blue rectangle indicates N – terminally sequenced protein band.      
 
AP1 fractions effectively processed all three LapA precursors. NP1 also processed most of 
the LapA precursors, except in the Clone 12 sample at 160 mM NaCl, where some pre-
protein was still present. The optimal pH of 7, reported for AP1 and NP1 proteins, was 
identical (Merz et al., 2015). The pH maintained in the LapA activation reactions was 1 pH 
unit above the optimal pH for these proteases. The reported optimal temperature for AP1 
and NP1 was 40 and 50 ºC, respectively. Therefore, both enzymes operated under almost 
ideal conditions. No other significant differences in processing efficacy were determined. 
Sampling at intermediate time points within a 60-minute interval could possibly reveal more 
differences between AP1 and NP1 proteases. Proteolytic degradation of LapA precursor 
proteins was also noticeable (to some extent) in all fractions.    
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To verify any differences in the resulting LapA N-terminus, following propeptide cleavage 
by the NP1 protease, the activated LapA sample (160 mM NaCl AEX fraction) was analysed. 
The first 5 residues identified at the LapA N – terminus were 'AVTYP', which was identical 
to that previously observed following treatment with isolated AP1 protein (see Figure 4.26). 
It is likely that both NP1 and AP1 proteases possess similar substrate specificity and, 
consequently, display an identical mechanism for wtproLapA processing. Another 
possibility is that the 160 mM NaCl NP1 fraction contained a small amount of co-purified 
AP1 protease, which was able to further modify the LapA N – terminus. In the CAX-AEX 
purification experiment, the last fraction of AP1 eluted at 120 mM NaCl concentration, 
whereas the first NP1 fraction appears at 140 mM NaCl concentration, suggesting a slight 
overlap in elution (Figure 3.12). Therefore, NP1 might not even be able to process LapA 
zymogen, and only trace amounts AP1 are required for efficient cleavage of LapA 




Chapter 5 STRUCTURAL STUDIES OF RECOMBINANT WILD – 





5.1 Crystal structures of LapA precursor and mature enzyme: role 
of propeptide in inhibition and as intramolecular chaperone 
 
This sub-section of Chapter 5 was written in the format of publication to the scientific 
journal.  Therefore, the content is laid out in a slightly distinct manner to other chapters.  
 
5.1.1  Introduction 
Modification of the N-terminus is one of the most common polypeptide processing events, 
occurring in any cell. Aminopeptidases (EC 3.4.11) are a subset of hydrolase enzymes that 
either release a single N-terminal residue or dipeptides/tripeptides (in the case of dipeptidyl- 
and tripeptidyl-aminopeptidases). Metallo-aminopeptidases are a division in this class of 
enzymes, utilising one or two metal cofactors in the active site formation. Binuclear metallo-
aminopeptidases are ubiquitous enzymes, commonly displaying a broad substrate specificity 
and involved in general degradation of proteins at the cellular level. Abnormal 
aminopeptidase activity and aberrant protein degradation was linked to inflammation, 
ageing, cancer and leukemia (Taylor, 1993b, Taylor, 1993a). Also, metallo-β-lactamases 
(mβls), binding one or two zincs in the activate site, are active targets to combat multi-drug 
resistance in pathogenic bacteria. To date, no clinically useful inhibitor for mβl’s have been 
identified, with only a few potent compounds discovered recently (Wang et al., 2015). Thus, 
a mechanistic understanding of the principles behind the action of dizinc enzymes and 
subsequent design of novel inhibitors is critical (Tamilselvi and Mugesh, 2008, Tamilselvi 
et al., 2006).   
It is well established, that prodomains of secretory endo- and exopeptidases play an 
important role in inhibition of their cognate catalytic domains, which undergo activation by 
removal of the prodomain either by autocatalytic process or external endopeptidase activity. 
By secreting protease precursors in a zymogen form, undesirable cytosolic activation and 
proteolysis events are prevented (Lazure, 2002). Normally the zymogen conversion does not 
involve conformational changes of catalytic residues and the active sites are sterically 
rendered inaccessible to substrate by the unique residues of prodomain or prosegment, thus 




In addition, N-terminal propeptides are known to act as intramolecular chaperones (IMC), 
decreasing the energy barrier of transition from a molten globule intermediate to a kinetically 
trapped native state (Subbian, 2015). In this respect, a well-studied model enzyme,  
subtilisin, has been shown to be unable to escape the folding transition state between a 
molten-globule and a native conformation, without the presence of a prodomain; a rate-
limiting step in the folding process of subtilisin (Shinde and Inouye, 2000). Remarkably, 
prodomains of numerous proteinases have been reported to assist as chaperones in both inter- 
and intramolecular manner, following expression in trans- and cis- form, respectively 
(Beggah et al., 2000, Tang et al., 2002, Safina et al., 2011). An analogous mode of action, 
for such prodomains, with no requirement for a covalent link between propeptide and 
catalytic domain, has been discovered in other enzymes (Yurimoto et al., 2004).  
Subtle and rather complex relationships between propeptide and catalytic domain were 
found in subtilisin E, where unaltered, mature polypeptide chain of subtilisin E was shown 
to fold into a different conformation via a mutated intramolecular chaperone and to show 
altered substrate specificity; a phenomenon termed `protein memory` (Shinde et al., 1997).  
Normally, such intramolecular chaperones precede catalytic domain from the N-terminus, 
however, eukaryotic monozinc aminopeptidase A was found to recruit its C-terminal 
propeptide for this role (Rozenfeld et al., 2004). Such findings demonstrate the diverse and 
complex relationships between the essential prodomain and the cognate active conformation 
in the proteogenesis of proteases.    
The aminopeptidase from Vibrio proteolyticus (AAP) is a model bimetallohydrolase 
enzyme, representing the M28 peptidase family, MH clan, whose extensive structural and 
functional studies have provided an in-depth understanding of the mechanism of action and 
the substrate preferences for these bi-metallic enzymes (Schalk et al., 1992, Chevrier et al., 
1994, Chevrier et al., 1996, Bennett and Holz, 1997, Chen et al., 1997, Stamper et al., 2001, 
Stamper et al., 2004, Schurer et al., 2004, Desmarais et al., 2006, Kumar et al., 2007). 
Furthermore, the role of the propeptide in AAP and other homologous leucine 
aminopeptidases has been extensively studied in vitro (Zhang et al., 2000, Bzymek et al., 
2004, Nirasawa et al., 1999). A number of studies have provided structural insights into AAP 
inhibition via different synthetic compounds, acting as competitive inhibitors (Chevrier et 
al., 1996, Stamper et al., 2004, Hanaya et al., 2012, Stamper et al., 2001). However, until 
now, no report exists to provide a mechanistic insight for leucine aminopeptidase inhibition 
by its natural inhibitor – the N-terminal propeptide - at a molecular level.  
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In this article, we present the crystal structures of recombinantly expressed LapA precursor 
(wtproLapA) and mature recombinant LapA (wtLapA), both purified from P.pastoris culture 
supernatant. These structures reveal a plausible molecular mechanism of LapA catalytic 
domain inhibition by propeptide and we propose a role for the intramolecular chaperone N-
terminal domain in the process of maturation of LapA zymogen. We found that the mature 
catalytic domain of LapA does not achieve its native conformation, when produced in the 
absence of prosegment. This observation is reinforced by an expression and refolding study 
of 6xHis-tagged catalytic domain only (refLapA) from E.coli inclusion bodies, revealing a 
limited active conformation.  
To date, the exact mechanism of leucine aminopeptidase inhibition and the role of an 
intramolecular chaperone (IMC) by the prodomain has not been detailed at a molecular level. 
To the best of our knowledge, this is the first crystal structure of a leucine aminopeptidase 
precursor, revealing structural aspects of mature domain inhibition by the cognate 
propeptide. Based on this work, we are able to show that known synthetic aminopeptidase 
inhibitors and substrates mimic key contacts between pro- and catalytic domain. These 
findings could aid future design of more effective inhibitors of bimetallic aminopeptidases 
and other dizinc enzymes, sharing an analogous reaction mechanism.      
Several AAP crystal structures in complex with a natural substrate, LLL (Kumar et al., 2007) 
and substrate analog, 1-Butaneboronic acid (De Paola et al., 1999) have been reported. In 
this work, we also introduce the crystal structure of LapA with a single leucine trapped in 
the active site, termed wtLapA-Leu. We demonstrate that the binding mode of this leucine 
is analogous to the P1 moiety, observed in the AAP-LLL crystal structure.  
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5.1.2 Materials and Methods 
5.1.2.1 Strains and plasmids 
Pichia pastoris X33 strain was obtained from Biogrammatics Inc. (Carlsbad, CA, USA). 
Secretory expression vector, pJ902, was provided by DNA 2.0 (USA). Escherichia coli 
DH5α (fhuA2 ∆(argF-lacZ)U169 phoA glnV44 Φ80 ∆(lacZ)M15 gyrA96 recA1 relA1 endA1 
thi-1 hsdR17) cloning strain were purchased from New England Biolabs (NEB,UK). 
All primers used in this study were obtained from Sigma (UK). ZeocinTM was purchased 
from Invitrogen (USA). All other reagents were purchased from Sigma (UK) and were of 
analytical grade.  
5.1.2.2 Construction of recombinant expression vectors and 
transformations in Pichia pastoris 
Recombinant LapA open reading frames (Genebank accession: XP_001825745.1) were 
codon-optimised and cloned into the pJ902 vector, by DNA 2.0, using the EcoRI and NotI 
restriction sites. In this way, an expression construct, harbouring the LapA native signal 
peptide and propeptide sequences (pJ-npro-LapA), was obtained. A second expression 
construct, containing a deletion of the LapA propeptide (pJ-∆pro-LapA) was produced, 
utilising the QuickChangeTM II site-directed mutagenesis kit from Stratagene (USA). 
Deletion of the propeptide sequence was achieved by performing PCR with designed primers 
1; 5'-GGACGCTATCTGGATAAGCTAATGCGCTTGCC-3' and 2; 5'-
GGCAAGCGCATTAGCTTATCCAGATAGCGTCC-3', using the pJ-npro-LapA construct 
as a template.  
Following SacI linearization and clean-up, recombinant plasmids were transformed into an 
X33 expression strain by electroporation (a single 1500 V pulse in a 2 mm electroporation 
cuvette). Immediately following electroporation, the cells were resuspended in 0.5ml 1M 
sorbitol and 0.5ml YPD (1% yeast extract Y, 2% soy peptone P, 2% dextrose D) and 
incubated for 2h at 30ºC under gentle agitation. The revived cells were then plated onto YPD 
agar (1% yeast extract, 2% soy peptone, 2% dextrose, 2% agar), containing either 100 µg/ml 
or 2000 µg/ml ZeocinTM and incubated at 30 ºC 2-4 days. The resulting P.pastoris colonies 
were verified, by PCR, for appropriate genomic integration using the method previously 
described (Looke et al., 2011). In each case, 10 transformants were screened, picking the 
largest, single colonies. Each single colony was patch-plated onto a separate YPD agar plate 
and residual cells were re-suspended in 100µL lysis solution (200 mM lithium acetate, 1% 
SDS), followed by incubation at 70 ºC for 15 min. Following 96% ethanol precipitation, the 
140 
 
DNA pellet was re-suspended in 100 µL sterile water and 1µL (in each case) was used in 
each subsequent genomic PCR. Clone ID (Lucigen, USA), PCR pre-mix and a pair of AOX 
primers (AOX1-F; 5’-GACTGGTTCCAATTGACAAGC-3’ and AOX1-R; 5’-
GCAAATGGCATTCTGACATCC-3’) were used, under the following conditions: 1 cycle 
of 98 ºC for 2 min, 30 cycles at 98 ºC for 30 s, 56 ºC for 30 s, 72 ºC for 1 min, finishing with 
72 ºC for 5 min. The PCR products of predicted size were visualised on a 1% agarose gel.    
5.1.2.3 Construction of recombinant expression vectors and 
transformations in E.coli 
Mature LapA polypeptide (Genebank accession: XP_001825745.1) was codon-optimised 
and recombinantly cloned into a pET-21a expression vector (Eurofins, UK), using NdeI and 
BamHI restriction sites. In this way, a pET-6xHis∆proLapA expression construct resulted, 
comprised of the T7 bacteriophage promoter, an N-terminal hexahistidine tag, mature LapA 
polypeptide (minus propeptide) and an ampicillin resistance marker. This LapA expression 
construct was transformed into BL21 (DE3) competent cells, according to the manufacturer's 
instructions.  
5.1.2.4 Over-expression of recombinant LapA in P.pastoris 
Recombinant proteins were over-expressed in a P. pastoris X-33 strain (Mut+), under control 
of the PAOX1 methanol inducible promoter. Shake flask expression trials were conducted in 
BMGY (1% yeast extract, 2% soy peptone, 1% glycerol, 1.34% YNB, 4E-5% biotin, 100mM 
potassium phosphate, pH 6.0) and BMMY (as for BMGY with 1% glycerol replaced by 
0.5% methanol). Genomic PCR-verified P.pastoris clones were inoculated into 50 ml 
BMGY medium in 250 ml baffled conical flasks and incubated in a shaker (250 rpm) for 
16h at 28 ºC. Once the OD600 reached 2-8, an equivalent amount of cells (corresponding to 
OD600 of 1) were harvested and re-suspended in 100 ml of BMMY and shaken (250 rpm) in 
500 ml conical baffled flasks at 28 ºC for 4-5 days. Every 24h, the cultures were 
supplemented with 0.5% final concentration of methanol to maintain induction and OD600 
cell densities were recorded. After 120h of maintaining recombinant protein expression, the 
cell cultures were harvested by centrifugation at 6000 x g for 15 min. The supernatant was 
sampled and recombinant LapA protein detected by SDS-PAGE (NuPAGE® Novex® 4-
12% Bis-Tris gels).     
5.1.2.5 Purification of recombinant LapA from P.pastoris supernatant     
Over-expressed wtproLapA, wtLapA, wt∆proLapA proteins were purified from P.pastoris 
supernatant employing 2 different protocols: 1) crude P.pastoris supernatant, containing 
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recombinant LapA, was dialysed against 20 mM Tricine pH 8.0, 1 mM ZnCl2 for 16h at 4 
ºC, then filtered through a 0.22 µm steri-filter prior to loading onto a 5 mL HiTrapTM Q HP 
anion exchange column, pre-equilibrated with 20 mM Tricine pH 8.0, 1 mM ZnCl2. The 
column was washed (5 – 10 CV) with equilibration buffer until no trace of protein appeared 
in the eluate. Recombinant LapA was eluted using an increasing gradient (0 - 1M) of NaCl 
(20 mM Tricine pH 8.0, 1 mM ZnCl2, 1M NaCl). Active fractions were pooled and 
concentrated, using ultrafiltration membranes (10 kDa MWCO). In each case, the respective 
protein concentrate was loaded onto a HiLoad SuperdexTM 16/60 200pg (GE Healthcare, 
UK) column, pre-equilibrated with 20 mM Tricine pH 8.0, 1 mM ZnCl2. Homogeneous, 
recombinant LapA fractions were concentrated and stored at -20 ºC for further analysis; or 
2) crude P.pastoris supernatant, containing the respective recombinant LapA constructs, was 
saturated to 90% ammonium sulphate by adding hard salt, followed by stirring for 1h at 
ambient temperature. LapA precipitant was pelleted by centrifugation at 16,000 x g for 20 
minutes. The collected pellet was re-suspended in 20mM Tricine pH 8.0, 1 mM ZnCl2, 
followed by dialysis against the same buffer overnight at 4 ºC. At this point, the purification 
procedure was equivalent to 1), starting at the anion exchange chromatography step. 
Recombinant proteins purified, using protocols 1) and 2), were analysed on SDS-PAGE. 
5.1.2.6 Over-expression of recombinant LapA in E.coli 
All preliminary recombinant LapA over-expression trials were carried out using 10 mL 
cultures. A single BL21 (DE3) colony harbouring pET-6xHis∆proLapA expression 
construct was transferred to 2 mL LB broth and incubated at 37 ºC (shaker at 220 rpm) 
overnight. 200 µL of the overnight inoculum was transferred to 10 mL of fresh LB media. 
The optical density (OD) at 600 nm was monitored regularly to reach a value between 0.5 
and 1.0 absorbance units, after which IPTG (1 mM final concentration) was added to induce 
protein expression culture. The pre-induction sample was taken for further analysis on SDS 
– PAGE. The induced cultures were then incubated for 16-20h at either 37 ºC or 20 ºC. 
Following harvest at 16,000 x g, cells were lysed with BugBuster® Master mix (Novagen) 
and soluble versus insoluble protein fractions were analysed on SDS-PAGE.  
5.1.2.7 Purification and refolding of refLapA protein from E.coli inclusion 
bodies 
The pellet with inclusion bodies were re-solubilised in 8M urea buffer (50mM Tricine pH 
8.0, 500 mM NaCl, 8M urea) gently agitating for 1 hour. The non-dissolved debris was 
separated by centrifugation for 20 min at 16,000 x g. The resulting supernatant was loaded 
onto a HisTrapTM FF 5 ml (GE Healthcare, UK) nickel immobilisation affinity column 
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(IMAC), pre-equilibrated with wash buffer (50 mM Tricine pH 8.0, 500 mM NaCl, 8M urea) 
and re-solubilised refLapA was eluted in 50 mM Tricine pH 8.0, 500 mM NaCl, 8M urea 
and 200 mM imidazole. refLapA was allowed to slowly refold by reducing the concentration 
of urea in the buffer: IMAC-eluted fraction was dialysed against refolding buffer (10 mM 
Tricine pH 8.0, 1 mM ZnCl2) for 20h at 4 ºC. The refLapA was further purified using a 
HiLoad SuperdexTM 16/60 200pg (GE Healthcare, UK) gel filtration column pre-
equilibrated with 20 mM Tricine pH 8.0, 1 mM ZnCl2. Sample collection (2 ml fractions) of 
fractions exhibiting the highest specific activity were pooled and concentrated on Vivaspin 
15R – 10,000 Dalton Centrifugal Filter Units (Sartorius, UK) containing the HydroSart® 
membrane.  
5.1.2.8 Aminopeptidase assay 
LapA specific activity was determined spectrophotometrically, using a synthetic substrate 
(Leu-pNA) and monitoring the formation of the p-nitroanilide moiety (pNA), as absorbance, 
at 405nm (ε = 9.9 mmol-1cm-1) in a cuvette with a 1 cm path length. Peptidase assays were 
performed on a CE1020 1000 Series spectrophotometer (Cecil Instruments). One unit of 
LapA activity was defined to catalyse the hydrolysis of one micromole of L-leucine-p-
nitroanilide to L-leucine and p-nitroaniline, per minute at pH 7.2, 37 ºC. 
5.1.2.9 Quantification of recombinant LapA  
LapA proteins were quantified either by Bradford assay (Bio-Rad, USA), using BSA as a 
standard, or spectrophotometrically, employing a NanoDrop® ND-1000 (Thermo 
Scientific), using the LapA absorbance extinction coefficient (23,505 M-1cm-1). The 
concentration of recombinant LapA in crude P.pastoris supernatant could only be 
determined by Bradford assay due to impurities interfering with spectrophotometric 
measurements.     
5.1.2.10 CD spectroscopy of recombinant LapA  
The circular dichroism spectra for all resultant proteins were recorded in the range 360 to 
190 nm at 20 ºC, using a Chirascan series 800 spectrophotometer. Measurements were taken 
using a 1 nm step size in a 0.1 mm path length quartz cell. CD data were averaged from 5 
independent scans for each sample. Samples of refLapA, wtLapA and wt∆proLapA proteins 
were analysed at 36 µM, 21 µM and 40 µM concentrations, respectively, buffered in 20 mM 
HEPES pH 8.0.  
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5.1.2.11 Crystallisation and structure determination of recombinant 
LapA  
Crystallisation screening was carried out using HTP robotics at Oxford Protein Production 
Facility (OPPF-UK) (96 well commercial sparse matrix screens, sitting-drop vapour 
diffusion method) and crystallisation optimisation was carried out in the home laboratory 
using 24 well, hanging-drop vapour diffusion. wtproLapA, wtLapA recombinant proteins 
were crystallised at concentrations of 13 mg/ml and 11 mg/ml, respectively. Both proteins 
were buffer exchanged into 20mM Tricine pH 8.0, 1mM ZnCl2 prior to crystallisation. 
wtproLapA crystals with approximate dimensions 0.5 × 0.04 × 0.005 mm formed under F10 
condition (0.1 M Bis-Tris, pH 5.5, 0.2 M NaCl, 25% PEG 3,350) in the Index HT™ screen 
(Hampton Research, USA) in 3 days at 21 °C. wtLapA crystals were produced in 24-well 
plate format at room temperature under previously identified F2 (0.1M Citrate, pH 5.0, 3.2 
M Ammonium sulphate) crystallisation condition in JCSGPlus HTTM screen (Molecular 
Dimensions, UK).  
Prior to data collection, crystals were cryo-protected by quick transfer through a mixture of 
mother liquor and 20% ethylene glycol (except wtproLapA, which had 25% PEG in the 
mother liquor) and flash cooled to 100K in liquid nitrogen. Diffraction data were collected 
at Diamond Light Source (UK), on beamlines I02 and I03. The diffraction data were 
recorded, by fine slicing (0.1° degree oscillation), on a Pilatus 6M detector. Indexing and 
integration were completed automatically by XDS (Kabsch, 2010) and xia2 (Winter et al., 
2013).   
All the LapA structures were solved by maximum likelihood molecular replacement with 
PHASER (McCoy et al., 2005), using the coordinates of an established LapA homology 
model; LapA homology model was generated using the IntFold2 server (Roche et al., 2011), 
which identified aminopeptidase from Vibrio sp. (34% sequence identity) as a closely related 
structural homologue (PDBid: 1RTQ), as the template. Resulting LapA models were 
manually built, fitting to the resulting electron density maps using COOT (Emsley and 
Cowtan, 2004). All structures were refined using PHENIX (Adams et al., 2010). 
MolProbity4 was used for structure validation. Structural comparisons and superimpositions 
were generated using the TM-align server (Zhang and Skolnick, 2005). Structural images 
were prepared using PyMOL. Structural data was deposited in the PDB database with the 





5.1.3.1 General structural comparison of Lap peptidases 
Extracellular aminopeptidases from the M28 family share a very similar architecture of their 
open reading frames (ORF`s). In general, a short secretion signal sequence is preceded by a 
moderate length propeptide (removed in the maturation process), and a central catalytic 
domain. It is convenient to compare their primary sequences and their tertiary structure folds 
to establish conservation and evolutionary divergence at both the sequence and structural 
level. Evolutionary relationships between Lap1 from A.sojae and eukaryotic, as well as 
microbial homologues, were previously investigated (Chien et al., 2002). In our study, full 
ORF`s of several of these homologous fungal and microbial extracellular Lap enzymes were 
aligned together with LapA from A.oryzae (AoLapA) and Lap1 from A.sojae (AsLapA) 
(Figure 5.1). Compared to highly conserved catalytic core residues, a varying degree of 
homology was observed within the signal peptide and propeptide sequences.       
LapA from A.oryzae, Lap1 from A.sojae and AAP from Aeromonas proteolytica all belong 
to the M28 peptidase family; clan MH (MEROPS). AAP has been studied extensively and 
has been a model enzyme for this family, with regard to structural homology (Schalk et al., 
1992, Chevrier et al., 1994). Lap enzymes are typical structural representatives of this family 
with two Zn(II) ions sequestered from the surrounding environment and coordinated in the 
active site by 5 conserved residues in sequence order His, Asp (coordinates both Zn(II) ions), 
Glu, Asp, Glu, His. Also, an activated water molecule, associated with both metal ions, acts 
as nucleophile during catalysis. Additional Asp and Glu residues, considered to be essential 
for catalysis, reside in close proximity within His-Xaa-Asp and Glu-Glu motifs. Lap 
enzymes contain an archaic alpha/beta hydrolase fold with a five-stranded beta sheet (1 
strand antiparallel to the rest) sandwiched between a layer of helices on each side. The active 
site is parallel to the end of these beta strands.    
The coordinated divalent zinc ions form a functional charge/dipole complex along with 
conserved five amino acid ligands (LapA numbering: His176, Asp195, Glu234, Asp261, 
His343). Another conserved Glu233 residue, within the Glu-Glu motif, was supposed to 
assist in deprotonation of the terminal catalytic water molecule and, subsequently, donating 
a proton to newly formed amino-terminus, described as a rate-limiting step in the catalysis 
(Schurer et al., 2004). Several mutant forms of this residue rendered AAP enzyme inactive 
(Bzymek and Holz, 2004, Bzymek et al., 2005). Also, a complementary second-shell 
hydrogen bond network was identified in AAP and another homologous aminopeptidase 
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from Streptomyces griseus (SGAP), whose crystal structures have been solved (Gilboa et al., 
2000). We found that the Zn-D261-S315-Q259-D316-S240 network, identified in the AAP 
structure, also was conserved in A.orzyae LapA (AoLapA). Four residues (Met262, Tyr312, 
Cys314, Ile342), lining the hydrophobic specificity binding pocket, also were conserved in 
LapA and homologous extracellular aminopeptidases, including Lap1 from A.sojae and 






Figure 5.1. Multiple, full open reading frame alignment of homologous leucine 
aminopeptidases. LapA from Aspergillus oryzae (AoLapA, Q2U1F3), Lap1 from 
Aspergillus sojae (AsLap1, Q8J2N2), Lap1 from Aspergillus fumigatus (AfLap1, Q5VJG6), 
Lap from Agaricus bisporus (AbLap, Q8WZH8), Lap from Vibrio proteolyticus (AAP, 
Q01693), Lap from Aeromonas cholerae (AcholLap, P96152), Lap from Aeromonas caviae 
(AcavLAP, O82996) sequences were aligned. Secondary structure elements were assigned, 
according to structural data from the LapA precursor structure from this work. Conserved 
residues are displayed in red shading, Zn-coordinating residues – in blue shading, conserved 
His-Xaa-Asp and Glu-Glu motifs – labelled with pink stars, cysteine residues forming a 
single S-S bond are displayed in gold shading, and columns containing key LapA propeptide 
arginines - in green shading and green stars. Residues lining the hydrophobic specificity 
pocket and conserved second-shell hydrogen bond network are marked with red triangles 
and cyan stars, respectively. 11 different amino acids between AoLapA and AsLap1 open 
reading frames are displayed in brown shading. Residue accessibility (acc) bar depicts 
relative accessibility based on the LapA precursor structural coordinates (dark blue – very 
accessible, light blue – intermediate, white – inaccessible, red – not defined). Terminal parts 
of AAP C-terminal propeptide and the AcholLap PPC domain were truncated to achieve 
better alignment. Multiple sequence alignment produced using MAFF algorithm (Katoh et 
al., 2002). The figure was prepared using ESPript 3.0 (Gouet et al., 2003). 
 
The highly hydrophobic character of the specificity pocket allows such enzymes to favour 
bulky hydrophobic residues (Leu, Phe) in their active sites. The other four hydrophobic 
pocket residues varied among compared species; Phe329 in both AoLapA and AsLap1 was 
substituted with alternative hydrophobic residues – Leu in AbLap and Met in the rest of 
homologues, including AAP. Interestingly, two highly conserved residues Phe331 and 
Phe335 in AfLap1 were replaced by Thr and Met, respectively. The last distinct residue 
observed was Asp338 in AoLapA and AsLapA. At this position, a hydrophobic Tyr is placed 
in AAP, AcholLap, AcavLAP. Asp338 has been implicated in the hydrolysis of positively 
charged N-terminal amino acids by recombinant (rLap1) from A.sojae (Huang et al., 2015). 
LapA also contains a negatively charged Asp338. However, this does not render the enzyme 
capable of accommodating large positively charged residues (Arg or Lys), with the same 
efficiency as previously reported for rLap1 from A. sojae (Huang et al., 2015). LapA showed 
a preference for bulky hydrophobic residues in the active site and acted to remove N-terminal 
lysine with only 25% of the efficiency observed for the substrate with N-terminal leucine 
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(Matsushita-Morita et al., 2011). The reported differences in substrate specificity between 
LapA (AoLapA) and rLap1 (AsLapA) and wild-type Lap1 (AsLapA) must be associated 
with residue substitutions within the mature domain and propeptide (residues highlighted in 
brown in Figure 5.1).     
5.1.3.2 LapA expression in P.pastoris 
Coding regions of LapA precursor (wtproLapA) and prodomain-deleted version 
(wt∆proLapA) were codon-optimized for use by a Pichia pastoris host. Multiple gene 
dosage transformants were obtained for both (pJ-npro-LapA and pJ-∆pro-LapA) constructs. 
However, no real-time qPCR was attempted to quantify the number of integrated gene 
copies, in each case.  
Preliminary expression trials of the wild-type recombinant LapA with an alpha factor signal 
sequence and the native LapA signal peptide, resulted in slightly higher secretion levels with 
the latter (results not shown). Thus, it was decided to study further the expression of 
recombinant LapA harbouring the native signal peptide. 
In the case of wtLapA and wtproLapA, expression levels reached approximately 0.3 g per 
litre. SDS-PAGE analysis revealed significantly lower expression levels for wt∆proLapA in 
P.pastoris supernatant (Figure 5.2, A). We speculate that low expression levels were 
observed, due to the absence of the prosequence in the pJ-∆pro-LapA construct. 
Alternatively, it may be due to the integration of a lower copy number of LapA genes. 
However, pJ-∆pro-LapA  transformants were found to grow on YPD agar containing 2000 
ug/ml Zeocin, which is very unlikely for the P.pastoris strain harbouring only a single copy 
of the recombinant gene. The lack of propeptide in the wt∆proLapA expression construct 
could have yielded mis-folded protein with exposed hydrophobic patches, associating with 
molecular chaperones, the mechanism by which unfolded proteins are targeted for 
degradation within the ER (McIver et al., 1995, Yurimoto et al., 2004). Hence, observed 
expression levels were significantly lowered compared to wtproLapA, which contained 
propeptide in the expression cassette.  
wtproLapA and wtLapA recombinant proteins were obtained from the same expression 
cassette (pJ-npro-LapA) and were a result of clonal variation within P.pastoris 
transformants. In one of the clones, unresolved processing of expressed recombinant LapA 
precursor (wtproLapA) occurred, yielding mature active wtLapA. Most likely, cleavage of 
propeptide was a post-translational event since genomic PCR-based sequencing within the 
coding region showed no deletion of propeptide (results not shown). We propose that co-
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secreted non-specific proteolytic activity by an endogenous P.pastoris peptidase was 
responsible for the processing of the LapA precursor protein.  
N-terminal sequencing of wtLapA revealed three additional residues (AVT) preceding the 
N-terminal tyrosine, originally reported for LapA (Matsushita-Morita et al., 2011). 
Therefore, an unexplained endopeptidase activity, likely present in the P.pastoris 
supernatant, was different from that of native A.oryzae, which degrades the propeptide to N-
terminal tyrosine (Y80).      
As expected, P.pastoris supernatants with secreted wtLapA and wtproLapA contained no 
other contaminant host proteins (Figure 5.2, A). This facilitated the subsequent purification 
of these recombinant proteins in the absence of artificial tags.  
Figure 5.2 Purification of Lap proteins. A – purification of wtLapA, wtproLapA and 
wt∆proLapA: i) P.pastoris supernatants sampled (10 µl) at 120 h, containing recombinant 
LapA proteins: A1 – wtproLapA, A2 – wtLapA, A3 – wt∆proLapA; ii) purified from 
supernatant: B1 – wtproLapA, B2 – wtLapA; B – purification of refLapA (indicated by 
dotted arrow): i) initial IMAC purification step: A1 – resolubilized refLapA inclusion bodies 
in 8M urea, A2 – imidazole eluted fraction from IMAC column; ii) subsequent SEC 
purification of IMAC-eluted fraction and dialysis-refolded protein, each lane corresponds to 
individual fractions. Active (under blue triangular activity bar) and mostly active (black 
rectangle) fractions are indicated.       
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Purification of recombinantly expressed LapA (refLapA, wtproLapA, wt∆proLapA, 
wtLapA) enzymes was achieved as detailed in materials and methods (section 5.1.2.5). A 
dialysis step was required to liberate refLapA from 200 mM imidazole, present in the IMAC-
eluted fraction. It is worth noting that only a small portion of refolded refLapA was 
significantly active, following a size exclusion chromatography step (fractions 7 and 8, 
Figure 5.2 B(ii)). These fractions were pooled and utilised in subsequent CD analysis 
(Figure 5.3). A large population of refLapA separated as inactive, potentially aggregated 
protein (fractions 1- 3, Figure 5.2 B(ii)) on gel filtration column. These high-MW aggregates 
were even visible under denaturing SDS-PAGE and reducing buffer conditions. The specific 
activity of non-aggregated and refolded refLapA (fractions 7-8) reached 59.5 U/mg (Table 
5.1).  
Also, repetitive AEX purification cycles were required to liberate wtproLapA and wtLapA 
from brown pigment existing in P.pastoris supernatant. Elimination of these amber pigments 
proved very challenging, which was deemed mandatory for crystallisation trials. These two 
mysterious brown pigments (Mr < 2kDa) were reported previously to associate with other 
Lap peptidases and were briefly characterised by EPR to be spectroscopically active and 
contain an Fe(III) ligand (Schalk et al., 1992, Hartley et al., 2009, Aphale and Strohl, 1993, 
Bennett and Holz, 1997).      
5.1.3.3 Specific activities of Lap enzymes 
Standard leucine aminopeptidase assay was carried out to determine the differences in 
specific activity expressed by different LapA proteins, as demonstrated in Table 5.1. The 
importance of the observed specific activity diffences is discussed in the following section 
(5.1.3.4) along with Circular Dichroism data.  
Enzyme Specific activity (U/mg) 
wtLapA 140.15 ± 4.8 
wt∆proLapA 0.34 ± 0.1 
refLapA 59.5 ± 1.1 
Table 5.1 Specific activities of purified LapA proteins. Specific activity is averaged from 3 




5.1.3.4 Circular Dichroism (CD) experiments of LapA proteins 
LapA proteins were analysed by far-UV CD to estimate their secondary structure content 
and to study their folded state. The characteristic far-UV spectra of refLapA, wtLapA and 
wt∆proLapA proteins are shown in Figure 5.3. 
 
Figure 5.3 CD spectra and deduced folded state of LapA proteins. The observed CD signal 
from wtLapA, wt∆proLapA and refLapA A. Mean residue ellipticity - Θ222 versus Θ200 plot 
B. allows direct visualisation of the protein folded state, as described by Uversky et al. 
(Uversky, 2002). PCDDB database entries of proteins with similar spectra are also plotted.  
 
Ellipticities at 208 and 222nm relate to characteristic double minima of the alpha-helical 
spectrum. wtLapA displayed a typical double minimum at 222 and 208 nm and an intensive 
maximum near 195 nm, representing a protein with high α-helical secondary structure 
content (Figure 5.3, A). Also, by comparison to existing protein CD databases, LapA was 
predicted to exist in a native folded state (Figure 5.3, B), which is in good agreement with 
its specific activity data. refLapA exhibited almost identical CD spectrum. However, the 
observed lower mean residue ellipticity at 200nm suggests a minor loss of secondary 
structure and the prominent close-to- molten globule state of this protein. refLapA also 
showed a higher content of irregular structure compared to wtLapA. These observations 
coincide with a measured >2-fold reduction in specific activity relative to wtLapA (Table 
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5.1). A lower content of secondary structure also was found in recombinant refolded 
aminopeptidase from Vibrio proteolyticus (AAP) compared to natively expressed wild-type 
enzyme (Hernandez-Moreno et al., 2014). Finally, a spectral minimum at 200 nm and close-
to-zero ellipticity near 222 nm suggested a lack of secondary structure in the wt∆proLapA 
protein and a predominant pre-molten globule state, which explains its almost non-existent 
hydrolytic activity for this recombinant protein (Table 5.1). Importantly, this experiment, 
together with the specific activity data, demonstrates the negative effect of the absence of 
the propeptide in the expression construct of recombinant LapA in P.pastoris (wt∆proLapA) 
and E.coli (refLapA). Consequently, this reveals a potential role for the LapA propeptide in 
assisting the mature domain to gain a fully folded, functional conformation for its maximal 
activity.  
Enzyme Secondary structure content 
(%) 
 α-helix β-strand irregular 
wtLapA 10 36 37 
wt∆proLapA 3 42 62 
refLapA 20 27 49 
Table 5.2 Secondary structure prediction via CAPITO, based on the CD data analysis.   
 
5.1.3.5 Wild-type LapA structure 
The determined monomeric LapA structure (wtLapA) forms a classical α/β globular domain. 
The hydrophobic core is comprised of a twisted 8-stranded β-sheet, sandwiched between α-
helices, representing a typical archaic hydrolase fold (Figure 5.4, A). A secondary structure 
assignment, using the DSSP (Kabsch and Sander, 1983) server, showed that 45%, 16% and 
39% of the residues are involved in α-helices, β-strands and coil structures, respectively. The 
fairly accessible active site pocket is located on the surface of the protein. The catalytic 
binding pocket is formed by 6 conserved residues, coordinating two zinc ions, embedded in 
the loop region close to the core parallel β3 and β5 sheets, and hydrophobic specificity 
pocket residues, mostly arranged at the C-terminal end of the protein (Figure 5.4, B). The 
two Zn atoms exist in a distorted tetrahedral geometry with an interatomic distance of 3.6 Å. 
We also identified a nucleophilic water molecule bridging the two zinc atoms. Since both 
zinc ions significantly decrease the pKa of this water molecule (Desmarais et al., 2002), at 





Figure 5.4 Crystal structure of LapA catalytic domain (wtLapA) determined to 1.97Å 
resolution (A) and a detailed view of the active site (B). Catalytic residues and coordinated 
ZN atoms are coloured in red; nucleophilic water, HOH470, coordinated between the two 
ZN ions, indicated by cyan star; conserved hydrophobic binding pocket residues are shown 
in orange sticks; an essential S-S bond (C310 – C314) is depicted in cyan.    
5.1.3.6 LapA precursor structure 
We determined the three-dimensional structure of LapA precursor. All residues were well 
located in the electron density, with the exception of 7 and 11 residues at N- and C-terminal 
region of the prodomain, respectively, due to inherent flexibility in these regions (not 
uncommon in crystal structures of proteins). The final model, determined to 1.61 Å 
resolution, consisted of 359 residues, 517 water molecules, including the catalytic bridging 
water, a single chloride ion and an ethylene glycol molecule (arising from cryo-protection). 
From Figure 5.5, it is evident that the propeptide extends from the mature-prodomain 
junction, follows alongside the catalytic core (residues 66 – 76 are missing) until it enters 
and occludes the catalytic cleft, using its 3-turn α-helix motif. In the crystal structure of 
wtproLapA, the propeptide forms a separate domain (residues 19 - 79) (Figure 5.5). Its 
overall structure is highly disordered and flexible: only 23% of total residue content within 
the propeptide forms secondary structure. The middle part of the propeptide sequence forms 








Figure 5.5 Crystal structure of LapA precursor (wtproLapA) determined to 1.61 Å 
resolution. Cartoon and surface representation of the final protein model: prodomain is 
coloured in light blue, key arginines (R50’, R55’) are displayed as sticks in dark blue, 
catalytic ZN ions are depicted as red spheres, a single glycosylated asparagine (N87) is 
indicated by stick representation of the sugar moieties. N- and C-termini are indicated and 
coloured corresponding to the molecular surface of each domain. Also, missing residues (66 
– 76; connecting the prodomain and the catalytic domain) are indicated by a dashed yellow 




5.1.3.7 LapA precursor intradomain interactions 
The propeptide buries 8.8% of mature domain solvent-accessible surface area (1005 Å of 
11474 Å). Moreover, this does not take into account the missing 66 – 76 amino acid region 
of the propeptide. By corollary, the propeptide uses 29.7% of its surface area for the interface 
with the mature domain (Table 5.3).  
Interface Summary 
  Mature domain Propeptide 
Number of atoms         
 interface 116 5.1% 102 30.3% 
 surface 1078 47.4% 241 71.5% 
 total 2281 100.0% 337 100.0% 
Number of residues         
 interface 37 12.4% 21 48.8% 
 surface 241 80.9% 42 97.7% 
 total 298 100.0% 43 100.0% 
Solvent-accessible area, Å         
 interface 1005.5 8.8% 1096 29.7% 
 total 11474.5 100.0% 3684.7 100.0% 
      
Table 5.3 Summary of the protein surface statistics calculated between mature and 
prodomains in the crystal structure of LapA precursor. The structure coordinate file was 
analysed using PDBePISA (Krissinel and Henrick, 2007).  
 
The inter-domain network of interactions involves 37 and 21 (almost a half) of the residues 
for the catalytic and prodomains, respectively. More specifically, the inter-domain interface 
consists of 12 short-range (2.2 - 3.3 Å) H-bonds, 3 long-range (3.3 - 3.8 Å) H-bonds, 6 side 
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chain-side chain salt bridges (< 3.3 Å), and at least 10 aliphatic side-chain residues within 
the propeptide that make tight hydrophobic contacts with the mature domain (Table 5.4). 
 
Hydrogen bonds (2.2-3.3 Å) 
  Mature LapA domain  Dist. [Å]  LapA prodomain 
1   LYS 118[ NZ ]   3.20   TYR  29[ OH ]  
2  LYS 322[ NZ ]   3.07   GLU  32[ OE1]  
3  LYS 118[ NZ ]   2.74   GLU  43[ OE2]  
4  GLN 241[ NE2]   3.02   ASP  58[ O  ]  
5  SER 153[ OG ]   2.62   GLU  61[ OE1]  
6  ASN 288[ ND2]   3.21   VAL  67[ O  ]  
7  GLU 234[ O  ]   2.84   ARG  50[ NH1]  
8  GLU 234[ OE2]   2.99   ARG  50[ NH1]  
9  GLU 234[ OE2]   2.86   ARG  50[ NH2]  
10  GLY 236[ O  ]   3.02   ASP  58[ N  ]  
11  GLU 245[ OE2]   2.59   ARG  62[ NH2]  
12  ASP 242[ OD1]   2.69   ARG  62[ NH2]  
Long range H-bonds (> 3.3Å) 
1  TYR 116[ OH ]   3.66   GLU  43[ OE2]  
2  TYR 117[ OH ]   3.61   LYS  46[ NZ ]  
3  GLN 241[ OE1]   3.59   ARG  62[ NH1]  
Salt bridges (< 3.3A) side chain-side chain 
1   LYS 322[ NZ ]   3.07   GLU  32[ OE1]  
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2  LYS 118[ NZ ]   2.74   GLU  43[ OE2]  
3  GLU 234[ OE2]   2.99   ARG  50[ NH1]  
4  GLU 234[ OE2]   2.86   ARG  50[ NH2]  
5  GLU 245[ OE2]   2.59   ARG  62[ NH2]  
6  ASP 242[ OD1]   2.69   ARG  62[ NH2]  
Table 5.4 Contacts between the catalytic and prodomain. Contacts shaded in grey are 
visualised in Figure 5.6. 
 
 
Figure 5.6 Contacts between the catalytic (left) and prodomain (right). The prodomain is 
rotated 180 degrees to expose the corresponding surface contacts. The domain interface is 
stabilised mainly by salt bridges (positively charged residues – blue, negatively charged 





5.1.3.8 Fold comparison of Lap structures 
As expected, LapA precursor was found to deviate from mature LapA (wtLapA) only by 
0.38 RMSD and by 1.23 RMSD from AAP (PDBid: 2IQ6) over an equivalent range of 
residues, which indicates the high similarity between these protein folds. The active site 
geometry was found almost identical in all three crystal structures, with highly conserved 
catalytic residues and dizinc metal cofactors superimposing, almost precisely (Figure 5.7). 
Despite only 34% sequence identity to AAP, wtLapA and wtproLapA displayed an identical 
conserved fold, which is in agreement with proteins having greater conservation in tertiary 
structures and confirming their classification as M28 family members.   
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Figure 5.7 Superimposition of LapA precursor (cyan), mature LapA (yellow) and AAP-LLL 
(PDBid: 2iq6) (wheat) crystal structures. A. – similarity of overall folds, B. – 
superimposition of active sites only, C. – superimposition of active sites and hydrophobic 
binding pocket residues (narrow sticks). Residue labels correspond to general colouring 
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scheme, ZN atoms and bound Leu-Leu-Leu substrate are shown transparent for clarity. The 
main chain atom representation is omitted.  
5.1.3.9 Comparison of LapA precursor (wtproLapA) and mature (wtLapA) 
structures 
Alignment of the structures for proenzyme and mature protein show high similarity. 
Structural coordinates of LapA prodomain were omitted in the superpositions to achieve a 
more accurate representation of the RMSDs between catalytic domains. Superposition of 
LapA precursor (propeptide omitted) and mature structures via TM-align yielded an RMSD 
of 0.38, over 301 equivalent residues. Minor differences in secondary structure content were 
observed between wtproLapA and mature enzyme (Figure 5.8). Using the STRIDE 
(Frishman and Argos, 1995) web-based tool, which utilises a combined H-bond and 
geometrical restraint approach to secondary structure elements (SSE) assignment, SSE were 
identified for both proteins.  
 
Figure 5.8 Differences in the secondary structure of LapA proenzyme and mature proteins. 
Purple boxes indicate the differences in SSE.  
 
Although additional differences in secondary structure elements were found in PyMol 
representations, upon superimposition of these two forms of LapA enzyme, the more 
sophisticated STRIDE algorithm only identified an additional, significant 310 Helix in 




5.1.3.9.1 Comparison of overall B-factors 
Following cleavage of the N – terminal propeptide, an overall increase in B-factor values 
was observed within the catalytic domain. Not surprisingly, the most significant differences 
were apparent at the N – terminal region of the mature LapA protein (80 – 150 residue 
stretch) (Figure 5.9, B). This suggests an improved flexibility of the N – terminal part of the 
protein, following removal of the covalently linked prodomain. The increased intramolecular 
flexibility of the LapA mature domain (wtLapA) may be essential to perform the catalytic 
function.   
In fact, we determined an increase in thermal stability for the LapA precursor. The thermal 
melting midpoint value for the proenzyme increased by 10 °C, supporting the improved 
rigidity and overall thermal stability conferred by the covalently linked propeptide domain 
(Table 6.30). We concluded that, the higher temperature of unfolding is likely enthalpy 
driven, arising from the increased number of propeptide – mature domain interactions and 
providing more stability to the whole molecular edifice at elevated temperatures.  
 
Figure 5.9 Comparison of residue B-factor distribution in LapA proenzyme and activated 
protein. Lower to higher B-factor values are coloured from dark blue to red, respectively.  
A. LapA precursor, propeptide omitted for clarity; B. mature LapA protein, following 
cleavage of the propeptide. Residue ranges with the largest changes in B factor are indicated 




5.1.3.9.2 Prodomain induced structural changes 
 The major structural rearrangements within the LapA catalytic domain, observed in the 
presence and absence of propeptide, are discussed below.  
The presence of propeptide elicits a number of structural rearrangements in the catalytic 
cleft. Apart from the conformational changes in the hydrophobic binding pocket residues 
(discussed later), the architecture of the active site was not altered significantly. However, 
very subtle changes in the interatomic distances of the active site residues were detected. 
First, the distance between the two catalytic zinc atoms is longer (3.6 Å) in the mature 
enzyme compared to LapA precursor (3.4 Å). This stems from a minor change in 
coordination distances with catalytic residue ligands in LapA precursor.  
The only disulphide bridge in all of these structures is located within the loop adjacent to the 
catalytic site (C310-C314). The conformation of this loop is slightly altered in LapA 
precursor (Figure 5.10).   
 
 
Figure 5.10 Superimposition of wtproLapA (cyan) and mature wtLapA (yellow) Cα traces. 
Dashed circles indicate the affected loop regions. C310 and C314 residues, forming the 
disulphide bridge, are shown as sticks. Changes in the location of F335 (Cα atoms) are 
indicated by red arrows. Active site residues are coloured in red. Residue labels are coloured 




Given the very high conservation in active site geometries for dimetallic zinc peptidases, the 
crystal structure of AAP in complexation with the bona fide LLL (L-leucyl-L-leucyl-L-
leucine) substrate permits direct evaluation of propeptide-induced conformational changes 
within the substrate binding pocket and identification of the key residues involved. This 
conservation has been consolidated by our recent structure solution of wtLapA-Leu complex. 
With the aid of this structure, we demonstrate that the orientation of a single P1 leucine in 
the wtLapA-Leu complex is identical to one of the leucine residues of the LLL tripeptide in 
AAP. The structural coordinates of the P1 substrate moieties are directly superimposable 
(Figure 5.11, A).   
Following cleavage of the propeptide, a movement in both C310-314s and F335s loops is 
apparent. The former appears to be a genuine loop conformational change, resulting in 
shortening the distance to the carbonyl oxygen of C314, which is involved in making direct 
contact with the amide nitrogen of the Leucine substrate (P1’). This H-bond shortening is 
subtle (from 3.3 Å to 2.9 Å), but sufficiently significant to strengthen this polar contact 
(Figure 5.11, A). Also, it is possible that the H-bond angle of this contact becomes more 
favourable in the mature wtLapA conformation. Therefore, the increased bond distance in 
LapA precursor might contribute to an impaired ability to bind substrate. Residue Cys314 
has been identified as one of the key residues in the hydrophobic substrate binding pocket in 
Lap1 from A. sojae (Huang et al., 2015). And, residue F335 is directly involved in substrate 
binding (making a hydrophobic contact with the sidechain of P1 moiety). The transition of 
its side chain toward the active site, after cleavage of propeptide, might elicit a more 
catalytically competent conformation for the mature domain. In fact, from a more detailed 
analysis, it is apparent that the vdw distance between the side chains of F335 and the P1 
leucine moiety falls into the favourable region (4.5 Å), following the cleavage of propeptide 
(Figure 5.11, A).    
Additionally, at least two more residues were significantly affected by the movement of the 
C310-314s and F335s loops. An approximate reduction of > 2Å in the distance to leucyl 
hydrophobic side chain (P1) was observed for the aromatic ring of F331 in wtLapA structure 
(Figure 5.11, B). Also, quite remarkably, the side chain of Y312 is flipped, following the 
conformational change in the C310-314s loop. Finally, the side chains of other residues 
(D338, I342, H343), participating in stabilising the substrate (LLL), also move slightly 
deeper into the pocket following this transition. 
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A special consideration has to be made for the conformational change of Tyr312 in the LapA 
precursor structure. An conserved residue, Tyr225, in an equivalent location is found in the 
AAP protein. In the initial model of peptide hydrolysis, Tyr225 was proposed to interact 
with the N-terminus of the incoming substrate (Chen et al., 1997). However, this concept 
was later challenged by the analysis of AAP-bestatin and AAP-LPA complexes. It was 
concluded that Tyr225 may not be involved mechanistically, but it provides yet another 
stabilising hydrophobic contact (Stamper et al., 2004). Additionally, the phenolic oxygen of 
Tyr225 shares a H-bond with BES, Tris, LeuP and IDH. In contrast, we demonstrate that the 
N-terminus of the P1’ leucyl moiety is too distant to form a H-bond with the hydroxide of 
the Tyr312 side chain, but, rather it could make a favourable hydrophobic contact with the 
side chain of the P1’ leucyl moiety (Figure 5.11, B). In any scenario, this highlights the 
importance of the Tyr312 side chain in stabilising the hydrophobic substrate, which is 





Figure 5.11 Detailed analysis of the Leu substrate binding modes in wtproLapA (cyan) and 
mature wtLapA (yellow) structures. Active site residues are coloured red. Residue labels are 
coloured in agreement with their respective molecules. A. Leu (yellow) – leucine ligand 
observed in the crystal structure of wtLapA-Leu complex, sitting in the identical position to 
Leu-Leu-Leu (magenta) – leucine substrate from the complex with AAP (PDBid: 2IQ6); B. 




Differences between the wtproLapA and wtLapA structures indicate key structural 
rearrangements within the catalytic domain upon activation. Alternative side chain 
conformations, of the key conserved substrate binding residues, were observed in the 
activated structure of wtLapA, as a consequence of C310-314s and F335s loop movements. 
Several conserved hydrophobic binding pocket residues were seen to make closer contacts 
with the leucyl substrate, which are absent in the inhibited structure of the LapA precursor. 
However, these differences (in the wtLapA structure) were only associated with substrate 
binding residues and no major Cα backbone movements were observed in other parts of 
protein, following the transition to mature protein. 
5.1.3.10 Elucidation of the mechanism of inhibition by propeptide 
The crystal structure of LapA proenzyme enabled elucidation of the core inhibitory 
interactions exerted by the propeptide domain. A key residue in the propeptide domain is 
Arg50, which forms a tight 2.9 Å hydrogen bond with OE1 of the catalytic Glu234 in the 
main chain (Figure 5.12, A).  This interaction directly mimics the analogous H-bond (2.5 
Å) of Glu152 OE1 and the amide group of P3` LLL ligand – one of three essential H-bonds 
in forming the AAP-LLL pre-transition state complex (Kumar et al., 2007). In the novel 
proposed peptide hydrolysis mechanism for AAP, where a nucleophile was not delivered by 
a metal ion (Kumar et al., 2007), Glu152 was the most likely candidate to deprotonate a 
nucleophilic water molecule, so that the released metal-bound hydroxide could attack the 
activated scissile carbonyl carbon of the peptide substrate, resulting in formation of a gem-
diolate reaction intermediate and, ultimately, returning the proton to the nascent amino 
terminus of the substrate. While our data does not directly indicate a role for Glu234 in 
catalysis, it does show that inhibition by the propeptide is via blocking of one of the principal 





Figure 5.12 Mechanism of propeptide inhibition in LapA precursor (wtproLapA). 
Superimposition of three crystal structures: AAP with Leu-Leu-Leu ligand bound (wheat), 
AAP bound aminopeptidase inhibitor – bestatin BES (orange) and LapA precursor (cyan). 
Catalytic Zn(II) ions correspond to colouring of polypeptide chains. Key propeptide 
arginines (R50’, R55’), A. Leu-Leu-Leu substrate complex with AAP (PDBid: 2IQ6), B. 
bestatin (BES) substrate complex with AAP (PDBid: 1TXR), catalytic glutamates – E234 
(wtproLapA) and E152 (AAP-LLL, equivalent disulphide forming C314 (wtproLapA) and 




The mechanism of Glu234 inhibition by recruitment of the Arg50 side chain in the LapA 
prodomain provides additional support to the newly proposed carboxylate-mediated 
nucleophile delivery hypothesis presented by Kumar et al (2007). It is very likely that 
Glu234, rather than Glu233 (Glu151 in AAP), is more mechanistically important in the 
initiation step of the catalysis (deprotonation of the nucleophilic water). Therefore, from an 
evolutionary standpoint, Glu234 likely was preferentially targeted to achieve complete 
inhibition by LapA propeptide.  
In the case where Glu233 acts as a proton acceptor, from the bridging water species, the 
dangling oxygen of Glu234 was proposed to stabilise the activated hydroxide ion, or the 
protonated Glu233 carboxylate side chain, by participating in the H-bond, in either case 
(Desmarais et al., 2006). The Arg50 – Glu234 interaction had a significant effect on the 
coordination of this residue to the Zn1 atom. The Zn – O distance of Glu234 OE1 (dangling 
oxygen) atom is 2.64 Å in the mature LapA structure, while in the propeptide-inhibited 
structure this increases to 2.90 Å due to a strong electrostatic interaction with both the NH1 
and NH2 nitrogens delivered by Arg50. However, the lengthened Zn-O distance does not 
alter the distance of the Glu234 dangling oxygen to the reactive OH¯  species in the LapA 
precursor structure. The first coordination sphere for Glu234 OE2 was less affected with a 
marginal change in the Zn – O distance from 2.03 to 2.07 Å. 
Arg55 also contributes to the inhibitory nature of LapA propeptide by providing a flexible 
terminal guanidinium moiety, which (based on the electron density maps) we found to have 
three distinct orientations. Each of the three nitrogens in the guanidinium moiety can 
potentially form favourable van der Waals contact with the carbonyl oxygen of the adjacent 
Cys314 (Figure 5.12, B). This oxygen is involved in one of three key H-bond contacts and 
the only H-bond present in the AAP complex with the LLL substrate (PDBid: 2iq6) and 
aminopeptidase inhibitor – bestatin (PDBid: 1txr), respectively. We propose that, in a similar 
fashion, the NE atom of the Arg55 mobile side chain is mimicking an essential hydrogen 
bond contact between the backbone carbonyl oxygen of Cys227 and the N1 atom of bestatin 
(BES) (Figure 5.12, B). Also, partial occupancy of Arg55 in our electron density maps 
suggests dynamic behaviour of the side chain of this residue, possibly distorting the 
dinuclear ZN site by intervening with the terminal nitrogen on the guanidinium moiety. In 
this respect, Arg50 and likely together with Arg55, prevents binding and initiation of 
substrate hydrolysis in LapA. Thus, we propose two additional key inhibitory propeptide 
residues, Arg50 and Arg55, in LapA (AoLapA) and Lap1 (AsLap1) whereby their long side 
chains enter the catalytic cleft and block activation (Figure 5.12).  
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Also, in the homologous (57% identity to AoLapA) aminopeptidase from Aspergillus 
fumigatus, Arg50 is substituted for another positively charged residue, Lys60, and Arg55 is 
replaced by  a less structurally similar residue, Asn66 (Figure 5.1). Interestingly, Leu59 was 
found in the equivalent position to Arg50 in the homologous aminopeptidase (AbLap) from 
Agaricus bisporus (43% identity to LapA). However, there is an Arg at position 60, next to 
Leu59, in this homolog, suggesting it could be orientated to the identical location (to Arg50 
in AoLapA) in its tertiary structure (as yet, undetermined). Importantly, Arg55 is not only 
recruited by LapA and Lap1, but also by the latter AbLap aminopeptidase. Taken together, 
these observations support a plausible role for such a positively charged side chain in 
mimicking the substrate-like interactions in the active site of these aminopeptidases. 
Therefore, we propose that LapA, Lap1 and some other Lap precursors within the M28 
family of homologous extracellular aminopeptidases recruit positively charged side chain 
moieties, which, by making key contacts with conserved active site and substrate binding 
residues, resemble the interactions of known synthetic inhibitors (bestatin) and natural 
ligands (leucine). This emerged as a potential generic mechanism utilised by the precursors 
of eukaryotic fungal leucine aminopeptidases.  
Lastly, another interesting residue was identified in the LapA prodomain sequence, Leu49, 
which was found to be highly conserved amongst the aligned species (Figure 5.1). In the 
crystal structure of LapA precursor, Leu49 was found favourably interacting with at least six 
residues from distant parts of the prodomain (Figure 5.13). These multiple hydrophobic 
interfaces between the aliphatic side chain of Leu49 and side chains of interconnecting 
residues could be essential for stabilising the overall fold of the prodomain. Therefore, we 
conclude that the strategically placed Leu49 is making contacts with residues flanking both 
ends of the prodomain helix that occludes the active site and holds the correct orientation of 
adjacent loops connecting to/from this helix, stabilising the overall fold of the prodomain. 
The strategic orientation of the prodomain helix could be essential for steric occlusion of the 
active site cleft, also assisting the crucial orientation of the key inhibitory arginines (Arg50 






Figure 5.13 Multiple hydrophobic contacts of prodomain Leu49' (orange). Target residues 
making hydrophobic contacts with Leu49' are coloured in wheat. Distances to Leu49' are 




5.2    Crystal structure of LapA with natural substrate – Leucine 
(wtLapA-Leu) 
Crystal structure of the recombinant mature LapA (wtLapA) in complex with a single leucyl 
moiety was determined to 1.9 Å resolution. The crystallisation process involved briefly 
soaking the previously formed wtLapA crystals in leucine tripeptide (Leu-Leu-Leu). 
However, only a single leucine could be reliably traced in the resulting electron density map.  
Most likely, the enzyme exhibited hydrolytic activity in a crystalline state, cleaving the 
scissile bond between P1 and P1' residues of the Leu-Leu-Leu substrate.  
The coordination geometry of the leucyl moiety was identical to that observed in the 
analogous crystal structure of AAP-LLL (PDBid: 2iq6). This observation reflects the 
conservation of the; active site residues, substrate binding pocket geometries and reaction 
mechanism for these homologous leucine aminopeptidases, which display only 34% 
sequence identity (Figure 5.14).     
 
 
Figure 5.14 Comparison of the substrate binding pockets in wtLapA-Leu and AAP-LLL 
crystal structures. A. Superimposition of the resting LapA molecule (wtLapA) and leucine-
bound state. B. Superimposition of wtLapA-Leu and AAP-LLL coordinates. Colour code: 
wtLapA – yellow, wtLapA-Leu – marine, AAP-LLL - wheat; Narrow sticks – HBP 
(hydrophobic binding pocket) residues; wide sticks – catalytic residues; ZN (I,II) are 
depicted as spheres. Leu and Leu-Leu-Leu substrates are shown as solid and transparent 
sticks, respectively.  
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The distance between the two Zn atoms in wtLapA-Leu structure is 3.3 Å, which is slightly 
less than that observed in the resting LapA molecule (3.6 Å).      
The coordination geometry of the P1 leucine residue was directly superimposable with the 
P1 moiety of the Leu-Leu-Leu ligand observed in the AAP-LLL crystal structure (PDBid: 
2iq6) (Figure 5.14, B). The isobutyl sidechain of the P1 ligand interacts with an expansive, 
hydrophobic S1 subsite, formed by the intervening sidechains of residues Y312, C314, F335, 
F329, F331, M262 and I342, which all are within 5 Å of the ligand sidechain. 
Accommodation of the leucine ligand elicited the conformational changes of the key 
hydrophobic residues in the HBP pocket. Mainly, the phenyl rings of F331 and F335 
displayed altered conformations, whereby the distance to the P1 sidechain exceeded 5 Å. It 
is possible that we have trapped a transient state conformation of wtLapA in the substrate 
hydrolysis mechanism, since no equivalent sidechain movements were apparent in the AAP-
LLL complex (Figure 5.14, B) or the resting wtLapA molecule. The hydrophobic isobutyl 
sidechain of the P1 leucine could result in the observed movement of F331 and F335 phenyl 
rings (as a result of substrate hydrolysis) leading to temporarily induced conformations and 
product release. Interestingly, the movement of the equivalent residues is seen in the 
propeptide-inhibited LapA structure, which may be linked to the increased flexibility of this 
HBP region during catalysis. Leucine is known to be a poor, purely competitive inhibitor of 
AAP (Kumar et al., 2007). Thus, the determined substrate-inhibited state of LapA might 
mirror the conformational changes already present in natively inhibited LapA precursor. 
This transient state is the first of its type to be observed in the family of M28 




 Hydrogen bonds Non-bonded interactions 
Ligand Interacting partners Distance (Å) Interacting partners Distance (Å) 
       
Leucine N --- Met262 SD 3.40 O --- ZN1 2.20 
 N --- Asp195 OD1 3.32 O --- ZN2 1.87 
 N --- Asp195 OD2 3.37    
 N --- Asp261 OD2 3.28    
 N --- Asp261 OD1 3.16    
 O --- His176 NE2 3.15    
Table 5.5 Hydrogen bond and non-bonded distances between polar groups of wtLapA and 
leucine ligand, in the complexed state.  
   
5.3 Discussion 
LapA from A.oryzae was recombinantly produced as proenzyme (approx. molecular weight 
39 kDa). The mature enzyme has a molecular weight of 32.5 kDa. The final molecular weight 
is dependant on the extent of N-linked glycosylation at Asn87. The enzyme is not known to 
be capable of autoprocessing. The expression of precursor proteins is well established in 
other metalloenzymes, such as subtilisin, thermolysin and homologous aminopeptidases 
from Aeromonas caviae T-64 and Vibrio proteolyticus (Ikemura et al., 1987, Gao et al., 
2010, Nirasawa et al., 1999, Bzymek et al., 2004). Usually, these are extracellularly secreted 
enzymes, where propeptide acts as a competitive inhibitor, including subtilisin E (Hu et al., 
1996), carboxypeptidase A (Segundo et al., 1982), a metalloprotease from Brevibacillus 
brevis (Serkina et al., 1999). This could be an evolutionary adaptation to prevent non-
specific intracellular proteolysis. The catalytic nature of LapA can induce toxic affects to the 
host cell, therefore, most probably the activation and processing of the LapA precursor 
occurs following secretion into the extracellular environment.    
A more detailed understanding of the molecular action of these propeptide domains is 
required to ascertain the role of their cognate active domains in folding processes. Also, the 
design of more specific inhibitors for dimettalic proteins can be facilitated by mirroring the 
pre-determined interactions with these native prodomains.    
5.3.1.1 LapA protein purification and crystallisation 
Two major difficulties to crystallising recombinant LapA proteins were (1) potential 
heterogeneity of protein populations presented by native host glycosylation and (2) 
elimination of brown pigments associated with recombinant LapA. The former was not so 
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problematic, as only Asn87 appeared glycosylated and crystals were obtained in 24 - 72 
hours. However, long branched glycan chains can have a major effect on crystal packing 
and, we could expect improved molecular packing and better resolution quality data in the 
absence of glycosylation. On the other hand, liberating LapA proteins from bound brown 
pigment was a major challenge. Previous efforts to obtain crystals of Lap proteins suggested 
that the presence of this impurity could hinder crystallisation. Successive removal of these 
two pigments on AEX column gave rise to the rapid formation of LapA crystals. It is worth 
noting that, in later crystallisation attempts of LapA precursor, the enzyme preparation still 
contained moderate levels of brown pigments but this did not hinder single crystal formation.   
5.3.1.2 LapA precursor 
It is interesting to note, that unobserved electron density for C-terminal prodomain residues 
is a result of mobility, which is likely required for better accessibility to activating an 
endopeptidase involved in maturation of LapA precursor. This observation concurred with 
the unexplained N-terminal processing of LapA precursor in the P.pastoris supernatant. 
Specifically, the end of the missing C-terminal propeptide region (A77V78T79) is the 
beginning of the verified N-terminus of the processed precursor (wtLapA). Therefore, we 
speculate that LapA precursor was processed by a co-expressed, non-specific host 
endopeptidase. This would seem to be the only viable explanation since, in the other clones, 
the vast majority of recombinant protein was found in the form of the precursor in the culture 
supernatant (Figure 4.21).   
5.3.1.3 Mode of inhibition by LapA propeptide 
Since the active site geometry is almost identical in the crystal structures analysed, AAP 
complexed with Leu-Leu-Leu (PDBid: 2IQ6) and bestatin (PDBid: 1TXR) can be used as a 
guide to understanding the mechanism of LapA inhibition by propeptide and its implications 
for substrate binding. Therefore, superimposition of LapA precursor and AAP-LLL crystal 
structures enabled us to determine the mode of inhibition by propeptide and decipher the key 
residues involved.  
Given the conservation of the active site composition and geometry between LapA and AAP 
proteins, structure coordinates of LLL (substrate) and BES (inhibitor) ligands from AAP 
complex solutions could be incorporated into the active site of LapA to study the mimicry 
by prodomain residues. Also, we have solved the structure of wtLapA enzymes with a single 
bound leucyl moiety, which demonstrated binding of the leucyl moiety in the exact 
orientation to the P1’ ligand in the AAP-LLL complex (Figure 5.11, A).  
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Together, with the observed alterations of side chain conformation of the hydrophobic 
binding pocket residues in LapA precursor (Figure 5.11), a model of LapA inhibition can 
be proposed. In addition to sterically occluding the active site cleft, the propeptide acts by 
neutralising the key Glu234 and Tyr312 residues, thereby preventing any possible incidence 
of peptide hydrolysis. Therefore, the LapA prodomain utilises an obvious mimicry of 
binding the substrate (as seen in known synthetic inhibitor binding) as a mode of inhibiting 
the catalytic domain.   
In conclusion, our LapA precursor structure provides a motive to revisit the mechanism of 
catalysis in these dinuclear enzymes and, also to design more effective inhibitors for 
dimetallic peptidases aimed at the conserved Glu234 residue.           
5.3.1.4 LapA propeptide – role of intramolecular chaperone (IMC)  
In this study, the role of propeptide in the expression construct of LapA precursor was 
investigated, using a Pichia pastoris recombinant expression platform. Firstly, due to the 
propeptide deletion wt∆proLapA, recombinant LapA was secreted at significantly reduced 
levels compared to full LapA precursor (wtproLapA). Lack of the propeptide in wt∆proLapA 
expression cassette could have yielded inappropriately folded protein with exposed 
hydrophobic patches, associating with molecular chaperones, the mechanism by which 
unfolded proteins are targeted for degradation within the ER (McIver et al., 1995, Yurimoto 
et al., 2004). Hence, the observed expression levels of wt∆proLapA protein were 
significantly reduced compared to wtproLapA, which contained prodomain in the expression 
construct; in turn escaping the degradation mechanism. Secondly, the CD spectrum of 
wt∆proLapA exhibited a lack of secondary structure and showed a predominant pre-molten 
globule state, while LapA was able to acquire a native fold in the presence of propeptide. 
This experiment alone demonstrated the requirement of prosequence, which may act as a 
chaperone in an intramolecular manner.  
Also, in the in vitro refolding study, the N-terminally His-tagged mature LapA was unable 
to regain its native fold and exhibited decreased specific activity levels. The ability of 
refLapA to refold from E.coli inclusion bodies was not complete, as demonstrated by 
specific activity measurements and CD experiments. The specific activity of refLapA was 
only ~43% of that observed for wtLapA and it was predicted to exist in a molten globule 
state, according to CD analysis. This implies that absence of propeptide, in the expression 
construct of refLapA, gives rise to an improperly folded protein, which was unable to regain 
its full native conformation under 20 h of refolding conditions. The refolding process of Lap 
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from Vibrio proteolyticus (AAP) was demonstrated to be under kinetic control, as a 
significant increase in specific activity was achieved following incubation of refolded AAP 
at 37 °C for 72 h (Hernandez-Moreno et al., 2014). Therefore, it is possible that prolonged 
dialysis against refolding buffer could increase the population of molten globule state 
refLapA or yield native-like molecular conformation. However, this requires further 
experimental validation.  
It is important to note, that refLapA carried a hexahistidine tag on the N-terminus, which 
was implicated to potentially act as an intramolecular chaperone in a similar refolding study 
of Lap from Vibrio proteolyticus (Hernandez-Moreno et al., 2014). Similarly, the observed 
specific activity of rLap from V.proteolyticus was somewhat reduced compared to the wild-
type enzyme. These findings and our experiments highlight the importance of the propeptide 
region and its potential role as an intramolecular chaperone in the folding process of these 
aminopeptidases, leading to a completely functional conformation of the catalytic domain.   
To further validate the role of the propeptide as an intramolecular chaperone, it would be 
useful to study the unfolding/refolding process of recombinant LapA, in the presence and 
absence of propeptide, using urea or guanidinium chloride. The ability to fully regain activity 
in completely unfolded pro-LapA polypeptide would indicate the chaperonin effect of LapA 
propeptide, provided the mature unfolded segment would fail to refold into an active 
conformation. Also, addition of propeptide, as a separate peptide to refLapA refolding 
mixture, may induce the transition from a molten globule state to a native-like conformation. 
In a similar fashion, molten globule subtilisin could be converted to native molecule (Fu et 
al., 2000). Nevertheless, these experiments highlight the importance of prodomain in the 
expression constructs of wild-type LapA and suggest its potential role as an intramolecular 
chaperone, accelerating the rate of folding and secretion in the native and recombinant hosts.  
We have demonstrated that LapA propeptide acts as an intramolecular chaperone and is 
essential for the maturation of the catalytic domain when expressed in cis. Further, it is 
evident that LapA prodomain may be able to function in an intermolecular manner and assist 
with secretion and folding of the mature polypeptide when expressed in trans. Several 
successful studies of prodomain expression in non-covalently linked state (trans) were 
reported for homologous and more distantly related peptidases. Expression of propeptide 
and mature domains, as separate polypeptides, resulted in the recovery of activity for 
membrane Type 1-Matrix Metalloproteinase (Cao et al., 2000). Impeded secretion of the 
mature domain of aspartic proteinase Sap1p from C.albicants in P.pastoris was restored 
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upon co-expression of the pro-polypeptide in trans (Beggah et al., 2000). Unlinked 
propeptide co-expression in P.pastoris also was shown to rescue the appropriate secretion 
and activity levels of Streptomyces mobaraensis Transglutaminase (Yurimoto et al., 2004). 
We are currently investigating an expression platform for co-production of covalently 
unlinked LapA domains. Proven successful, this could overcome the requirement of 
downstream enzymatic processing of LapA proenzyme. This, in turn, would provide ready 
access to highly active, appropriately folded and relatively pure recombinant enzyme from 




Chapter 6 STRUCTURAL AND FUNCTIONAL STUDIES OF LAPA 
MUTANTS: CHARACTERISATION OF THERMOLABILITY  
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6.1 LapA thermolabile mutants M1 – M6: 1st round mutagenesis  
6.1.1 Rationale and structural bioinformatics 
The inherent thermolability of cold-adapted (psychrophilic) proteins encouraged the 
exploration of protein sequence databases in an effort to identify key sequence and structural 
differences that could lead to improved thermolability of LapA. Equally, it was essential to 
understand hot-adapted (thermophilic) homologues to clearly establish the structural links 
between increased rigidity and thermostability in thermophiles, which should be avoided in 
LapA mutagenesis.  
Homologous sequences of psychrophilic and thermophilic aminopeptidases were obtained 
by performing a BLAST search (of non-redundant sequences) using the mature sequence of 
LapA as the query sequence. Only sequences above 60 - 70% query coverage were chosen 
for subsequent analysis.  
Multiple sequence alignment was performed with selected psychrophilic and thermophilic 
sequences, which were manually inspected, to determine the habitat of their respective 
organisms (Figure 10.5, Appendix II). The most homologous peptidase (38% identity, 98% 
sequence cover) was aminopeptidase from the Antarctic fungus Glaciozyma antarctica. 
Other sequences from genuine psychro- and thermophilic organisms shared a significantly 
lower degree of homology to LapA mature sequence (<25% identity, 50-60% sequence 
cover). The region showing the most sequence homology, across selected 15 sequences, was 
between residues 78(156) – 293(372), where the number in brackets corresponds to a full 
reading frame. This region spans the conserved α/β sandwich fold in M28 peptidases, 
harbouring the catalytic and substrate binding pocket residues. The least homologous region 
was found at the N-terminus from residues 60(139) – 77(155), where some of the 
psychrophilic homologues contained an additional long insert, which formed a separate 
domain in the predicted structure model (Figure 10.6, Appendix II).  
Structural models, using a template-based approach, of select sequences (M28 peptidases 
from Psychroserpens burtonensis and Rhodonellum psychrophilum) were obtained using the 
online structure prediction server Phyre 2 (Bennett-Lovsey et al., 2008). The homology 
models obtained were superimposed with the newly acquired LapA crystal structure (Figure 
10.6, Appendix II) for comparison.   
The highest sequence and structural disparity between LapA and temperature-adapted 
homologues were found in variable loop regions and mainly the protein surface. Therefore, 
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it was postulated that one of the routes to temperature adaptation in psychrophilic proteins 
was via optimisation of residue content in these flexible loop regions and modulation of 
interactions with the solvent by surface residues. This observation is in agreement with 
evidence in the literature, which suggests that additional flexibility leads to cold adaptation 
and thermolability in psychrophilic proteins (as discussed in sections 1.5 and 1.6). These 
observations helped guide our mutagenesis strategy, whereby the protein core was left intact, 
and residue substitutions were targeted to the loop regions and ends of secondary structure 
elements of release conformational entropy - favouring increased flexibility and increased 
entropy. 
The first round of LapA thermolability mutations (Table 6.1) were designed based on the 
multiple sequence alignments of the identified psychro- and thermophilic homologues 
(Figure 10.5, Appendix II) and the newly acquired structure of native LapA (flavLapA) from 
Flavourzyme (section 3.2). The flavLapA crystal structure provided detailed information 
regarding secondary structure elements, precise interatomic distances and key salt bridges 
stabilising the protein, as well as localised residue rigidity, as a mean of B-factor (a 
crystallographic thermal motion parameter) - features that could be exploited during 
mutagenesis to impart thermolability.  
For tertiary structure prediction, the selected sequences containing the M1 – M6 mutations 
were submitted to the SWISS-MODEL server (Biasini et al., 2014), using the flavLapA 
structural coordinates as a template. However, no major structural rearrangements or protein 
backbone movements, in the vicinity of the mutation sites, were predicted in the resulting 
structural models, suggesting no major structural changes should be exerted by the M1 – M6 
point mutations.   
In this round, also the effort was directed toward investigation of the importance of the 
glycosylation site, N87, previously confirmed in the flavLapA crystal structure. This N-
linked sugar moiety, in the recombinant LapA protein, could hinder subsequent 
crystallisation attempts of thermolabile mutants. However, more importantly, glycosylation 
has been shown to have a thermostabilizing effect on numerous protein structures (Guo et 
al., 2016, Shental-Bechor and Levy, 2008). Thus, removal of this post-translational 
modification could result in the desired reduction in thermostability of LapA. On the other 
hand, some studies suggested a possible influence of glycosylation on the folding process 
and protein stability (Imperiali and O'Connor, 1999, Xu and Ng, 2015). Therefore, this 
warranted further study. 
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An alternative mutagenesis strategy also was available, whereby the lowest B-factor residues 
would be targeted (referred to as rigid ‘hot spots’). This approach has lead to destabilisation 
and significantly increased thermolability of lipase from Pseudomonas aeruginosa (Reetz et 
al., 2009). Using the flavLapA crystal structure, key rigid ‘hot spot’ residues were identified, 
as follows: Q246 (Bfactor: 16.3 Å2), G324 (Bfactor: 19.7 Å2), G174 (Bfactor:20.2 Å2). 
However, these residues are conserved and located within the protein core, forming essential 
secondary structure elements. Destabilising LapA in the conserved fold regions might have 
a detrimental effect on tertiary structure and overall stability. A high-throughput mutant 
screening platform would be required to take a directed protein evolution approach, which 
was available in the Reetz et al. study. Considering the complexity of recombinant cloning 




Table 6.1 Library of M1 – M6 LapA thermolability mutants. B-factor analysis was based on the crystal structure of native LapA enzyme from 
Flavourzyme (Bav = 33.9 Å2).    





Conservation Location  Rationale 
M1 P155/G Increase local 
flexibility 
30.1 Not conserved β turn Very few psychrophilic homologoues have prolines 
at this position. 
Proline to glycine mutation has rendered Subtilisin 
Carlsberg more thermolabile (Fuchita et al., 2012).   
M2 P304/A Increase local 
flexibility 
37 Not conserved Loop Proline was found in LapA and GAP, but no other 
psychrophilic homologues. However, thermophilic 
counterparts contain proline at this position.  
M3 R252/K Weaken the 
salt bridge 
31.3 Not conserved Loop No arginine present in other psychrophilic 
homologues, but in thermophilic conterparts. Forms 
a very strong salt bridge with E226.  
M4 Q91/A Brake the salt 
bridge 
35.5 Not conserved Helix Forms a strong salt bridge with R362, which is part 
of a rigid helical secondary structure element. 
M5 N87/A Eliminate 
glycosylation 
site 
32.2 Not conserved Helix Glycosylation might contribute to added 
thermostability of LapA protein, therefore 
elimination of the sugar moieties should render 
LapA more thermolabile.  
M6 C310/A Brake the 
disulphide 
bond 
55.5 Not conserved Loop Strong covalent disulphide bond in C310 – C314 
loop largely contributes to overall stability of LapA 
structure. Removal of this interaction should 
significantly destabilise the whole structure.   
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6.1.2 Recombinant cloning and expression of M1 – M6 mutants 
Due to the complex and laborious nature of recombinant LapA expression and purification 
from P.pastoris supernatant, only a limited number of LapA variants could be screened in 
the first round of mutagenesis. In this initial round of mutagenesis, six LapA thermolability 
point mutations were generated (Table 6.2).  
All LapA thermolability mutants were generated using the Quickchange site – directed 
mutagenesis protocol (section 2.2.6). The wild – type LapA precursor expression construct, 
pD-npro-LapA, served as a template in the mutagenic PCR reaction using the primers pairs 
given in Table 6.2.  
Mutant 
name 
Mutation  Mutagenic primers 
M1 P155G 5'-AATCTTTGCGATCAAGGATGATTGACCAAACGAATGTTTGAAAGGCTCTAC-3' 
5'-GTAGAGCCTTTCAAACATTCGTTTGGTCAATCATCCTTGATCGCAAAGATT-3' 
M2 P304A 5'-CGCCTACTGTACTATCGCTACTGTCGATTCTAAGT-3' 
5'-ACTTAGAATCGACAGTAGCGATAGTACAGTAGGCG-3' 
M3 R252K 5'-GTTGTAACATAGCTTTAACATCTTTTGACTTCTGAGAATACTGTTCG-3' 
5'-CGAACAGTATTCTCAGAAGTCAAAAGATGTTAAAGCTATGTTACAAC-3' 
M4 Q91A 5'-TTTTTTGTCCAACGATTTGATAAGATTAGCCACAGTTTCATTGTGTTGGACGCTATC-3' 
5'-GATAGCGTCCAACACAATGAAACTGTGGCTAATCTTATCAAATCGTTGGACAAAAAA-3' 






Table 6.2 Primers used to generate M1 – M6 point mutations 
 
Five colonies, of each mutant E.coli clones, were tested to verify that these carried the gene, 
by colony PCR using AOX1 primers. All E.coli clones were found to harbor the expected 
mutant LapA plasmids. Subsequent plasmid DNA purification and sequence verification 
showed successful integration of site – directed mutations (results not shown).  
Following integration of all LapA mutant expression cassettes into the P. pastoris X33 strain, 
approximately 20 colonies were observed on high concentration (‘Bonus’) zeocin plates for 
each mutant strain. It was decided to omit transformant verification by colony PCR at this 
stage, since the very high concentration of antibiotic only selects for multiple genomic 
integration events of the expression cassette.  
Using a high-throughput micro-fermentor, 1 mL cultures were set up to determine the 
secretion profiles of M1 – M6 mutants (2.13.3). Variation of ‘Bonus’ and regular 
transformants was picked for inoculation to test any differences in the secretion levels.  
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After 115h of continuous induction and a final concentration of 0.5% MeOH, supernatants 
were harvested and analyzed by SDS – PAGE (Figure 6.1). 
 
Figure 6.1 Analysis of the secretion profiles of the M1 – M6 LapA thermolability mutants.  
All lanes represent a 10 µL supernatant load. ‘Bonus’ transformants are indicated by a star.  
 
All six thermolability LapA mutants yielded extracellularly secreted recombinant protein in 
the P. pastoris supernatant. ‘Bonus’ transformants showed higher secretion levels in all 
mutants, except clones of the M6 mutant. This suggests that screening for multiple 
homologous recombination events was an effective strategy to increase secretion levels of 
the LapA mutants of interest. 
The M1 and M6 P. pastoris clones secreted partially mature LapA protein. The remaining 
LapA mutants were secreted primarily in the form of precursor. The M5 (N87A) precursor 
migrated at a slightly lower molecular weight as expected, due to the successful elimination 
of the N – glycosylation site. Thus, M5 served as a reference, leading to the conclusion that 
the remaining higher – migrating LapA mutants were glycosylated.  
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Based on SDS-PAGE analysis, clones of M2, M3, M4, and M5 showed comparable levels 
of secretion. M1 and M6 mutations negatively affected secretion of the recombinant protein, 
possibly due to adverse implications for structural integrity and polypeptide folding. 
Interestingly, only M1 and M6 mutants showed indicative maturation events, which could 
render the precursor more susceptible to proteolytic processing by co-secreted P. pastoris 
non-specific proteases.    
 
6.1.2.1 Scale-up expression of selected LapA mutant clones 
400 mL shake flask cultures were set up with selected LapA mutant clones (Table 6.3). Wild 
– type LapA protein also was expressed, as a positive control. After 120h of continuous 
induction, with a final concentration of 0.5% MeOH, supernatants were harvested and 
analyzed by SDS – PAGE (Figure 6.2). 
LapA mutant Clones selected  
M1 2 and 4 
M2 2 and 8 
M3 2 and 4  
M4 5 and 6 
M5 1 and 3 
M6 1 and 4 






Figure 6.2 Recombinant expression data from large – scale trial of wild-type and M1-M6 
LapA mutants. A – analysis of supernatants sampled after 72 and 120h; B – OD600 values 
after 120h; C – protein quantification, by Bradford assay, after 120h. LapA proenzyme and 
mature protein populations are indicated by red and blue arrows, respectively. 
 
Figure 6.2 (A) shows that wtproLapA, M2, M4 and M6 proteins were secreted in a pro – 
form (precursor protein). M1 mutant appeared in a mature form, but suffered from 
degradation within 72 – 120h time interval. Maturation and concomitant degradation of M5 
mutant also seemed to occur within a similar time interval. Removal of the N – linked 
glycosylation site (N87) may have rendered the M5 mutant more susceptible to proteolytic 
degradation during the 5 – day culture incubation period. The M3 mutant showed no full – 
length secreted target protein, but this was due to culture contamination, which was 
indicative from the smell of the culture.  
In this trial, wtproLapA secreted the largest amount of protein (0.63 mg/mL). Other mutants 
showed moderate levels of secretion (0.3 – 0.4 mg/mL), except M1 and M5, both of which 




6.1.3 Purification and AP1 – mediated enzymatic activation of M1 – M6 mutant 
precursors          
Mutants M1 – M6 were purified and their active forms were obtained, using the workflow 
described in Figure 2.1. Briefly, all LapA mutant proteins were concentrated and separated 
from bulk media by AmSO4 precipitation, and loaded onto a gel filtration resin to isolate the 
recombinant protein from the pigmented small molecular weight peptides. Active fractions 
were pooled and loaded onto a Q HP AEX column, to eliminate residual brown pigments. 
Typically, the 140 mM NaCl eluted fraction contained pigment – free LapA precursor. 
However, in some cases, the brown pigment could not be completely separated from 
recombinant LapA protein, and repetitive AEX cycles were required.  
The established AP1 – mediated enzymatic processing protocol (section 2.13.4.1) was 
employed for activation of all purified mutant LapA precursor proteins. Approximately 1 µg 
of Flavourzyme – purified AP1 protease was able to fully process 1 mg of purified LapA 
precursor within 60 minutes at 37 ºC. Following the propeptide cleavage reaction, AP1 – 
LapA mixture was re-applied onto an AEX column. The 140 mM NaCl eluted fraction 
typically contained activated mature LapA protein, which was subsequently used in 
thermolability assays (as described in section 6.5.1).    
Following 120 h incubation, M1 and M5 mutants were already in the active mature form 
(Figure 6.2). However, purified protein batches were still processed to ensure consistent 
successive comparisons of LapA specific activity.  wtproLapA, M2, M3 and M4 proteins 
showed 6 – 7 fold activation, following treatment with AP1 (Table 6.4). Interestingly, M1 
still encountered 4.5-fold activation, suggesting that the protein was not secreted in fully 
mature form and was still inhibited by the propeptide domain, although showing a descent 
on the SDS-PAGE gel (Figure 6.2, A). M5 and M6 were degrading throughout the course 











wtproLapA 32.0 165.0 -5.15 
M1 16.0 71.4 -4.46 
M2 21.5 150.0 -6.97 
M3 12.5 87.14 -6.97 
M4 26.7 159.0 -5.95 
M5 39.0 35.0 degradation 
M6 1.36 0.64 degradation 
Table 6.4 Specific activity values of LapA proteins before and after enzymatic treatment 
with AP1 protease.      
 
M5 (N87A substitution at the N – terminal glycosylation site) is worthy of special 
consideration, since  reduced thermal stability of recombinant LapA enzyme was anticipated. 
It was vital also to evaluate a role for this post – translational modification on enzyme folding 
and specific activity. Also, high-mannose hyper-linked oligosaccharides, attached upon 
secretion in P. pastoris, are quite distinct from usually shorter and less complex A. oryzae 
N-linked sugars (Kainz et al., 2008). Therefore, natively expressed LapA might possess a 
modified N-glycosylation profile, with subsequent affects that should be determined.  
Surprisingly, expression of M5 in P. pastoris triggered the release of other ER proteins into 
the culture supernatant (Figure 6.3, lane 1), suggesting compromised folding and secretion 
processing of this heterologous protein. The active pool of M5 was eluted at slightly higher 
(200 mM) NaCl concentration, implying a stronger association with the AEX resin, which 
might be a consequence of an increase in exposure of charged residues in unfolded M5 
protein. The N87A mutation also severely reduced the catalytic ability of LapA enzyme, 
with only 21 – 25% remaining activity in relation to the wild-type protein (Table 6.4). 
Although the N87 residue is very distant from the active site (located approximately 32 Å 
away from the active site and surface exposed), it must be indirectly involved in activity, 
most likely exhibiting its effects via the folding mechanism. Interestingly, another A. oryzae 
protease showed no change in specific activity following the elimination of its N-linked 
sugar and expression in P. pastoris (Lei et al., 2013). Substantially decreased secretion levels 
of M5 protein also indicates the importance of this modification in processing. 
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Figure 6.3 SDS-PAGE analysis of the purification of M5 LapA mutant. Lanes: 1 – M5 crude 
supernatant; 2 – active fractions pooled from gel filtration step; 3 – AEX purification step: 
200 mM NaCl eluted fraction; 4 - AEX purification step: 400 mM NaCl eluted fraction. The 
active fraction of M5 is indicated.   
 
The introduction of an N-glycosylation site has been shown to improve the secretion of 
numerous heterologous proteins in yeasts (Sagt et al., 2000). The process of N-glycosylation 
is known to occur in two steps in yeast. Firstly, asparagine modification begins in the 
endoplasmic reticulum, as a co-translational event involving attachment of pre-assembled 
sugar moieties. The process is finalised in the golgi, where glycans are restructured into more 
complex assemblies (Bretthauer and Castellino, 1999). Negatively affected secretion and 
specific activity in the LapA M5 mutant, suggested that this post-translational modification 
is somehow mediating the folding of LapA enzyme. Successfully obtained crystals of 
wtLapA and wtproLapA (section 5.1) confirmed that N87-linked glycan was not interfering 
with crystallisation process. As a result, the N87 site was left unmodified in the 2nd round of 




6.2 LapA thermolabile mutants M7 – M13: 2nd round mutagenesis 
6.2.1 Rationale and structural bioinformatics 
In this round of mutagenesis, more emphasis was given to the sequence and structural 
comparison with the closest genuine psychrophilic homologue – GAP M28 peptidase, 
identified during the bioinformatics search (see section 6.1.1). A GAP homology model (see 
section 8.1) was superimposed on the recombinant LapA crystal structure (wtLapA) and the 
main differences were deduced (see Figure 8.2). The key structural differences involved a 
missing K267 – A272 helix and a 6-residue insertion in P164 – G165 region. This 
comparision suggested targeting of the K267 – A272 helix in an effort to destabilise the 
helix, contributing to enhanced thermolability (M8 mutant, Table 6.6). Furthermore, in this 
round of mutagenesis, it was decided to exploit the concept of more flexible and heat – labile 
active sites, as observed in other psychrophilic proteins. Consequently, the GAP homology 
model and the wtLapA crystal structure were analysed using the CASTp (Liang et al., 1998) 
server to determine the difference in the number and size of cavities and pockets within each 
of their respective molecular scaffolds. One unique pocket was identified to be substantially 
distinct in GAP homology model (POC 57, Table 6.5). This pocket was in the active site 
crevice and contained residue substitutions with notably less bulky side-chains (Table 6.5). 
In fact, the CASTp server identified 37 cavities and pockets in the wtLapA structure, 
compared to 57 cavities found in the GAP homology model. This difference could give rise 
to greater overall plasticity in the GAP protein and be one of the major cold-adaptation 































165.83 216.44 88.25 M26
2 
F329 F331 S333 D33
8 
I342 
*molecular surface area in Ångstroms; **molecular surface volume in Ångstroms 
Table 6.5 CASTp pocket analysis of LapA and GAP proteins. Residues in LapA containing 




This analysis led to the design of M12 (D338S) and M13 (S333G) mutations (Table 6.6). 
Moreover, these observations coincided with an analysis of rigid clusters in wtLapA 
conducted using the KINARI-Web server (Fox et al., 2011), whereby D338 formed part of 
the identified D338 – Y341 rigid cluster.  And finally, residue content analysis (using Prot 
Param server (Gasteiger et al., 2003)) indicated that GAP possessed a significantly lower 
number of lysines (21 versus 14), but a greater number of bulky hydrophobic tryptophan (3 
versus 1), methionine (8 versus 2) and phenylalanine (19 versus 16) residues. Therefore, 
reducing the property of core hydrophobicity seemed counter-intuitive in wtLapA.  
Other possible mutations identified were as follows: LPESKT stretch of residues could be 
inserted between residues P164 and G165 to mimic an analogous insert in the GAP structure; 
P164, which is part of the loop interconnecting β2 and β3 strands, could be mutated to E or 
K, as observed in psychrophilic homologues at this position; Q241 and A299 could be 
substituted to E, D or K residues, also present in psychrophilic homologues. More negatively 
charged and surface exposed conserved residues were previously identified in psychrophilic 
proteins (Feller et al., 1999). Alternatively, non-conserved P185, P222, P191 residues, 
located in loop regions, could be targetted to confer more flexibility to neighboring residues. 
The introduction of more cavities in the protein core, by the elimination of bulky side-chains, 
is another feasible mutagenesis strategy, which could be achieved by I94A substitution in 
wtLapA. It is reported that psychrophilic proteins soften the hydrophobic compactness effect 
by reducing the size and relative hydrophobicity of nonpolar residue clusters (Saelensminde 
et al., 2009). The S333G mutation could confer localised flexibility in the vicinity of the 
active site. Strategically placed glycine residues also have been reported in psychrophilic 
proteins (Kulakova et al., 2004, Mavromatis et al., 2002).  
In summary, the LapA mutagenesis library in this round included a selection of different 
approaches to achieve thermolability: elimination of salt bridges, unraveling helical 
elements, replacing prolines in loops and conferring flexibility to the active site (Table 6.6). 
The location of these residues in the recombinant wtLapA tertiary structure is shown in 





Figure 6.4 Proposed LapA thermolability mutations mapped onto the wtLapA crystal 
structure. Targetted residues and active site residues are shown as sticks and are coloured in 




Table 6.6 Library of M7 – M13 LapA proposed thermolability mutants. B-factors were obtained from the wtLapA crystal structure (Bav = 36.8).  





Conservation Location Rationale 






Not conserved Loop + 
Helix 
M2 (P304A) and M4 (Q91A) single point mutants were 
combined to test the additive effect on thermolability.   
M8 D271T Unravel the 
helix 
47.3 Not conserved Helix D271 is part of the K267 – A272 helix, which is absent in 
GAP. Also, D271 is involved in the formation of  stabilising a 
3.1 Å salt bridge with K267. Threonine was chosen to weaken 
the side chain – side chain interaction and increase the number 
of surface exposed nonpolar residues, which is an entropy-
driven destabilising factor (Aghajari et al., 1998, Russell et al., 
1998, Georlette et al., 2003). This substitution  also could 
unravel the helix.  
M9 K99V Increase 
overall 
flexibility 
31.6 Not conserved Helix K99 forms a strong salt bridge with D335, connecting two 
distant long helical elements. Valine is identified in pairwise 
alignment in GAP at this position.  
M10 P275A Increase local 
flexibility 
48.6 Not conserved Loop Located in the variable loop connecting helical and β strand 
secondary structure elements. Expected to be as successful as 
P304A mutation. 








Quite rigid residue, possessing multiple electrostatic 
interactions surrounding the active site, potentially involved in 
2nd shell electrostatic network. 
M12 D338S Increase 
active site 
plasticity 
31.3 Not conserved Active 
site 
crevice 
Determined by CASTp analysis of pockets and cavities. 
Substitution was analogous to the residue in GAP present at 
this position.  
M13 S333G Increase 
active site 
plasticity 
29.1 Not conserved Active 
site 
crevice 
Determined by CASTp analysis of pockets and cavities. 




6.2.2 Recombinant cloning and expression of M7 – M13 mutants 
All LapA thermolability mutants were generated using Quickchange site – directed 
mutagenesis (section 2.2.6). The wtLapA precursor expression construct pD-npro-LapA 
served as a template in the mutagenic PCR reaction, using the primer pairs given in Table 
6.7, except for generation of the M7 double-mutant construct, whereby an expression 
cassette containing P304 (M2) mutation was used as a template.   
Mutant 
name 
Mutation  Mutagenic primers 
M7 P304/Q91 5'-TTTTTTGTCCAACGATTTGATAAGATTAGCCACAGTTTCATTGTGTTGGACGCTATC-3' 
5'-GATAGCGTCCAACACAATGAAACTGTGGCTAATCTTATCAAATCGTTGGACAAAAAA-3' 
M8 D271T 5'-TCTGGTTTACCAGCAGTTGTAGTACCCTTTGTGTAACCAGTCA-3' 
5'-TGACTGGTTACACAAAGGGTACTACAACTGCTGGTAAACCAGA-3' 
M9 K99V 5'-CGGTTGCAAAACAGTTTCGAAATTTTTAACGTCCAACGATTTGATAAGATTTTGCAC-3' 
5'-GTGCAAAATCTTATCAAATCGTTGGACGTTAAAAATTTCGAAACTGTTTTGCAACCG-3' 
M10 P275A 5'-TATACCAATGGACTCAGCTTTACCAGCATCTGTAGTACCC-3' 
5'-GGGTACTACAGATGCTGGTAAAGCTGAGTCCATTGGTATA-3' 






M13 S333G 5'-GAGTCATCACCGAAAGCACCCTCAAATGCGAAAGCCG-3' 
5'-CGGCTTTCGCATTTGAGGGTGCTTTCGGTGATGACTC-3' 
Table 6.7 Primers used to generate M7 – M13 point mutations. 
 
Five colonies of each mutant E.coli clones were tested to carry the gene by colony PCR 
using AOX1 primers. All E.coli clones were found to harbor the expected mutant LapA 
plasmids. Subsequent plasmid DNA purification and sequence verification showed 
successful integration of site – directed mutations (data not shown).  
Following integration of all LapA mutant expression cassettes into the P.pastoris X33 strain, 
>100 colonies were observed for each mutant strain on high concentration (‘Bonus’) zeocin 
plates. It was decided to omit transformant verification, by colony PCR, since the very high 
concentration of antibiotic only selects for multiple genomic integration events of the 
expression cassette. Therefore, directly 1 mL cultures were set up in a high-throughput 
micro-fermentation experiment to determine the secretion profiles of the M7 – M13 mutants 
(section 2.13.3). This time only ‘Bonus’ transformants were picked for inoculation, since 
these should give rise to higher levels of secretion. After 96h of continuous induction, with 
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a final concentration of 0.5% MeOH, supernatants were harvested and analyzed by SDS – 
PAGE (Figure 6.5). 
 
Figure 6.5 SDS-PAGE analysis of the secretion profiles of M7 – M13 LapA mutants.  10 
µL supernatant load, after 96h of induction, was used. Quantified LapA protein is provided 
for each mutant, with chosen clone number in brackets.    
 
All seven LapA mutants yielded extracellularly secreted recombinant protein in P. pastoris 
supernatant. Clonal variation was almost absent among different transformants of LapA 
mutants. Not a single mutant gave rise to significant levels of mature LapA protein in the 
supernatants analyzed, with LapA precursor dominating in all samples. All mutants, in this 
round, secreted comparable levels of protein (0.29 – 0.39 mg/ml), except the M7 double-
mutant, which yielded ~ 50% reduction in the level of secretion. Also, the M7 supernatants 
tested contained one or two co-secreted higher molecular weight proteins, either implying 
release of other ER proteins in P.pastoris or higher associations (oligomers) of LapA 
recombinant protein. In either case, this could suggest that the M7 double-mutant might 
posess a less stable molecular conformation and that cooperativity of single point mutations 




LapA mutant Clones selected  
M7 1 and 8 
M8 3 and 7 
M9 4 and 6  
M10 3 and 4 
M11 2 and 4 
M12 2 and 4 
M13 1 and 6 
Table 6.8 LapA mutant clones selected for subsequent large-scale expression. 
 
6.2.3 M7 – M13 recombinant expression in YNB synthetic media 
Standard YP – based (yeast extract, soy peptone) medium, utilized for the expression of 
recombinant LapA proteins, contains unidentified brown pigments associating with secreted 
LapA protein. The underlying rationale of conducting this experiment (in YNB synthetic 
media) was to try to eliminate the pigments arising, potentially from the YP ingredients. 
Complete segregation of these pigments from recombinant LapA was problematic (at the 
time) when using Q HP AEX resin for purification. It was hypothesised further, that the 
residual pigments could hinder the crystallisation process for successive LapA mutants and 
prohibit crystal structure determination. Therefore, a new formulation of YP – free media 
was established, whereby the yeast nitrogen base was supplemented with amino acids and 
the YP component was substituted with sterilized water. However, a significant reduction in 
P. pastoris biomass was anticipated, due to diminished nutrient complexity in the growth 
medium. Indeed, compared to YP – based expression, on average ~ 50% decrease in biomass 
was observed, when measuring optical density at 600 nm for the wild – type and mutant 











Table 6.9 Cell density measured in the secondary culture of LapA supernatants.  
 
500 mL shake flask cultures were set up with selected LapA mutant clones, using YNB 
synthetic media. M2 and M4 mutants were also added to the trial, in an effort to obtain 
pigment-free preparations for crystallization. Wild – type LapA protein also was expressed 
as a positive control.  M10 and M12 mutant cultures did not grow well in YNB synthetic 
media. In general, the OD’s reached by all cultures (after 96h) was variable, yet smaller than 
those routinely observed in YP rich cultures (typically reaching 30 – 40 OD600 units).   
 
Figure 6.6 SDS-PAGE analysis of LapA protein supernatants, following 96h induction with 
MeOH. 10 µL of each supernatant was loaded for analysis. 
  
LapA proteins OD600 48h OD600 96h 
WT LapA 13 18 
M2 15 26 
M4 13 21 
M7 13 21 
M8 14 21 
M9 10 18 
M10 8 8 
M11 9 15 
M12 8 5 
M13 13 19 
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The secretion level, typically observed for wild – type LapA protein grown in YP rich media, 
reaches 0.3 – 0.4 mg/ml after 96h. In this trial, possibly due to culture contamination, 
wtproLapA only revealed 0.022 mg/ml of protein (Figure 6.6). Final recombinant protein 
content was severely reduced for all mutant proteins, except M9, which displayed almost 
equivalent to rich media secretion levels. Therefore, it was concluded that growth of P. 
pastoris and subsequent production of heterologous protein was restricted by the limited 
availability of nutrients in the expression media.  
The M9 mutant precursor was successfully purified and crystallized from its resulting 
supernatant (according to section 2.13.4). No associating brown pigments were observed for 
this particular batch of protein. However, in general, significantly lower yields of target 
protein, using this expression protocol in YNB synthetic media, prevented further 
exploration of other proteins. Fortunately, alternative crystallization strategies were later 
discovered for LapA precursor proteins, expressed in YP rich media and containing residual 
pigments. 
6.2.4 Purification and AP1 – mediated enzymatic activation of M7 – M13 mutant 
precursors  
LapA M7 – M13 mutants were purified and their active forms were obtained (Figure 6.7), 
using the equivalent procedure for the M1 – M6 mutants, as described in section 6.1.3. 
However, the previously encountered problem of incomplete pigment separation on a Q HP 
column was resolved by use of a MonoQ AEX column. Consequently, all LapA mutant 
proteins could be expressed in complex BMMY medium with no further need to eliminate 
the brown pigments during downstream processing (as discussed in the previous section 





Figure 6.7 SDS-PAGE analysis for purification and enzymatic activation of LapA mutants. 
A Lanes: 1 – M8 prior to AP1 protease treatment, 80 mM NaCl elution peak; 2 – M8 after 
AP1 protease treatment, 140 mM NaCl elution peak; 3 – M9 prior to AP1 protease treatment, 
80 mM NaCl elution peak; 4 – M9 after AP1 protease treatment, 140 mM NaCl elution peak; 
5 – M10 prior to AP1 protease treatment, 80 mM NaCl elution peak; 6 – M10 after AP1 
protease treatment, 140 mM NaCl elution peak; B Lanes: 1 – M12 prior to AP1 protease 
treatment, 80 mM NaCl elution peak; 2 – M12 after AP1 protease treatment, 140 mM NaCl 
elution peak; 3 - M13 prior to AP1 protease treatment, 80 mM NaCl elution peak; 4 - M13 
prior to AP1 protease treatment, 200 mM elution peak; 5 - M13 after AP1 protease treatment, 
140 mM NaCl elution peak;  
 
In the established purification protocol, a size exclusion chromatography step was followed 
by MonoQ AEX column chromatography to separate the resultant 80 mM and 200 mM NaCl 
peaks. The former contained a larger population of LapA precursor, whereas the latter was 
usually dominated by a mature LapA population (e.g. Figure 6.7, B lanes 3 and 4). These 
AEX fractions still contained traces of brown pigment. The 80 mM NaCl elution peak was 
concentrated (to 40 – 50 mg/ml) and aliquots of this protein preparation were used in 
subsequent crystallisation trials (see section 2.8.2.3).  Remaining 80 mM and 200 mM NaCl 
fractions were then recombined, and 1 µg of AP1 was added to 1 mg of mutant protein to 
enable cleavage of the propeptide. Following the propeptide cleavage reaction, the AP1 – 
LapA mixture was re-applied onto the MonoQ column. The eluted 140 mM NaCl fraction 
contained fully activated pigment-free LapA mutant protein (Figure 6.7 A lanes 2, 4, 6; B 
lanes 2, 5). The AP1 activated and purified mutant fractions were subsequently used in 
characterisation of their thermal properties (see section 6.5.2).  
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6.3 Crystallisation of LapA thermolabile mutant structures 
Structure solution and refinement, from the 1st and 2nd round of mutagenesis, are described 
herein. LapA thermolability mutants were purified and crystallised in the proenzyme form, 
harbouring the propeptide domain, according to section 2.8.2.3. An alternative route to 
obtaining overnight crystals was accidentally discovered during the course of this 
experiment, consequently, the previously described prerequisite of having a homogenous 
pigment-free LapA sample prior to crystallisation was no longer required. Furthermore, 
attempts to overexpress and purify LapA proteins from YNB synthetic media, lacking the 
pigmenting YP components, was found unnecessary (section 6.2.3). LapA mutant 
proenzymes were produced in BMMY complex media and purified according to the 
workflow in section 2.13.4, Figure 2.1. Following separation of the 80 mM and 200 mM 
peak fractions on a MonoQ AEX column, LapA pools still contained a considerable amount 
of brown pigments. However, rather surprisingly, crystal formation was not hindered by 
these pigments. Also, the 80 mM pool typically contained a significantly larger population 
of LapA proenzyme, whereas the 200 mM pool showed a substantial amount of mature 
protein present. Nevertheless, both peaks gave rise to similar quality of LapA proenzyme 
crystals (evident from similar size and shape of mutant crystals arising from 80 mM and 200 
mM NaCl pools, Figure 6.8). Since the concentration of LapA mutant proteins in the crystal 





Figure 6.8 Crystal images of LapA thermolability mutants. A – M2 (from 80 mM NaCl 
pool); B – M7 (from 200 mM NaCl pool); C – M8 (from 80 mM NaCl pool); D – M9 (from 





6.4 Analysis and comparison of wild-type LapA and thermolabile 
mutant structures 
It was essential to identify the key structural differences between wild-type and mutant 
proteins to decipher the extent of the mutation-induced changes that occurred in the tertiary 
structure of LapA, which might contribute to thermolability.  
Structures of LapA thermolabile mutants were solved in the form of proenzyme, bearing the 
covalently linked propeptide domain. This was due to a simplified crystallisation protocol 
(described in section 2.8.2.3), avoiding enzymatic processing of prodomain and requirement 
of successive additional purification cycles and purity checks.  
A structural comparison was carried out by structural superimposition of two - domain LapA 
precursors, whereas the functional thermolability assays were performed on AP1-activated 
single – domain LapA mutant enzymes.  
6.4.1 Comparison of LapA precursor (wtproLapA) and M7, M8, M12 structures 
Interesting (M12) and relevant (M7, M8) mutants identified in thermolability assays (section 
6.5) were structurally compared to the wild-type protein (wtproLapA). Structures of most 
thermolabile (M7 – double mutant, M8) and the most thermostable (M12) mutants were 




   
Figure 6.9 Superimposition of LapA wild-type and mutant proenzyme structures. 
wtproLapA – cyan, M7 – light orange, M8 – light blue, M12 – marine; A Overall view of 
overlaid structures, mutated residues are shown in red sticks; B Detailed superposition of the 
active site, 2nd shell electrostatic network, and hydrophobic specificity pocket residues. 
Atomic coordinates were superimposed using PyMOL.     
 
As demonstrated in Figure 6.9, the tertiary structures of wtproLapA and the thermolabile 
mutants are almost identical. This is even more apparent when observing functionally 
important residues (Figure 6.9, B). Site-directed thermolability mutation did not appear to 
induce any visible conformation changes within the active site, second shell electrostatic 
network, or hydrophobic binding pocket residues. This finding was very promising because 
it provided firm evidence that no adverse effects on substrate binding or impairment of 
hydrolytic activity would likely be observed for these mutants.   
6.4.1.1 Alignment of secondary structure elements (SSE) 
 
Analysis using the STRIDE algorithm (Frishman and Argos, 1995) only highlighted a few 
minor differences between wild-type LapA precursor and mutant precursor proteins. The 
P304A mutation caused lengthening of the β6 strand in the M7 mutant, as S277 was able to 
form a side chain to backbone H-bond to A304. By constrast, SSE visualisation in PyMOL 
suggested that this strand is shorter by 2 residues in the M7 mutant. Also, STRIDE predicted 
204 
 
2 new beta bridges over a single residue in M7. M8 showed identical to wild-type secondary 
structural elements. Finally, STRIDE prediction of M12 secondary structure elements 
identified E111 residue to extend the α3 helix by a single residue. Based on the SSE analysis 
using STRIDE, a lack of significant secondary structure differences between wild-type LapA 
proenzyme and mutant structures was observed, suggesting a subtle effect on the overall fold 
and secondary structure elements of LapA protein.  
6.4.1.2 Structural alignment using TM-align  
For comparison of structural similarity between LapA wild-type and mutant proteins, the 
TM-align server (Zhang and Skolnick, 2005) was utilised. 
Superimposition of the full proenzyme structures of wtproLapA and M7 mutant yielded an 
RMSD value of 0.21 over 338 residues. Whereas, if only the residue range corresponding to 
the catalytic domain after activation is superimposed for these proteins, the RMSD value 
drops to 0.12 over 301 residues. This indicates half of the differences (change in atomic 
positions/distances) between wtproLapA and M7 structures reside within the propeptide 
domain, consisting of only 37 fully defined residues. However, we are primarily interested 
in differences within the catalytic domain since these could provide an explanation for the 
observed modulated thermal properties. Overall, the RMSD scores indicated only very subtle 
differences between wtproLapA and the thermolabile mutant structures. The TM-align 
results for the superimposed catalytic domains are provided in Table 6.10.   
Superimposition  





Number of residues 
aligned 
wtproLapA versus M7 0.12 0.99964 301 
wtproLapA versus M8 0.16 0.99936 301 
wtproLapA versus M12 0.13 0.99623 
 
300 
Table 6.10 TM-align results from the superimposition of wtproLapA and mutant structures 




6.4.1.3 Superimposition of tertiary structures  
No major structural rearrangements were observed in the LapA structure as a result of the 
thermolabile mutations M7, M8, and M12. Figure 6.10 illustrates the effect of the site-
directed thermolability mutations on the Cα backbone. With respect to the Cα trace, only 
minor differences in the following regions were found: 81 - 95, 140 - 144, 210 - 220, 270 - 
275, 310 - 314 and 335 – 360, all of which appear to cluster on one side of the molecule 
adjacent to the active site and the mutations (Figure 6.10, A).       
Further detailed analyses of individual juxtaposed structures are provided below. 
wtproLapA vs. M7 
Residue Q91 makes an electrostatic interaction with the side chain carbonyl of N87, which 
is glycosylated and has a covalently linked NAG to its amide nitrogen.  This interaction is 
tight and measures 3.0Å in the wtLapA structure. The absence of this contact in M7 causes 
the N87 - attached glycan to change orientation. Further, the Q91A mutation caused a 
backbone movement of a loop of residues 86 – 95, including markedly altered orientation of 
their respective side chains.  In addition, the second mutation, P304A, caused local and long-
distance backbone movements, which translated to the C310-C314 loop, which is involved 
in a disulphide bridge adjacent to the active site and could have implications for substrate 
affinity, as Y312 (in this loop) is involved in binding the substrate. Figure 6.10, B illustrates 
the effect of the M7 mutation on the catalytically important 310 – 314 loop, adjacent to 
Y312. Atomic transitions, of 0.4 – 0.5 Å, were observed throughout this loop, which could 
result in altered substrate affinity and altered thermolabile behaviour. 
wtproLapA vs. M8 
The expectation of the D271T substitution was to weaken the 3.2Å electrostatic interaction 
with K267. In the M8 mutant structure, we observed the complete abrogation of this 
electrostatic interaction, which caused 0.4Å, 0.3Å and 0.2Å movements of the Cα atoms of 
the adjacent A272, G273, K274 residues, respectively. This ripple effect was commonly 
observed in other regions flanking the mutation sites. Also, movement of the nascent T271 
residue added to the pre-existing T270 and T269, forming a surface-exposed triplet of 
threonine side-chains, which would contribute to an additional entropy-driven destabilising 
factor of surface-exposed non-polar side-chains.    
Interestingly, this mutation also affected the C310 – C314s loop, altering the position of 
Y312 Cα atom by 0.3Å. The D271T mutation in the M8 structure caused 0.1 – 0.3Å 
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positional displacement for the atoms of residues going in both directions from the mutation. 
Towards the C-terminus, in particular, these backbone and side chain adjustments 
propogated to the 360 – 365 residue region. And, close to the N-terminus, shifts in the 134 
– 144 and 210 – 220 residue regions were apparent. In fact, from this detailed analysis, all 
differences were more apparent compared to other mutants (M8 showed the highest RMS 
difference score among all mutants, Table 6.10). 
wtproLapA vs. M12 
The D338S mutation caused movement of the adjacent hydrophobic binding pocket residue 
F335 by 0.3 – 0.4Å, which could have implications in substrate binding, as this residue has 
been observed to rotate upon substrate binding (Figure 5.14). No other major alterations in 
structure towards the C-terminus were observed in M12. However, significant changes to 
the protein backbone and side chains were detected nearer to the N-terminus in M12 mutant, 
particularly in the 81 – 86 and 180 – 189 residue regions, whereby the differences in atom 





Figure 6.10 Detailed structural comparison of LapA wild-type and thermolabile mutant 
structures. M7, M8, M12 and wtproLapA structures are superimposed. A Shows the 
common protein regions, where backbone and side chain movements were observed. M7 
(P304A, Q91A), M8 (D271T), M12 (D338S) mutations are depicted in red, orange and 
yellow spheres, respectively. Moving residue regions: 81 – 95 (brown dots), 140 – 144 (blue 
dots), 210 220 (green dots), 270 – 275 (orange dots), 310 – 314 (red dots), 335 – 360 (yellow 
dots). Propeptides are omitted for clarity. B Overlay of wtproLapA (cyan) and M7 (light 
orange). Closer view of the moving 310 – 314 loop (sticks) and 81 – 95 region (dashed circle, 




6.4.1.4 Analysis of molecular flexibility via structural B - factors 
Experimentally determined B factors (a parameter of thermal motion) can give an indication 
of changes in the local backbone or side-chain flexibility. The most thermostable mutant, 
M12, displayed quite remarkable changes in overall structural rigidity. Figure 6.11 
demonstrates significantly lowered overall B-factors for M12. The differences are seen in 
previously flexible surface loops compared to wtproLapA. For example, the average whole 
chain (main chain + side chain) B factor in M12 drops from 33.9 Å2 to 26.23 Å2 and 28.2 Å2  
to 20.5 Å2  in 270 – 275 and 310 -314 residue regions, respectively (Figure 6.11, A). The 
overall reduction in average whole chain B-factor value across all residues was from 21.7 
Å2  (wtproLapA) to 16.9 Å2 (M12) (Table 6.11). The experimentally observed reduction in 
B values for the M12 mutant suggests an overall increase in structural rigidity, which is 
likely responsible for the significantly improved thermostability of this mutant.        
Figure 6.11 Comparison of overall B factor representation for wtproLapA and M12 
structures. Average B-factor in each residue is depicted by a ‘putty representation’. Lower 
to higher B-factor values go from dark blue to red, respectively. Both sides (180° rotation) 
of the molecule are represented. Propeptide is omitted for clarity. A. B-factor putty of 
wtproLapA protein, significantly higher B-factor areas are circled (dashed lines); B. B-factor 




Interestingly, the thermolability mutants M7 and M8 showed no significant changes in 
overall B-factor compared to wtproLapA (Table 6.11). In the structure of M8, the most 
substantial increase in flexibility was observed in the 182 – 188 residue region, with an 
average whole chain B-factor shift from 25.8 Å2 to 32.3 Å2. This was accompanied by a 0.2 
– 0.45Å residue movement. This loop is adjacent to the active site pocket and connects the 
β3 strand to the α4 helix. The B-factor data (summarised in Table 6.11) suggests that the 
overall increase in thermal motion and flexibility for M7 and M8 mutant structures could 
not be determined from simply all-atom temperature factors and, importantly, more localised 
differences need to be deduced.  






wtproLapA 2369 19.6 23.9 21.7 
M7 2395 18.7 22.6 20.7 
M8 2428 18.9 24.3 21.5 
M12 2372 14.9 19.2 16.9 
* T_atoms – total number of atoms measured;  
Table 6.11 Temperature factor (B) analysis of LapA crystal structures. The analysis was 




6.5 Functional studies of LapA  
6.5.1 High-temperature inactivation assays for M1 – M6 thermolabile mutants 
The wild-type and mutant recombinant enzymes were expressed and secreted as pro-
proteins, which were subsequently activated with Flavourzyme-derived AP1 protease, as 
detailed in section 2.13.4.1. The observed N-terminal sequence for each of these activated 
processed wild-type and mutant proteins was identical to wtLapA, described previously, 
namely, possessing an 'AVT' sequence extension to the original N-terminus.    
6.5.1.1 Full temperature range comparison 
A LapA thermolability assay was designed to determine the thermostability of LapA variants 
at various temperatures, relevant to industry. Aliquots of LapA enzymes were incubated at 
5 different temperatures: 37, 50, 60, 70 and 80 °C. Measurements of residual specific activity 
at 37 °C served as a reference, where no loss of activity was anticipated. Measurements in 
the 50 – 60 °C range were key to the identification of potential thermolabile LapA variants. 
Finding a LapA mutant that could be completely inactivated >60 °C would be considered 
successful, according to the industrial requirement from Biocatalysts Ltd. Incubation in the 
70 – 80 °C range was expected to completely denature and inactivate LapA proteins. As a 
starting point, complete inactivation conditions for the LapA enzyme were as follows: 80 °C 
for 30 – 60 min. Therefore, to be considered successful, a mutation should induce a 
significant reduction in LapA thermal stability and should maintain 80 – 100% specific 
activity equivalent to wtLapA.  
Full temperature range profiles were obtained for LapA proteins, incubating each enzyme at 
5 distinct temperatures and withdrawing aliquots for measurement of residual specific 
activity, promptly, every 15 minutes for 60 – 90 minutes. The thermolability assay protocol 
is described in section 2.10.3. An initial assay, to assess thermostability of LapA mutants, 
was implemented in a 3ml cuvette format and using a conventional spectrophotometer. Once 
initiated, the reaction was allowed to proceed, and the difference in absorption was manually 
recorded after 60 seconds. Subsequently, in the second round of mutagenesis, this manual 
cuvette assay was replaced by a more automated microtiter plate assay. Specific activities, 




The M1 (P155G) mutation caused a reduction in activity of ~ 65%. It is likely that glycine-
induced flexibility at this position was potentially detrimental to fold integrity. This can be 
supported by the observed concomitant reduction in secretion levels of the M1 LapA mutant 
(section 6.1.2, Figure 6.2). A more conservative P155A mutation could be tried in the future 
to see whether a glycine substitution caused excessive backbone plasticity. Also, the 
observed M1 thermolability profile was not promising, as it retained 77% and 46% of initial 
activity at 60 °C following 30 and 60-minute incubation, respectively.  
The M3 (R252K) mutation showed a substantial loss of specific activity, while maintaining 
a high degree of thermostability at 60 °C; 81% and 74% of initial activity following 30 and 
60-minute incubation, respectively. Substitution of Arg252 with another positively charged 
residue – lysine – may not have resulted in complete elimination of R252 – E226 salt bridge. 
Hence, the altered (but not abolished) electrostatic interaction at this position only had an 
adverse effect on LapA activity and not thermostability.    
The M5 (N87A) mutation resulted in a major loss of LapA activity and the remaining 
specific activity of 25% did not meet qualifying criteria. Therefore, a full thermolability 
profile was not obtained for this mutant. From the structure solution of wtLapA, we found 
the N87 residue to be glycosylated. Glycosylation is known to have a thermodynamic 
stabilization effect on protein structures (Shental-Bechor and Levy, 2008). Therefore, 
decreased thermostability of the M5 mutant was expected, following the N87A mutation. 
However, the significantly reduced activity and lowered secretion levels of M5 (section 
6.1.2) highlight the importance of glycosylation in proteogenesis and folding of the LapA 
enzyme.          
The M6 (C310A) mutation had a detrimental effect on LapA specific activity. M6 only 
retained 0.45% of wtLapA activity. Hence, a full thermolability profile was not completed 
for this protein either. C310 forms an intramolecular disulphide bond with C314. This post-
translational modification is considered highly stabilizing and necessary for proper folding 
of LapA. However, the high expression levels acquired for M6 (section 6.1.2) suggest that 
formation of the C310 – C314 disulphide bond may not be rate limiting step in the LapA 
folding pathway, although, appropriate positioning of the C314 carbonyl oxygen likely is 
crucial for enzyme ability to bind substrate. The equivalent carbonyl oxygen of cysteine 
residue C227, in the Lap structure from Vibrio proteolyticus, was shown to be involved in 
interaction with the Leu-Leu-Leu substrate (Kumar et al., 2007). Thus, elimination of the 
Cys-Cys bond in LapA could compromise its catalytic function.           
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In conclusion, both M2 and M4 mutations had no major effect on LapA specific activity. 
Initial thermolability profiles showed a significant reduction in thermostability (Figure 6.12) 
for both mutants. Taken together, with similar to wild-type expression levels (section 6.1.2, 
Figure 6.2), M2 and M4 appeared to be the best candidate mutants from the first round of 
matagenesis. 








Table 6.12. Specific activity values observed for LapA variants in the 1st round of 
mutagenesis. Retained percentage activities for mutant proteins were calculated in relation 
to wild-type LapA.  
  
LapA variant Specific activity (U/mg) Activity retained (%) 
WT LapA 140.15 ± 4.8 - 
M1 48.48   ± 4.4 34.60% 
M2 128.46 ± 13 91.40% 
M3 87.14   ± 13 62.10% 
M4 143.59 ± 9.9 102.10% 
M5 35.01   ± 5.5 25% 
M6 0.64 0.45% 
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Figure 6.12 Temperature inactivation profiles of LapA variants. A – wild-type LapA, B – M2 
mutant, C – M4 mutant. 100% reference (yellow line) is specific activity measured at 37 °C, 
following 15 minute incubation.   
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In Figure 6.12, the remaining percentage activity was plotted against the full temperature 
range for wtLapA, M2, and M4 mutants. The wtLapA enzyme exhibited very thermostable 
behavior at 60 and 70 °C. Additionally, wtLapA maintained consistently higher specific 
activity values across 50 – 60 °C range, which was not unexpected since native LapA, 
produced in Aspergillus oryzae, also was shown to have a temperature optimum at 60 °C 
(Matsushita-Morita et al., 2011). M2 and M4 showed a progressive decline in specific 
activity within a 60 minute incubation period, at 60 and 70 °C (Figure 6.12, B and C). Also, 
no overall increase in activity was observed when incubating these enzymes at 50 °C, 
suggesting negatively affected thermostability, even at this temperature.  
Further detailed thermolability analysis of selected mutants, M2 and M4, is provided in the 
following sections.        
6.5.1.2 Analysis of thermal inactivation of M2 and M4 mutants at 60 °C 
Remaining activities (as percentage) for wtLapA and mutants were expressed, taking 155 
U/mg specific activity as 100% reference (Table 6.13). This value was the highest activity 
measured for the wild-type enzyme, after 15-minute incubation at 37 °C. Data normalization 
was necessary to perform a non-linear regression fit to the inactivation data and to compare 
the remaining percentage activities at different temperatures.  






Table 6.13 Remaining percentage activities of LapA proteins, following incubation at 60 
°C. Data normalised to 155 U/mg (100%) activity value. Given percentage values are means 





15 30 45 60 
wtLapA  82.20% 83.90% 82.10% 74.65% 
M2 50.50% 31.65% 23.25% 12.15% 
M4 87.25% 65.80% 51.50% 41.25% 
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The inactivation data plot in Figure 6.14 and percentage values in Table 6.13 clearly 
demonstrate that WT LapA retains substantially more activity at 60 °C as opposed to mutant 
enzymes (reflected in the height of the fitted curve on Y-axis). M2 LapA mutant retained the 
lowest amount of activity at this temperature.   
Figure 6.13 Comparison of remaining percentage activity of LapA proteins at 60 °C, within 
the first 60 minutes of incubation. Standard deviation (SD) of each measurement is presented 
by an error bar. All measurements were carried out in triplicate or quadruplicate. 
Figure 6.14 A single exponential rate model fitted to LapA protein inactivation data at 60 
°C by non-linear regression. Thermal inactivation rate constant (k) and half-life were 
obtained from best-fit to inactivation data of LapA wild-type and mutant enzymes.  
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According to the fitted exponential rate decay model the wtLapA enzyme exhibited the 
longest (351 min) half-life, compared to the thermolability mutants M2 and M4 (Table 
6.14). Both single point mutations decreased the inactivation time of LapA, at 60 °C, with 
40.7 and 23.9 minute half-lives for M4 and M2 mutants, respectively. The determined 
inactivation rate constants showed a substantial increase in inactivation rate, with 8.62- and 
14.71-fold for M4 and M2 mutants, respectively. This is represented also by significant 
differences in ∆∆G values between wild-type LapA and mutants, at this temperature.  
 





Rate constant of 




Difference in activation 
free energy of inactivation 
∆∆G (kJmol-1) b 
wtLapA 351 0.0019     
M2 23.9 0.0291  14.71 -7.45 
M4 40.7 0.017  8.62 -5.97 
a Thermolability profiles of LapA proteins were determined from 3-4 independent measurements at 60 °C. 
Protein half-lives, inactivation rate constants and standard errors were calculated using nonlinear regression to 
fit a single exponential rate model to the inactivation data (using Graph-Pad Prism software).  
b ∆∆G = ∆Gmutant – ∆Gwild-type = - RTln(kmutant/kwild-type) 
 
Based on the remaining percentage activity and calculated half-life values at 60 °C, M2 
emerged as the most thermolabile mutant, from the first round of mutagenesis. A 15-fold 
increase in inactivation rate for M2 clearly demonstrates the negative effect of the P304A 




6.5.2 High-temperature inactivation assays for M7 – M13 thermolability 
mutants 
A new microtiter plate enzymatic LapA assay format was introduced to expedite the 
analysis. Also, 300 µL total assay volume allowed enzyme handling using an electronic 
multi-channel pipette, which in turn permitted more time points of thermal inactivation to 
be recorded. This way, 80 and 90-minute data points were added to the analysis, ensuring a 
more accurate fit of a single exponential rate model to the inactivation data.        
The LapA inactivation data, presented herein, corresponds to the thermolability assays 
performed at 50 and 60 °C, since this represents a desirable inactivation temperature range 
for industrial application. 
Remaining percentage activities for wtLapA and mutants were expressed, taking 155 U/mg 
specific activity as 100% reference. This value was the highest activity measured for the 
wild-type enzyme after 15-minute incubation at 37 °C. This data normalisation was 
necessary to perform non-linear regression fits to the inactivation data and to compare 
remaining percentage activities at different temperatures appropriately. 
6.5.2.1 Thermal inactivation profile for M7 double mutant 
The previously identified most thermolabile LapA variants (M2 and M4) were combined to 
yield a double mutant, M7, to explore whether or not the thermostability of LapA could be 
decreased further via the additive effect of the two single point mutations. Fresh protein 
batches of wtLapA, M2 and M4 were prepared for analysis. 
The inactivation data of M2/M4 (single) and M7 (double) mutants is presented in the 









15 30 45 60 80 90 
wtLapA  80.30% 59.03% 69.10% 53.97% 50.30% 48.80% 
M4 77.40% 62.05% 61.82% 54.59% 50.42% 39.45% 
M2 73.40% 61.20% 60.73% 46.63% 40.50% 36.30% 
M7 67.87% 61.73% 56.40% 41.33% 33.00% 23.50% 
 
Table 6.15 Remaining % activities of LapA proteins following incubation at 50 °C. Data 
normalised to 155 U/mg (100%) activity. Given percentage values are means of multiple 
independent measurements.  The data are visualised in Figure 6.15.  
 
Figure 6.15 Comparison of remaining percentage activity of LapA proteins, at 50 °C, within 
the first 90 minutes of incubation. SD of each measurement is presented by error bar. All 









Rate constant of 
inactivation  




Difference in activation  
free energy of inactivation ∆∆G 
(kJmol-1) b 
wtLapA 110.7 0.0063     
M4 93.69 0.0074  1.18 -0.49 
M2 75.67 0.0091  1.46 -1.02 
M7 57.14 0.0121  1.98 -1.78 
a Thermolability profiles of LapA proteins were determined from 3-4 independent measurements at 50 °C. 
Protein half-lives, inactivation rate constants and standard errors were calculated using nonlinear regression to 
fit a single exponential rate model to the inactivation data (using Graph-Pad Prism software).  
b ∆∆G = ∆Gmutant – ∆Gwild-type = - RTln(kmutant/kwild-type) 
 
The M7 mutation increased the inactivation rate of the LapA enzyme by 1.98-fold at 50 °C. 
At this temperature, differences in the inactivation profiles were not very significant across 
LapA enzymes. The M7 double mutant showed the shortest half-life, as expected. This is 
also reflected in only a modest difference in ∆∆G values between wtLapA and the mutants, 
at this temperature.  
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Table 6.17 Remaining % activities of LapA proteins, following incubation at 60 °C. Data 
are normalised to 155 U/mg (100%) activity value. Given percentage values are means of 
multiple independent measurements. The data are visualised in Figure 6.16. 
Figure 6.16 Comparison of remaining % activity of LapA proteins at 60 °C within first 90 
minutes of incubation. SD of each measurement is presented by error bar. All measurements 
carried out in triplicate or quadruplicate.  
 
The obtained inactivation profiles of LapA proteins at 60 °C exhibited more substantial 
differences. The inactivation data plots (Figure 6.17) clearly indicate that wtLapA protein 
retains significantly more activity at 60 °C, compared to the mutant enzymes (height of the 
fitted curve on Y-axis, Figure 6.17). M7 double mutant retained the lowest amount of 




15 30 45 60 80 90 
WT LapA 65.07% 60.47% 50.57% 43.13% 39.90% 37.50% 
M4 50.83% 48.00% 39.23% 29.77% 28.65% 27.82% 
M2 45.67% 30.53% 24.43% 20.67% 19.60% 16.80% 




Figure 6.17 A single exponential rate model fitted to LapA protein inactivation data, at 60 
°C by non-linear regression. Thermal inactivation rate constant (k) and half-life were 
obtained from best-fit to the inactivation data of LapA wild-type and mutant enzyme.  
 






of inactivation  




Difference in activation  
free energy of inactivation ∆∆G 
(kJmol-1) b 
wtLapA 87.85  0.0079  
 
M4 74.55  0.0093 1.18 -0.45 
M2 48.61 0.0143 1.81 -1.63 
M7 29.68 0.0234 2.96 -3.01 
a Thermolability profiles of LapA proteins were determined from 3-4 independent measurements at 60 °C. 
Protein half-lives, inactivation rate constants and standard errors were calculated using nonlinear regression to 
fit a single exponential rate model to the inactivation data (using Graph-Pad Prism software).  
b ∆∆G = ∆Gmutant – ∆Gwild-type = - RTln(kmutant/kwild-type) 
 
The M7 mutation increased the inactivation rate of LapA by nearly 3-fold. at 60 °C ( Table 
6.18). In fact, at 60 °C, the inactivation temperature differences were very significant across 
LapA enzymes. The M7 double mutant showed the shortest half-life (29.68 min), with more 
than half of that observed for wtLapA (87.85 min). This is represented also by substantial 
differences in ∆∆G values between wtLapA and mutants at this temperature ( Table 6.18).    
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In conclusion, the LapA thermolability assay data showed the varying extent of thermal 
instability introduced by the selected mutations. The two most thermolabile mutants, M4 
and M2, (identified in the first round of mutagenesis) were combined in the following round 
to yield a double mutant, M7, with futher enhanced thermolability at 60 °C. The additive 




6.5.2.2 Validation of the non-linear regression model to the inactivation 
data 
To validate the fit between the plotted data points and the fitted exponential one-phase decay 
model (Figure 6.17 and  Table 6.18), visual plots of residuals (Figure 6.18) and fitted vs. 
observed data points (Figure 6.19) were used. Statistical parameters of the best-fit values 
also are provided in  Table 6.19.  
 
Table 6.19 Statistical evaluation of exponential one-phase decay model fitted to the 
inactivation data of select LapA thermolability variants. 
 
In Figure 6.18, apart from M2, the data points are quite tightly distributed along the zero 
dotted line, suggesting a good model-to-data fit. Similarly, Figure 6.19 shows a reasonably 
good fit of the model to the inactivation data, particularly for the M7 mutant. The almost 
ideal model-to-data fit of M7 also can be seen from the narrow confidence interval of protein 
half—life parameter in  Table 6.19. 
   
 
wtLapA M4 M2 M7 
ka 0.005425 to 0.01044 0.006806 to 0.01189 0.009899 to 0.0191 0.01936 to 0.02782 
Half Lifea 66.38 to 127.8 58.3 to 101.8 36.28 to 70.02 24.91 to 35.79 
Degrees of Freedomb 16 10 16 16 
R squareb 0.7474 0.8783 0.769 0.9291 
a 95% CI (profile likelihood) 
   
b Goodness of Fit 





Figure 6.18 Plot of residuals linked to LapA inactivation data fit in Figure 6.17. 
.  
Figure 6.19 Overlay of observed versus predicted remaining activity values relative to the 
LapA inactivation data fit in Figure 6.17. Solid curves represent observed data (_obs), and 
transparent curves correspond to values predicted by fitting the exponential decay model to 


































6.5.2.3 Temperature-induced decay for specific activity of LapA proteins 
In this analysis, the observed absolute specific activity (U/mg) for wtLapA and M2, M4, M7 
thermolability mutants were compared (Figure 6.20). It was important to perform this 
comparison to further validate the identified differences in thermostability across the 
different mutants. The specific activity values herein are not expressed as a relative 
percentage (by 155 U/mg value) but are represented as absolute numbers, calculated 
according to section 2.10.1.  
 
Figure 6.20 Comparison of determined LapA specific activity values, following 60 min 
incubation at increasing temperatures. Error bars for each data point are calculated from 3 – 
4 independent measurements.  
 
As shown in Figure 6.20, within the 4 - 37 °C temperature interval the specific activity is 
similar for each of the wtLapA and M2, M4, M7 mutants. Specific activity profiles begin to 
diverge at 40 °C and are completely distinct by 50 °C. In agreement with the results from 
the regression analysis (see Figure 6.17), the M7 double mutant displays the lowest specific 
activity at temperatures above 40 °C, with the most rapid activity decay of the mutants 
compared.   
Based on these activity profiles, it is clear that the optimal activity temperature range for 
wtLapA is between 37 – 40 °C. This is quite different from reported optimal activity 
temperature of 60 °C, first described by Matsushita-Morita et al. (2011). This wtLapA 
protein batch displayed significantly increased thermolabile behaviour compared to the 
batch from the 1st round of mutagenesis (section 6.5.1.1). These differences were most 
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evident following incubation at 70 °C. This can be clearly seen in Figure 6.12 (A), where 
wtLapA batch 1 retained over 90% of its original activity after 15 minute incubation at 70 
°C. One possible explanation for the batch-to-batch thermostability difference between 
wtLapA proteins could be due to the additional cooling step at 4 °C before the activity 
measurement in the 2nd round of mutagenesis (section 2.10.3). In the latter thermolability 
300 µL assays, the enzyme samples were incubated at 4 °C for 5 minutes before initiating 
the reaction, compared to the 3 mL initial assay protocol, whereby the incubation step was 
carried out on ice for 3 minutes. This step was necessary to normalize the reaction kinetics 
for LapA samples incubated at a wide range of temperatures (37 – 70 °C). Possibly, batch 1 
of wtLapA achieved a lower degree of cooling, hence showed an increase in residual activity, 
following 70 °C pre-incubation. However, even more importantly, we noticed a possible 
degeneration of the developed recombinant wild-type LapA P.pastoris strain. Numerous 
subsequent growth attempts of this strain, from glycerol stock, resulted in significantly 
reduced biomass levels and reduced specific activity of purified LapA protein. Therefore, it 
is very likely that batch 1 was the most representative of wild-type LapA and batch 2 already 
had slightly altered thermostability due to the latterly identified expression strain 
repercussions. Importantly, no significant changes in growth or biomass were observed for 





6.5.2.4 Functional characterisation of M8 – M13 site-directed mutants 
Temperature inactivation data for M8 – M13 thermolability mutants were collected over the 
full temperature range (37 – 80 °C), however, only the 60 °C segment is presented below 
(Figure 6.21), since the most significant changes occurred at this temperature (as previously 
determined).  At 60 °C, inactivation temperature differences were very significant across M8 
– M13 LapA mutant enzymes. The bar plot, shown in Figure 6.21, clearly demonstrates that 
M12 protein exhibited increased thermostability, while M8 and M13 mutants showed the 
most rapid decline in specific activity at 60 °C.  
 
Figure 6.21 Comparison of remaining % activity of LapA proteins at 60 °C, within the first 
90 minutes of incubation. SD of each measurement is presented by an error bar. All 
measurements are carried out in triplicate or quadruplicate.  
 
As demonstrated in Table 6.20, the M8 double mutant showed the shortest half-life (29.55 
min), with almost 1/3 of that observed for wild-type LapA (87.85 min) at this temperature. 
Interestingly, the M8 single site – directed mutant exhibited a comparable thermolability 
profile to the M7 double mutant, which showed 29.68 min half-life. M7 and M8 LapA 
mutants also displayed an almost identical increase in the inactivation rate, 2.96- and 2.97-
fold, respectively, as well as similar differences in their activation free energy of inactivation 
(∆∆G) at 60 °C.  
M10 displayed a lower degree of thermolability (45.49 min half-life). However, this estimate 
is close to the M2 mutant (48.61 min half-life) ( Table 6.18). Structurally, both M2 (P304A) 
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and M10 (P275A) involve elimination of proline from the distant-to-active-site loop. Hence, 
the exerted effect on thermolability may be very similar.  
M11 (D316A mutation) almost completely abolished the hydrolytic activity of LapA.  
M12 (D338S mutation) showed an opposite effect with regards to thermostability. This 
mutation resulted in an impressive 3.5–fold increase in half-life at 60 °C. The exact 
mechanism of induced thermostability for this mutant is not clear.   
M13 appeared as a comparatively short-lived enzyme (35.78 min half-life). However, the 
S333G substitution had an adverse effect on protein specific activity, retaining only 60 – 70 
% that of wtLapA, therefore, this mutation was not considered successful.     
 
Table 6.20 Kinetic parameters for thermal inactivation of wild-type and mutant LapA 
enzymes. The M7 double mutant from the previous analysis was included for comparison.   
 a Thermolability profiles of LapA proteins were determined from 3-4 independent measurements at 60 °C. 
Protein half-lives, inactivation rate constants and standard errors were calculated using nonlinear regression to 
fit a single exponential rate model to the inactivation data (using Graph-Pad Prism software).  




Rate constant of 
inactivation  





activation free energy 
of inactivation ∆∆G 
(kJmol-1) b 
wtLapA 87.85 0.0079   
M7 29.68 0.0234 2.96 -3.01 
M8 29.55 0.0235    2.97 -3.02 
M9 57.57 0.012 1.53 -1.17 
M10 45.49 0.0152 1.93 -1.82 
M12 311 0.0022 - 3.50 
M13 37.84 0.0183 2.32 -2.33 
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6.5.3 Comparison of the most thermolabile mutants by additional parameters 
Based on an analysis of the kinetic parameters of LapA mutant thermal inactivation (from 
the two rounds of mutagenesis), the most thermolabile mutants meeting all the qualifying 
criteria were M2, M8, and M10 (single point mutations) and M7 (double mutant).  
6.5.3.1 Comparison of LapA enzyme activity at 37 °C 
The most thermolabile mutants identified from two rounds of mutagenesis were evaluated 
using a standard industrial LapA assay to verify any potential differences in specific activity, 
as a result of the point mutations. It is important to note that the calculated specific activity 
values (Table 6.21) are slightly underestimated due to the differences in the path length 
provided by 300 µL well volume in a microtitre plate. Instead of 1 cm path length, in the 
standard 3 ml cuvette, 300 µL reaction volume gives rise to a 0.865 cm pathlength. Adjusting 
the calculation of the observed specific activity (116.7 U/mg, Table 6.21) of the wtLapA to 
1 cm pathlength would result in 132.5 U/mg activity value, which closely resembles the one 





Table 6.21 Determined absolute specific activity values of LapA proteins. Data represents 
measurements from 3 - 4 independent experiments with standard deviations (SD).  
  
 
wtLapA M2 M7 M8 M10 
U/mg 116.6698 109.547 100.086 119.3595 112.9799 
SD 9.935978 14.38779 4.975062 31.76096 4.593031 
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Figure 6.22 Visual representation of the determined specific activity differences of LapA 
proteins. SD is depicted by error bars.  
 
The specific activity of LapA enzymes, from the standard LapA assay, showed no major 
differences between wtLapA and the thermolability mutants analysed. Site - directed 
mutations in M2, M7, M8 and M10 LapA enzymes did not significantly alter specific activity 
towards the synthetic LPNA substrate. All aforementioned LapA mutants retained 
comparable levels of specific activity to wtLapA, under the conditions of a standard 
industrial LapA assay. Arguably, in the case of the M8 mutant, a slight overall increase in 
specific activity was noted.  
6.5.3.2 Comparison of best LapA thermolability mutants by T60/30 
parameter 
Industrial relevance of T60/30 estimate: 
The industrial hydrolysis reaction was allowed to proceed and peptidase inactivation was 
performed by heating the reaction mixture at 60 °C for 30 minutes to prevent adverse heating 
effects on the reaction products. Data were normalised to 155 U/mg (100%) activity value 
(Table 6.22).  
The M7 LapA mutant displayed the lowest T60/30 value (24.13%; Table 6.22, Figure 6.23) 
among the most thermally labile LapA mutant proteins, with more than a half of that 
displayed by wtLapA (60.47%; Table 6.22, Figure 6.23). M2 and M8 mutants displayed 
comparable T60/30 values, however, in this instance, M7 was superior to M8, with respect to 







15 30 45 60 
wtLapA  65.07% 60.47% 50.57% 43.13% 
M7 35.50% 24.13% 16.70% 11.07% 
M8 52.54% 36.34% 28.77% 16.10% 
M2 45.67% 30.53% 24.43% 20.67% 
M10 54.10% 43.70% 32.73% 27.46% 
Table 6.22 Remaining percentage activities of LapA proteins following incubation at 60 °C.  
 
 
Figure 6.23 Comparison of wtLapA and thermolability mutants by T60/30 estimate. The data 
represent an average remaining percentage activity for different enzymes following 
incubation at 60 °C for 30 minutes, based on 3-4 independent measurements (SD is shown 




6.5.4 Stability of recombinant LapA proteins at the room temperature (RT) 
Protein stability at room temperature is a considerably important property regarding 
industrial application. Very stable proteins are likely to have longer shelf-lives in industrial 
formulations. In this regard, the observed LapA and mutant stability data at room 
temperature (Table 6.23), showed that the recombinant proteins retained a large proportion 
of their initial specific activity after prolonged incubation periods.  
 
Table 6.23 shows that wtLapA retains 85.37% and 73.37% of its original activity after RT 
incubation at 72h and 168h, respectively. Most of the thermolability mutants remained 
highly active, even after 7-day incubation at RT, suggesting that the single point mutations 
did not severely affect fold integrity and stability of the LapA enzyme.  
Table 6.24 provides a quantitative measurement of LapA ability to remain active at room 
temperature. High long-term stability of LapA proteins is even more evident from the protein 
half-lives calculated by non-linear regression. wtLapA, M2, M4, M7 and M12 appeared to 
be the most stable variants, exhibiting (extrapolated) half-lives of >250-300h at room 















Table 6.23 Remaining percentage activities of WT and mutant LapA enzymes following 
prolonged incubation at room temperature. 0h, 100% activity – average specific activity 
observed for each LapA protein at 37 °C, following incubation for 15 minutes.  
 
  Duration of incubation at RT 
  0h 24h 72h 
7 days 
(168h) 
WT LapA 100.00% 94.71% 85.37% 73.37% 
M2 100.00% 90.74% 82.03% 79.53% 
M4 100.00% 95.27% 87.41% 73.66% 
M7 100.00% 90.34% 87.68% 60.93% 
M8 100.00% 90.90% 80.09% 57.47% 
M9 100.00% 80.74% 72.92% 76.08% 
M10 100.00% 64.42% 57.74% 53.33% 
M12 100.00% 85.33% 85.91% 69.94% 
M13 100.00% 73.04% 56.01% 33.21% 
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  WT LapA M2 M4 M7 M8 
k (h-1) 0.001926 0.00169 0.001835 0.002724 0.003269 
Half life (h) 359.9 410.2 377.8 254.5 212 
Days 15.0 17.1 15.7 10.6 8.8 
      
 
M9 M10 M12 M13 LapA Kex2 
k (h-1) 0.002367 0.00557 0.002249 0.007685 0.003213 
Half life (h) 292.8 124.5 308.2 90.2 215.7 
Days 12.2 5.2 12.8 3.8 9.0 
Table 6.24 Room temperature inactivation profiles for wtLapA and mutants. Protein half-
lives and inactivation rate constants were calculated using nonlinear regression to fit a single 
exponential rate model to the inactivation data (using Graph-Pad Prism software).  
 
 
6.5.5 Exploring low-temperature activity of recombinant LapA proteins 
To determine whether or not the LapA thermolability mutants gained any increase in specific 
activity at lower temperatures, due to the acquired structural flexibility, the protein samples 
were assayed in triplicate at 4, 10, 20 °C (Table 6.25), using the standard Lap assay protocol 
(section 2.10.2), following pre-incubation at the given temperature for 60 minutes. Due to 
insufficient sample, data for the M8 mutant was not collected.   
At 4 °C, all LapA proteins exhibited severely reduced specific activity (Figure 6.24), with 
only one quarter of the activity levels normally observed at 37 °C (~100 - 130 U/mg). The 
increase in reaction temperature between 10 - 20 °C led only to a slight improvement in 
activity values. It is clear that temperature is a significant factor for the activity of wtLapA 






  4°C 10°C 20°C 
WT LapA 17.59 ± 4.65 20.8 ± 2.87 34.22 ± 6.24 
M2 18.57 ± 2.4 21.27 ± 4.83 34.66 ± 1.91 
M4 21.91 ± 3.32 20.77 ± 4.04 33.96 ± 8.63 
M7 17.93 ± 5.95 20.5 ± 1.89 28.35 ± 2.95 
M10 18.5 ± 1.51 23.04 ± 3.1 30.7 ± 0.23 




Figure 6.24 Specific activity values for LapA mutants over a lower temperature range.  
  
The expected result of this experiment was enhanced ability of LapA thermolability mutants 
to perform the reaction at low temperatures compared to the wild - typeenzyme. It was 
assumed that the potential increase in molecular flexibility, for these mutations, would allow 
M2, M4, M7 and M10 mutants to exhibit more specific activity under higher viscosity and 
reduced kinetic energy environment, however, this was not the case. 
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6.5.6 Industrial pasteurisation for LapA protein inactivation  
Industrial pasteurisation can be utilised to thermally inactivate the enzymes performing the 
hydrolysis of whey protein. The standard process used in the food industry is 72 °C exposure 
for <1 minute. As a result of the short exposure time to heat, the quality of the reaction 
products can be preserved and, in this case, gelation effects of whey protein hydrolysates are 
less likely to be induced.  The previously obtained thermal inactivation data suggested that 
the M7 thermolabile mutant could be completely inactivated, following incubation at 70°C 
for 15 minutes. Therefore, industrial pasteurisation was predicted to be effective in rendering 
M7 and, possibly, M8 mutants inactive.     
The full procedure for this method is described in section 2.11.  
6.5.6.1 Inactivation of native LapA in Flavourzyme 
In brief, 1 mg/ml Flavourzyme solution in ultrapure water was used to test whether the native 
LapA (flavLapA), present in the commercial fungal extract, could be completely inactivated 
by industrial pasteurisation. Commercially available Flavourzyme was used to evaluate the 
effectiveness of this method for thermal inactivation, prior to testing the recombinant LapA 
proteins. 
A 15 second holding time (duration of exposure) was selected for inactivation of Lap 
proteins (flavLapA and Lap2) in Flavourzyme. The remaining activity measurements were 
carried out within a 60-minute period, following pasteurisation. The hydrolytic contribution 
from Lap2 was considered negligible, in subsequent residual activity measurements of post-
pasteurised samples. The remaining percentage activities are summarised in Table 6.26. 
Pasteurisation of Flavourzyme effectively inactivated native LapA in the 75 – 80 °C 
temperature range, within 15 seconds. 
  Pasteurisation temperature (°C) 
Enzyme  Untreated 70 72 75 80 
flavLapA  
(in Flavourzyme) 100.00% 26.70% 12.50% 3.30% inactivated 
Table 6.26 Remaining percentage activities of flavLapA in post-pasteurisation samples. 
 
6.5.6.2 Inactivation of LapA thermolability mutants 
Wild-type LapA and the two previously determined thermolabile mutants, M7 and M8, were 
used to determine the thermal inactivation profiles by industrial pasteurisation. These 
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recombinant LapA proteins were expressed as proenzymes and had undergone enzymatic 
activation by AP1 protease, prior to the pasteurisation experiment. The homogeneity of the 
mature population of LapA was confirmed by SDS–PAGE analysis (not shown). It was 
essential to eliminate the pro-protein, exhibiting propeptide-induced higher thermostability, 
prior to analysis.  
In this experiment, the holding time (temperature exposure) was increased to 30 seconds in 
an effort to improve the enzyme inactivation rate. The remaining activity measurements were 
carried out within a 2 – 3 hour period, following pasteurisation. The post-pasteurisation 
inactivation profiles of wtLapA, M7 and M8 proteins are summarised in Table 6.27. 
A  Pasteurisation temperature (°C) 
Enzyme Untreated 65 70 72 75 80 
wtLapA 88.3 81.7 77.0 NA 48.4 35.7 
M7 23.4 14.0 9.8 6.6 3.5 2.1 
M8 55.0 34.5 25.3 20.5 15.3 12.2 
 
B  Pasteurisation temperature (°C) 
Enzyme  Untreated 65 70 72 75 80 
wtLapA 100.00% 92.55% 87.23% NA 54.79% 40.43% 
M7 100.00% 59.70% 41.79% 28.36% 14.93% 8.96% 
M8 100.00% 62.70% 46.03% 37.30% 27.78% 22.22% 
Table 6.27 Inactivation profiles of wtLapA, M7 and M8 proteins by industrial pasteurisation. 
A Remaining specific activity (U/mg); B Remaining percentage activity with reference to 
Untreated samples (100%). NA – not available. 
 
Interestingly, wtLapA and the thermolabile mutant enzymes exhibited a degree of 
thermostability in the 65 - 80 °C temperature range. Complete (100%) inactivation could not 
be achieved, even at 80 °C. However, a progressive temperature inactivation was observed 
in all proteins. The most thermosensitive enzyme was the M7 mutant, with only a negligible 
amount of specific activity (2.1 U/mg / 8.96%) remaining, following pasteurisation at 80 °C 
for 30 seconds.  As expected, wtLapA exhibited the greatest thermostability, at all 
temperatures.  
It is important to note that the specific activity measurements were conducted after a 2 - 3 
hour time lapse, post-pasteurisation. Unfortunately, due to restricted access to a 
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spectrophotometer, all samples (from every temperature) were collected first, which was 
followed by a LapA activity assay in a different laboratory, to quantify the remaining 
activity. These experiments could suggest that the LapA enzymes were not completely 
unfolded within the short 30 second exposure time and, therefore, were capable of retaining 
(even regaining) an active conformation. This would impact the final amount of measured 
residual activity. We confirmed this by a measurement of wtLapA activity, immediately 
following pasteurisation at 80 °C, where the enzyme displayed complete momentary 
inactivation (no evidence of hydrolytic activity). However, after 3 hour incubation at room 
temperature, the same sample exhibited 40% activity increase (Table 6.27, B), supporting 
the possibility of refolding to regain an active conformation.  
Therefore, we conclude that very short, high temperature exposure periods are not sufficient 
to completely disrupt the highly compact and thermostable hydrolase fold. The temporarily 
induced inactive conformation of LapA could involve unravelling surface sub-structures, 
loop regions, stripping the catalytic dinuclear zinc, but it fails to completely abolish the 
stable hydrophobic core. Significantly longer exposure times or increased temperature 
(kinetic energy) are likely required to break these enthalpy-driven intramolecular 
interactions. In addition, in this experiment, LapA proteins were diluted in 20 mM Tricine 
pH 8.0, 1 mM ZnCl2 buffer, which is equivalent to the buffer used for successful in vitro 
refolding refLapA protein (section 4.1.2.3). It is plausible that the additional zinc ions in this 
buffer highly promote and accelerate the formation of active LapA conformers.  
With respect to native LapA, the observed increase in thermostability of recombinant LapA 
proteins may have a number of plausible explanations. For example, more time was allowed 
for recovery of recombinant proteins, following pasteurising. And, there are apparent minor 
structural differences between native and recombinant LapA proteins, which could have a 
profound effect on thermostability. Specifically, the AP1-activated wtLapA, M7 and M8 
proteins all were demonstrated to possess an additional N-terminal ‘AVT’ extension (section 
4.3.7.2), which could alter the thermostability profile. Finally, and probably most 
importantly, the highly branched mannosylated N-glycan pattern, as present in extracellular 
yeast proteins, may contribute to the improved thermostability of these recombinant LapA 
proteins, whereas the fungal flavLapA from Flavourzyme, is likely to possess less 
hyperglycosylated N-glycan structures (Deshpande et al., 2008) and, therefore, exhibit lower 
thermostability by comparison.   
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6.6 Kinetic characterisation of wild-type LapA and mutant 
enzymes  
6.6.1 Determination of kinetic parameters of LapA hydrolytic reaction 
To investigate whether any of the LapA thermolability mutants led to alteration of the 
reaction kinetics, a steady-state kinetic analysis was performed. LapA wild-type and mutant 
enzyme velocities were determined, with increasing concentrations of LPNA substrate at 37 
°C (section 2.10.4). A Michaelis-Menten model was implemented and analysed by non-
linear regression, using GraphPrism software package. Non-linear regression is superior to 
Lineweaver-Burk plot linear regression analysis due to less internal error and no requirement 
of data transformation. Vmax, Km and kcat values were calculated for each enzyme.   
Table 6.30 summarises the determined kinetic constants for LapA enzymes from steady-
state kinetic data, using non-linear regression. The wtLapA enzyme displayed a kcat of 76.53 
s-1. Overall, M2 – M13 thermolability mutations had a slightly negative effect on LapA 
turnover number with a modest effect showed by the M8 mutant (65.4 s-1). All of the mutants 
showed a retention to convert a comparable quantity of substrate molecules per unit of time.  
The Michaelis-Menten constant (Km) was affected significantly across all thermolability 
mutants. All of the LapA mutants showed a trend toward increased substrate affinity (Km), 
which in turn increased their respective catalytic efficiency (kcat/Km) towards LPNA 
substrate. M10 and M12, in particular, displayed 1.59- and 1.81-fold decrease in Km, 
respectively. The most thermolabile mutants M2, M7 and M8 showed no significant increase 
in catalytic efficiency compared to wtLapA. Their apparent increase in substrate affinity was 
outweighed by the equivalent reduction in turnover number, hence, no substantial change 
was observed in the kcat/Km ratio.   
This experiment showed that the most catalytically efficient LapA mutants were M10 and 
M12 owing to their improved substrate affinity values. These enzymes were able to achieve 
their maximum reaction velocity at lower substrate concentration compared to wtLapA. 
However, the substrate turnaround rates (kcat) were slightly reduced in these enzymes 
compared to wtLapA. Using LPNA, as a substrate, the determined Km (120 µM) and kcat 
(76.53 s-1) values for recombinant wild-type enzyme were substantially different from the 
values (244 µM, 50.9 s-1) originally reported for native LapA expressed in Aspergillus oryzae 




Table 6.28 shows that overall catalytic efficiency, for recombinant LapA, was 3-fold higher 
under the conditions used in our assay (37 °C, pH 7.2). However, the kinetic constants for 
native LapA were determined at significantly higher reaction temperature and pH (50 °C, 
pH 8.5). This could also be attributed to the differences in LapA precursor processing 
(wtLapA had 3-residue 'AVT' addition to its N-terminus) in relation to flavLapA, although 
further work (deletion of the AVT residues) would be needed to confirm this conclusion. 
However, this modification alone could have enhanced wtLapA catalytic capabilities. It is 
reasonable to speculate that, due to higher kinetic energy at 50 °C, the enzyme-substrate 
collisions would be more frequent and flavLapA would display higher turnover rate (kcat) 
per unit of time. However, this should be validated experimentally, looking for an increase 
in kcat for wtLapA at 50 °C. Nevertheless, this observation further supports the notion, that 
wtLapA is genuinely able to turn over more LPNA molecules per second than native LapA.  





Table 6.28 Comparison of kinetic constants between recombinant LapA and native LapA 
enzymes.   
 
The underlying rationale, for determining the steady-state kinetics of LapA mutants, was 
two-fold. Firstly, it was necessary to confirm that point mutations did not severely reduce 
either the affinity for LPNA substrate or the ability to turn over the substrate. Secondly, via 
an increase in molecular flexibility, LapA thermolability mutants were expected to display 
higher kcat values; a phenomenon observed with cold-adapted proteins at low temperatures 
(Feller and Gerday, 1997). Conversely, an overall minor reduction in turnover rates and a 
tendency toward improved affinity for LPNA substrate suggests that more measurements 
would be required to determine the full extent of these mutations on LapA enzyme kinetics, 
particularly at <37 °C, whereby the likely gain in flexibility of the thermolability mutants 
would permit an outperformance of the wild-type enzyme on substrate turnover rate (ie. an 





Native LapA  
(flavLapA) 
kcat (s-1) 76.53 50.9 
Km (µM) 120 244 



















Figure 6.26 Reaction velocity plots versus LPNA substrate concentration for LapA enzymes. A – representation of individual enzyme data on 
a single-plot.  
242 
 
6.7 Thermodynamic characterisation of wild-type LapA and 
mutant enzymes 
6.7.1 LapA characterisation by differential scanning fluorimetry (DSF) 
6.7.1.1 DSF of M1 – M6 mutants 
A 96-well plate format thermofluor assay (section 2.9.1) allowed us to quickly obtain the 
melting temperature of each LapA variant, in a high – throughput format, without consuming 
significant amounts of protein sample. This served as a rapid screening protocol for LapA 
thermolability mutants. 
In the first round of mutagenesis, Tm values of purified M1 - M6 mutant precursors were 
obtained together with wtproLapA and wtLapA (mature) enzymes for direct comparison 
(Figure 6.27).  
      
Figure 6.27 Plot showing the derivative of the fluorescence signal versus temperature. 
‘LapA WT+propeptide’ corresponds to wtproLapA enzyme, ‘LapA WT-propeptide’ 
corresponds to wtLapA (mature) enzyme. Signal intensity is positively correlated with the 
enzyme concentration. 
The presence of propeptide had a significant thermostabilising effect on the wtproLapA 
enzyme (Tm = 83.3 °C, Table 6.30). Following cleavage of propeptide, wtLapA displayed a 




































precursors showed lower than wild-type Tm values. A temperature shift for M6 was the most 
significant, possibly due to elimination of the stabilising disulphide bond. Due to insufficient 
protein quantities, Tm values for M1, M3 and M5 mutants were not determined in this 
instance.     
 




temperature, Tm  
(°C) 
∆Tm (°C) 
wtproLapA (+propeptide) 6.5 83.3  
wtLapA (-propeptide) 11 74.3 -9.0 
M1 (+propeptide) 1.2 ND ND 
M2 (+propeptide) 5.5 79.3 -4.0 
M3 (+propeptide) 0.5 ND ND 
M4 (+propeptide) 7.0 80.3 -3.0 
M5 (+propeptide) 0.4 ND ND 
M6 (+propeptide) 5.8 77.3 -6.0 
Table 6.30 Differences in Tm values for wild-type LapA and thermolability mutants. ∆Tm 
represents a difference in comparison to wtproLapA enzyme. ND – not determined. 
   
In the following experiment, the LapA precursors were enzymatically processed and a 
thermofluor assay was performed for the second time (Figure 6.28). Tm values were obtained 
for the activated LapA mutant proteins and compared to the wtLapA enzyme (Table 6.31). 
The most thermolabile mutants, M2 and M4, displayed a 5.1 and 3.8 °C decrease in melting 
temperature, respectively, in comparison to the wild-type enzyme. Melting temperature 
profiles, for M5 and M6 mutants, were not collected due to the previously determined severe 





Figure 6.28 Plot of the derivative of the fluorescence signal versus temperature. In this 
instance, all LapA enzymes were analysed in the mature state. Signal intensity is positively 
correlated with enzyme concentration. 
 




Tm  (°C) 
∆Tm (°C) 
wtLapA (-propeptide) 7.8 73.3  
M1 (-propeptide) 4.5 70.4 -2.9 
M2 (-propeptide) 17.7 68.2 -5.1 
M3 (-propeptide) ND 72.2 -1.1 
M4 (-propeptide) 24 69.5 -3.8 
Table 6.31 Differences in Tm values of wild-type LapA and thermolability mutants. ∆Tm 
represents a difference in comparison to wtLapA enzyme. ND – not determined.  
 
Findings from this experiment were in agreement with the temperature incubation assay data 
(see section 6.5.1), which confirmed that both the M2 and M4 mutants, from the first round 
of mutagenesis, exhibited the most thermolabile profiles while retaining equivalent to wild-






















LapA WT-propeptide M1 -propeptide M2 -propeptide
M3 -propeptide M4 -propeptide BLANK-buffer
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6.7.1.2 DSF of M7 – M13 mutants 
The remaining LapA thermolability mutants also were characterised by DSF, following the 
second round of mutagenesis. This time all LapA samples were measured in triplicate, to 
determine the extent of experimental/sample handling error (Figure 6.29).  
All the LapA thermolability mutant samples have undergone the same enzymatic activation 
procedure, prior to performing the thermal shift assay.  
      
Figure 6.29 Plot of the derivative of the fluorescence signal versus temperature. All LapA 
enzymes were analysed in the mature state. Signal intensity is positively correlated with 
enzyme concentration. 
 
In this round of analysis, a new batch of M2 (the most thermolabile mutant from round one) 
also was included. Based on the DSF data (Table 6.32), M2 still displayed the most 
significant thermal shift (∆Tm = -5.78 °C). The M7 double mutant showed an almost 
identical ∆Tm value (-5.48°C, Table 6.32). The thermal shifts of other mutants were less 
substantial, with the exception of the M12 mutant, which exhibited higher thermostability 
(∆Tm = +4.98 °C) in relation to wild-type LapA. The M13 mutant was not characterised, due 























LapA WT -propeptide M2 -propeptide M7 -propeptide




The standard deviations obtained from triplicate measurements were found to be very narrow 
(Table 6.32), confirming the accuracy and high data redundancy in the DSF experiment.     




Tm  (°C) (SD) 
∆Tm (°C) 
wtLapA (-propeptide) 8.93 70.27 ± 0.07  
M2 (-propeptide) 13.88 64.49 ± 0.27 -5.78 
M7 (-propeptide) 7.19 64.79 ± 0.27 -5.48 
M8 (-propeptide) 5.52 67.93 ± 0.61 -2.34 
M9 (-propeptide) 3.85 66.71 ± 0.54 -3.56 
M10 (-propeptide) 12.7 67.38 ± 0.10 -2.89 
M12 (-propeptide) 5.76 75.25 ± 0.30 +4.98 
Table 6.32 Differences in Tm values of wild-type LapA and thermolability mutants. ∆Tm 
value represents the difference compared to wtLapA enzyme.  
 
6.7.2 LapA characterisation by differential scanning calorimetry (DSC) 
In the DSC experiment, the difference in energy uptake between protein sample solution and 
sample buffer, under increasing temperature, was measured. In this way, it was possible to 
establish the original thermodynamic parameters for the endothermic transition of wild-type 
LapA protein. In turn, it was possible to characterise how these parameters are altered, 
following targeted thermolability mutations. DSC allowed direct tracking of the energetic 
changes occurring in the unfolding process for the LapA mutants.  
Protein endothermic curves, expressed as molar heat capacity, were obtained in a 20 – 90 °C 
temperature range (Figure 6.30). Transition peak (Tm) values were determined from a 
dynamic 2-state equilibrium, at which half of the protein population is unfolded. 
Thermodynamic data, for each transition, were obtained by fitting a simple 2-state unfolding 
model following normalisation by protein concentration and baseline correction. The 
calorimetric enthalpy (∆H) was calculated as the area under the endothermic peak.  
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Figure 6.30 Analysis of LapA proteins by DSC. Dashed line and solid red line represent raw data curve and fitted two-state model curve, respectively. 
Thermodynamic transition midpoint (Tm) and enthalpy (∆H) values were obtained from these curves. The 'bumps' and 'dents' in the traces for M2 and M8 
were caused by impurities.     
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Endothermic peak data, obtained for the LapA variants, were fitted to the two-state transition 
model, available in the analysis software (Table 6.33). Due to some difficulties encountered 
with the experimental equipment, DSC traces were determined only for wild-type 
recombinant LapA proteins (mature and precursor) and two thermolability mutants (M2 and 
M8).  
Table 6.33 Thermodynamic parameters for LapA variants, as analysed by DSC.  
 
LapA proenzyme appeared as the most thermostable variant, owing to its added prodomain 
at the N-terminus. Mature LapA protein showed a Tm value of 71.47 °C, suggesting the 
prodomain contributes an additional 9 °C to the midpoint transition temperature. This is 
reflected also in the difference in enthalpic contribution, adding another 113 kJmol-1 to ∆H 
for the wtproLapA proenzyme. M8 showed the lowest enthalpic difference of 497.9 kJmol-
1, suggesting a reduction in the number of intramolecular interactions in this protein. This 
was in agreement with the observed thermolabile behaviour of M8 mutant and the 
determined low half-life values (see section 6.5.2.4).  
Protein Tm (°C) ∆H (kJmol-1) ∆S (kJmol-1K) 
wtproLapA 80.22 809.9 2.08 
wtLapA 71.47 696.8 2.40 
M2 68.79 574.7 1.40 
M8 68.18 497.9 1.24 
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Chapter 7 EXPLORATION OF THE ALTERNATIVE ROUTES TO 





Post – translational activation of recombinant LapA precursor presents significant 
challenges. It is time consuming, with many additional steps in the purification protocol, to 
obtain mature, active and pure LapA protein. Also, LapA enzymatic processing, via addition 
of an exogenous protease, is highly undesirable and cost-ineffective for industry, which may 
not be directly applicable to Biocatalysts enzyme production pipeline. 
Alternative ways of directly acquiring activated LapA domain in P.pastoris supernatant were 
sought after. Attempts to secrete solely mature LapA domain were somewhat successful, 
however, the resultant polypeptide was found to exist in a molten globule – like state, with 
negligible residual specific activity (section 4.3.2.1). It was obvious that LapA propeptide 
sequence cannot be omitted in the P. pastoris expression cassette to obtain functional 
enzyme. 
7.2 LapA trans – acting propeptide  
Several successful studies of prodomain protein expression in a non-covalently linked state 
(trans) have been reported for homologous and more distantly related peptidases. Expression 
of propeptide and mature domains, as separate polypeptides, resulted in the recovery of 
active membrane Type 1-Matrix Metalloproteinase (Cao et al., 2000). Impeded secretion of 
the mature domain of aspartic proteinase, Sap1p, from C.albicants in P. pastoris was 
restored upon co-expressing the pro-polypeptide in trans (Beggah et al., 2000). Unlinked 
propeptide co-expression in P. pastoris was also shown to rescue the appropriate secretion 
and activity levels of Streptomyces mobaraensis Transglutaminase (Yurimoto et al., 2004).  
 
We have already shown that LapA propeptide acts as an intramolecular chaperone and is 
essential for the maturation of the catalytic domain, when expressed in cis. From the 
literature search, it was evident that LapA prodomain may be able to function in an 
intermolecular manner and to assist with secretion and folding of mature polypeptide, if 
expressed in trans. Most importantly, this could solve subsequent downstream processing 
problems of LapA pro-protein.  
 
For this purpose, a recombinant system of LapA propeptide expression in trans in P. pastoris 
was designed (Figure 7.1).  
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Figure 7.1 P. pastoris cassettes for LapA A. pro- and B. mature domain expression in trans. 
5’ AOX1, P_AOX1, AOX_TT: promotor and terminator regions; n_SS: native LapA 
secretion signal; Pro: LapA propeptide sequence; mLapA: mature domain sequence; HIS4 – 
histidine auxotrophy marker; ZeoR: zeocin resistance marker; SacI and StuI linearization 
sites are indicated by an arrow.         
 
LapA propeptide and mature domain were treated as two individual genes in this experiment. 
Due to the requirement of positive selection of P. pastoris transformants for the two separate 
genes, two different chromosomal integration loci had to be utilized, namely HIS4 and 
AOX1. HIS4 auxotrophy marker allowed screening of positive transformants of LapA 
propeptide expression cassette (Figure 7.1, A), whereas zeocin resistance marker allowed 
screening of mature LapA domain (mLapA) transformants (Figure 7.1, B).   
As illustrated in Figure 7.2, pPpHIS4_BgIII vector was propagated in E.coli and linearized 
with EcoRI to enable subsequent InFusion cloning reaction. DNA fragment equivalent to 
LapA native signal sequence and prodomain (nS-pLapA) was amplified by PCR using the 
pD-npro-LapA vector as a template and the following set of primers: 5’ – 
ATTATTGAAAGAATTCAAAACGATGAGATTCCTACCAT – 3’ and 5’ – 




Figure 7.2 Experimental plan to generation of LapA propeptide (pLapA) and mature 
domain (mLapA) P.pastoris GS115 expression strains.    
 
Amplified nS-pLapA DNA fragment was inserted into pPpHIS4_BgIII expression cassette 
by InFusion cloning to yield the nS-pLapA_pPpHIS4 vector. Following scale-up, nS-
pLapA_pPpHIS4 DNA was linearized with StuI and transformed into competent P. pastoris 
GS115 strain. The transformed cells were plated on histidine-deficient minimal-dextrose 
(MD) agar. However, due to unidentified reasons, no transformants were obtained after 3-
day incubation at 28 ºC. 
It was found that GS115 cells were not able to grow on minimal agar due to the lack of 
essential amino acids. Therefore, in the next P. pastoris transformation experiment, MD agar 
was supplemented with all essential amino acids, except histidine (to see if histidine 
auxotrophy was restored in pLapA-GS115 transformants). However, yet again no 
transformants were obtained on MD agar (- histidine) plates after a 3-day incubation at 28 
ºC, suggesting histidine auxotrophy was not restored. Nevertheless, GS115 colonies were 
visible on the YPD agar plate. No further PCR-based clone identification was performed, 
using these colonies, since these could simply be empty GS115 cell colonies, which failed 
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to uptake pLapA_pPpHIS4 DNA. Colonies were also visible on the positive control MD 
agar plate, as expected (Figure 7.3).     
 
Figure 7.3 GS115 agar plates generated in the transformation experiment. Positive and 
negative controls are shown on the left. Variants transformed with pLapA_pPpHIS4 DNA 
are shown on the right.  
 
One of the reasons why GS115 P. pastoris failed to uptake the recombinant DNA could be 
due an old competent cell batch. A new transformation should be attempted in the future 
using a freshly prepared GS115 cell batch.  
 
7.3 Kex2/Ste13 – mediated cleavage of LapA  
Another approach to successful secretion of mature LapA polypeptide into the culture 
supernatant of P. pastoris was undertaken. Yeast mating pheromone α – factor (MATα) pre-
pro leader polypeptide has been known to be able to direct the secretion of a target protein 
to the yeast culture supernatant; first observed in budding yeast Saccharomyces cerevisiae 
(Brake et al., 1984). 
 
The MATα secretion leader sequence is the most commonly used sequence in P. pastoris 
secretory expression trials. The sequence is comprised of a 19 amino acid long signal pre-
sequence, followed by 60 amino acid propeptide sequence. Cleavage of this pre-pro leader 
sequence is mediated by a Kex2 protease in the Golgi, recognizing a di-basic (Lys-Arg) site, 
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which is present at the C-terminal end of the MATα polypeptide sequence. The Kex2 
cleavage site is followed by two Glu-Ala repeats, which are further trimmed by type IV 
dipeptidyl aminopeptidase, Ste13, also present in the Golgi (Daly and Hearn, 2005).  
 
Therefore, it was desirable to engineer a dibasic Kex2 recognition site (Lys-Arg) between 
LapA propeptide and its mature sequence, thereby mimicking the processing of the MATα 
leader sequence. In this way, it was hypothesised that LapA propeptide cleavage could occur, 
as part of the natural secretion process in P. pastoris. This would be highly favourable for 
industrial processing, as no subsequent downstream enzymatic treatments would be 
necessary to obtain fully functional, mature LapA.  
   
Insertion of the Glu-Ala repeats, between the N-terminus of the target protein and the Kex2 
cleavage site, would increase the proportion of correctly processed propeptide by preventing 
steric hindrance of the Kex2 cleavage site. However, due to the inability of Ste13 to cope 
with large amounts of recombinant protein produced (Daly and Hearn, 2005), the target 
protein could possess N-terminal Glu-Ala adducts, which could affect both structural and 
functional properties of the resultant enzyme. Therefore, in anticipation of potential 
processing problems (arising from the additional Glu-Ala N-terminal repeats), two separate 
LapA expression constructs were engineered. One possessing only Kex2 recognition site 
(Lys-Arg) and the other - Kex2/Ste13 site (KR/EAEA), as outlined in Figure 7.4. 
Additionally, two Kex2/Ste13 processing variants were modified to possess a C-terminal 
hexahistidine tag to facilitate downstream purification of expressed protein. Thus, four 






Figure 7.4 Engineered LapA expression cassettes for integration into P. pastoris X33 strain. 
The corresponding Kex2 and Ste13 cleavage sites are indicated by arrows. Construct number 
2 (blue rectangle) yielded secretion of mature active LapA in the culture supernatant.    
 
To introduce the Kex2/Ste13 recognition sites, a Quickchange™ mutagenesis protocol was 
implemented using the pD-npro-LapA vector as a template and the primer pairs shown in 
Table 7.1.  
Table 7.1 Primers used in Quickchange™ cloning PCR reaction.  
 
Colony PCR was carried out on randomly selected E.coli transformants using the following 
primers: 5’ – GACTGGTTCCAATTGACAAGC – 3’ and 5’ – 
GCAAATGGCATTCTGACATCC – 3’. Three colonies were picked for each of the four 
constructs, and all gave a positive band when analysed on an agarose gel (not shown). 
Thereon, the established P. pastoris expression strain generation protocol (see section 

















strain, around 30 ‘Bonus’ transformants were obtained for each of the four constructs. A 48-
well high-throughput expression plate was set up using the Biolector micro-fermentation 
protocol (section 2.13.3). Eight ‘Bonus’ transformants were tested for expression of each 
construct. P. pastoris cultures were harvested after 70 h post-induction in secondary culture 
and the supernatants were analysed on SDS-PAGE (Figure 7.5).   
 
Figure 7.5 Recombinant protein secretion analysis of LapA Kex2/Ste13 constructs (1 – 4). 
M - molecular weight marker, R – wtproLapA protein as reference. Engineered LapA 
proteins, labeled to correspond to the designed expression constructs as in Figure 7.4.   
 
Based on analysis of the expression of Kex2/Ste13 engineered LapA constructs in P. 
pastoris, only the expression strain harbouring LapA with both cleavage sites (Kex2/Ste13) 
secreted active mature LapA into the culture supernatant. Clonal variation was also visible 
in this strain, with only 6 out of 8 clones secreting the target protein and 2 yielding no 
secretion. P. pastoris clones with only the Kex2 cleavage site engineered, primarily secreted 
unprocessed LapA precursor. Therefore, the Kex2 site alone was not sufficient for 
appropriate cleavage of LapA propeptide, possibly due to inaccessibility and steric 
hindrance, which was reduced by adding the 'EAEA' Ste13 recognition site. Interestingly, 
almost no secretion of recombinant LapA was observed for constructs containing the 
additional C-terminal hexahistidine tag, which probably impeded correct folding of the 
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resulting LapA polypeptide chain and potentially triggered ER – associated protein 
degradation (ERAD) or unfolded protein response (UPR) in P. pastoris. 
N – terminal sequencing (Appendix I, Figure 10.4) of secreted mature LapA protein showed 
an 'EAEA' extension to protein N – terminus, hence this recombinant protein was named -  
EALapA. As expected, Ste13 aminopeptidase was not able to cope with the processing of 
highly secreted LapA protein and, following Kex2 cleavage, no further modification of the 
N – terminus occurred. Inefficient processing likely affected the observed secretion level of 
EALapA protein, which was 0.05 mg/ml – six-fold reduction compared to wtproLapA 
protein.  
7.3.1 Purification of EALapA protein 
Maturely secreted EALapA was purified using the newly established 3 – step protocol 
(section 2.13.4). The protein displayed apparent stronger affinity for the AEX resin (MonoQ 
column) and eluted at 250 mM NaCl, compared to wtLapA, which typically eluted at 140mM 
NaCl. This could be explained by the additional highly negatively charged 'EAEA' extension 
to the N – terminus, which is probably exposed on the protein surface, contributing to a net 
negative charge for LapA. Also, this increased negative charge appeared to render EALapA 
more prone to precipitation on an ultrafiltration membrane. Approximately 30 – 40% loss, 
in total protein quantity, was observed after each concentration step, using a typically inert 
Hydrosart membrane. Another distinguishing feature of EALapA was its strong association 
with media – derived brown pigments. Three purification passes on a MonoQ column still 
were not sufficient to completely eliminate the pigments, possibly because EALapA eluted at 
a higher concentration of NaCl, where pigmented LapA populations are typically released.           
The measured specific activity of purified EALapA protein was 130 ± 1.2 U/mg and was not 
significantly different from purified wtLapA protein (140.15 ± 4.8 U/mg). A slight reduction 
in activity may be linked to residual pigment – induced inhibition, as previously observed. 
Thus, it was concluded that the N – terminal 'EAEA' adduct had no significant effect on the 






7.4 MATα-mediated secretion of mature LapA  
The α-mating factor (MATα) from Saccharomyces cerevisiae is the most commonly utilised 
leader sequence in P.pastoris expression cassettes, directing the polypeptide into culture 
supernatant. It is comprised of 19-aa signal sequence followed by 67-aa pro-region 
containing three glycosylation sites and a dibasic Kex2 recognition site (Kurjan and 
Herskowitz, 1982). Three-step processing of MATα leader prepro sequence includes 
removal of signal peptide by signal peptidase in ER followed by Kex2-mediated cleavage of 
pro-region and, finally, N-terminal elimination of Glu-Ala repeats mediated by Ste13 
aminopeptidase in Golgi (Brake et al., 1984).  
Within MATα leader sequence the pre-peptide is deemed to be important for translocation 
to ER by either co-translational or post-translational mechanism (Hegde and Bernstein, 
2006). The role mostly hydrophobic propeptide region has not been established yet. It is 
speculated, that MATα prodomain may act as molecular chaperonin to slow down and ensure 
proper folding process of secreted protein, because secretion of some heterologous proteins 
is abolished in the absence of pro-sequence (Chaudhuri et al., 1992, Kjeldsen et al., 1997).         
7.4.1 Background rationale 
Lower than expected secretion levels, of EALapA recombinant protein, prompted us to 
explore alternative ways to produce mature LapA protein in the P. pastoris supernatant. 
Previous work, by Biocatalyst Ltd, to successfully express recombinant LapA in eukaryotic 
yeast P. pastoris strain X33 with a MATα leader sequence, yielded comparable amounts of 
secreted LapA polypeptide harbouring the native secretion signal. However, due to the 
presence of the native LapA prodomain, located between the MATα and LapA catalytic 
domains, the nascent secreted precursor protein still required enzymatic activation to reveal 
functional, mature protein.  
Within the MATα leader sequence, the pre-peptide is deemed to be important for 
translocation to the ER by either a co-translational or a post-translational mechanism (Hegde 
and Bernstein, 2006). The role of the hydrophobic propeptide region has not been established 
yet. It is speculated that the MATα prodomain may act as a molecular chaperonin to slow 
down and ensure proper folding of secreted protein because secretion of some heterologous 
proteins is abolished in the absence of the pro-sequence (Chaudhuri et al., 1992, Kjeldsen et 
al., 1997).  
Interestingly, as illustrated in Figure 7.6, a striking structural similarity was discovered 
between the MATα leader sequence prodomain region and the native LapA prodomain. This 
259 
 
structural comparison was only possibly following determination of the crystal structure of 
full LapA precursor, containing the pro-region obtained during the course of this thesis work. 
MATα prodomain was modeled using the SWISS-MODEL server, and the resulting 
structural coordinates of the two pro-regions in question were visually compared (Figure 
7.6).       
 
Figure 7.6 Structural comparison of MATα prodomain (A) and LapA prodomain (B). 
MATα prodomain was modeled using SWISS-MODEL server (Biasini et al., 2014); the 
structure of LapA prodomain was determined by X-ray crystallography (see section 5.1).  
 
The structural comparison led to the hypothesis that the MATα prodomain alone might be 
able to assist in molecular folding of LapA prodomain, thus omitting the LapA propeptide 
in the expression construct. Consequently, we would anticipate efficient cleavage of MATα 
leader polypeptide and high-level secretion of a correctly folded, active form of LapA – the 
result, which could not be achieved completely with EALapA protein, as it was hampered by 
the design of an optimal Kex2/Ste13 recognition site that prevented processing of LapA 
prodomain.    
Similarly, Lin-Cereghino and colleagues attempted modeling of a MATα prodomain region 
(Lin-Cereghino et al., 2013). However, in their molecular model, obtained using JPRED3 
secondary structure prediction server followed by Modeller structure modeling, the MATα 
propeptide was predicted to form two aligned helices spanning the C-terminal region 
(Figure 7.7), contrary to two antiparallel β-sheets predicted in our model following template 





Figure 7.7 Model of MATα propeptide obtained in the study by Lin-Cereghino et al., 2013.    
 
7.4.2 MATα-LapA cloning and expression in P. pastoris 
All LapA recombinant protein precursors, processed by the AP1 protease containing fraction 
from Flavourzyme, contained an additional 3-residue extension ('AVT') to the original LapA 
N-terminus observed in the crystal structure of flavLapA. The effect of omitting these three 
residues, on protein thermolability, was not experimentally determined. Therefore, given the 
successful secretion of appropriately folded LapA from this experiment, any characterized 
thermolability mutants would have to be reconstructed in the expression cassette, harbouring 
the 'AVT' extension. In this way, the resulting thermolability profiles would be internally 
consistent for any mutants produced. For this reason, two expression constructs, namely Mα-
AVT-LapA and Mα-YPD-LapA (Mα corresponds to MATα prepro leader), were designed, 
possessing distinct N-termini, as shown in Figure 7.8. 
 
Figure 7.8 Engineered LapA expression cassettes for integration into P. pastoris X33 strain. 
A - Mα-AVT-LapA protein with 3-residue extension; B - Mα-YPD-LapA protein equivalent 
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to native LapA from Aspergillus oryzae (flavLapA). MATα pre pro leader sequence is shown 
in yellow, with a Kex2/Ste13 cleavage site in grey; released LapA catalytic domain (mLapA) 
is depicted in blue.         
 
Deletion mutagenesis of LapA propeptide was performed by a Quickchange™ protocol, 
using a previously constructed MATα-pro-LapA vector from Biocatalysts Ltd. Table 7.2 




Table 7.2 Primers used in Quickchange™ deletion mutagenesis reaction.  
 
Positive E.coli transformants were verified by Sanger sequencing (section 2.12.2). 
Approximately 10 µg of linearized constructs A and B were transformed into P. pastoris 
X33 strain. After 3 days, >50 colonies were observed on high concentration Zeocin 
(‘Bonus’) plates for both recombinant strains. 200 mL shake flask expression trial was 
performed, providing the P.pastoris strains with 0.5% final concentration of MeOH. 
Monitored optical cell density is reported in Table 7.3.     
 
Table 7.3 Cell density measured in the secondary culture of different clones of Mα-AVT-
LapA and Mα-AVT-LapA strains.  
 
Constructs Primers 
Construct A  5'-AAAGAGAGGCCGAAGCTGCTGTGACCTATCCA-3'  
5'-TGGATAGGTCACAGCAGCTTCGGCCTCTCTTT-3' 




LapA OD600 72h OD600 115h 
Mα-YPD-
LapA OD600 72h OD600 115h 
Clone 1 28 32 Clone 1 23 28 
Clone 2 34 36 Clone 2 29 34 
Clone 3 27 32 Clone 3 23 33 
Clone 4 25 28 Clone 4 28 29 
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P. pastoris cultures were harvested after 115h from induction in secondary culture and the 
supernatants were analysed by SDS-PAGE (Figure 7.9).   
Figure 7.9 Recombinant protein secretion analysis of Mα-AVT-LapA and Mα-AVT-LapA 
constructs. Protein secretion levels were quantified by Bradford assay and summarized in 
the shaded box (right). POI is indicated by red arrow.  
 
As seen in Figure 7.9, protein secretion products were obtained from all clones tested. A 
protein migrating at approximately 37 kDa corresponds to mature LapA, presumably 
containing the 'AVT' extension to its N-terminus (Mα-AVT-LapA). Rather surprisingly, 
exclusion of these three residues, in the Mα-YPD-LapA construct, completely abolished 
secretion of the 37 kDa species. Low specific activity (0 – 5 U/mg) towards the LPNA 
substrate was observed in all supernatants (only qualitative measurements carried out). 
Furthermore, for the Mα-YPD-LapA supernatants, activity was extremely low 
(approximately 10-fold reduced) compared to the Mα-AVT-LapA supernatants. This finding 
supports the absence of the 37 kDa LapA protein in the Mα-YPD-LapA supernatants. 
However, residual LapA specific activity in these supernatants could be attributed to an 
observed 70 kDa species. The presence of high molecular weight bands, under reducing 
conditions, indicates that recombinant LapA is prone to formation of compact higher order 
oligomeric states, which could suggest the existence of populations of improperly folded 
protein in solution. It is not clear why the Mα-YPD-LapA construct only produced mostly 
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inactive oligomers. The identity of these oligomers should be experimentally confirmed by 
Western Blot using LapA antibody. 
This experiment indicates that substituting the LapA prodomain with the MATα leader 
sequence may not be a feasible solution, to yield secreted, correctly folded LapA in P. 
pastoris. Purification and subsequent quantification of Mα-AVT-LapA activity may provide 
a some clarity and insight toward the actual potential of this enzyme for industrial use.  
7.4.2.1 Purification and specific activity of Mα-AVT-LapA  
Maturely secreted Mα-AVT-LapA protein was purified using the newly established 3 – step 
protocol (section 2.13.4). A typical separation from pigmented fractions, during SEC 
purification, was compromised for this protein. Specifically, the peak exhibiting high LapA 
activity was very broad and overlapped the brown pigment fractions with higher than usual 
elution volume. Additionally, the isolated fractions (from SEC) showed stronger affinity to 
the AEX resin of the Q HP column and eluted at 500 mM NaCl compared to wtLapA 
typically eluting at 140 mM NaCl. These observations, during purification of this construct, 
are highly suggestive of non-specific association with the chromatographic resin by partially 
unfolded (or mis-folded) Mα-AVT-LapA protein. The specific activity measured for purified 
Mα-AVT-LapA protein was only 7 ± 0.5 U/mg, indicating almost inactive LapA, which 
would corroborate the presence of unfolded/mis-folded protein.  
This experiment negated the hypothesis that a MATα prodomain could replace the native 
LapA propeptide to act as an intramolecular chaperone and yield active mature LapA.      
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7.5 Considerations for pilot scale production of selected LapA 
wild-type and thermolabile mutant proteins 
This section slightly deviates from the main story line of this chapter. However, it was 
incorporated here, at the end of all result chapters, relating to production of LapA wild-type 
and mutant proteins in P. pastoris. It was necessary to integrate all the secreted expression 
data, in light of the pilot scale production.  
In this part of the project, a series of LapA mutants with improved thermolability properties 
were over-expressed in food-grade yeast – Pichia pastoris. The apparent clean secretion 
profiles of these mutant proteins would the enable Biocatalysts to carry out application trials 
in whey hydrolysis with crude culture supernatant samples, thus, bypassing subsequent 
downstream purification steps. However, at the current stage of this project, WT LapA and 
thermolability mutants are secreted as inactive precursors, limiting the direct transformation 
of P.pastoris supernatant into product. In the established LapA precursor processing protocol 
we utilise Flavourzyme-derived non-specific alkaline protease 1 (AP1). Co-expression of 
this proteolytic enzyme with recombinant LapA precursor in a single P.pastoris strain could 
potentially yield an interesting endo/exopeptidase blend to the culture supernatant, which 
would not only contain an active LapA population, but also non-specific endoproteolytic 
activity, both of which could be exploited for efficient whey hydrolysis. Also, separately 
over-expressed LapA and AP1 could be recombined in pre-determined proportions at the 
latest stage of product preparation. Other commercially available proteolytic enzymes (e.g. 
trypsin) could be added directly to bioreactor upon LapA production to enable processing, 
however, recombinant LapA precursor was demonstrated to be susceptible to complete 
degradation by some other non-specific endopeptidases (Figure 4.35).         
Secreted expression levels of LapA variants 
Since recombinant protein expression levels are one of the key factors for industrial scale 
production, comparisons of the observed expression levels in shake flask fed-batch culture 
of the most thermolabile LapA mutants and WT enzyme are necessary, to identify the ‘best 




Figure 7.10 Secretion levels of different LapA thermolability mutants. Table (right) 
represents the measured range of secreted protein depending on the P.pastoris clone (left).    
Expression levels of all LapA thermolability mutants are comparable after harvesting the 
supernatants at 120 h, except M7 double mutant showing 2-fold reduction compared to the 
WT LapA (Figure 7.10). In this double mutant, the two site-directed mutations could have 
caused fold disruptions. Thus, potential explanation could be a larger distribution of 
unfolded M7 protein populations across P.pastoris secretion pathway. This could decrease 
the secretion levels of M7 due to an elimination of misfolded protein by P. pastoris secretion 
machinery.  
Also, EALapA (Kex2 processed) expression construct, which gave access to mature LapA 
polypeptide in Pichia supernatant, showed 6-fold reduction in expression levels. 
Introduction of site-directed thermolability mutations in EALapA protein might give a further 
reduction of secreted protein, which may hamper utilisation of this recombinant protein.   
The requirement of post-translational processing of LapA mutants by exogenous proteases 
may further decrease the end yield of recombinant protein. However, large-scale 
fermentation in a bioreactor (available at Biocatalysts) under tightly controlled growth 
conditions (T, pH, CO2, carbon source) would permit to obtain greater biomass and, hence, 
recombinant protein yields.     
The determination of the integrated copy number of recombinant LapA gene might be 
essential in order to enhance the productivity of P.pastoris strain. All the thermolability 
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mutant strains were generated under high antibiotic (zeocin) concentrations (‘‘Bonus’ 
transformants’), suggesting multiple LapA gene integration events. However, it was reported 
that the assumption ‘higher gene dosage equals higher production’ was not necessarily true 
due to detrimental effects on cell metabolism and survival by certain genes (Aw and Polizzi, 
2013). Therefore, determination of gene copy number by qPCR in mutant strains might be 
the first step towards improving secretion levels. The batch culture mode (shake-flasks or 
deep-well plates) can be used for screening the secretion levels of different gene dosage 
clones. 
Lastly, considering the thermolability aspect of all recombinantly produced proteins in this 
project, LapA lacking the N-terminal propeptide in the expression construct, termed 
wt∆proLapA, displayed the greatest instability and heat sensitivity, as discussed in section 
5.1. However, the main pitfalls with this enzyme was that (i) it was secreted as folding 
intermediate in pre-molten/molten globule state due to the absence of propeptide-mediated 
chaperonin effect, with (ii) consequential severely reduced specific activity. Also, the 
secretion levels of wt∆proLapA protein were very low in P.pastoris, nonetheless comparable 
to M7 mutant. Therefore, if appropriate ways to stabilise this polypeptide, immediately after 
large-scale production, could be identified, Biocatalysts could consider exploiting this 
already partially unfolded, heat labile peptidase. Importantly, wt∆proLapA protein is 
secreted in its mature active form and would not require additional enzymatic activation.              
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Chapter 8 AMINOPEPTIDASE FROM GLACIOZYMA 




8.1 Introduction and preliminary bioinformatics study 
During the latter stages of this thesis work, Glaciozyma antarctica leucine aminopeptidase 
(GAP), an obligatory psychrophilic Antarctic yeast protein, was identified as having 40% 
sequence identity to LapA, following release of the GAP sequence in 2015 (Figure 8.1). 
Biochemical characterisation and structure determination of this Antarctic protein could 
provide a better understanding of M28 peptidase cold adaptation. If GAP is naturally a cold 
- adapted peptidase, then a crystal structure of this enzyme would allow determination of 
potential structural features of cold adaptivity and thermolability, by extension to other 
members of the M28 peptidase domain family, which would be completely novel discovery.  
Indeed, it is very likely that GAP is genuine cold adapted aminopeptidase, since other 
isolated and characterised enzymes from this Antarctic fungus showed optimal activity 
temperatures around 15 - 20 ºC, instability and low inactivation temperature below 40 ºC, 
traits characteristic of psychrophilic proteins (Alias et al., 2014, Turkiewicz et al., 2003).  
An homology model of GAP was constructed using the IntFold2 modeling server (Roche et 
al., 2011), and the newly determined structure (from this thesis work) of wtLapA. Despite 
only 40% sequence identity to LapA, GAP showed almost an identical tertiary fold (Figure 
8.2), confirming the canonical model of observing a higher degree of conservation at the 
structural level. The striking similarity of these proteins provided a strong impetus to pursue 
characterisation of GAP aminopeptidase in an effort to study natural structural adaptations 
to cold environments and tentative thermolability of this new aminopeptidase homologue.  
Figure 8.1 Pairwise alignment of LapA and GAP full open reading frame sequences. 





Figure 8.2 Structural superimposition of the crystal structure of wtLapA (yellow) and the 
homology model of GAP (blue). RMSD, based on the cα backbone, between the two models 
is 0.865.  
 
8.2 Recombinant cloning and expression of GAP in P.pastoris 
Given the experience of recombinant expression of Lap, presented herein in working leading 
up to this discovery, and since GAP originates from a fungal organism, recombinant 





Codon optimized and synthetized GAP open reading frame (Table 8.1), containing the N-
terminal native signal sequence and propeptide, was placed under control of the PAOX 
methanol-inducible promotor in the pD902 expression vector. In this way, an expression 
cassette, harbouring the native GAP signal peptide and propeptide sequences (pD-npro-
GAP), was obtained. Another variant of GAP expression cassette also was produced in 
pD912 vector, sharing the same features, except the native GAP signal sequence was 
replaced by the MATα secretion signal. The rationale behind making the latter construct was 
to evaluate the potential difference in secretion levels between the two constructs.   
 
Table 8.1 Open reading frame sequences of LapA expression cassettes synthesized in pD902 
and pD912 P. pastoris expression vectors. Native GAP and MATα secretion signals, 
propeptide, mature sequences are depicted in red, blue and black, respectively.  
Expression 
construct 






























7.4 µg and 7 µg of SacI – linearized DNA was transformed into competent P. pastoris cells 
for pD902-npro-GAP and pD912-MATαpro-GAP constructs, respectively. The latter 
construct produced ‘Bonus’ transformants with potential multiple - copy gene recombination 
events. The expression cassette, harbouring the native signal sequence (pD902-npro-GAP), 
gave no ‘Bonus’ transformants and colonies were only visible on low antibiotic plates.  
Therefore, colony PCR was carried out to determine genuine transformants, using the 
standard AOX1 primer pair: 5’ – GACTGGTTCCAATTGACAAGC – 3’ and 5’ – 
GCAAATGGCATTCTGACATCC – 3’. All ten randomly selected pD-npro-GAP 
transformants produced a positive signal in the colony PCR experiment (Figure 8.3), 
suggesting these all contained at least one copy of the GAP target gene. Clones 1 and 2 were 
selected for subsequent shake flask expression trial.  
200 mL shake flask cultures were used for recombinant expression of pD902-npro-GAP and 
pD912-MATαpro-GAP in the P. pastoris strains.  The rest of the heterologous GAP 
expression protocol was according to the procedure described in section 2.13.3. As 
illustrated in Table 8.2, the observed growth of both recombinant GAP strains was quite 
slow (typically the OD600 exceeds 35 absorbance units after 96 h). After 96 h of MeOH 
induction, the supernatants were harvested and analysed by SDS – PAGE (Figure 8.4).   
 
  
Figure 8.3 1% DNA agarose gel analysis of PCR amplicons of pD-npro-GAP transformants. 
Positive (+, PCR using pD-npro-LapA as a template) control is indicated. The expected size 







Table 8.2 Cell density measured in the secondary culture of different GAP expression 
clones.  
 
Figure 8.4 Expression analysis of secreted putative GAP protein. A – wtproLapA loaded for 
reference, nSS – GAP clones harbouring native signal peptide, MATα – GAP clones 
harbouring MATα secretion leader; B – concentrated nSS_clone 2 supernatant, 2x – 50% 
dilution of the same supernatant; C – results from N – terminal sequencing of indicated 
bands.   
pD902-npro-
GAP OD600 24h OD600 48h OD600 72h OD600 96h 
Clone 1 12 21.5 22 20 




OD600 24h OD600 48h OD600 72h OD600 96h 
Clone 3 10 12 25 30 
Clone 4 12 16.85 21 27.5 
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The expected molecular weight of GAP precursor protein is 42.5 kDa (383 aa), which is 
quite similar to 39.3 kDa (359 aa) theoretical molecular weight of LapA precursor. However, 
due to N – linked glycosylation wtproLapA migrates around 42 – 43 kDa. In GAP, N115 
and N169 are predicted to be glycosylated, which should increase the molecular weight of 
the final protein product to approximately 45 – 47 kDa, assuming the extent of glycosylation 
is similar.  
From an analysis of the GAP supernatants, it was apparent that the secretion profile was 
heterogeneous. Two main protein bands were predominant in all GAP supernatants: one 
migrating at 42 – 45 kDa and another at approximately 70 kDa. Both proteins bands were 
excised and N – terminally sequenced (Figure 8.4, C part). The first five residues expected 
at the N- terminus of GAP precursor is 'APQQF'. However, both N – termini observed for 
the unknown secreted proteins were very distinct from that expected, namely 'MKIVL' and 
'AIPVG', for the 42 – 45 kDa protein and 70 kDa protein, respectively (Figure 8.4, C part).  
Also, there was very low activity observed towards LPNA (leucine p-nitroanilide) substrate, 
which might indicate low levels of expression of GAP precursor, which could not be readily 
identified in this experiment. In addition, despite the sequence and structural homology to 
LapA, the substrate specificity of GAP peptidase may be quite distinct. Therefore, activity 
towards LPNA substrate may not be the best indicator of active aminopeptidase in GAP 
P.pastoris supernatants.    
In general, P. pastoris does not secrete detectable levels of native proteins into culture 
supernatant, therefore recombinantly produced protein usually constitutes vast majority of 
extracellular protein content (Macauley-Patrick et al., 2005). In particular, Figure 8.4 B part 
shows the presence of secreted multiple unidentified protein bands in supernatant of GAP 
clones harbouring native signal peptide. It was concluded, that integration of GAP precursor 
gene triggered aberrant protein secretion response in P.pastoris.  
 
8.3 Conclusions and future possibilities 
The optimal growth temperature (28 °C) of the P. pastoris X33 strain sets a considerable 
challenge for the correct folding and structural integrity of this Antarctic aminopeptidase. 
The next step in successful heterologous expression of GAP protein would be a low 
temperature expression trial, which time did not permit. A thermolabile aspartic proteinase 
from Mucor mucedo DSM 809 showed improved activity in P. pastoris expression upon 
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incubating the strain at 20 – 24 °C (Yegin and Fernandez-Lahore, 2013). Similarly, the 
optimal hydrolytic activities at 20 °C were observed for cold-adapted serine protease from 
G. antarctica expressed in P. pastoris (Alias et al., 2014). It is reasonable to assume that 
lowering the post-induction temperature in BMMY medium might have a positive effect on 
GAP expression. To date, there are no available yeast expression systems, specifically 
tailored to the expression of cold-adapted proteins. However, several such systems are 
available for E.coli host: i) based on co-expression with cold-adapted chaperonins, allowing 
an operational folding system at 4 – 12 °C (Ferrer et al., 2003); and low temperature 
inducible promoter utilising a cold shock protein (cspA) (Vasina and Baneyx, 1996). 
Therefore, GAP over-expression in these cold-temperature targeted E.coli host systems is 
another possible option. 
The absence of recombinant yeast expression hosts, specifically for psychrophilic proteins, 
could encourage Biocatalysts Ltd (or other industry leaders) to explore alternative cold-
tolerant fungal yeasts in order to exploit the ever-increasing number of psychrophilic protein 














This chapter presents an overall discussion and suggestions for future work based on the 
experimental results obtained throughout this thesis work. It highlights the main obstacles 
and identifies potential solutions, on the pathway toward engineering thermolabile 
industrial peptidases. Also, the chapter reiterates the novelty of the thesis work, presented 
in Chapters 3 -8, with regard to an unconventional engineering approach for peptidase cold-
adaptation and thermal sensitivity via destabilisation and mimicry of structural features 
observed in homologous psychrophilic enzymes.    
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9.1 Industrial relevance of cold-adapted proteases: the driving 
force 
Industrial biocatalysis can benefit from enzymes that remain active at low temperatures. 
Reduction of the reaction temperature, at no expense of catalytic rates, provides an apparent 
advantage to cold-active enzymes (over warm-adapted counterparts) and permits significant 
energy savings in industrial enzymatic processing (Feller, 2013). The widespread chemical 
elimination of biocatalysts is a special concern in the food industry, where high-temperature 
inactivation is detrimental to the reaction products. In this respect, psychrophilic enzymes 
present another useful property; complete inactivation at low-to-moderate temperatures, 
termed structural thermolability (Georlette et al., 2004, Gerday et al., 2000). The inherent 
intramolecular flexibility of such enzymes results in increased thermal sensitivity and 
permits superior kinetic characteristics in a low entropy environment (cold). 
Industrial processes, sensitive to the occurrence of secondary reactions, heat-sensitive 
substrates, or increased risk of microbial contamination, all benefit from reduced 
temperature biocatalysis (Jeon et al., 2009). In food and feed industries, it is imperative to 
avoid harming or changing the nutritional value and flavour of the heat-sensitive substrates 
and products. Furthermore, selective inactivation at moderate temperatures by heat-labile 
enzymes permits controllable inhibition of sequential reactions at intermediate steps in the 
food industry (Cavicchioli et al., 2011).  
Enzymatic hydrolysis is a preferred method in the production of functional foods, where 
soybean and whey protein hydrolysates (WPH) are used as hypoallergenic ingredients. Due 
to the simultaneous action of endo- and exopeptidases such hydrolysates display improved 
techno-functional properties, such as solubility, emulsifying capacity along with sensory 
perception properties: (i) reduced bitterness and (ii) more pleasant taste, which in turn 
favours customer acceptance (Meinlschmidt et al., 2016).  Commercial enzyme blends, 
including endo-acting Subtilisin Carlsberg (Alcalase) and exo-acting leucine 
aminopeptidase A (Flavourzyme) are often used to achieve the aforementioned 
characteristics in whey and soy peptide hydrolysates (Ma et al., 2013). 
To prevent excessive bitterness, or when the desired degree of hydrolysis (DH) and 
characteristics of the hydrolysate have been achieved, the active endoprotease and/or 
exopeptidase needs to be deactivated, preventing further proteolysis (Conesa and FitzGerald, 
2013). This is usually achieved by heat treatment (>85 – 90 °C for >20 minutes) causing 
thermal denaturation of previously active peptidases. Yet, upon heating, various undesirable 
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chemical (Maillard reaction products) and physical (peptide denaturation) effects have been 
observed. Hence, the biological, functional and nutritional properties of hydrolysates are 
affected by heat processing, for which energy input must be minimised (Nicoli et al., 1997, 
Lijun et al., 2012). For example, gelation of peptide hydrolysates upon elevated (>70 °C) 
temperatures is a well-recognised problem in the whey hydrolysis industry, resulting in 
spoiling the end product and clogging heat exchange vessels.  
Therefore, there is a high demand by Industry for thermolabile endo- and exo-peptidases that 
can be inactivated by mild heat treatment such that the beneficial properties and quality of 
the vegetable and whey protein hydrolysates are preserved. In this project, the industrial 
partner – Biocatalysts Ltd – identified a commercial need for both endo- and exo-peptidases 
that can be inactivated <50 °C. The common utilisation of Subtilisin Carlsberg (sC) and 
leucine aminopeptidase A (LapA), in industrial vegetable and whey protein hydrolysis, 
determined the selection of these enzymes for the development of cold-activation and 
thermolability, via protein engineering. Consequently, the overall aim of this study was to 
engineer two commercially utilised mesophilic peptidases, namely sC and LapA, to confer 
psychrophilic-like behaviour (improved cold-activity) and, in particular, thermolability 
(complete low-to-moderate temperature inactivation). To address this aim, a number of 
specific objectives were identified, as follows: (i) identification of structurally viable 
mutations, using the known crystal structure of Subtilisin Carlsberg, which may lead to 
improved thermolability, (ii) production and characterisation of identified sC mutants in 
E.coli, (iii) isolation of native LapA from Flavourzyme and subsequent structure 
determination using X-ray crystallography, (iv) determination of structurally viable 
mutations, using newly elucidated LapA structure, (v) kinetic and thermodynamic 
characterisation of the most thermolabile sC and LapA mutants, and (vi) production of the 
most promising mutant protein(s), on a pilot scale at Biocatalysts, for evaluation of such 
mutants in whey hydrolysis application.         
To date, no alternative industrial formulations (containing either cold-adapted or 
thermolabile peptidases) are available to the food protein hydrolysis market. The novelty of 
engineering cold adaptivity in mesophilic proteases, lack of cold-adapted and thermolabile 
proteins in multiple industries, as well as the paucity of structural information concerning 
cold-adapted proteins, signifies the importance of this project from both: (i) the perspective 
of fundamental understanding of protein structural properties governing thermal 
stability/lability and temperature adaptation and, (ii) the commercial perspective for the 
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industrial partner (Biocatalysts Ltd), which, upon achieving the targets of this project, could 
use the obtained sC and LapA mutants in formulating unique enzyme blends.  
 
9.2 Project highlights: from inception to completion 
This project is focused toward altering the thermal properties of industrially relevant 
proteases, namely, increasing the thermolability of select endo- and exo-peptidases. As this 
is an industrial case study, this project involved close collaboration with Biocatalysts Ltd, 
who previously had identified an industrial need for an exopeptidase and/or endoprotease 
that could be inactivated at temperatures <50 ºC. At the time of this project, the two most 
relevant proteases for Biocatalysts Ltd were leucine aminopeptidase (LapA) from 
Aspergillus sp. and Subtilisin Carlsberg (sC) from Bacillus sp. These proteases display 
mesophilic-like thermal adaptation. Thus, the initial overall aim of this project was to alter 
their thermal properties in order to confer thermolability and potentially increase low 
temperature activity, thus achieving psychrophilic thermal adaptation. 
The project was initiated by performing a thorough literature review of structural and 
functional determinants of protein thermal properties, with a focus on understanding the 
existing strategies for mutational analysis of Subtilisin Carlsberg (sC) to achieve the desired 
thermolability. A three dimensional structure for Subtilisin Carlsberg was already available, 
which enabled identification and exploration of potential mutational sites. Once a list of 
potential mutations was agreed with Biocatalysts, the project proceeded with cloning and 
expression of wild - typesC gene in E.coli (4.1). 
Concomitantly, Biocatalysts had received a set of potential thermal mutants for LapA (20.3) 
and Lap2 (20.1), as a result of a separate project effort. After approximately 18 months, these 
mutant constructs were released to us, for optimisation of soluble expression of these 
mutants in E.coli (section 4.1.2.1). Additionally, wild - typemature LapA (10_20.3) was 
recombinantly expressed in E.coli, omitting the propeptide in the original construct (section 
4.1.2.2), followed by successful in vitro refolding studies of refLapA protein from inclusion 
bodies (section 4.1.2.3). Based on the lack of solubility for recombinant wild - typemature 
LapA, the construct was amended to include the N-terminal propeptide sequence flanking 
the mature sequence of LapA (section 4.1.2.4).   
Since there was no three-dimensional structure available for LapA, it was decided in parallel 
to purify native LapA and Lap2 (which were abundantly present) from crude Aspergillus 
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oryzae cell extract – Flavourzyme, in order to expedite the crystallisation and structure 
determination. A crystal structure for native Lap proteins would facilitate a rational 
mutagenesis approach to achieve thermolability, in a similar manner to that utilised for sC. 
The entire purification, crystallisation and structure determination process is laid out in 
Chapter 3. These experiments were carried out along with recombinant expression of sC and 
LapA proteins in E.coli.  
These experiments were completed in approximately 2 years from project initiation. The 
challenging expression of sC in E.coli proved that a more suitable expression host is required 
for this protein. At the same time the determined crystal structure of native LapA from 
Flavourzyme enabled the design of structure-based, rational mutation library to render this 
protein thermolabile (section 6.1). Also, the insoluble and difficult to purify recombinant 
LapA present in the intracellular E.coli fraction encouraged us to explore alternative 
expression hosts for this eukaryotic natively glycosylated protein. The preliminary 
expression trials in yeast Pichia pastoris proved to be successful, yielding relatively pure, 
properly folded LapA proenzyme in the culture supernatant. As a result, in the following 
years the project proceeded with studies of heterologous over-production of different forms 
of LapA in P. pastoris.  
Optimisation of heterologous expression and purification protocols for LapA is discussed in 
Chapter 4 (section 4.3). X-ray crystallographic analysis of a LapA precursor, mature and 
liganded structures enabled us to provide detailed structural insights into processes of LapA 
maturation, inhibition, substrate binding (Chapter 5). Subsequently, two generations of 
LapA thermolability mutants were characterised structurally and functionally in an effort to 
allow complete thermal inactivation of this exopeptidase at moderated temperatures, 
culminating with evaluation of the best mutants in industrial pasteurisation trials (Chapter 
6). At the same time, the acquired knowledge of the role propeptide in the folding and 
maturation process of LapA enabled exploration of the alternative routes to secretion of the 
desired mature LapA population in P. pastoris supernatant, as opposed to the secretion of 
inactive proenzyme (Chapter 7). Finally, following an exhaustive analysis of cold-adaptive 
and thermolabile determinants in psychrophilic proteins, an homologous sequence of a 
related leucine aminopeptidase from Antarctic fungus Glaciozyma antarctica (GAP) was 
identified.  This was followed by an attempt of recombinant expression in P. pastoris, 
however, these initial efforts yielded no distinguishable GAP protein, suggesting further 
optimisation was needed to obtain this potentially thermolabile and desirable peptidase 
(Chapter 8).  
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It is important to note that all the work, commencing from LapA over-expression through to 
GAP over-expression in P. pastoris (Chapters 4 – 8), was completed in less than 1.5 years, 
highlighting the importance and urgency of the selection of an appropriate expression host 
for Industrial use. The duration was not affected by significantly increased cultivation times 
of P. pastoris (120h growth for a full expression cycle), which was repeated multiple times 
throughout this project. Therefore, it cannot be stressed enough that, identification of an 
appropriate over-expression strategy for these target proteins was clearly a rate-limiting 
factor in this project and a crucial driving force for the Industrial partner.  
The experimental timeline for this 4-year PhD project is summarised in Table 9.1. The 




    
Experimental workflow Timeline Year in the 
project 
Literature review and study of protein thermal properties and 
bioinformatics of Subtilisin Carlsberg and LapA 
10.2013 – 02.2014 1st  
Initial cloning and expression attempts in E.coli: 
• Recombinant expression trials with sC 
• Recombinant expression trials with LapA: set of 
thermolability mutants, optimisation of soluble 
expression of wild - typemature sequence; refolding 
from inclusion bodies; expression of LapA proenzyme 
  
02.2014 – 06.2015 1st and 2nd   
Purification and structural studies of native LapA (flavLapA) 
from Flavourzyme (in parallel to E.coli work) 
02.2014 – 12.2015  1st and 2nd   
Optimisation of recombinant LapA expression in yeast Pichia 
pastoris: 
• Structural studies of wild-type proenzyme 
(wtproLapA) and mature enzyme (wtLapA)  
06.2015 – 01.2016 2nd and 3rd  
Structural and functional studies of LapA thermolability: 
• 1st round of LapA thermolability mutants M1 –M6 
• 2nd round of LapA thermolability mutants M7 –M13 
• X-ray structure determination 
• Thermal inactivation assays 
• Kinetic and thermodynamic characterisation of 
mutant proteins 
03.2016 – 01.2017 3rd and 4th  
Exploration of alternative routes to LapA mature secretion in 
P.pastoris supernatant: 
• ‘LapA trans-acting propeptide’ project 
• ‘Kex2/Ste13 – mediated propeptide cleavage’ project 
• ‘Matα prepro – mediated secretion’ project 
01.2016 – 03.2017 3rd and 4th  
Expression of homologous cold – adapted aminopeptidase 
from Glaciozyma antarctica 
06.2016 – 03.2017 3rd and 4th 
Summarising results in thesis format; Publication writing  03.2017 – 09.2017 4th  





Figure 9.1 Experimental synopsis and highlights of the LapA thermolability project. 
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9.3 Isolation of native peptidases from Flavourzyme 
At the start of the project it was imperative to obtain  the crystal structure of LapA to enable 
a rational design of thermolability mutant libraries. Considering the challenging over-
expression of recombinant LapA constructs in E.coli, Flavourzyme (a crude mixture of 
Aspergillus oryzae extracellular enzymes) offered putatively ready access to native LapA 
and other relevant proteases, in abundance. Therefore, in parallel to targetting heterologous 
protein expression in E.coli, isolation of LapA, Lap2 and other non-specific proteases (AP1, 
NP1, NP2) was carried out from Flavourzyme. Importantly, an automated purification 
protocol of all Flavourzyme proteins was reported in the literature (Merz et al., 2015), during 
the course of this work. However, our purification procedure was quite distinct in that, 
initally we were only interested in isolation of LapA and Lap2. However, an equivalent 
protocol to the Merz paper was later utilised to facilitate purification of alkaline protease 1 
(AP1) and neutral protease 1 (NP1), both of which subsequently were used in enzymatic 
processing of LapA precursor proteins (section 4.3.7). The isolation of native LapA (termed 
flavLapA) presented a number of obstacles due to the absence of artificial affinity tags and 
the highly negatively charged nature of the protein (molecular adhesiveness to other proteins 
and ultrafiltration membranes). The inability to separate flavLapA from TAKA α-amylase 
even resulted in obtaining crystals and high quality structural data for the latter (section 
3.2.3.1). In addition, repetitive purification cycles on AEX and HIC resins were required to 
liberate flavLapA from two unidentified brown pigments, which have been reported to 
associate with Lap peptidases in a number of studies (Schalk et al., 1992, Hartley et al., 2009, 
Aphale and Strohl, 1993, Bennett and Holz, 1997). The characteristic high thermal stability 
of flavLapA permitted the final separation from NP1 protease, but only in the presence of a 
high ionic strength environment (section 3.2.1). Overnight growth of flavLapA crystals 
yielded a structure solution to 2.7 Å resolution. The refined model of flavLapA showed quite 
distinct molecular packing in the crystal lattice to the later determined structures of 
recombinant enzymes wtLapA and wtproLapA. Subsequent detailed structural analysis 
indicated novel primary unfolding states in which the flavLapA molecules were trapped by 
X-ray crystallography (section 3.2.6). These thermally unfolded transition states appeared 
likely as a result of thermal heating of the enzyme preparation to 67 °C for 20 minutes as a 
penultimate purification step. Thus, the observed distinct molecular packing and medium 
resolution quality X-ray diffraction probably was a consequence of structural non-uniformity 
of the different flavLapA unfolded populations (as shown in Figure 3.8). This incidentally 
obtained, partially unfolded native LapA structure provided important insights to the 
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initiation of a thermal unfolding event of this otherwise highly thermostable peptidase. The 
surface solvent exposed regions (corresponding to residues 180 – 190, 215 – 220, 265 – 275) 
were mostly affected by heating. Importantly, the active site geometry and coordination of 
the dizinc catalytic center was altered substantially in flavLapA, as observed in each of the 
monomers in the assymetric unit. No catalytically essential nucleophilic water/hydroxide 
was found in the active site of flavLapA. Despite that, the enzyme retained 67% of the 
specific activity determined for the folded recombinant protein, raising intriguing questions 
about the actual requirement for stringent ZN coordination geometry and the role of the 
nucleophilic water in the postulated reaction mechanism of dimetallic zinc aminopeptidases 
(Chen et al., 1997). In fact, Zn1, deemed to be involved in the nucleophile delivery in the 
catalysis, is stripped out in half of the flavLapA monomers, suggesting the hydrolysis may 
proceed via alternative mechanism.   
Lastly, isolation of native AP1, NP1 and NP2 proteases enabled the study of processing the 
LapA zymogen with the inference to native Aspergillus and recombinantly secreted protein 
from P. pastoris. We were not able to conclude exactly which (AP1 or NP1) protease is 
likely to be responsible for processing the LapA precursor. These proteases may work 
simultaneously and may be able to cleave distinct sites within the LapA propeptide sequence. 
However, the N-termini of both AP1- and NP1-processed polypeptide displayed identical 
terminal 'AVT' amino acids, suggesting yet another activity (secreted by native A.oryzae) is 
responsible for complete N-terminal truncation to 'YPD' residues, as observed in the 
flavLapA structure and originally reported by Morita et al. (Matsushita-Morita et al., 2011). 
NP2 might be responsible for this ultimate modification, however, no attempt to incubate 




9.4 Exploration of suitable routes to recombinant production of 
active mature target proteases    
The initial attempts of sC endopeptidase expression in E.coli proved very challenging. After 
numerous efforts, sC proenzyme was successfully expressed intracellularly and in the 
periplasmic fraction (section 4.1). However, the majority of sC recombinant enzyme 
appeared in inclusion bodies and only a small population of soluble mature protein could be 
detected by Western Blot following 6xHis-tag – mediated affinity purification from 1.6 litre 
starting culture volume (Figure 4.5). Only marginal improvement in solubility was observed 
following the reduction of post-induction temperature to facilitate the folding process of sC 
proenzyme. These findings were indicative of a severe autocatalytic degradation, further 
supported by disappearance of soluble protein band after 16 hours from induction (Figure 
4.5, lane 6), suggesting the activity and autolysis of recombinant sC in E.coli cytoplasm. In 
addition, over-expression of sC serine protease caused an acute cell toxicity in E.coli. This 
was apparent from descending cell density (OD) readings following overnight incubation of 
induced E.coli culture. Interestingly, the N-terminally His-tagged (sC-pOPINF) construct 
showed the most severe cell death rates, suggesting the release of even more potent toxic sC 
population following autocatalytic self-cleavage of 6xHis-prodomain motif. The formation 
of inclusion bodies and increased cell toxity is well documented for some subtilisin-like 
serine proteases (Parry, 2002). Therefore, our experiments only confirmed these predictions. 
Altogether, we demonstrated that it would be overly complicated to utilise E.coli – based 
recombinant expression system to study the thermal mutant properties of Subtilisin 
Carlsberg non-specific endoprotease. The only viable solution was to employ a Bacillus 
expression host for extracellular for over-production of this protein, which could offer more 
native folding and extracellular secretion machinery to this protease.  
Heterologous expression of eukaryotic LapA exopeptidase in E.coli also presented 
significant challenges. At the start of the project a set of supposedly thermolabile LapA and 
Lap2 constructs were received from our industrial partner, Biocatalysts. These constructs 
were pre-designed by another collaborating party (J. Mullins, University of Swansea) using 
proprietary bioinformatics methods able to predict the thermostability/lability of target 
protein. The attempts of over-expression of these constructs employing SoluBL21 solubility-
enhancing E.coli strain are presented in section 4.1.2.1. None of the tested Lap constructs 
expressed soluble intracellular protein. Carefull analysis of the constructs indicated 
engineering of extensive alterations in the core regions of secondary structure of these 
proteins, possibly targeting the resulting polypeptides towards misfolding and subsequent 
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aggregation. The only partially soluble protein obtained in this experiment was the wild-type 
N-terminally His-tagged LapA construct (20.3-10), lacking the native N-terminal 
propeptide. Access to 20.3-10 construct was the only useful outcome from this endeavour, 
which was followed by optimisation of soluble expression in various E.coli strains and media 
conditions (Figure 4.7), culminating in in vitro refolding studies (section 4.1.2.3) and 
contribution towards revealing the role of intramolecular chaperone of LapA propeptide 
domain (section 5.1). Subsequent cloning and over-expression attempts of LapA constructs 
harbouring N-terminal propeptide encountered solubility problems under standard induction 
and growth conditions. This problem was somewhat alleviated by dropping the post-
induction temperature to 15 °C (Figure 4.11). However, the resultant soluble pro-LapA 
population was prone to aggregation (evident from higher MW oligomers on Western Blot), 
suggesting improper folding pattern in E.coli cytoplasm. Importantly, one of the contributing 
factors to misfolding of pro-LapA could be the engineered C-terminal hexahistidine tag, 
which was later demonstrated to completely abolish secretion of LapA precursor in 
P.pastoris (Figure 7.5), suggesting the artificial tag likely interferes with folding mechanism 
of LapA polypeptide. Isolation of intracellularly produced recombinant LapA precursor 
would be improbable from E.coli cell lysate in the absence of recombinant tag. Therefore, 
to circumvent folding and solubility problems, series of alternative tags could be tried (GST, 
MBP, STREP).  Nevertheless, this would not guarantee the successful  over-production of 
this eukaryotic protein in E.coli, since we later demonstrated the potential requirement of N-
linked glycosylation in obtaining fully active conformation of LapA in P.pastoris (discussed 
in section 6.1.3). This post-translational modification pathway is absent in E.coli, thus 
making this prokaryotic host unsuitable for in vitro functional studies of LapA fungal 
exopeptidase.   
In summary, due to the challenges encountered with recombinant over-expression of both 
bacterial endopeptidase – sC and fungal exopeptidase – LapA in E.coli, the most time-
efficient alternative seemed switching to eukaryotic expression host Pichia pastoris for over-
production of LapA. In fact, P.pastoris was a food grade organism, preliminarily shown to 
successfully secrete LapA proenzyme into the culture supernatant in the expression trials 
conducted by Biocatalysts. In addition, P.pastoris offered a significantly more homologous 
secretion and post-translational modification machinery to LapA protein in relation to the 
native Aspergillus host. As a result, further studies and mutant development proceeded in 
eukaryotic Pichia pastoris strain X33.  
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9.4.1 Secretion and post – translational activation of recombinant LapA 
precursor 
Recombinant proteins can be made either intracellularly or directed into the extracellular 
environment of P.pastoris. This organism secretes almost no endogenous protein, therefore, 
recombinantly produced protein usually constitutes the vast majority of extracellular protein 
content. In this way, secretion of heterologous protein (into the medium) acts as a first 
purification step in the pipeline (Macauley-Patrick et al., 2005).  
In this project, the requirement of the prosequence, in the expression construct of LapA, was 
clearly demonstrated. As a result, LapA in P.pastoris was secreted as inactive precursor 
polypeptide, which required treatment by exogenous protease (AP1 – purified from 
Flavourzyme). Post – translational activation of recombinant LapA precursor presented 
significant challenges. It was time – consuming additional step in the protocol of obtaining 
mature, active and pure LapA protein. Also, enzymatic processing of LapA, by added 
exogenous protease activity, is a highly undesirable and a cost-ineffective process in 
industry, which may not be directly applicable to Biocatalysts enzyme production pipeline. 
Therefore, direct secretion of mature fully functional LapA polypeptide was desirable.   
We have demonstrated already that the LapA propeptide acts as an intramolecular chaperone 
and is essential for the maturation of catalytic domain when expressed in cis (section 5.1). 
From available evidence, in the literature, it was apparently that the LapA propeptide may 
function also in trans (covalently detached from the mature domain). Therefore, recombinant 
cloning and expression experiment of mature LapA polypeptide and covalently unlinked 
propeptide in histidine auxotrophic P.pastoris GS115 strain was designed (see section 7.2). 
However, due to problems encountered in the transformation step this experiment could not 
be completed. Nevertheless, one important discovery was made in this process: 
supplementation with amino acids was shown to be essential, to ensure optimal GS115 cell 
growth on minimal MD agar, which likely would facilitate future transformations utilising 
this P.pastoris strain. 
A more successful attempt was the Kex2/Ste13 – mediated cleavage of the LapA propeptide 
(see section 7.3). Generation of several different propeptide processing constructs (Figure 
7.4) led to mature secretion of the polypeptide, termed EALapA, containing an unprocessed 
N-terminal ‘EAEA’ dipeptidyl adduct. This exogenous extension only caused a 6-fold 
reduction in secretion levels, but affected the specific activity of EALapA. Importantly, 
preliminary LapA thermolability assays showed an increase in thermal inactivation rate, by 
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this variant of the wild-type protein. Cloning the currently determined best thermolability 
mutants (M7 and M8) into the EALapA expression cassette could yield a mutant with even 
further enhanced thermal lability properties. Also, the Kex2/Ste13 recognition site 
(KR/EAEA) could be further optimised, in future work, for more efficient processing.  
Compromised post-translational processing and secretion levels of EALapA protein have led 
to subsequent exploration of alternative routes to mature LapA secretion in appropriate 
folded state and comparable to wild-type quantities. It was recognised that the pre-pro 
sequence of the α-mating factor (MATα), used to direct recombinant protein to the 
extracellular environment, could be placed upstream of the mature LapA sequence. The role 
of mostly hydrophobic propeptide region has not been established yet. It is speculated, that 
the MATα prodomain may act as a molecular chaperonin to slow down and to ensure proper 
folding of secreted protein, because secretion of some heterologous proteins is abolished in 
the absence of pro-sequence (Chaudhuri et al., 1992, Kjeldsen et al., 1997). In this way, the 
hydrophobic pro-region of MATα was predicted to exhibit the analogous function of 
intramolecular chaperonin by the LapA prodomain. Subsequent structural modelling of the 
MATα prodomain identified a striking structural similarity to the LapA prodomain, 
determined in our studies (Figure 7.6). These observations encouraged us to pursue a full 
recombinant cloning and expression study in P.pastoris to verify predictions (section 7.4). 
However, the secreted LapA polypeptide, with N-terminal ‘AVT’ extension, exhibited poor 
levels of secretion and almost negligible specific activity, suggesting that, despite structural 
resemblance to LapA prodomain, the MATα propeptide was unable to mirror the essential 
interactions with the catalytic domain required to induce the rate-limiting transition from 
molten globule state to native-like conformation.  
In summary, our experiments in Chapter 7 demonstrated that the most plausible way of 
obtaining properly folded, mature LapA enzyme was via engineering the Kex2/Ste13 
recognition site, which also may have further implications for LapA thermolability. 
However, the potential of propeptide production in trans should not be underestimated and 





9.5 LapA proenzyme structure: elucidation of the mechanism of 
prodomain-mediated inhibition and its role as intramolecular 
chaperone        
Heterologous secretion of LapA precursor protein using P.pastoris expression platform 
provided access to semi-purified, which could subsequently be readily purified  and studied 
by X-ray crystallography.  High resolution crystal structures of LapA proenzyme 
(wtproLapA) and mature protein (wtLapA), determined to  1.61 Å and 1.97 Å, respectively, 
permitted in-deph analysis, elucidation of the inhibition mechanism and determination of 
interdomain contacts that may be essential to elicit the proposed role of intramolecular 
chaperone by prodomain (section 5.1). The role of their respective propeptides was 
extensively studied for the multitude of dimetalloaminopeptidase enzymes (Zhang et al., 
2000, Bzymek et al., 2004, Nirasawa et al., 1999). However, no report existed to provide a 
mechanistic insight on leucine aminopeptidase inhibition by its natural inhibitor – N-
terminal propeptide - on a structural level. We also demonstrated that mature domain of 
LapA is not able to attain its native conformation when produced in the absence of 
prosegment. This was reinforced by the expression and refolding study of 6xHis-tagged 
catalytic domain (refLapA) from E.coli inclusion bodies, revealing the limited active 
conformation (section 4.1.2.3). For the first time, we are able to show that known synthetic 
aminopeptidase inhibitors and substrates actually mimic key contacts between pro- and 
catalytic domains in the herein determined crystal structure of LapA precursor. These 
findings might aid future design of more effective inhibitors for bimetallic aminopeptidases. 
To date, the exact mechanism of leucine aminopeptidase inhibition and the role of 
intramolecular chaperone (IMC) by prodomain have not been elucidated at a structural level. 
Therefore, with an aid of the first of its kind crystal structure of the leucine aminopeptidase 




9.6 Achieving thermolability 
An abundance of relevant mutational studies facilitated the creation of a thermolability 
mutant library for endopeptidase – Subtilisin Carlsberg (sC) (Table 4.1). However, the 
scarcity of engineering studies towards cold adaptivity/thermolability of leucine 
aminopeptidases have provided additional challenges to more accurate and rational 
generation of similar mutant libraries. The only available crystal structure of a cold-adapted 
aminopeptidase (deposited in the PDB) was from Colwellia psychrerythraea strain 34H 
(PDBid: 3CIA). A cold-active peptidase, termed ColAP, belonging to the family of M1 
peptidases, harbours a conserved ‘HEXXHX(18)H’ motif (Bauvois et al., 2008). Synergistic 
action of multiple structural elements was attributed to cold-adaptation and consequential 
thermolability of ColAP. Given very low sequence and structural homology, LapA, also a 
family member of M28 peptidases, could not be directly compared to ColAP. Therefore, any 
subsequent analysis of the determinants of cold adaptivity and thermolability within the 
family of M28 peptidases, relied on multiple sequence alignments, using manually inspected 
sequences of psychrophilic and thermophilic homologues, and homology modelling of the 
most identical sequences (sections 6.1.1 and 6.2.1). The identification of a genuine 
psychrophilic homologue – family M28 leucine aminopeptidase from Glaciozyma 
Antarctica (termed GAP) – subsequently led to attempts to recombinantly clone and secrete 
this protein in P.pastoris, discussed in Chapter 8.  
Initial feasibility studies of mutational strategies included utilisation of high-throughput 
approaches to laboratory evolution of protein thermolability: iterative saturation 
mutagenesis (ISM) in the structurally predetermined rigid ‘hot spots’. However, these 
approaches were only cost- and time-effective utilising an E.coli expression platform, and 
physically could not be implemented utilising P.pastoris, given the laboratory resources 
available and the time constraints of the project. Despite the fact that a 48-well Biolector 
microfermentation system was accessible at the facility of our industrial partner 
(Biocatalysts), the clonal variation of P.pastoris transformants impeded screening of an 
excessive number of variants. Therefore, the implemented mutagenesis strategy involved a 
highly rationalised, site-directed approach based on accumulated knowledge from the 
literature and, LapA sequence and structural comparisons to psychrophilic homologues. The 
highest sequence and structural disparity between LapA and temperature-adapted 
homologues was found in the variable loop regions located mainly on the protein surface. 
Therefore, it was assumed that one of the possible routes to temperature adaptation for 
psychrophilic proteins was via optimisation of residue content in flexible loop regions and 
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modulation of interactions to solvent by the surface residues. This observation coincided 
with evidence in the literature regarding cold adaptation and thermolability of psychrophilic 
proteins, and in turn guided our further mutagenesis strategy, whereby the protein core was 
left intact and any residue substitutions were targeted to the loop regions and ends of 
secondary structure elements of lower conservation.  
Once the recombinant LapA expression in P.pastoris was optimised (Chapter 4, section 4.3), 
two rounds of thermolability mutant generation were performed. Structural and functional 
characterisation of these mutants is presented in Chapter 6. The most significant differences 
in thermolability were determined following incubation in the 50 – 60 °C range. All of the 
characterised mutants displayed very poor thermostability at 70 °C, resulting in almost 
complete inactivation (following incubation for 15 minutes), contrary to the control wild-
type LapA retaining almost 100% of initial specific activity under equivalent conditions. The 
specific activity was only adversely affected in 5 of the 13 thermolability mutants studied. 
The remaining mutants maintained comparable to wild-type levels of specific activity, with 
added thermolabile behaviour. Based on an analysis of the thermal inactivation data, by non-
linear regression, and obtained kinetic parameters of the inactivation process of each M1 – 
M13 mutant, the most thermolabile mutants were M7 (M2/M4 double mutant) from the 1st 
round and M8 (single point mutant) from the 2nd round of mutagenesis, displaying almost 
equivalent half-lives of 29.68 and 29.55 minutes at 60 °C, respectively.  
Although thermolability mutations were selected in an effort to destabilise the overall LapA 
fold, to increase molecular flexibility and to disrupt LapA molecular edifice, most of the 
single point mutations did not induce severe effects on LapA structural integrity, as studied 
by X-ray crystallography (section 6.4). However, some of the site-directed mutations (M1, 
M5) were quite disruptive and detrimental to the overall fold, as deduced from adversely 
affected expression profiles in P.pastoris. Other mutants (M3, M6, M11) only compromised 
the specific activity and showed no significant differences in secretion levels, indicative of 
an unaffected overall structure. Therefore, carefully chosen single site substitution is 
unlikely to force such a stable and compact polypeptide fold as LapA to fall apart, however, 
a combination of two residue substitutions (M7) could have an additive, more pronounced 
disruptive effect on fold, as deduced from the observed 2 – 3-fold reduction in secretion 
levels.    
Structural factors leading to the altered thermal properties of the most heat labile LapA 
mutants include:  
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M7: in this double mutant the synergistic destabilising affect of single Q91A (M4) and 
P304A (M2) point mutations expressed in the most thermolabile behaviour of all mutants. 
The additive effect of elimination of the salt bridge (M4) and improved local flexibility by 
proline substitution (M2) led to increased plasticity within the secondary structure elements. 
It was reported that flexibility between secondary structure elements is achieved by reducing 
the number of proline residues in loops joining these elements (Sakaguchi et al., 2007).  
M8: one of the possible explanations to the exerted thermolability effect of D271T mutation 
could be the elimination of a stabilizing salt bridge with K267 and substitution with 
threonine increases the number of surface exposed nonpolar residues, which is an entropy-
driven destabilising factor (Aghajari et al., 1998, Russell et al., 1998, Georlette et al., 2003).  
All the mutations, except M12 (D338S), had a destabilising effect and elicited a desired 
reduction in thermostability. This substitution displayed overall increased structural rigidity 
in M12 molecule (Figure 6.11), indicative of observed 3.5-fold improvement of 
thermostability at 60 °C. The exact mechanism of this rigidifying mutation could not be 
deduced, however, a serine at this position is found in the homology model of psychrophilic 
GAP protein. Thus, amino acid context must play a role in this thermostability mechanism 
of M12 and a less bulky sidechain of S338 was not a determining factor favouring 
thermolability in this mutant. Also, D338 residue is a part of hydrophobic substrate binding 
pocket in LapA. Y251 is found in AAP enzyme at this position. D338 was implicated in the 
ability to hydrolyse positively charged N-terminal amino acids by recombinant (rLap1) from 
A.sojae (Huang et al., 2015). Therefore, one could speculate that, in LAP proteins, residue 
substitutions at this position is not only responsible for substrate specificity, but also is subtly 
involved in determining the thermostability.  
A comparison of the most successful mutants by thermolability (M2, M7, M8 and M10) 
showed a very similar specific activity to the wild-type enzyme, under standard reaction 
conditions, indicating that the chosen mutations had not altered the ability of LapA to 
hydrolyse the substrate (Table 6.21). M8 arguably displayed elevated levels of activity at 37 
°C, which may be linked to improved local flexibility in the vicinity of the active site pocket, 
rendering this mutant even more attractive for industrial application. M7 was superior to 
other mutants, according to the industrially relevant T60/30 estimate (Figure 6.23), showing 
the most thermolabile character following incubation at 60 °C for 30 minutes. The 
remarkable stability of the LapA hydrolase fold was further demonstrated by incubation of 
WT and mutant variants at the room temperature (Table 6.23). Extrapolated half-lives of 
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M7 and M8 mutants exceeded 200 h (Table 6.24), where the t1/2 of WT protein was almost 
twice that, suggesting a negative impact on fold integrity by these destabilising mutations. 
However, the projected shelf-life of most of the thermolability mutants could still be 
extraordinary if one considers adding protein stabilising aids to liquid formulations or spray 
drying the enzyme.   
Selected LapA thermolability mutants also were evaluated for low temperature activity (cold 
adaptivity) (section 6.5.5). Specific activity measurements indicated no improvement in 
hydrolytic ability by M2, M4, M7 and M10 mutants, following incubation at 4, 10 and 20 
°C. However, determination of kinetic catalytic parameters (kcat and Km) would probably be 
more appropriate in this instance. The emphasis throughout this thesis work was toward 
obtaining a LapA mutant that could be inactivated at significantly lower temperature (i.e 
more thermolabile). Thus, the chosen mutants were not kinetically characterised to 
determine substrate turnover rates at low temperatures. Also, distant-to-active-site mutations 
(M7/M8/M9/M10) were not predicted to particularly effect low temperature activity. It is 
more likely that the substitutions targeted to the proximity of the active site (M11/M12/M13) 
would show more cold adaptive behaviour. However, this requires further experimental 
validation.  
In the final experimental stages of this work, our industrial partner Biocatalysts suggested 
utilisation of an industrial pasteurisation process as a method of inactivating LapA mutant 
proteins (section 6.5.6). Importantly, this approach would resemble the industrial procedure 
of protease thermal inactivation, following hydrolysis reaction. A standard pasteurising 
process used in the food industry is 72 °C exposure for <1 minute. As a result of a short 
exposure time to heat, the quality of reaction products can be preserved and, in this case, 
gelation effects of whey protein hydrolysates are less likely to be induced.  However, the 
previously determined most thermolabile LapA mutants (M7 and M8) still exhibited 28% 
and 37% residual activity, respectively, following pasteurisation at 72 °C for 30 seconds 
(Table 6.27). Longer (~1 min.) pasteurisation times may be required to fully inactivate these 
mutants at this temperature. More importantly, this experiment highlighted the ability of 
LapA to rapidly regain an active conformation, following a short-duration heat exposure and 
incubation at room temperature. Therefore, we speculate that very short, high temperature 
exposure periods are not sufficient to completely disrupt the highly compact and 
thermostable hydrolase fold. The temporarily induced inactive conformation of LapA might 
involve unravelling surface sub-structures, loop regions, stripping off catalytic dinuclear 
zinc, but it fails to completely abolish the stable hydrophobic core. Significantly longer 
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exposure times or increased temperature (kinetic energy) are likely required to break these 
enthalpy-driven intramolecular interactions.   
Thermodynamic measurements of wild-type and mutant LapA enzymes also indicated 
significant changes in melting temperature (Tm) and enthalpic-entropic parameters (section 
6.7). All the thermolability mutants tested displayed a varying degree of reduction in Tm in 
both DSF and DSC experiments. A slight variation in determined transition midpoint values 
(seen in both methods) could be a result of the differences in final sample concentration or 
the rate of heating. It is important to note that, although the difference in transition midpoint 
values between wtLapA and thermolability mutants never exceeded more than 6 °C in the 
DSF experiment, the most thermolabile mutants (M7 and M8) exhibited a 3-fold reduction 
in half-life determined in the thermal inactivation assays (Table 6.20). This observation 
suggests that the LapA thermal inactivation process can be uncoupled from a thermal 
unfolding event. Therefore, an elevated temperature may primarily induce substantial 
alterations to the active site structure (zinc coordination geometry) even before thermal 
unfolding affects other structural regions of the protein. This notion would explain the 
observed higher thermal lability of LapA at 60 °C based on activity assays, where no sign of 
unfolding can be detected in either DSF or DSC thermograms.        
 
9.7 Future structure-to-function evolution of LapA thermolability 
and cold adaptivity 
It is well established in the literature that different packing of external surface residues play 
a major role in thermal adaptation of proteins from a multitude of functional families 
(Glyakina et al., 2007). Recently, more generally accepted concept of protein thermal 
stability is not only based on the number of ion pairs (single short-range salt bridges), but 
also on long-range interactions with charged or polar residues, referred to as electrostatic 
context (Pezzullo et al., 2013). The ability of cold adapted proteins to operate in a low kinetic 
energy environment emerged from improved backbone flexibility and subsequent trade-off 
in thermal stability. Any effort to mimic the properties of cold-active enzymes should focus 
on mainly increasing the overall flexibility of the molecular edifice and improving 
interactions with solvent. Therefore, one can utilise the enthalpic destabilisation effect to 
achieve the desired thermolability in target enzymes and entropic compensation (flexibility 
effect) to ensure conformational mobility, leading to improved catalytic efficiency at low 
temperatures (Arnold et al., 2001).   
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The chosen mutagenesis strategy for LapA, targeting residues situated within distant-to-
active-site surface loops and small helical regions, was reasonably successful. Surveying the 
crystal structures of the LapA thermolability mutants, the protein backbone movements were 
mainly observed in the loop regions, clustered on one side of the LapA molecule (Figure 
6.10, A). Several reports indicated that the thermal unfolding process might be initiated from 
the disordered surface loop (Deng et al., 2014, Anbar et al., 2012). Thus, the successfully 
chosen destabilizing point mutantions on the surface of LapA could expedite the thermal 
unfolding process. This was further evidenced by an analysis of the flavLapA crystal 
structure, which supposedly represents primary unfolding states of LapA protein, exhibiting 
structural alterations in surface loops and helical regions, following the implemented heating 
step (67 °C, 20 minutes) in the purification protocol (section 3.2.6). 
However, to further engineer LapA to enable it to operate at significantly lower temperatures 
(cold adaptivity), one needs to consider targeting hydrophobic clusters within the very 
compact hydrolase fold, in order to confer core plasticity to LapA. This could be achieved 
by reducing the number of intramolecular interactions by substitution of hydrophobic bulky 
amino acids (Leu, Trp, Ile), in a similar fashion to the reported study of cold-adaptation of 
B.subtilis lipase (LipJ), which was altered to a significantly lower Topt of 20 °C (from 37 °C) 
by a single point mutation (I137M) targeted to the vicinity of the substrate binding pocket 
(Goomber et al., 2016). Such mutations, aimed at the active site, usually have the purpose of 
lowering the activation energy by providing the required local plasticity to operate at cold 
temperatures. Also, the required core flexibility may be attained via engineering of cavities 
in a hydrophobic cluster (removal of bulky hydrophobic sidechains). The engineering of low 
crystallographic B-factor (‘rigid hot-spot’) residues is another viable strategy, successfully 
implemented in thermolability and cold adaptivity evolution of bacterial lipase, containing 
an analogous stable hydrolase fold (Reetz et al., 2009). Not surprisingly, the lowest 
temperature factors were observed for residues forming the conserved β-strand regions in 
the crystal structure of LapA. In this respect, our chosen mutagenesis strategy was more 
predictable, since a drastic substitution of the key residue involved in stabilisation of the 
hydrophobic core might lead to unforeseeable and detrimental disruptive effects within the 
conserved hydrolase fold.  
Lastly, towards the end of this project an established collaboration with a research group 
from Bath University led to a rigidity analysis of our LapA crystal structure, using a 
proprietary algorithm that enabled identification of specific destabilising mutations (N114M, 
N181W, T170P, E226P). All the proposed mutations reside within the hydrophobic core and 
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were predicted to increase the overall flexibility of the LapA macromolecule without directly 
affecting the active site residues. Experimental validation of these mutants, in future work, 
might result in further and/or additional cold adaptivity and thermolability of LapA.    
     
9.8 Cold adaptation of a psychrophilic homologue – GAP 
aminopeptidase 
To date, there is only a single cold-adapted aminopeptidase crystal structure deposited on 
Protein Data Bank (Bauvois et al., 2008), which indicates a large paucity of such structural 
data and limits our understanding of temperature adaptation of this important class of 
metalloaminopeptidases. Therefore, an effort to overexpress the naturally, cold-adapted 
GAP aminopeptidase sequence in P.pastoris was made. GAP represents a close sequence 
(40% identity) and structural (RMSD 0.865) homologue of LapA, making it an ideal target 
for structural studies of cold adaptivity and likely thermal lability for M28 class of 
peptidases, which is not reported in the literature to date. A successful over-expression and 
subsequent structure – function characterisation of GAP aminopeptidase would help deduce 
natural molecular adaptations of this enzyme to operate at low temperatures. Also, structure 
solution of GAP would permit an in-depth understanding of its likely thermal lability. In 
turn, this knowledge could guide future engineering of LapA for enhanced thermolability. It 
is plausible that, identification of subtle water networks and a single residue substitution, in 
the vicinity of the active site, could lead to heat sensitivity of LapA, as demonstrated in the 
comparative structural study of psychrophilic β – glucosidase, where a loop insertion and 
unique binding pocket His299 residue were shown to confer thermolability in a cooperative 
fashion (Miao et al., 2016). However, to gain an equivalent level of detailed insight, a crystal 
structure of GAP is required.       
One of the plausible explanations as to why GAP secretion was impeded in P.pastoris could 
be the cultivation temperature (28 ), which was not compatible with an optimal folding 
temperature of such a naturally, cold-adapted protein. This is a commonly encountered 
obstacle in the heterologous production of temperature sensitive proteins in conventional 
expression systems, such as Pichia pastoris (Bjerga et al., 2016). Given the close 
evolutionary relationship to LapA, the GAP sequence also should be readily secreted in 
P.pastoris. In addition, prior to the synthesis of GAP expression cassette, the sequence was 
analysed using a proprietary secretion prediction algorithm (DFM), developed by 
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Biocatalysts, which identified a high likelihood of secretion of the GAP sequence, with a 
high confidence score.  
Given these considerations, optimisation of the over-expression of GAP aminopeptidase in 
P.pastoris should be a priority target, in the future, since this could provide direct access to 
a cold-active, potentially thermolabile leucine aminopeptidase, exhibiting analogous 
substrate specificity to LapA.       
   
9.9 Concluding remarks 
This project has provided scope for unconventional engineering of cold adaptivity and  
thermolability of commercially relevant peptidases – Subtilisin Carlsberg (sC) and Leucine 
aminopeptidase A (LapA). Innate cytotoxic effects of sC recombinant protein have 
prevented further moderation of its thermoproperties. However, successive heterologous 
expression of LapA in E.coli and P.pastoris provided an immense amount of structural and 
functional data, which has contributed significantly to elucidation of the complex 
mechanisms of; (i) recombinant secretion, (ii) folding, and (iii) thermal lability of this fungal 
aminopeptidase.  
The initial aims and objectives, identified at the start of this project, have been achieved. 
Development of an engineered enzyme, with reduced thermal stability, without 
compromising catalytic efficiency, initially was successful due to the rational design of 
LapA variants with information obtained from extensive bioinformatics and literature 
analysis. Additionally, structure elucidation of native flavLapA peptidase provided a more 
accurate prediction of the effect of individual destabilising mutations on the precise 3D fold. 
The characterised LapA thermolability mutants showed a significant reduction in 
thermostability at 60 ºC, which delivered a proof of concept of the chosen mutagenesis 
strategy. Continued experimental work, along these lines, will contribute to a deeper 
understanding of the precise structural determinants that govern the thermal properties of 
these enzymes exhibiting a stable hydrolase fold.  
To date, there are no studies reporting thermal engineering of dimetallic aminopeptidases. 
In fact, the deliberate engineering of thermolability in any type of enzyme is largely an 
unexplored area, with only a single such study, unsurprisingly concerning an industrial 
hydrolase (Reetz et al., 2009).  
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Scientific findings from this project should lead to three manuscripts in peer-reviewed 
journals: (i) reporting the isolation and structure solution of native LapA from Flavourzyme 
(Chapter 3), (ii) studying the inhibitory and intramolecular chaperone role of LapA 
propeptide (Chapter 5), and (iii) discussing the structural and functional studies of LapA 





















Figure 10.3 MS identification of native TAKA α-amylase enzyme in Flavourzyme 
 
Figure 10.4 N-terminal sequencing result of EALapA protein. Sequencing performed by Alta 











Figure 10.5 Multiple sequence aligment of LapA with homologous psychrophilic and thermophilic sequences. 
Psychrophilic peptidases: [GAP] – aminopeptidase from Glaciozyma Antarctica; [T9SS_P.b., M28_P.b., 
aminopep_P.b., peptidase_P.b.] – four different peptidases from Psychroserpens burtonensis; [M28_R.p.] – 
peptidase from Rhodonellum psychrophilum; [M28_P.a.4BY, peptidase_P.a.4BY] – two different peptidases 
from Pedobacter antarcticus 4BY; [M28_Sph., peptidase_Sph.] – two different peptidases from 
Sphingobacterium sp. IITKGP-BTPF85; [M28_P.t.] – peptidase from Psychroflexus torquis; [M28_C.p.] – 
peptidase from Colwellia psychrerythraea; Thermophilic peptidases: [ther_C.t.] – aminopeptidase-like protein 
from Chaetomium thermophilum DSM 1495; [ther_M.t.] – hypothetical protein from Myceliophthora 




Figure 10.6 Superimposition of LapA crystal structure and homologous psychrophilic 
proteins. LapA is shown in green, M28 peptidase from Psychroserpens burtonensis – cyan, 
M28 peptidase from Rhodonellum psychrophilum – purple.  
Figure 10.7 Homology model of LapA from Aspergillus oryzae. Generated using IntFold2 





  flavLapA 
Resolution (Å) 75.55  - 2.71 (2.807  - 2.71) 
Space group C 1 2 1 
Cell dimensions  
a, b, c (Å) 
α, β, γ (°) 
138.697 150.16 87.562  
90 125.84 90 
Total reflections 69962 (3291) 
Unique reflections 39074 (943) 
Multiplicity 3.3 (3.5) 
Completeness (%) 99.06 (98.73) 
Mean I/sigma(I) 5.69 (0.88) 
Wilson B-factor 38.38 
R-merge 0.2212 (1.359) 
R-meas 0.2646 
CC1/2 0.974 (0.363) 
CC* 0.993 (0.73) 
R-work 0.2663 (0.3683) 
R-free 0.3496 (0.4192) 
Number of non-hydrogen atoms 8981 
  macromolecules 8718 
  ligands 97 
  water 166 
Protein residues 1158 
RMS(bonds) 0.014 
RMS(angles) 1.88 
Ramachandran favored (%) 88 
Ramachandran outliers (%) 2.8 
Clashscore 31.7 
Average B-factor 33.9 
  macromolecules 33.9 
  ligands 48.9 
  solvent 28.7 
 
Table 10.1 Data collection and refinement statistics of flavLapA. Statistics for the highest-






  wtLapA 
Resolution (Å) 73.81  - 1.97 (2.041  - 1.97) 
Space group P 63 2 2 
Unit cell 
153.92 153.92 88.64  
90 90 120 
Total reflections 574615 (56213) 
Unique reflections 43994 (4297) 
Multiplicity 13.1 (13.1) 
Completeness (%) 1.00 (0.99) 
Mean I/sigma(I) 10.35 (1.18) 
Wilson B-factor 33.91 
R-merge 0.2203 (2.178) 
R-meas 0.2293 (2.267) 
CC1/2 0.997 (0.653) 
CC* 0.999 (0.889) 
Reflections used in refinement 43993 (4297) 
Reflections used for R-free 2125 (197) 
R-work 0.1672 (0.3374) 
R-free 0.1913 (0.3791) 
CC(work) 0.941 (0.390) 
CC(free) 0.939 (0.388) 
Number of non-hydrogen 
atoms 
2759 
  macromolecules 2334 
  ligands 83 
Protein residues 303 
RMS(bonds) 0.007 
RMS(angles) 0.93 
Ramachandran favored (%) 98 
Ramachandran allowed (%) 1.3 
Ramachandran outliers (%) 0.66 
Rotamer outliers (%) 0.79 
Clashscore 4.7 
Average B-factor 40.13 
  macromolecules 36.83 
  ligands 75.98 
  solvent 53.91 
Number of TLS groups 1 
 
Table 10.2 Data collection and refinement statistics of wtLapA. Statistics for the highest-





  wtproLapA 
Resolution (Å) 42.61  - 1.61 (1.668  - 1.61) 
Space group P 21 21 21 
Unit cell 43.43 94.39 99.11 90 90 90 
Total reflections 231145 (22301) 
Unique reflections 53338 (5269) 
Multiplicity 4.3 (4.2) 
Completeness (%) 99.48 (99.55) 
Mean I/sigma(I) 11.36 (1.59) 
Wilson B-factor 20.19 
R-merge 0.07303 (0.8915) 
R-meas 0.08292 
CC1/2 0.998 (0.55) 
CC* 1 (0.842) 
Reflections used for R-free  
R-work 0.1527 (0.2876) 
R-free 0.1739 (0.2899) 
CC(work)  
CC(free)  
Number of non-hydrogen atoms 3281 
  macromolecules 2698 
  ligands 101 
  water 482 
Protein residues 341 
RMS(bonds) 0.007 
RMS(angles) 1.25 
Ramachandran favored (%) 98 
Ramachandran allowed (%)  
Ramachandran outliers (%) 0 
Clashscore 2.56 
Average B-factor 27 
  macromolecules 23.1 
  ligands 56.7 
  solvent 42.5 
 
Table 10.3 Data collection and refinement statistics of wtproLapA. Statistics for the highest-







  LapA M7 
Resolution (Å) 45.14  - 1.43 (1.481  - 1.43) 
Space group P 21 21 21 
Unit cell 
43.15 90.28 99.15 90 90 
90 
Total reflections 140274 (12041) 
Unique reflections 71455 (6528) 
Multiplicity 2.0 (1.8) 
Completeness (%) 98.66 (91.08) 
Mean I/sigma(I) 11.32 (2.07) 
Wilson B-factor 15.43 
R-merge 0.04158 (0.3396) 
R-meas 0.05881 (0.4803) 
R-pim 0.04158 (0.3396) 
CC1/2 0.996 (0.622) 
CC* 0.999 (0.876) 
Reflections used in 
refinement 
71434 (6526) 
Reflections used for R-free 3545 (331) 
R-work 0.1571 (0.3159) 
R-free 0.1801 (0.3327) 
CC(work) 0.972 (0.789) 
CC(free) 0.958 (0.763) 
Number of non-hydrogen 
atoms 
3233 
  macromolecules 2757 
  ligands 71 
  solvent 405 
Protein residues 339 
RMS(bonds) 0.005 
RMS(angles) 0.84 
Ramachandran favored (%) 98.51 
Ramachandran allowed (%) 1.49 
Ramachandran outliers (%) 0 
Rotamer outliers (%) 1.36 
Clashscore 5.77 
Average B-factor 25.91 
  macromolecules 21.98 
  ligands 59.78 
  solvent 46.67 
Number of TLS groups 1 
Table 10.4 Data collection and refinement statistics of LapA M7 mutant. Statistics for the 




  LapA M8 
Resolution range 43.13  - 1.67 (1.73  - 1.67) 
Space group P 21 21 21 
Unit cell 42.99 87.76 99.05 90 90 90 
Total reflections 84937 (6805) 
Unique reflections 42807 (3594) 
Multiplicity 2.0 (1.9) 
Completeness (%) 96.51 (81.72) 
Mean I/sigma(I) 13.74 (2.86) 
Wilson B-factor 15.9 
R-merge 0.03682 (0.2529) 
R-meas 0.05207 (0.3577) 
R-pim 0.03682 (0.2529) 
CC1/2 0.999 (0.694) 
CC* 1 (0.905) 
Reflections used in refinement 42806 (3594) 
Reflections used for R-free 2211 (216) 
R-work 0.1630 (0.2821) 
R-free 0.2087 (0.3248) 
CC(work) 0.976 (0.820) 
CC(free) 0.954 (0.761) 
Number of non-hydrogen atoms 3224 
  macromolecules 2764 
  ligands 113 
  solvent 347 
Protein residues 342 
RMS(bonds) 0.008 
RMS(angles) 1.06 
Ramachandran favored (%) 97.34 
Ramachandran allowed (%) 2.37 
Ramachandran outliers (%) 0.3 
Rotamer outliers (%) 0.34 
Clashscore 5.85 
Average B-factor 25.75 
  macromolecules 23.53 
  ligands 44.27 
  solvent 37.36 
Number of TLS groups 3 
 
Table 10.5 Data collection and refinement statistics of LapA M8 mutant. Statistics for the 





Figure 10.8 LapA precursor topology diagram. Generated with TopDraw tool in CCP4 
program suite. Αlpha 10 helix (purple rectangle) is not present in the proenzyme and only 
appears in the mature enzyme, following activation.   
 
Structural solution Resolution (Å) PDB accession 
flavLapA 2.71 5NRJ 
LapA proenzyme 1.61 5NQJ 
LapA mature enzyme 1.97 5NQL 
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